Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location Prognostic p-value RNA cancer category RNA tissue category RNA TS RNA TS TPM TPM max in non-specific ADNP ADNP1, KIAA0784 ENSG00000101126 Activity-dependent neuroprotector homeobox 20 50888919-50931240 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA006371 Supported Approved Nucleoplasm Liver cancer:1.65e-5 (unfavourable) Expressed in all Expressed in all parathyroid gland: 80.3 ADNP2 KIAA0863, ZNF508 ENSG00000101544 ADNP homeobox 2 18 80109031-80147523 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA007126 Uncertain Approved Mitochondria
Cytosol Renal cancer:6.39e-5 (favourable), Thyroid cancer:9.90e-4 (unfavourable) Expressed in all Mixed testis: 39.6 AEBP2 MGC17922 ENSG00000139154 AE binding protein 2 12 19404045-19720801 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA020893, HPA022282 Uncertain Supported Nucleus Liver cancer:3.24e-4 (unfavourable) Expressed in all Expressed in all placenta: 57.6 AHR bHLHe76 ENSG00000106546 Aryl hydrocarbon receptor 7 17298622-17346152 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB005072, HPA029722, HPA029723 Supported Validated Nucleoplasm
Cytosol Expressed in all Mixed urinary bladder: 57.6 AHRR AHH, AHHR, bHLHe77, KIAA1234 ENSG00000063438 Aryl-hydrocarbon receptor repressor 5 304176-438291 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA021483 Supported Nucleoplasm
Cytosol Mixed Tissue enriched 8 testis: 65.3 skin: 7.9 AIRE APECED, APS1, PGA1 ENSG00000160224 Autoimmune regulator 21 44285838-44298648 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA038267 Uncertain Tissue enriched Not detected lymph node: 0.3 ALX1 CART1 ENSG00000180318 ALX homeobox 1 12 85280107-85301784 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001598, HPA018905 Uncertain Supported Nucleoplasm
Nuclear bodies
Golgi apparatus Tissue enriched Tissue enhanced epididymis: 4.2;kidney: 3.1 ovary: 1.8 ALX3 FND ENSG00000156150 ALX homeobox 3 1 110059994-110070700 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Not detected Mixed fallopian tube,skin: 7.7 ALX4 FPP, KIAA1788, PFM, PFM2 ENSG00000052850 ALX homeobox 4 11 44260444-44310166 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001903 Supported Nucleoplasm Tissue enhanced Tissue enhanced breast: 2.2 endometrium,testis: 1.0 AR AIS, DHTR, HUMARA, NR3C4, SBMA, SMAX1 ENSG00000169083 Androgen receptor X 67544032-67730619 Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB000001, HPA065701, CAB065764 Supported Approved Mitochondria Renal cancer:1.03e-8 (favourable), Liver cancer:8.77e-4 (favourable) Mixed Mixed fallopian tube: 42.6 ARGFX ENSG00000186103 Arginine-fifty homeobox 3 121570704-121586634 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA043049 Uncertain Tissue enriched Not detected testis: 0.6 ARID1A B120, BAF250, BAF250a, C10rf4, C1orf4, P270, SMARCF1 ENSG00000117713 AT rich interactive domain 1A (SWI-like) 1 26696033-26782104 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA005456, CAB016334 Supported Validated Nucleoplasm Liver cancer:4.18e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 40.4 ARID1B 6A3-5, BAF250b, DAN15, ELD/OSA1, KIAA1235, p250R ENSG00000049618 AT rich interactive domain 1B (SWI1-like) 6 156777374-157210779 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA016511, HPA075291 Approved Supported Nucleoplasm Breast cancer:1.04e-4 (unfavourable), Ovarian cancer:4.16e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 75.6 ARID2 BAF200, DKFZp686G052, FLJ30619, KIAA1557 ENSG00000189079 AT rich interactive domain 2 (ARID, RFX-like) 12 45729665-45908040 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA063044 Supported Nucleoplasm
Plasma membrane Head and neck cancer:5.75e-4 (favourable) Expressed in all Expressed in all testis: 47.3 ARID3A BRIGHT, DRIL1 ENSG00000116017 AT rich interactive domain 3A (BRIGHT-like) 19 925781-975934 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA004793 Approved Supported Nucleoplasm
Vesicles
Cytosol Pancreatic cancer:1.95e-5 (favourable), Renal cancer:3.22e-4 (unfavourable) Expressed in all Tissue enhanced placenta: 33.3 testis: 9.7 ARID3B BDP, DRIL2 ENSG00000179361 AT rich interactive domain 3B (BRIGHT-like) 15 74541177-74598131 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA050320 Approved Supported Nucleoplasm Expressed in all Tissue enhanced testis: 36.7 placenta: 22.1 ARID3C ENSG00000205143 AT rich interactive domain 3C (BRIGHT-like) 9 34621379-34628107 Predicted intracellular proteins, Transcription factors Evidence at transcript level Group enriched Tissue enriched 8 liver: 5.9 cerebral cortex: 0.7 ARID4A RBBP1, RBP-1, RBP1 ENSG00000032219 AT rich interactive domain 4A (RBP1-like) 14 58298385-58373887 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA048899 Supported Nucleoplasm
Plasma membrane
Cytosol Head and neck cancer:1.91e-4 (favourable), Lung cancer:7.82e-4 (favourable) Expressed in all Expressed in all cerebral cortex: 24.1 ARID4B BCAA, BRCAA1, RBP1L1, SAP180 ENSG00000054267 AT rich interactive domain 4B (RBP1-like) 1 235131634-235328219 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA027333, HPA053692 Approved Approved Nucleoplasm
Vesicles Renal cancer:2.23e-4 (unfavourable) Expressed in all Expressed in all testis: 30.3 ARID5A MRF-1, RP11-363D14 ENSG00000196843 AT rich interactive domain 5A (MRF1-like) 2 96536743-96552638 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA002860, HPA023879 Approved Supported Nucleus
Nucleoli Renal cancer:4.24e-8 (unfavourable), Breast cancer:2.05e-6 (favourable) Expressed in all Expressed in all appendix: 26.1 ARID5B FLJ21150, MRF2 ENSG00000150347 AT rich interactive domain 5B (MRF1-like) 10 61901300-62096944 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA015037 Uncertain Approved Plasma membrane
Cytosol Expressed in all Expressed in all gallbladder: 62.1 ARNT bHLHe2, HIF-1beta ENSG00000143437 Aryl hydrocarbon receptor nuclear translocator 1 150809705-150876768 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001759, CAB004318 Supported Supported Nucleus
Nuclear bodies Expressed in all Expressed in all ovary: 46.6 ARNT2 bHLHe1, KIAA0307 ENSG00000172379 Aryl-hydrocarbon receptor nuclear translocator 2 15 80404350-80597937 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001056, CAB005081 Approved Approved Nucleus
Mitochondria Pancreatic cancer:1.46e-6 (favourable), Renal cancer:7.51e-4 (favourable) Expressed in all Tissue enriched 8 cerebral cortex: 154.5 testis: 19.3 ARNTL bHLHe5, BMAL1, JAP3, MOP3, PASD3 ENSG00000133794 Aryl hydrocarbon receptor nuclear translocator-like 11 13276652-13387266 Predicted intracellular proteins, Predicted secreted proteins, Transcription factors Evidence at protein level CAB045962, HPA050938 Supported Supported Nucleoplasm
Vesicles Expressed in all Expressed in all testis: 27.5 ARNTL2 bHLHe6, BMAL2, CLIF, MOP9, PASD9 ENSG00000029153 Aryl hydrocarbon receptor nuclear translocator-like 2 12 27332854-27425289 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA059074, HPA065355 Uncertain Validated Nucleus
Nucleoli Pancreatic cancer:5.29e-6 (unfavourable), Renal cancer:1.56e-5 (unfavourable) Mixed Tissue enhanced esophagus: 31.3 tonsil: 21.0 ARX CT121, EIEE1, ISSX, MRX29, MRX32, MRX33, MRX36, MRX38, MRX43, MRX54, MRX76, MRX87, MRXS1, PRTS ENSG00000004848 Aristaless related homeobox X 25003694-25015948 Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Endometrial cancer:3.54e-7 (unfavourable) Mixed Tissue enriched 6 ovary: 41.0 skeletal muscle: 6.9 ASCL1 ASH1, bHLHa46, HASH1 ENSG00000139352 Achaete-scute family bHLH transcription factor 1 12 102957686-102960516 Predicted secreted proteins, Transcription factors Evidence at protein level HPA029217 Supported Group enriched Group enriched 8 cerebral cortex: 16.3;liver: 6.5 adrenal gland: 1.4 ASCL2 ASH2, bHLHa45, HASH2 ENSG00000183734 Achaete-scute family bHLH transcription factor 2 11 2268495-2270952 Predicted intracellular proteins, Transcription factors Evidence at protein level Pancreatic cancer:4.73e-4 (favourable), Cervical cancer:5.11e-4 (favourable) Group enriched Mixed placenta: 6.4 ASCL3 bHLHa42, HASH3, Sgn1 ENSG00000176009 Achaete-scute family bHLH transcription factor 3 11 8937579-8938211 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA027032 Uncertain Not detected Tissue enriched 9 salivary gland: 3.3 prostate,testis: 0.3 ASCL4 bHLHa44, HASH4 ENSG00000187855 Achaete-scute family bHLH transcription factor 4 12 107774385-107776644 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA036116 Uncertain Tissue enhanced Not detected parathyroid gland: 0.7 ASCL5 bHLHa47 ENSG00000232237 Achaete-scute family bHLH transcription factor 5 1 201113953-201127184 Predicted intracellular proteins, Transcription factors No evidence Mixed Not detected endometrium: 0.6 ATF1 TREB36 ENSG00000123268 Activating transcription factor 1 12 50763710-50821122 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB016222, HPA055069, HPA055406 Supported Validated Nucleoplasm Liver cancer:1.53e-5 (unfavourable) Expressed in all Expressed in all thyroid gland: 39.5 ATF2 CRE-BP1, CREB2, HB16, TREB7 ENSG00000115966 Activating transcription factor 2 2 175072250-175168382 Enzymes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB003769, HPA022134 Supported Validated Nucleoplasm Liver cancer:7.08e-5 (unfavourable) Expressed in all Expressed in all thyroid gland: 53.7 ATF3 ENSG00000162772 Activating transcription factor 3 1 212565334-212620777 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001562 Approved Validated Nucleus
Nucleoli Expressed in all Expressed in all smooth muscle: 445.6 ATF4 CREB-2, TAXREB67, TXREB ENSG00000128272 Activating transcription factor 4 22 39519695-39522685 Predicted intracellular proteins, Transcription factors Evidence at protein level CAB011596 Approved Supported Microtubule organizing center
Cytosol Renal cancer:9.77e-5 (unfavourable), Liver cancer:4.07e-4 (unfavourable) Expressed in all Expressed in all bone marrow: 531.3 ATF5 ENSG00000169136 Activating transcription factor 5 19 49928702-49933935 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA030187 Uncertain Supported Nucleoplasm
Cytosol Renal cancer:3.39e-7 (unfavourable), Cervical cancer:1.14e-4 (favourable), Endometrial cancer:1.16e-4 (unfavourable) Tissue enriched Group enriched 7 liver: 387.7;thyroid gland: 190.1 appendix: 43.6 ATF6 ATF6A ENSG00000118217 Activating transcription factor 6 1 161766294-161964070 Plasma proteins, Predicted membrane proteins, Transcription factors Evidence at protein level HPA005935 Approved Approved Cytosol Expressed in all Expressed in all parathyroid gland: 40.6 ATF6B CREBL1, G13 ENSG00000213676 Activating transcription factor 6 beta 6 32098176-32128253 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors Evidence at protein level HPA046871 Uncertain Supported Nucleus
Nucleoli Expressed in all Expressed in all parathyroid gland: 55.8 ATF7 ATFA ENSG00000170653 Activating transcription factor 7 12 53507856-53626410 Predicted intracellular proteins, Predicted membrane proteins, Transcription factors Evidence at protein level HPA003384 Approved Approved Nucleus
Cytosol Stomach cancer:2.10e-4 (unfavourable) Expressed in all Expressed in all endometrium: 40.1 ATOH1 bHLHa14, HATH1, MATH-1, Math1 ENSG00000172238 Atonal bHLH transcription factor 1 4 93828753-93830964 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at transcript level Colorectal cancer:3.26e-5 (favourable) Tissue enhanced Group enriched 9 colon: 18.0;duodenum: 11.4;rectum: 20.1;small intestine: 22.8 appendix: 2.0 ATOH7 bHLHa13, Math5 ENSG00000179774 Atonal bHLH transcription factor 7 10 68230624-68232103 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA027008 Uncertain Not detected Tissue enriched 6 cerebral cortex: 2.2 endometrium,kidney,small intestine: 0.3 ATOH8 bHLHa21, FLJ14708, HATH6 ENSG00000168874 Atonal bHLH transcription factor 8 2 85751344-85788066 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA028406 Supported Nucleoplasm Pancreatic cancer:8.98e-6 (favourable), Renal cancer:3.80e-5 (favourable) Tissue enhanced Tissue enhanced adipose tissue: 31.6 lung: 17.1 ATRX JMS, MRX52, RAD54, XH2, XNP ENSG00000085224 Alpha thalassemia/mental retardation syndrome X-linked X 77504878-77786269 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001906, CAB009372, HPA064684, CAB068176 Supported Supported Nuclear bodies Expressed in all Expressed in all parathyroid gland: 53.5 BACH1 BACH-1, BTBD24 ENSG00000156273 BTB and CNC homology 1, basic leucine zipper transcription factor 1 21 29194071-29630751 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA034949 Approved Nucleus
Cytosol Pancreatic cancer:3.11e-5 (unfavourable), Renal cancer:7.14e-4 (unfavourable) Expressed in all Expressed in all placenta: 71.6 BACH2 BTBD25 ENSG00000112182 BTB and CNC homology 1, basic leucine zipper transcription factor 2 6 89926529-90296908 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA051384, HPA058384 Supported Supported Nucleus
Cytosol Mixed Tissue enhanced lymph node: 21.4 tonsil: 12.5 BARHL1 ENSG00000125492 BarH-like homeobox 1 9 132582185-132590266 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA004809 Approved Not detected Not detected all non-specific tissues: 0.0 BARHL2 ENSG00000143032 BarH-like homeobox 2 1 90711539-90717237 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA028176, HPA031326 Uncertain Not detected Tissue enriched 37 testis: 3.6 all non-specific tissues: 0.0 BARX1 ENSG00000131668 BARX homeobox 1 9 93951622-93955372 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA055858 Approved Nucleoplasm
Vesicles Endometrial cancer:8.16e-6 (unfavourable), Head and neck cancer:1.02e-4 (unfavourable) Tissue enhanced Tissue enriched 7 stomach: 11.2 testis: 1.5 BARX2 ENSG00000043039 BARX homeobox 2 11 129375940-129452279 Predicted intracellular proteins, Transcription factors Evidence at protein level CAB033311, HPA068414 Supported Supported Nucleoplasm
Cytosol Urothelial cancer:3.06e-4 (unfavourable) Mixed Tissue enhanced esophagus: 104.2;salivary gland: 60.6 fallopian tube: 28.0 BATF B-ATF, BATF1, SFA-2 ENSG00000156127 Basic leucine zipper transcription factor, ATF-like 14 75522425-75547015 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA059588, HPA064962 Approved Validated Nucleoplasm Renal cancer:3.74e-9 (unfavourable), Endometrial cancer:5.35e-6 (favourable), Head and neck cancer:7.91e-5 (favourable), Urothelial cancer:4.30e-4 (favourable), Colorectal cancer:8.30e-4 (unfavourable) Expressed in all Tissue enhanced lymph node: 31.9 appendix: 27.3 BATF2 MGC20410 ENSG00000168062 Basic leucine zipper transcription factor, ATF-like 2 11 64987943-64997045 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA062496 Approved Approved Nucleoli Ovarian cancer:9.39e-5 (favourable), Pancreatic cancer:2.12e-4 (unfavourable) Expressed in all Mixed spleen: 17.8 BATF3 JDP1, JUNDM1, SNFT ENSG00000123685 Basic leucine zipper transcription factor, ATF-like 3 1 212686418-212699985 Predicted intracellular proteins, Transcription factors Evidence at protein level Mixed Mixed spleen: 4.7 BBX HBP2, HSPC339, MDS001 ENSG00000114439 Bobby sox homolog (Drosophila) 3 107522936-107811324 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA006049, HPA050646 Supported Validated Nucleoplasm
Cytosol Expressed in all Expressed in all testis: 115.3 BCL11A BCL11A-L, BCL11A-S, BCL11A-XL, CTIP1, EVI9, HBFQTL5, ZNF856 ENSG00000119866 B-cell CLL/lymphoma 11A (zinc finger protein) 2 60451167-60553567 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB014891, HPA029003 Approved Validated Nucleoplasm
Nuclear bodies Mixed Tissue enhanced skin: 41.0 tonsil: 31.8 BCL11B CTIP-2, CTIP2, hRIT1-alpha, ZNF856B ENSG00000127152 B-cell CLL/lymphoma 11B (zinc finger protein) 14 99169287-99271524 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA049117 Supported Supported Approved Nucleus
Nucleoli fibrillar center Urothelial cancer:7.48e-4 (favourable) Mixed Tissue enhanced lymph node: 12.4;skin: 18.8 tonsil: 7.7 BCL3 BCL4, D19S37 ENSG00000069399 B-cell CLL/lymphoma 3 19 44747705-44760044 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB002051, HPA047514 Approved Supported Nucleoplasm
Vesicles
Midbody Renal cancer:3.13e-14 (unfavourable), Melanoma:3.74e-4 (favourable), Glioma:5.58e-4 (unfavourable), Breast cancer:9.67e-4 (favourable) Expressed in all Expressed in all appendix: 30.9 BCL6 BCL5, BCL6A, LAZ3, ZBTB27, ZNF51 ENSG00000113916 B-cell CLL/lymphoma 6 3 187721377-187745727 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB000307, HPA004899, HPA050645 Supported Validated Nucleoplasm
Golgi apparatus Renal cancer:1.27e-9 (unfavourable) Expressed in all Expressed in all adipose tissue: 112.8 BCL6B BAZF, ZBTB28, ZNF62 ENSG00000161940 B-cell CLL/lymphoma 6, member B 17 7023020-7030290 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA059147 Uncertain Head and neck cancer:8.56e-5 (favourable), Renal cancer:4.04e-4 (unfavourable) Expressed in all Mixed adipose tissue: 34.5 BHLHA15 bHLHa15, BHLHB8, MIST1 ENSG00000180535 Basic helix-loop-helix family, member a15 7 98211427-98212979 Predicted intracellular proteins, Transcription factors Evidence at protein level CAB034083, HPA047834 Supported Approved Nucleoplasm
Golgi apparatus Tissue enhanced Group enriched 9 pancreas: 85.5;salivary gland: 54.2 prostate: 7.9 BHLHA9 bHLHa9, BHLHF42 ENSG00000205899 Basic helix-loop-helix family, member a9 17 1270559-1271460 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA062632 Uncertain Tissue enhanced Not detected cerebral cortex: 0.8 BHLHE22 Beta3, BHLHB5, bHLHe22, CAGL85, TNRC20 ENSG00000180828 Basic helix-loop-helix family, member e22 8 64580367-64583628 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA064128, HPA064872, HPA067500 Supported Mixed Tissue enhanced cerebral cortex: 12.2 seminal vesicle: 3.3 BHLHE23 bA305P22.3, Beta4, BHLHB4, bHLHe23 ENSG00000125533 Basic helix-loop-helix family, member e23 20 63005927-63007035 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA030575 Uncertain Tissue enriched Not detected testis: 0.1 BHLHE40 BHLHB2, bHLHe40, DEC1, STRA13 ENSG00000134107 Basic helix-loop-helix family, member e40 3 4979116-4985323 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA028922 Uncertain Supported Nuclear bodies Pancreatic cancer:8.74e-4 (unfavourable) Expressed in all Expressed in all esophagus: 230.8 BHLHE41 BHLHB3, bHLHe41, DEC2, SHARP-1, SHARP1 ENSG00000123095 Basic helix-loop-helix family, member e41 12 26120026-26125127 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA056035 Approved Nucleoplasm Renal cancer:8.73e-5 (unfavourable), Urothelial cancer:1.09e-4 (favourable) Expressed in all Tissue enhanced thyroid gland: 94.0 fallopian tube: 70.3 BNC1 BNC, HsT19447 ENSG00000169594 Basonuclin 1 15 83255903-83284716 Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transcription factors Evidence at protein level HPA063183, HPA066947 Approved Nucleoplasm Tissue enhanced Tissue enhanced testis: 55.7 esophagus: 11.9 BNC2 BSN2, FLJ20043 ENSG00000173068 Basonuclin 2 9 16409503-16870843 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA018525 Approved Supported Nucleus
Cytosol Mixed Tissue enhanced endometrium: 44.4;ovary: 39.3;smooth muscle: 47.3 fallopian tube: 19.3 BSX BSX1 ENSG00000188909 Brain-specific homeobox 11 122977570-122981720 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA015654 Uncertain Not detected Not detected testis: 0.2 CASZ1 castor, cst, FLJ20321, SRG, ZNF693 ENSG00000130940 Castor zinc finger 1 1 10636604-10796650 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA028222, HPA029927 Approved Supported Nucleoplasm
Cytosol Mixed Tissue enhanced skin: 26.9 prostate: 14.2 CDC5L CDC5, CEF1, hCDC5, PCDC5RP ENSG00000096401 Cell division cycle 5-like 6 44387525-44450426 Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA006302, HPA011361, CAB012275 Supported Supported Nucleoplasm Melanoma:7.02e-5 (unfavourable) Expressed in all Expressed in all parathyroid gland: 35.6 CDX1 ENSG00000113722 Caudal type homeobox 1 5 150166795-150184558 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA055196 Supported Tissue enhanced Group enriched 9 colon: 132.2;duodenum: 66.3;rectum: 137.0;small intestine: 107.0 appendix: 12.7 CDX2 CDX3 ENSG00000165556 Caudal type homeobox 2 13 27962137-27971139 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB002221, HPA045669, HPA049580 Supported Supported Nucleoplasm Tissue enriched Group enriched 6 colon: 31.4;duodenum: 22.9;rectum: 25.3;small intestine: 30.8 appendix: 4.9 CDX4 ENSG00000131264 Caudal type homeobox 4 X 73447254-73455245 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA056528 Uncertain Tissue enriched Tissue enriched 8 skin: 1.3 seminal vesicle,testis: 0.1 CEBPA C/EBP-alpha, CEBP ENSG00000245848 CCAAT/enhancer binding protein (C/EBP), alpha 19 33299934-33302564 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA052734, HPA065037, HPA067937 Approved Approved Nucleoplasm
Vesicles Expressed in all Expressed in all adipose tissue: 107.9 CEBPB C/EBP-beta, CRP2, IL6DBP, LAP, NFIL6, TCF5 ENSG00000172216 CCAAT/enhancer binding protein (C/EBP), beta 20 50190734-50192689 Predicted intracellular proteins, Transcription factors Evidence at protein level CAB004213, HPA061355, HPA062267 Supported Validated Nucleoplasm Renal cancer:2.44e-12 (unfavourable) Expressed in all Expressed in all adrenal gland: 112.9 CEBPD C/EBP-delta, CELF, CRP3, NF-IL6-beta ENSG00000221869 CCAAT/enhancer binding protein (C/EBP), delta 8 47736909-47739086 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA067581 Supported Nucleoplasm Renal cancer:2.87e-7 (unfavourable), Breast cancer:2.28e-5 (favourable) Expressed in all Expressed in all adipose tissue: 71.2 CEBPE CRP1 ENSG00000092067 CCAAT/enhancer binding protein (C/EBP), epsilon 14 23117304-23119616 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA002928, CAB005113 Supported Validated Nucleoplasm Not detected Tissue enriched 9 bone marrow: 26.0 small intestine: 2.8 CEBPG GPE1BP, IG/EBP-1 ENSG00000153879 CCAAT/enhancer binding protein (C/EBP), gamma 19 33373330-33382686 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA012024 Supported Supported Nucleoplasm Endometrial cancer:7.97e-5 (unfavourable), Renal cancer:7.23e-4 (unfavourable) Expressed in all Expressed in all thyroid gland: 41.2 CIC KIAA0306 ENSG00000079432 Capicua transcriptional repressor 19 42268537-42295797 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB026388, HPA044341, HPA064725 Approved Supported Nucleoplasm
Vesicles Expressed in all Expressed in all testis: 55.0 CLOCK bHLHe8, KAT13D, KIAA0334 ENSG00000134852 Clock circadian regulator 4 55427903-55547138 Enzymes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001867, HPA027565 Supported Validated Nucleoplasm Expressed in all Mixed testis: 26.3 CNOT4 CLONE243, NOT4, NOT4H ENSG00000080802 CCR4-NOT transcription complex, subunit 4 7 135361795-135510127 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA005737 Approved Renal cancer:7.67e-6 (favourable), Liver cancer:1.19e-4 (unfavourable), Ovarian cancer:1.61e-4 (favourable) Expressed in all Expressed in all testis: 33.2 CRAMP1 CRAMP1L, KIAA1426 ENSG00000007545 Cramped chromatin regulator homolog 1 16 1612325-1677908 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA041752 Uncertain Approved Nucleus
Nucleoli
Cytosol Stomach cancer:4.93e-4 (favourable) Expressed in all Mixed testis: 31.8 CREB1 ENSG00000118260 CAMP responsive element binding protein 1 2 207529737-207603431 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB003803, HPA019150 Supported Validated Nucleoplasm Liver cancer:2.77e-5 (unfavourable) Expressed in all Expressed in all testis: 58.7 CREB3 Luman, LZIP, sLZIP ENSG00000107175 CAMP responsive element binding protein 3 9 35732320-35737007 Predicted membrane proteins, Transcription factors Evidence at protein level HPA030978 Supported Cytosol Renal cancer:3.77e-5 (favourable), Ovarian cancer:5.40e-4 (favourable), Liver cancer:5.57e-4 (unfavourable) Expressed in all Expressed in all prostate: 54.5 CREB3L1 OASIS ENSG00000157613 CAMP responsive element binding protein 3-like 1 11 46277661-46321422 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors Evidence at protein level HPA024069, CAB026151 Supported Uncertain Plasma membrane
Cytosol Renal cancer:2.97e-4 (unfavourable), Endometrial cancer:3.92e-4 (favourable), Thyroid cancer:8.59e-4 (unfavourable) Expressed in all Mixed stomach: 66.1 CREB3L2 BBF2H7, TCAG_1951439 ENSG00000182158 CAMP responsive element binding protein 3-like 2 7 137874979-138002067 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors Evidence at protein level HPA015068, HPA015534 Uncertain Supported Nucleoplasm
Endoplasmic reticulum Expressed in all Expressed in all thyroid gland: 109.9 CREB3L3 CREB-H ENSG00000060566 CAMP responsive element binding protein 3-like 3 19 4153601-4173054 Predicted intracellular proteins, Predicted membrane proteins, Transcription factors Evidence at protein level HPA040671, HPA056228 Supported Renal cancer:3.53e-6 (unfavourable) Tissue enriched Group enriched 104 duodenum: 248.3;liver: 61.3;small intestine: 284.6 colon: 1.9 CREB3L4 AIbZIP, ATCE1, CREB3, CREB4, hJAL ENSG00000143578 CAMP responsive element binding protein 3-like 4 1 153967534-153974363 Predicted intracellular proteins, Predicted membrane proteins, Transcription factors Evidence at protein level HPA038122 Supported Approved Nucleoplasm
Nuclear membrane
Mitochondria Endometrial cancer:7.21e-4 (favourable) Group enriched Expressed in all prostate: 171.5 CREB5 CRE-BPA, H_GS165L15.1 ENSG00000146592 CAMP responsive element binding protein 5 7 28299321-28825894 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA050020, HPA061622 Approved Nucleus
Vesicles
Plasma membrane Mixed Mixed gallbladder: 18.6 CREBL2 ENSG00000111269 CAMP responsive element binding protein-like 2 12 12611827-12645108 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA043738 Uncertain Approved Nucleoplasm
Mitochondria
Cytosol Renal cancer:2.26e-5 (favourable) Expressed in all Expressed in all adrenal gland: 174.3 CREBZF ZF ENSG00000137504 CREB/ATF bZIP transcription factor 11 85659708-85682908 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA021526, HPA063652 Uncertain Approved Nucleus
Mitochondria Expressed in all Expressed in all endometrium,parathyroid gland: 31.1 CREM hCREM-2 ENSG00000095794 CAMP responsive element modulator 10 35126791-35212958 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001818, CAB018352 Supported Supported Nucleus
Vesicles Renal cancer:1.23e-5 (unfavourable) Expressed in all Expressed in all testis: 337.8 CRX CORD2, CRD, LCA7, OTX3 ENSG00000105392 Cone-rod homeobox 19 47819779-47843330 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA036762, HPA036763 Supported Not detected Not detected epididymis,testis: 0.3 CSRNP1 AXUD1, DKFZp566F164, FAM130B, TAIP-3, URAX1 ENSG00000144655 Cysteine-serine-rich nuclear protein 1 3 39141855-39154562 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA045207, HPA058463 Validated Nucleoplasm
Vesicles Renal cancer:1.07e-4 (favourable), Stomach cancer:6.47e-4 (unfavourable) Expressed in all Expressed in all bone marrow: 123.7 CSRNP2 C12ORF2, C12orf22, FAM130A1, PPP1R72, TAIP-12 ENSG00000110925 Cysteine-serine-rich nuclear protein 2 12 51061205-51083664 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA018503, HPA019914 Approved Approved Nuclear speckles Liver cancer:1.08e-4 (unfavourable), Urothelial cancer:2.78e-4 (favourable), Renal cancer:6.51e-4 (unfavourable) Expressed in all Expressed in all testis: 49.1 CSRNP3 FAM130A2, FLJ32093, PPP1R73, TAIP-2 ENSG00000178662 Cysteine-serine-rich nuclear protein 3 2 165469647-165689407 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA017905 Supported Approved Nucleus
Nucleoli Mixed Tissue enhanced cerebral cortex: 16.2 endometrium: 4.6 CTCF ENSG00000102974 CCCTC-binding factor (zinc finger protein) 16 67562407-67639183 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA004122, CAB062550, CAB068181, CAB068182 Supported Supported Nucleoplasm Renal cancer:4.06e-4 (favourable), Liver cancer:4.21e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 57.7 CTCFL BORIS, CT27, dJ579F20.2 ENSG00000124092 CCCTC-binding factor (zinc finger protein)-like 20 57495966-57525652 Predicted intracellular proteins, Predicted membrane proteins, Transcription factors Evidence at protein level HPA001472 Supported Tissue enhanced Tissue enriched 19 testis: 20.6 epididymis: 1.1 CUX1 CASP, CDP, CDP/Cut, CDP/Cux, CDP1, Clox, CUT, CUTL1, CUX, Cux/CDP, GOLIM6 ENSG00000257923 Cut-like homeobox 1 7 101815904-102283957 Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors Evidence at protein level HPA003277, HPA003317 Approved Supported Nucleoplasm
Golgi apparatus Renal cancer:5.72e-7 (favourable), Glioma:9.90e-4 (unfavourable) Expressed in all Expressed in all thyroid gland: 82.3 CUX2 CDP2, CUTL2, KIAA0293 ENSG00000111249 Cut-like homeobox 2 12 111034024-111350554 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors Evidence at protein level HPA044772 Uncertain Tissue enhanced Tissue enhanced cerebral cortex: 12.2;liver: 9.6;prostate: 17.1 thyroid gland: 6.8 CXXC1 CFP1, CGBP, hCGBP, HsT2645, PCCX1, PHF18, SPP1, ZCGPC1 ENSG00000154832 CXXC finger protein 1 18 50282343-50288304 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA044511 Supported Validated Nucleus Liver cancer:4.18e-6 (unfavourable), Pancreatic cancer:2.60e-4 (favourable) Expressed in all Expressed in all lymph node: 28.6 DBP DABP ENSG00000105516 D site of albumin promoter (albumin D-box) binding protein 19 48630030-48637438 Predicted intracellular proteins, Transcription factors Evidence at protein level Lung cancer:1.16e-5 (favourable), Renal cancer:2.41e-5 (favourable), Head and neck cancer:5.49e-4 (favourable) Expressed in all Expressed in all thyroid gland: 41.3 DBX1 ENSG00000109851 Developing brain homeobox 1 11 20156155-20160613 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA039802 Uncertain Not detected Not detected testis: 0.2 DBX2 FLJ16139 ENSG00000185610 Developing brain homeobox 2 12 45014672-45051099 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA066053 Uncertain Tissue enriched Group enriched 5 cerebral cortex: 4.1;testis: 1.2 skin: 0.5 DDIT3 CHOP, CHOP10, GADD153 ENSG00000175197 DNA-damage-inducible transcript 3 12 57516588-57520517 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA058416, HPA068416 Approved Approved Nucleoplasm Liver cancer:6.55e-4 (unfavourable) Expressed in all Expressed in all thyroid gland: 263.1 DEAF1 NUDR, SPN, ZMYND5 ENSG00000177030 DEAF1 transcription factor 11 644233-706715 Disease related genes, Predicted secreted proteins, Transcription factors Evidence at protein level HPA030302 Approved Supported Nucleus
Nucleoli fibrillar center Liver cancer:1.75e-4 (unfavourable) Expressed in all Expressed in all cerebral cortex: 40.8 DLX1 ENSG00000144355 Distal-less homeobox 1 2 172084740-172089677 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA035666, HPA045884 Approved Approved Nucleus
Vesicles
Cell Junctions Tissue enhanced Tissue enhanced adrenal gland: 1.6;cerebral cortex: 5.0 prostate: 0.7 DLX2 TES-1 ENSG00000115844 Distal-less homeobox 2 2 172099439-172102900 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA056965 Approved Nuclear speckles Mixed Not detected cerebral cortex: 0.8 DLX3 ENSG00000064195 Distal-less homeobox 3 17 49990005-49995224 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Endometrial cancer:4.61e-4 (unfavourable) Mixed Group enriched 5 placenta: 10.6;skin: 21.9 thyroid gland: 3.1 DLX4 BP1, DLX7, DLX8, DLX9 ENSG00000108813 Distal-less homeobox 4 17 49968970-49974959 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA059933 Uncertain Approved Nucleoplasm Mixed Tissue enhanced placenta: 5.3 skin: 1.2 DLX5 ENSG00000105880 Distal-less homeobox 5 7 97020392-97025097 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA005670 Approved Uncertain Nucleus Tissue enriched Tissue enhanced endometrium: 20.1;placenta: 13.5;skin: 17.2 cervix, uterine: 9.5 DLX6 ENSG00000006377 Distal-less homeobox 6 7 97005548-97011039 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA030608, HPA061460 Uncertain Approved Nuclear bodies Tissue enriched Tissue enhanced endometrium: 4.4;placenta: 4.3;testis: 5.4 cervix, uterine: 3.0 DMAP1 DNMAP1, DNMTAP1, EAF2, FLJ11543, KIAA1425, MEAF2, SWC4 ENSG00000178028 DNA methyltransferase 1 associated protein 1 1 44213455-44220681 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA028419, CAB033018 Uncertain Supported Nucleoplasm
Cytosol Liver cancer:1.44e-4 (unfavourable) Expressed in all Expressed in all adrenal gland: 40.5 DMBX1 OTX3, PAXB ENSG00000197587 Diencephalon/mesencephalon homeobox 1 1 46506996-46514226 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA026811 Uncertain Endometrial cancer:7.13e-5 (unfavourable) Mixed Tissue enhanced testis: 1.2 adrenal gland,thyroid gland: 0.4 DMRT1 CT154, DMT1 ENSG00000137090 Doublesex and mab-3 related transcription factor 1 9 841690-969090 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA027850 Supported Tissue enriched Tissue enriched 107 testis: 50.7 thyroid gland: 0.4 DMRT2 ENSG00000173253 Doublesex and mab-3 related transcription factor 2 9 1049858-1057552 Predicted intracellular proteins, Predicted membrane proteins, Transcription factors Evidence at transcript level HPA029297 Uncertain Tissue enhanced Tissue enriched 7 parathyroid gland: 106.9 kidney: 16.0 DMRT3 DMRTA3 ENSG00000064218 Doublesex and mab-3 related transcription factor 3 9 976964-991731 Predicted intracellular proteins, Transcription factors Evidence at protein level Tissue enhanced Tissue enriched 6 parathyroid gland: 64.1 testis,thyroid gland: 10.3 DMRTA1 ENSG00000176399 DMRT-like family A1 9 22446841-22455740 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA044764, HPA062253 Uncertain Approved Vesicles Renal cancer:1.14e-6 (favourable) Mixed Tissue enhanced parathyroid gland: 6.4 liver: 4.3 DMRTA2 ENSG00000142700 DMRT-like family A2 1 50417550-50423500 Predicted secreted proteins, Transcription factors Evidence at protein level HPA043098, HPA062958 Uncertain Approved Mitochondria Tissue enhanced Not detected testis: 0.7 DMRTB1 ENSG00000143006 DMRT-like family B with proline-rich C-terminal, 1 1 53459399-53467488 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA036490, HPA058553 Supported Tissue enhanced Tissue enriched 68 testis: 69.6 epididymis: 1.0 DMRTC1 ENSG00000269502 DMRT-like family C1 X 72872025-72943814 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA046874, HPA046992 Uncertain Not detected Tissue enhanced cerebral cortex: 2.3 thyroid gland: 1.4 DMRTC1B ENSG00000184911 DMRT-like family C1B X 72777009-72848802 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA046874, HPA046992 Uncertain Not detected Tissue enhanced cerebral cortex: 16.7 ovary: 10.3 DMRTC2 ENSG00000142025 DMRT-like family C2 19 41844743-41852333 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA045016 Uncertain Not detected Tissue enriched 127 testis: 48.7 lymph node,parathyroid gland,thyroid gland: 0.3 DMTF1 DMP1, DMTF, hDMP1, MRUL ENSG00000135164 Cyclin D binding myb-like transcription factor 1 7 87152361-87196337 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA023846 Supported Supported Nucleoplasm Renal cancer:4.39e-5 (unfavourable) Expressed in all Expressed in all testis: 83.7 DNAJC1 DNAJL1, ERdj1, MTJ1 ENSG00000136770 DnaJ (Hsp40) homolog, subfamily C, member 1 10 21756537-22003769 Predicted membrane proteins, Transcription factors Evidence at protein level HPA013432 Approved Approved Endoplasmic reticulum Liver cancer:1.96e-5 (unfavourable), Renal cancer:2.33e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 56.8 DNAJC2 MPHOSPH11, MPP11, ZRF1, ZUO1, zuotin ENSG00000105821 DnaJ (Hsp40) homolog, subfamily C, member 2 7 103312474-103344873 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA020454 Approved Supported Cytosol Renal cancer:1.12e-5 (unfavourable) Expressed in all Expressed in all testis: 61.7 DNMT1 CXXC9, DNMT, MCMT ENSG00000130816 DNA (cytosine-5-)-methyltransferase 1 19 10133345-10231286 Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA002694, CAB005876 Supported Validated Nucleoplasm Liver cancer:1.46e-4 (unfavourable) Expressed in all Expressed in all placenta: 51.2 DNMT3A ENSG00000119772 DNA (cytosine-5-)-methyltransferase 3 alpha 2 25227855-25342590 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB009469, HPA026588 Approved Supported Nucleoplasm Pancreatic cancer:1.18e-4 (favourable), Endometrial cancer:1.55e-4 (unfavourable), Liver cancer:1.58e-4 (unfavourable), Renal cancer:2.49e-4 (unfavourable) Expressed in all Expressed in all placenta: 22.6 DNMT3B ENSG00000088305 DNA (cytosine-5-)-methyltransferase 3 beta 20 32762385-32809356 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001595, CAB069896 Approved Approved Nucleoplasm
Vesicles Renal cancer:1.87e-7 (unfavourable), Endometrial cancer:5.04e-4 (unfavourable) Tissue enriched Tissue enhanced testis: 9.2 skin: 4.5 DNMT3L MGC1090 ENSG00000142182 DNA (cytosine-5-)-methyltransferase 3-like 21 44246339-44262216 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA055234, HPA066780 Uncertain Approved Nuclear speckles Tissue enriched Group enriched 6 kidney: 7.4;liver: 10.8;lymph node: 2.3 spleen: 1.1 DPRX ENSG00000204595 Divergent-paired related homeobox 19 53632056-53637009 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA043682 Uncertain Tissue enriched Tissue enhanced placenta: 1.9 epididymis,testis: 0.5 DRGX DRG11, PRRXL1 ENSG00000165606 Dorsal root ganglia homeobox 10 49364181-49396016 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA043978 Uncertain Approved Nucleus
Nucleoli
Cytosol Mixed Tissue enriched 11 adrenal gland: 8.9 skin: 0.8 DUX4 ENSG00000260596 Double homeobox 4 4 190173774-190185942 Disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters Evidence at protein level HPA058451 Approved Nucleus
Nucleoli
Cytosol Not detected Tissue enhanced testis: 1.5 seminal vesicle: 0.5 DUXA ENSG00000258873 Double homeobox A 19 57154021-57167443 Predicted intracellular proteins, Transcription factors No evidence HPA059358 Uncertain Not detected Not detected appendix,lung,spleen,testis: 0.3 E2F1 RBBP3, RBP3 ENSG00000101412 E2F transcription factor 1 20 33675683-33686404 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB000329, HPA008003, CAB019308, HPA029735 Approved Validated Nucleoplasm
Centrosome Cervical cancer:9.22e-6 (favourable), Liver cancer:3.83e-5 (unfavourable), Endometrial cancer:4.33e-5 (unfavourable), Renal cancer:8.99e-5 (unfavourable), Thyroid cancer:1.62e-4 (favourable), Pancreatic cancer:4.18e-4 (unfavourable) Expressed in all Tissue enhanced bone marrow: 22.9 testis: 12.7 E2F2 E2F-2 ENSG00000007968 E2F transcription factor 2 1 23506430-23531220 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB016313 Uncertain Mixed Tissue enhanced bone marrow: 15.3 lymph node: 3.9 E2F3 ENSG00000112242 E2F transcription factor 3 6 20401906-20493715 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA065012 Supported Nucleoplasm
Cytosol Renal cancer:1.63e-8 (unfavourable), Ovarian cancer:1.69e-4 (favourable) Expressed in all Mixed thyroid gland: 14.3 E2F4 E2F-4 ENSG00000205250 E2F transcription factor 4, p107/p130-binding 16 67192169-67198918 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA054128 Supported Nucleoplasm Expressed in all Expressed in all placenta: 63.7 E2F5 ENSG00000133740 E2F transcription factor 5, p130-binding 8 85177225-85217158 Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transcription factors Evidence at protein level HPA055723 Supported Nucleus
Nucleoli Renal cancer:1.89e-6 (unfavourable) Expressed in all Mixed lymph node: 31.3 E2F6 E2F-6 ENSG00000169016 E2F transcription factor 6 2 11444375-11466177 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA065719 Supported Nucleus
Nucleoli Liver cancer:1.20e-5 (unfavourable), Endometrial cancer:7.13e-4 (unfavourable) Expressed in all Mixed endometrium: 7.1 E2F7 ENSG00000165891 E2F transcription factor 7 12 77021247-77065580 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA064866 Supported Nuclear speckles Mixed Tissue enhanced testis: 5.1 bone marrow: 3.1 E2F8 FLJ23311 ENSG00000129173 E2F transcription factor 8 11 19224063-19241620 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA064882 Supported Nucleus
Nucleoli
Cytosol Mixed Mixed bone marrow: 9.2 E4F1 E4F ENSG00000167967 E4F transcription factor 1 16 2223566-2235742 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA052042, HPA071325 Validated Nucleoplasm Head and neck cancer:1.10e-4 (favourable), Renal cancer:5.50e-4 (unfavourable), Cervical cancer:9.13e-4 (favourable) Expressed in all Expressed in all skin,spleen: 12.8 EBF1 EBF, OLF1 ENSG00000164330 Early B-cell factor 1 5 158695916-159099761 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA061169 Approved Nucleoplasm
Vesicles Renal cancer:9.62e-7 (unfavourable), Stomach cancer:7.80e-4 (unfavourable) Mixed Tissue enhanced adipose tissue: 41.6 placenta: 16.6 EBF2 COE2, FLJ11500 ENSG00000221818 Early B-cell factor 2 8 25841730-26045397 Predicted intracellular proteins, Transcription factors Evidence at protein level Renal cancer:2.51e-6 (unfavourable) Mixed Tissue enhanced adipose tissue: 20.6 heart muscle: 6.7 EBF3 COE3, DKFZp667B0210 ENSG00000108001 Early B-cell factor 3 10 129835283-129963841 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA061169 Approved Nucleoplasm
Vesicles Mixed Tissue enhanced adipose tissue: 20.1 lymph node: 12.9 EBF4 COE4, KIAA1442, O/E-4, RP5-860F19.3 ENSG00000088881 Early B-cell factor 4 20 2692878-2760108 Predicted intracellular proteins, Transcription factors Evidence at transcript level Pancreatic cancer:2.47e-5 (favourable), Colorectal cancer:6.59e-4 (unfavourable) Expressed in all Mixed parathyroid gland: 23.4 EGR1 AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268, ZNF225 ENSG00000120738 Early growth response 1 5 138465490-138469315 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB019427, HPA029937, HPA029938 Supported Validated Nucleoplasm Expressed in all Expressed in all ovary: 1184.1 EGR2 KROX20 ENSG00000122877 Early growth response 2 10 62811996-62919900 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA031165 Supported Nucleoplasm Breast cancer:7.30e-5 (favourable) Expressed in all Tissue enhanced epididymis: 97.2;thyroid gland: 215.5 gallbladder: 46.3 EGR3 PILOT ENSG00000179388 Early growth response 3 8 22687659-22693302 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA006206, CAB009373 Uncertain Uncertain Nucleus
Vesicles Breast cancer:1.83e-4 (favourable), Melanoma:4.78e-4 (favourable) Mixed Mixed gallbladder: 49.7 EGR4 NGFI-C, PAT133 ENSG00000135625 Early growth response 4 2 73290929-73293705 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA028983 Approved Mixed Group enriched 29 cerebral cortex: 9.7;testis: 3.2 adipose tissue,appendix: 0.2 EHF ESE3, ESEJ ENSG00000135373 Ets homologous factor 11 34621093-34661057 Predicted intracellular proteins, Predicted secreted proteins, Transcription factors Evidence at protein level HPA050923, HPA060734 Approved Supported Nucleoplasm
Golgi apparatus Colorectal cancer:5.81e-4 (favourable), Pancreatic cancer:6.94e-4 (unfavourable) Mixed Mixed esophagus: 229.2 ELF1 ENSG00000120690 E74-like factor 1 (ets domain transcription factor) 13 40931920-41061440 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001755, CAB005172 Approved Supported Nucleoplasm Expressed in all Expressed in all bone marrow: 133.1 ELF2 EU32, NERF, NERF-1A, NERF-1B, NERF-2 ENSG00000109381 E74-like factor 2 (ets domain transcription factor) 4 139028112-139177218 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA006057, HPA071166 Supported Supported Nucleoplasm
Nuclear bodies Expressed in all Expressed in all testis: 69.0 ELF3 EPR-1, ERT, ESE-1, ESX ENSG00000163435 E74-like factor 3 (ets domain transcription factor, epithelial-specific ) 1 202007945-202017188 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003316, HPA003479 Supported Validated Nucleoplasm Mixed Mixed small intestine: 164.9 ELF4 ELFR, MEF ENSG00000102034 E74-like factor 4 (ets domain transcription factor) X 130064874-130110716 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA058595, HPA060277 Approved Supported Nucleoplasm
Nuclear bodies Renal cancer:6.49e-6 (unfavourable), Urothelial cancer:1.42e-4 (favourable) Expressed in all Mixed placenta: 34.7 ELF5 ENSG00000135374 E74-like factor 5 (ets domain transcription factor) 11 34478793-34513805 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA062706 Supported Nucleoplasm Lung cancer:3.64e-4 (favourable) Tissue enhanced Tissue enhanced breast: 173.4;salivary gland: 64.6 seminal vesicle: 41.8 ELK1 ENSG00000126767 ELK1, member of ETS oncogene family X 47635521-47650604 Predicted intracellular proteins, RAS pathway related proteins, Transcription factors Evidence at protein level CAB003808, HPA036084, HPA064381 Supported Validated Nucleoplasm Renal cancer:3.25e-5 (unfavourable) Expressed in all Expressed in all ovary: 50.8 ELK3 ERP, NET, SAP2 ENSG00000111145 ELK3, ETS-domain protein (SRF accessory protein 2) 12 96194382-96269835 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001600 Approved Supported Nucleoplasm
Mitochondria Ovarian cancer:4.93e-4 (unfavourable) Expressed in all Expressed in all spleen: 58.6 ELK4 SAP1 ENSG00000158711 ELK4, ETS-domain protein (SRF accessory protein 1) 1 205597556-205631962 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA028863 Uncertain Supported Nucleoplasm Renal cancer:2.94e-6 (unfavourable), Head and neck cancer:4.65e-4 (favourable) Expressed in all Expressed in all prostate: 41.5 ELMSAN1 C14orf117, C14orf43, LSR68 ENSG00000156030 ELM2 and Myb/SANT-like domain containing 1 14 73715122-73790285 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003111 Approved Validated Nucleoplasm Ovarian cancer:3.86e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 21.8 EMX1 ENSG00000135638 Empty spiracles homeobox 1 2 72916260-72936071 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA006230, HPA006421 Uncertain Approved Nucleoli Renal cancer:1.54e-6 (favourable) Tissue enhanced Tissue enhanced cerebral cortex: 8.3;kidney: 15.5;parathyroid gland: 5.1 testis: 2.6 EMX2 ENSG00000170370 Empty spiracles homeobox 2 10 117542444-117549546 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003497, HPA065294 Approved Supported Approved Nucleus Renal cancer:2.28e-13 (favourable), Cervical cancer:2.80e-4 (favourable) Group enriched Group enriched 5 cervix, uterine: 59.4;endometrium: 114.7;epididymis: 113.9;fallopian tube: 72.9;kidney: 38.3;seminal vesicle: 64.9;smooth muscle: 59.6 cerebral cortex: 14.0 EN1 ENSG00000163064 Engrailed homeobox 1 2 118842171-118847678 Predicted intracellular proteins, Transcription factors Evidence at protein level CAB014884, HPA073141 Approved Supported Nucleus
Nucleoli Tissue enhanced Group enriched 13 adipose tissue: 1.3;breast: 1.0;lymph node: 1.9;skeletal muscle: 4.7;skin: 2.2 testis: 0.1 EN2 ENSG00000164778 Engrailed homeobox 2 7 155458129-155464831 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB025088, HPA045646, HPA069809 Uncertain Supported Nucleus
Nucleoli fibrillar center Glioma:2.82e-6 (unfavourable) Tissue enhanced Tissue enhanced parathyroid gland: 1.9;testis: 1.1 endometrium: 0.6 EOMES TBR2 ENSG00000163508 Eomesodermin 3 27715949-27722711 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA028896 Uncertain Renal cancer:9.45e-6 (unfavourable) Tissue enhanced Tissue enhanced lymph node: 18.4;spleen: 19.7 tonsil: 5.6 EPAS1 bHLHe73, HIF2A, HLF, MOP2, PASD2 ENSG00000116016 Endothelial PAS domain protein 1 2 46293667-46386703 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA031200 Approved Nucleoplasm
Cytosol Renal cancer:2.63e-4 (favourable) Expressed in all Expressed in all placenta: 636.7 ERF PE-2, PE2 ENSG00000105722 Ets2 repressor factor 19 42247572-42255157 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA058532, HPA067952 Approved Validated Nucleoplasm Breast cancer:8.07e-4 (favourable) Expressed in all Expressed in all gallbladder: 79.2 ERG erg-3, p55 ENSG00000157554 V-ets avian erythroblastosis virus E26 oncogene homolog 21 38380027-38661780 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB018377, HPA046598 Approved Approved Nucleoplasm
Cytosol Cervical cancer:6.18e-6 (unfavourable), Renal cancer:3.94e-4 (unfavourable) Expressed in all Expressed in all spleen: 37.3 ESR1 Era, ESR, NR3A1 ENSG00000091831 Estrogen receptor 1 6 151656691-152129619 Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB000037, HPA000449, HPA000450, CAB055099, CAB072858 Supported Approved Nucleus
Vesicles Endometrial cancer:5.47e-7 (favourable) Group enriched Group enriched 8 breast: 37.4;cervix, uterine: 127.3;endometrium: 179.7;fallopian tube: 105.5;smooth muscle: 75.9 seminal vesicle: 13.5 ESR2 Erb, NR3A2 ENSG00000140009 Estrogen receptor 2 (ER beta) 14 64084232-64338112 Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB022544 Approved Nucleoplasm Not detected Tissue enhanced testis: 10.5 adrenal gland: 6.3 ESRRA ERR1, ERRa, ERRalpha, ESRL1, NR3B1 ENSG00000173153 Estrogen-related receptor alpha 11 64305572-64316743 Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA053785 Approved Nucleus
Nucleoli fibrillar center
Microtubules
Cytokinetic bridge Renal cancer:1.34e-7 (favourable) Expressed in all Expressed in all duodenum: 89.0 ESRRB DFNB35, ERR2, ERRb, ERRbeta, ESRL2, NR3B2 ENSG00000119715 Estrogen-related receptor beta 14 76310614-76501841 Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level Mixed Group enriched 6 heart muscle: 2.5;kidney: 5.2;skeletal muscle: 1.7;stomach: 1.5;testis: 1.4 breast: 0.3 ESRRG NR3B3 ENSG00000196482 Estrogen-related receptor gamma 1 216503246-217137755 FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA044678 Uncertain Approved Nucleus Renal cancer:1.13e-11 (favourable) Mixed Tissue enhanced parathyroid gland: 76.1 kidney: 31.1 ESX1 ESX1L, ESXR1 ENSG00000123576 ESX homeobox 1 X 104250038-104254933 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA051992 Supported Supported Nuclear speckles Tissue enriched Tissue enriched 64 testis: 12.0 placenta: 0.1 ETS1 ETS-1, EWSR2, FLJ10768 ENSG00000134954 V-ets avian erythroblastosis virus E26 oncogene homolog 1 11 128458761-128587558 Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors Evidence at protein level CAB002575, HPA063230 Supported Validated Nucleoplasm Renal cancer:1.30e-5 (unfavourable) Expressed in all Expressed in all lymph node: 324.7 ETS2 ENSG00000157557 V-ets avian erythroblastosis virus E26 oncogene homolog 2 21 38805307-38824955 Predicted intracellular proteins, RAS pathway related proteins, Transcription factors Evidence at protein level HPA003176 Supported Nucleoplasm
Plasma membrane Expressed in all Expressed in all spleen: 256.3 ETV1 ER81 ENSG00000006468 Ets variant 1 7 13891228-13991425 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA077249 Approved Nucleoplasm Expressed in all Tissue enhanced cerebral cortex: 106.6 lung: 43.3 ETV2 ER71 ENSG00000105672 Ets variant 2 19 35641745-35644871 Predicted intracellular proteins, Transcription factors Evidence at transcript level Mixed Tissue enhanced testis: 8.8 duodenum: 2.1 ETV3 PE-1 ENSG00000117036 Ets variant 3 1 157121191-157138474 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA004794 Supported Approved Nucleus Expressed in all Expressed in all parathyroid gland: 44.9 ETV3L FLJ16478 ENSG00000253831 Ets variant 3-like 1 157092044-157099808 Predicted intracellular proteins, Transcription factors Evidence at transcript level Not detected Not detected breast: 0.9 ETV4 E1A-F, E1AF, PEA3 ENSG00000175832 Ets variant 4 17 43527844-43579620 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA005768 Approved Supported Nucleoli Liver cancer:2.48e-4 (unfavourable), Thyroid cancer:7.60e-4 (favourable) Expressed in all Tissue enhanced parathyroid gland: 29.7 cerebral cortex: 13.7 ETV5 ERM ENSG00000244405 Ets variant 5 3 186046308-186110318 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB009590, HPA063065 Approved Supported Nucleoplasm Liver cancer:7.85e-9 (unfavourable) Expressed in all Tissue enhanced parathyroid gland: 112.2 cerebral cortex: 74.9 ETV6 TEL ENSG00000139083 Ets variant 6 12 11649854-11895402 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA000264 Supported Validated Nucleoli
Cytosol Renal cancer:4.66e-8 (unfavourable), Urothelial cancer:1.54e-5 (favourable), Pancreatic cancer:9.38e-5 (unfavourable) Expressed in all Expressed in all bone marrow: 26.5 ETV7 TEL-2, TEL2 ENSG00000010030 Ets variant 7 6 36354091-36387800 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA029033 Uncertain Supported Nucleoplasm Urothelial cancer:2.95e-6 (favourable), Cervical cancer:5.16e-4 (favourable), Ovarian cancer:5.32e-4 (favourable) Expressed in all Mixed skin: 19.9 EVX1 ENSG00000106038 Even-skipped homeobox 1 7 27242700-27250493 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA055132 Approved Nucleoplasm Mixed Tissue enhanced adrenal gland: 3.7;prostate: 4.6;seminal vesicle: 4.3 testis: 1.5 EVX2 ENSG00000174279 Even-skipped homeobox 2 2 176077472-176083913 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA041576 Uncertain Not detected Tissue enhanced prostate: 2.0;seminal vesicle: 2.2;testis: 2.7 cervix, uterine: 1.1 FERD3L bHLHa31, N-TWIST, NATO3 ENSG00000146618 Fer3-like bHLH transcription factor 7 19144782-19145421 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA043494 Uncertain Not detected Not detected cerebral cortex: 0.5 FEV Pet-1 ENSG00000163497 FEV (ETS oncogene family) 2 218981087-218985657 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA067679 Supported Approved Nuclear speckles Pancreatic cancer:4.85e-4 (favourable) Group enriched Tissue enhanced adrenal gland: 2.1;duodenum: 3.0;stomach: 2.4 prostate: 1.9 FEZF1 ZNF312B ENSG00000128610 FEZ family zinc finger 1 7 122301394-122310691 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA064639, HPA073693 Approved Supported Nucleus
Cytosol Mixed Tissue enriched 40 testis: 7.2 adipose tissue,cerebral cortex,prostate: 0.1 FEZF2 FEZL, FKSG36, FLJ10142, TOF, Zfp312, ZNF312 ENSG00000153266 FEZ family zinc finger 2 3 62369681-62374324 Predicted intracellular proteins, Transcription factors Evidence at transcript level Tissue enhanced Tissue enriched 29 cerebral cortex: 11.8 colon: 0.4 FIGLA bHLHc8 ENSG00000183733 Folliculogenesis specific bHLH transcription factor 2 70777310-70790643 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Not detected Tissue enriched 6 testis: 1.2 cervix, uterine: 0.2 FIZ1 FLJ14768, ZNF798 ENSG00000179943 FLT3-interacting zinc finger 1 19 55591371-55601970 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA074026 Approved Nucleus Urothelial cancer:2.02e-4 (favourable), Pancreatic cancer:8.42e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 20.6 FLI1 EWSR2, SIC-1 ENSG00000151702 Fli-1 proto-oncogene, ETS transcription factor 11 128686535-128813267 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA073099 Supported Nucleus
Nuclear bodies Renal cancer:4.60e-4 (unfavourable) Expressed in all Tissue enhanced spleen: 48.1 placenta: 16.2 FOS AP-1, c-fos ENSG00000170345 FBJ murine osteosarcoma viral oncogene homolog 14 75278774-75282230 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA018531 Approved Supported Nucleoplasm Prostate cancer:7.81e-4 (favourable) Expressed in all Expressed in all fallopian tube: 1834.8 FOSB AP-1, DKFZp686C0818, G0S3, GOS3, GOSB, MGC42291 ENSG00000125740 FBJ murine osteosarcoma viral oncogene homolog B 19 45467995-45475179 Predicted intracellular proteins, Transcription factors Evidence at protein level CAB010267, HPA054663 Approved Supported Nucleoplasm
Vesicles Expressed in all Mixed gallbladder: 560.0 FOSL1 fra-1 ENSG00000175592 FOS-like antigen 1 11 65892049-65900573 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB004396, HPA066901 Uncertain Validated Nucleoplasm Renal cancer:6.40e-6 (unfavourable), Pancreatic cancer:9.26e-5 (unfavourable), Lung cancer:1.95e-4 (unfavourable), Head and neck cancer:2.05e-4 (unfavourable), Glioma:2.46e-4 (unfavourable) Expressed in all Tissue enhanced adipose tissue: 35.2;gallbladder: 51.8 urinary bladder: 27.7 FOSL2 FLJ23306, FRA2 ENSG00000075426 FOS-like antigen 2 2 28392448-28417312 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA004817, CAB013460, HPA061417 Supported Validated Nucleus Expressed in all Expressed in all adrenal gland: 226.0 FOXA1 HNF3A ENSG00000129514 Forkhead box A1 14 37589984-37596059 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB011595, HPA050505 Supported Supported Nucleoplasm
Nucleoli fibrillar center Urothelial cancer:1.00e-4 (favourable) Tissue enhanced Tissue enhanced prostate: 145.4 breast: 36.3 FOXA2 HNF3B ENSG00000125798 Forkhead box A2 20 22581005-22585455 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB001388, HPA066846 Approved Supported Nucleoplasm
Cell Junctions Endometrial cancer:7.57e-6 (favourable), Pancreatic cancer:2.34e-4 (favourable), Ovarian cancer:6.28e-4 (favourable) Mixed Tissue enhanced cervix, uterine: 21.3;lung: 20.6;stomach: 31.3 liver: 11.5 FOXA3 HNF3G ENSG00000170608 Forkhead box A3 19 45863989-45873797 Predicted intracellular proteins, Transcription factors Evidence at protein level CAB015154, HPA054034 Uncertain Approved Nucleoplasm Mixed Group enriched 5 colon: 17.0;duodenum: 10.6;liver: 32.5;pancreas: 9.8;rectum: 18.2;small intestine: 14.2;stomach: 34.1 gallbladder: 3.6 FOXB1 FKH5, HFKH-5 ENSG00000171956 Forkhead box B1 15 60004222-60061730 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA073369 Approved Nucleoplasm
Mitochondria Tissue enhanced Not detected testis: 0.7 FOXB2 bA159H20.4 ENSG00000204612 Forkhead box B2 9 77019655-77020953 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA067947 Uncertain Tissue enhanced Not detected all non-specific tissues: 0.0 FOXC1 ARA, FKHL7, FREAC3, IGDA, IHG1, IRID1 ENSG00000054598 Forkhead box C1 6 1609972-1613897 Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA040670 Approved Supported Nucleoplasm
Cytosol Colorectal cancer:3.53e-4 (unfavourable) Expressed in all Tissue enhanced salivary gland: 66.5 kidney: 21.6 FOXC2 FKHL14, MFH-1 ENSG00000176692 Forkhead box C2 16 86567251-86569728 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA056302 Supported Nucleoplasm
Nuclear bodies Renal cancer:3.57e-7 (unfavourable) Mixed Mixed kidney: 2.8 FOXD1 FKHL8, FREAC4 ENSG00000251493 Forkhead box D1 5 73444827-73448362 Predicted intracellular proteins, Transcription factors Evidence at transcript level Head and neck cancer:2.73e-4 (unfavourable), Urothelial cancer:9.65e-4 (unfavourable) Mixed Tissue enhanced testis: 4.8 adrenal gland: 2.9 FOXD2 FKHL17, FREAC9 ENSG00000186564 Forkhead box D2 1 47436017-47440691 Predicted intracellular proteins, Transcription factors Evidence at transcript level Mixed Tissue enhanced colon: 3.8;rectum: 3.5 prostate: 1.1 FOXD3 Genesis, HFH2 ENSG00000187140 Forkhead box D3 1 63323041-63325126 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB022455 Uncertain Group enriched Mixed testis: 1.0 FOXD4 FKHL9, FOXD4a, FREAC5 ENSG00000170122 Forkhead box D4 9 116231-118204 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA012836 Uncertain Approved Nucleus Mixed Tissue enhanced testis: 1.0 cerebral cortex: 0.3 FOXD4L1 FOXD5 ENSG00000184492 Forkhead box D4-like 1 2 113498665-113501155 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA012836 Uncertain Approved Nucleus Not detected Not detected testis: 0.7 FOXD4L3 FOXD6 ENSG00000187559 Forkhead box D4-like 3 9 68302867-68304905 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA012836 Uncertain Approved Nucleus Not detected Not detected spleen: 0.3 FOXD4L4 bA460E7.2, FOXD4L2 ENSG00000184659 Forkhead box D4-like 4 9 65736555-65738784 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA012836 Uncertain Approved Nucleus Not detected Not detected appendix,cerebral cortex,fallopian tube: 0.1 FOXD4L5 bA15J10.2 ENSG00000204779 Forkhead box D4-like 5 9 65282101-65285209 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA012836 Uncertain Approved Nucleus Not detected Tissue enhanced epididymis: 1.2 cerebral cortex: 0.6 FOXD4L6 ENSG00000273514 Forkhead box D4-like 6 9 41126430-41128463 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA012836 Uncertain Approved Nucleus Not detected Not detected cerebral cortex: 0.3 FOXE1 FKHL15, FOXE2, HFKH4, TITF2, TTF-2 ENSG00000178919 Forkhead box E1 9 97853254-97856715 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Tissue enhanced Tissue enriched 14 thyroid gland: 326.9 tonsil: 22.9 FOXE3 FKHL12, FREAC8 ENSG00000186790 Forkhead box E3 1 47416072-47418052 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Tissue enhanced Not detected testis: 0.6 FOXF1 FKHL5, FREAC1 ENSG00000103241 Forkhead box F1 16 86510527-86515418 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA028886 Approved Nucleoplasm Mixed Mixed placenta: 32.8 FOXF2 FKHL6, FREAC2 ENSG00000137273 Forkhead box F2 6 1389834-1395597 Predicted intracellular proteins, Transcription factors Evidence at protein level Mixed Mixed lung: 18.5 FOXG1 BF1, FKH2, FKHL1, FKHL2, FKHL3, FKHL4, FOXG1A, FOXG1B, FOXG1C, HBF-3, HFK1, HFK2, HFK3, QIN ENSG00000176165 Forkhead box G1 14 28765388-28770277 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Tissue enriched Tissue enriched 6 cerebral cortex: 29.7 testis: 5.3 FOXH1 FAST1 ENSG00000160973 Forkhead box H1 8 144473412-144476335 Predicted intracellular proteins, Transcription factors Evidence at protein level Tissue enriched Tissue enhanced rectum: 2.3 colon: 1.0 FOXI1 FKHL10, FREAC6 ENSG00000168269 Forkhead box I1 5 170105897-170109725 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA071469 Supported Uncertain Nucleoli
Vesicles Group enriched Tissue enhanced breast: 10.4;kidney: 19.9;prostate: 6.5 salivary gland: 6.3 FOXI2 FLJ46831 ENSG00000186766 Forkhead box I2 10 127737235-127741186 Predicted intracellular proteins, Transcription factors Evidence at transcript level Renal cancer:4.23e-7 (favourable) Tissue enriched Tissue enhanced cervix, uterine: 2.6 kidney: 1.6 FOXI3 ENSG00000214336 Forkhead box I3 2 88446787-88452656 Predicted intracellular proteins, Transcription factors Evidence at transcript level Tissue enhanced Tissue enriched 8 placenta: 7.3 testis: 0.8 FOXJ1 FKHL13, HFH-4, HFH4 ENSG00000129654 Forkhead box J1 17 76136333-76141299 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA005714 Supported Renal cancer:2.03e-5 (unfavourable), Breast cancer:9.39e-4 (favourable) Tissue enhanced Tissue enriched 8 fallopian tube: 82.8 lung: 10.4 FOXJ2 FHX ENSG00000065970 Forkhead box J2 12 8032703-8055503 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA008723 Approved Supported Nucleus
Nucleoli fibrillar center Renal cancer:4.63e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 28.5 FOXJ3 KIAA1041 ENSG00000198815 Forkhead box J3 1 42176539-42335877 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA067284 Approved Nucleoplasm
Nuclear speckles
Vesicles Renal cancer:4.51e-7 (unfavourable), Liver cancer:5.17e-6 (unfavourable) Expressed in all Expressed in all parathyroid gland: 39.5 FOXK1 IMAGE:5164497 ENSG00000164916 Forkhead box K1 7 4682309-4771443 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA017998, HPA018864 Supported Supported Nucleoplasm
Nucleoli fibrillar center Liver cancer:2.54e-6 (unfavourable) Expressed in all Mixed cerebral cortex: 12.4 FOXK2 ILF, ILF1 ENSG00000141568 Forkhead box K2 17 82519713-82644662 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA027523 Approved Supported Nucleoplasm
Vesicles Liver cancer:1.24e-6 (unfavourable) Expressed in all Expressed in all testis: 64.8 FOXL1 FKH6, FKHL11, FREAC7 ENSG00000176678 Forkhead box L1 16 86576368-86582160 Predicted intracellular proteins, Transcription factors Evidence at transcript level Tissue enhanced Tissue enhanced gallbladder: 8.4 duodenum: 3.2 FOXL2 BPES, BPES1 ENSG00000183770 Forkhead box L2 3 138944224-138947140 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA069613 Supported Supported Nucleus
Cytokinetic bridge Mixed Tissue enhanced endometrium: 12.1;ovary: 29.6;parathyroid gland: 24.2 fallopian tube: 7.6 FOXM1 FKHL16, HFH-11, HNF-3, INS-1, MPHOSPH2, MPP2, TGT3, trident ENSG00000111206 Forkhead box M1 12 2857681-2877155 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB017832, HPA029974 Uncertain Supported Nucleus
Nucleoli
Cytosol Renal cancer:0.00e+0 (unfavourable), Liver cancer:1.95e-6 (unfavourable), Pancreatic cancer:3.03e-5 (unfavourable), Lung cancer:2.92e-4 (unfavourable) Expressed in all Tissue enhanced testis: 39.5 bone marrow: 15.9 FOXN1 FKHL20, RONU, WHN ENSG00000109101 Forkhead box N1 17 28506243-28538896 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at transcript level Head and neck cancer:5.00e-4 (favourable), Cervical cancer:6.43e-4 (favourable) Tissue enhanced Tissue enhanced esophagus: 7.2;skin: 35.3 tonsil: 5.3 FOXN2 HTLF ENSG00000170802 Forkhead box N2 2 48314637-48379294 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003485 Supported Supported Nucleus
Vesicles Renal cancer:2.81e-5 (unfavourable), Glioma:5.14e-4 (favourable) Expressed in all Expressed in all bone marrow: 36.5 FOXN3 C14orf116, CHES1 ENSG00000053254 Forkhead box N3 14 89124871-89619149 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA059209 Approved Approved Nucleus
Plasma membrane
Cytokinetic bridge Renal cancer:9.58e-5 (favourable) Expressed in all Expressed in all parathyroid gland: 109.4 FOXN4 ENSG00000139445 Forkhead box N4 12 109277979-109309220 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA050018 Uncertain Approved Nucleus
Mitochondria
Cytosol Tissue enhanced Tissue enriched 13 testis: 10.7 cervix, uterine: 0.7 FOXO1 FKH1, FKHR, FOXO1A ENSG00000150907 Forkhead box O1 13 40555667-40666597 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001252, CAB022326 Approved Approved Supported Nucleoplasm
Cytosol Renal cancer:1.33e-5 (favourable), Liver cancer:3.74e-4 (favourable) Expressed in all Expressed in all ovary: 80.5 FOXO3 AF6q21, FKHRL1, FOXO2, FOXO3A ENSG00000118689 Forkhead box O3 6 108559835-108684774 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB004074, HPA063104 Supported Validated Nucleus Expressed in all Expressed in all ovary: 54.9 FOXO4 AFX1, MLLT7 ENSG00000184481 Forkhead box O4 X 71096197-71103535 Cancer-related genes, Disease related genes, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors Evidence at protein level HPA039560, HPA040232 Approved Supported Nuclear speckles
Cytosol Renal cancer:3.46e-4 (favourable), Head and neck cancer:4.61e-4 (favourable) Expressed in all Expressed in all placenta: 171.9 FOXO6 ENSG00000204060 Forkhead box O6 1 41361922-41383590 Predicted intracellular proteins, Transcription factors Evidence at protein level Endometrial cancer:7.65e-6 (unfavourable) Expressed in all Tissue enhanced cerebral cortex: 1.7 prostate: 0.7 FOXP1 12CC4, hFKH1B, HSPC215, QRF1 ENSG00000114861 Forkhead box P1 3 70954693-71583989 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003876, CAB011501 Supported Validated Nucleoplasm Expressed in all Expressed in all ovary: 39.5 FOXP2 CAGH44, SPCH1, TNRC10 ENSG00000128573 Forkhead box P2 7 114086327-114693772 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA000382, HPA000383, HPA001679 Supported Supported Nucleoplasm
Vesicles
Centrosome Mixed Mixed endometrium: 13.6 FOXP3 AIID, DIETER, IPEX, JM2, PIDX, SCURFIN, XPID ENSG00000049768 Forkhead box P3 X 49250436-49264826 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB026301, HPA045943 Supported Approved Nucleoplasm Cervical cancer:1.91e-4 (favourable), Head and neck cancer:4.90e-4 (favourable), Endometrial cancer:7.02e-4 (favourable) Mixed Tissue enhanced appendix: 9.0 lymph node: 6.1 FOXP4 FLJ40908 ENSG00000137166 Forkhead box P4 6 41546426-41602384 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA007176 Approved Approved Nucleoplasm
Cytosol Endometrial cancer:1.17e-6 (unfavourable), Liver cancer:9.72e-4 (unfavourable) Expressed in all Expressed in all stomach: 37.2 FOXQ1 HFH1 ENSG00000164379 Forkhead box Q1 6 1312473-1314187 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA059700 Supported Nucleus Prostate cancer:6.68e-4 (favourable) Expressed in all Tissue enhanced stomach: 102.1;urinary bladder: 41.0 skin: 28.3 FOXR1 DLNB13, FOXN5 ENSG00000176302 Forkhead box R1 11 118971707-118981291 Predicted intracellular proteins, Transcription factors Evidence at protein level Tissue enriched Tissue enriched 14 testis: 3.1 thyroid gland: 0.2 FOXR2 FOXN6, MGC21658 ENSG00000189299 Forkhead box R2 X 55623400-55625325 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA034487, HPA057358 Uncertain Uncertain Nucleoplasm
Nuclear bodies Tissue enhanced Tissue enriched 15 testis: 2.8 epididymis: 0.1 FOXS1 FKHL18, FREAC10 ENSG00000179772 Forkhead box S1 20 31844301-31845619 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA042475 Approved Approved Nucleoplasm
Cytosol Renal cancer:1.10e-8 (unfavourable) Expressed in all Mixed placenta: 7.0 GABPA E4TF1-60, E4TF1A, NFT2, NRF2, NRF2A ENSG00000154727 GA binding protein transcription factor, alpha subunit 60kDa 21 25734570-25772460 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003258, CAB004411, HPA028791 Supported Validated Nucleoplasm Renal cancer:3.97e-5 (unfavourable) Expressed in all Expressed in all thyroid gland: 37.9 GATA1 ERYF1, GATA-1, GF1, NF-E1, NFE1 ENSG00000102145 GATA binding protein 1 (globin transcription factor 1) X 48786554-48794311 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA000232, HPA000233, CAB009195 Supported Not detected Tissue enriched 18 bone marrow: 33.3 testis: 1.8 GATA2 NFE1B ENSG00000179348 GATA binding protein 2 3 128479427-128493185 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA005633, CAB024847 Approved Supported Nucleoplasm Urothelial cancer:5.22e-5 (favourable), Renal cancer:2.04e-4 (favourable) Expressed in all Tissue enhanced seminal vesicle: 76.1 prostate: 60.0 GATA3 HDR ENSG00000107485 GATA binding protein 3 10 8053604-8075198 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB016217, HPA029730, HPA029731 Supported Supported Nucleoplasm Renal cancer:3.13e-4 (unfavourable) Group enriched Tissue enhanced parathyroid gland: 231.0;skin: 149.3 placenta: 44.1 GATA4 ENSG00000136574 GATA binding protein 4 8 11676959-11760002 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB013125, HPA073899 Uncertain Supported Nuclear bodies Tissue enhanced Tissue enhanced duodenum: 74.5;heart muscle: 61.7;ovary: 111.8 testis: 51.4 GATA5 bB379O24.1, GATAS ENSG00000130700 GATA binding protein 5 20 62463497-62475970 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA067583 Approved Nucleoplasm
Cytosol Tissue enhanced Tissue enhanced duodenum: 11.7;small intestine: 11.3;testis: 8.8 stomach: 7.6 GATA6 ENSG00000141448 GATA binding protein 6 18 22169443-22202528 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB011581, HPA066629 Uncertain Supported Nucleus Renal cancer:1.92e-9 (unfavourable) Tissue enhanced Mixed adrenal gland: 51.1 GATAD1 FLJ22489, ODAG, RG083M05.2 ENSG00000157259 GATA zinc finger domain containing 1 7 92447453-92458836 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA006105, HPA072785 Supported Nucleus Expressed in all Expressed in all thyroid gland: 42.5 GATAD2A p66alpha ENSG00000167491 GATA zinc finger domain containing 2A 19 19385826-19508931 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA006759, HPA024373 Supported Validated Nucleoplasm Expressed in all Expressed in all testis: 64.2 GATAD2B P66beta ENSG00000143614 GATA zinc finger domain containing 2B 1 153804725-153922975 Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA017015 Approved Validated Nucleoplasm Colorectal cancer:1.30e-4 (unfavourable), Renal cancer:3.08e-4 (unfavourable) Expressed in all Expressed in all testis: 16.0 GBX1 ENSG00000164900 Gastrulation brain homeobox 1 7 151148589-151174745 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA055783 Uncertain Tissue enhanced Group enriched 57 skeletal muscle: 4.4;testis: 6.9 all non-specific tissues: 0.0 GBX2 ENSG00000168505 Gastrulation brain homeobox 2 2 236165236-236168369 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA067809 Supported Nucleoplasm Group enriched Not detected cerebral cortex: 0.6 GCM1 GCMA, hGCMa ENSG00000137270 Glial cells missing homolog 1 (Drosophila) 6 53126964-53148829 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA011343 Supported Approved Vesicles Not detected Tissue enriched 21 placenta: 29.0 kidney: 1.4 GCM2 GCMB, hGCMb ENSG00000124827 Glial cells missing homolog 2 (Drosophila) 6 10873223-10881941 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Not detected Tissue enriched 985 parathyroid gland: 762.5 testis: 0.7 GFI1 GFI-1, GFI1A, ZNF163 ENSG00000162676 Growth factor independent 1 transcription repressor 1 92474762-92486876 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB011197 Uncertain Colorectal cancer:5.68e-5 (favourable) Mixed Tissue enhanced bone marrow: 34.9 lymph node: 8.2 GFI1B ZNF163B ENSG00000165702 Growth factor independent 1B transcription repressor 9 132945533-132991687 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB004420 Supported Not detected Tissue enriched 15 bone marrow: 23.7 testis: 1.5 GLI1 GLI ENSG00000111087 GLI family zinc finger 1 12 57460135-57472262 Predicted intracellular proteins, Transcription factors Evidence at protein level CAB009460, HPA065172 Uncertain Supported Nucleoplasm
Cytosol Tissue enhanced Tissue enhanced cervix, uterine: 15.0;endometrium: 15.1 gallbladder: 8.5 GLI2 HPE9, THP1, THP2 ENSG00000074047 GLI family zinc finger 2 2 120735623-120992653 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB008558, HPA074275 Approved Supported Nucleus
Nucleoli Mixed Tissue enhanced ovary: 11.6 endometrium: 5.9 GLI3 ACLS, GCPS, PAP-A, PAPA, PAPA1, PAPB, PHS, PPDIV ENSG00000106571 GLI family zinc finger 3 7 41960950-42237870 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA005534 Approved Mixed Mixed endometrium: 15.8 GLI4 HKR4, ZNF928 ENSG00000250571 GLI family zinc finger 4 8 143267433-143276931 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA023131 Uncertain Approved Nucleus
Cytokinetic bridge Expressed in all Expressed in all spleen: 9.0 GLIS1 FLJ36155 ENSG00000174332 GLIS family zinc finger 1 1 53506237-53738106 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA001409 Uncertain Tissue enhanced Tissue enhanced seminal vesicle: 10.8 prostate: 3.2 GLIS2 NPHP7 ENSG00000126603 GLIS family zinc finger 2 16 4314761-4339597 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA056976 Approved Nucleoplasm
Plasma membrane
Cytosol Renal cancer:8.06e-6 (favourable), Endometrial cancer:1.59e-5 (unfavourable) Expressed in all Mixed gallbladder: 9.7 GLIS3 MGC33662, ZNF515 ENSG00000107249 GLIS family zinc finger 3 9 3824127-4348392 Disease related genes, Predicted intracellular proteins, Predicted secreted proteins, Transcription factors Evidence at protein level HPA056426 Approved Supported Nucleoplasm Mixed Tissue enhanced thyroid gland: 34.8 fallopian tube: 17.0 GMEB1 P96PIF, PIF96 ENSG00000162419 Glucocorticoid modulatory element binding protein 1 1 28668732-28719353 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA044811, HPA052975 Supported Validated Nucleoplasm Liver cancer:8.91e-7 (unfavourable), Endometrial cancer:1.94e-4 (favourable) Expressed in all Mixed bone marrow: 8.6 GMEB2 KIAA1269, P79PIF, PIF79 ENSG00000101216 Glucocorticoid modulatory element binding protein 2 20 63587602-63627041 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA009706, HPA067455 Approved Validated Nucleoplasm Expressed in all Expressed in all testis: 12.8 GRHL1 LBP-32, MGR, TFCP2L2 ENSG00000134317 Grainyhead-like transcription factor 1 2 9951693-10002277 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA005798, HPA006420 Approved Validated Nucleus
Golgi apparatus
Vesicles Mixed Tissue enhanced esophagus: 111.9;skin: 106.8 parathyroid gland: 51.7 GRHL2 BOM, DFNA28, FLJ13782, TFCP2L3 ENSG00000083307 Grainyhead-like transcription factor 2 8 101492432-101669726 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA004820, HPA062839 Uncertain Supported Nucleoplasm Pancreatic cancer:6.27e-4 (unfavourable), Breast cancer:6.43e-4 (unfavourable) Mixed Tissue enhanced prostate: 38.8 skin: 34.0 GRHL3 SOM, TFCP2L4 ENSG00000158055 Grainyhead-like transcription factor 3 1 24319322-24364482 Disease related genes, Predicted intracellular proteins, Predicted secreted proteins, Transcription factors Evidence at protein level HPA059960 Approved Nucleoplasm Tissue enhanced Group enriched 10 esophagus: 85.4;skin: 50.1;tonsil: 23.6;urinary bladder: 29.2 testis: 4.5 GSC ENSG00000133937 Goosecoid homeobox 14 94768216-94770230 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA075650 Approved Nucleus
Nuclear bodies Mixed Tissue enhanced adipose tissue: 2.1 breast: 1.1 GSC2 GSCL ENSG00000063515 Goosecoid homeobox 2 22 19148576-19150283 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA043011 Uncertain Not detected Tissue enriched 31 testis: 3.0 all non-specific tissues: 0.0 GSX1 Gsh-1, GSH1 ENSG00000169840 GS homeobox 1 13 27792643-27794768 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA047096 Uncertain Tissue enriched Not detected cerebral cortex: 0.7 GSX2 Gsh2 ENSG00000180613 GS homeobox 2 4 54099523-54102505 Predicted intracellular proteins, Transcription factors Evidence at transcript level Tissue enriched Not detected testis: 0.4 GTF3A AP2, TFIIIA ENSG00000122034 General transcription factor IIIA 13 27424544-27435823 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA007990 Supported Supported Nucleus Renal cancer:3.43e-6 (unfavourable) Expressed in all Expressed in all lymph node: 99.6 GZF1 dJ322G13.2, ZBTB23, ZNF336 ENSG00000125812 GDNF-inducible zinc finger protein 1 20 23362182-23373063 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA024520 Uncertain Supported Nucleus
Nucleoli Liver cancer:9.81e-7 (unfavourable) Expressed in all Expressed in all adrenal gland: 25.5 HAND1 bHLHa27, eHand, Hxt, Thing1 ENSG00000113196 Heart and neural crest derivatives expressed 1 5 154474972-154478264 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA040925 Approved Uncertain Nucleus
Nuclear membrane Group enriched Tissue enhanced smooth muscle: 16.6 adrenal gland: 6.3 HAND2 bHLHa26, dHand, Hed, Thing2 ENSG00000164107 Heart and neural crest derivatives expressed 2 4 173524969-173530229 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA019591, CAB025576 Approved Supported Nucleoplasm
Vesicles Tissue enhanced Tissue enhanced endometrium: 83.7 smooth muscle: 77.6 HBP1 ENSG00000105856 HMG-box transcription factor 1 7 107168961-107202529 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA020225, CAB032824 Approved Validated Nuclear speckles Renal cancer:7.70e-5 (favourable) Expressed in all Expressed in all thyroid gland: 108.7 HDX CXorf43, FLJ30678 ENSG00000165259 Highly divergent homeobox X 84317874-84502479 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA047189 Approved Approved Cytosol Mixed Mixed cerebral cortex: 3.8 HELT bHLHb44, HCM1228, HESL, MEGANE, Mgn ENSG00000187821 Helt bHLH transcription factor 4 185018841-185020804 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA036188, HPA036189 Uncertain Not detected Not detected lung: 0.5 HES1 bHLHb39, FLJ20408, HES-1, Hes1, HRY ENSG00000114315 Hes family bHLH transcription factor 1 3 194136145-194138732 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA050504 Supported Nucleoplasm Urothelial cancer:2.04e-5 (favourable) Expressed in all Mixed thyroid gland: 97.6 HES2 bHLHb40 ENSG00000069812 Hes family bHLH transcription factor 2 1 6412418-6424670 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA039462 Uncertain Mixed Tissue enhanced skin: 17.0 placenta: 9.8 HES3 bHLHb43 ENSG00000173673 Hes family bHLH transcription factor 3 1 6244192-6245578 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA047927, HPA072697 Uncertain Uncertain Nucleus Tissue enriched Not detected testis: 0.1 HES4 bHLHb42 ENSG00000188290 Hes family bHLH transcription factor 4 1 998962-1000172 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA062465 Approved Nucleoplasm
Vesicles
Cytosol Liver cancer:2.99e-4 (unfavourable), Endometrial cancer:3.85e-4 (favourable), Renal cancer:6.27e-4 (unfavourable) Expressed in all Mixed cerebral cortex: 7.5 HES5 bHLHb38 ENSG00000197921 Hes family bHLH transcription factor 5 1 2528745-2530245 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA065458 Approved Nucleoplasm
Nuclear speckles
Cytosol Tissue enhanced Tissue enhanced cerebral cortex: 1.8 skin: 0.9 HES6 bHLHb41 ENSG00000144485 Hes family bHLH transcription factor 6 2 238238267-238240662 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA061763 Approved Nucleus
Nucleoli
Nuclear bodies
Cytosol Lung cancer:9.18e-5 (favourable), Liver cancer:2.79e-4 (unfavourable) Expressed in all Tissue enhanced cerebral cortex: 77.0 fallopian tube: 22.1 HES7 bHLHb37 ENSG00000179111 Hes family bHLH transcription factor 7 17 8120590-8124092 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA072105 Uncertain Approved Nucleoplasm
Nucleoli Not detected Tissue enhanced placenta: 1.1 testis: 1.0 HESX1 ANF, RPX ENSG00000163666 HESX homeobox 1 3 57197843-57226521 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA024187 Approved Approved Nucleus Tissue enhanced Tissue enhanced testis: 12.5 epididymis,skin: 5.4 HEY1 bHLHb31, CHF-2, CHF2, HERP2, HESR-1, HESR1, HRT-1 ENSG00000164683 Hes-related family bHLH transcription factor with YRPW motif 1 8 79764010-79767863 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA055599, HPA063472 Uncertain Approved Nucleoplasm
Nuclear membrane
Cytosol Expressed in all Tissue enhanced cerebral cortex: 96.6 placenta: 28.7 HEY2 bHLHb32, HERP1, HESR2 ENSG00000135547 Hes-related family bHLH transcription factor with YRPW motif 2 6 125747664-125761269 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA030205, HPA074851 Approved Approved Nuclear bodies
Aggresome Expressed in all Mixed fallopian tube: 21.5 HEYL bHLHb33, HESR3, HEY3 ENSG00000163909 Hes-related family bHLH transcription factor with YRPW motif-like 1 39624153-39639945 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001438 Approved Mitochondria
Cytosol Renal cancer:2.26e-6 (unfavourable), Urothelial cancer:2.63e-5 (unfavourable), Stomach cancer:3.57e-4 (unfavourable) Expressed in all Mixed placenta: 44.0 HHEX HEX, HOX11L-PEN, PRHX ENSG00000152804 Hematopoietically expressed homeobox 10 92689951-92695646 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA051894, HPA055460 Approved Approved Nucleoplasm
Mitochondria Renal cancer:3.25e-5 (unfavourable), Cervical cancer:3.91e-5 (favourable), Liver cancer:6.23e-4 (unfavourable), Breast cancer:8.83e-4 (favourable) Expressed in all Expressed in all thyroid gland: 163.9 HIC1 ZBTB29, ZNF901 ENSG00000177374 Hypermethylated in cancer 1 17 2054154-2063241 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA043372 Uncertain Supported Nucleoplasm
Cytosol Renal cancer:9.36e-6 (unfavourable) Expressed in all Mixed endometrium: 16.2 HIC2 HRG22, KIAA1020, ZBTB30, ZNF907 ENSG00000169635 Hypermethylated in cancer 2 22 21417404-21451463 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA031884, HPA059399 Uncertain Supported Nucleus Endometrial cancer:7.42e-5 (unfavourable) Tissue enriched Mixed placenta: 8.4 HIF1A bHLHe78, HIF-1alpha, HIF1, MOP1, PASD8 ENSG00000100644 Hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) 14 61695513-61748259 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA000907, HPA001275, CAB017442 Supported Supported Nucleoplasm
Nuclear bodies
Plasma membrane Expressed in all Expressed in all bone marrow: 292.9 HIF3A bHLHe17, IPAS, MOP7, PASD7 ENSG00000124440 Hypoxia inducible factor 3, alpha subunit 19 46297046-46343433 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA041141 Approved Supported Nucleoplasm
Plasma membrane
Cytosol Endometrial cancer:6.90e-9 (unfavourable) Mixed Tissue enhanced placenta: 39.5 spleen: 20.3 HINFP DKFZP434F162, HiNF-P, MIZF, ZNF743 ENSG00000172273 Histone H4 transcription factor 11 119121587-119136044 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA059053, HPA061008 Uncertain Supported Nucleus
Cell Junctions
Cytosol Liver cancer:4.44e-8 (unfavourable), Thyroid cancer:5.26e-4 (favourable) Expressed in all Expressed in all testis: 12.0 HIVEP1 CIRIP, CRYBP1, MBP-1, PRDII-BF1, Schnurri-1, ZAS1, ZNF40, ZNF40A ENSG00000095951 Human immunodeficiency virus type I enhancer binding protein 1 6 12008762-12164999 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA050724 Approved Supported Nucleoplasm
Nuclear bodies
Mitochondria Expressed in all Mixed parathyroid gland: 25.7 HIVEP2 HIV-EP2, MBP-2, MIBP1, Schnurri-2, ZAS2, ZNF40B ENSG00000010818 Human immunodeficiency virus type I enhancer binding protein 2 6 142751467-142945201 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA055954 Supported Nucleoplasm Expressed in all Expressed in all cerebral cortex: 31.5 HIVEP3 FLJ16752, KBP-1, KBP1, KIAA1555, KRC, Schnurri-3, SHN3, ZAS3, ZNF40C ENSG00000127124 Human immunodeficiency virus type I enhancer binding protein 3 1 41506365-42035925 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA005728 Approved Approved Nucleoplasm Mixed Mixed skin: 5.7 HKR1 ZNF875 ENSG00000181666 HKR1, GLI-Kruppel zinc finger family member 19 37312837-37369365 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA036126, HPA044855 Approved Supported Nucleoplasm
Golgi apparatus
Mitochondria Prostate cancer:5.18e-5 (unfavourable), Pancreatic cancer:4.41e-4 (favourable) Expressed in all Expressed in all thyroid gland: 54.4 HLF MGC33822 ENSG00000108924 Hepatic leukemia factor 17 55265012-55325065 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA068156, HPA071210 Validated Nucleus Lung cancer:2.71e-7 (favourable), Renal cancer:3.55e-6 (favourable), Head and neck cancer:1.88e-4 (favourable) Tissue enhanced Mixed cerebral cortex: 65.6 HLX HB24, HLX1 ENSG00000136630 H2.0-like homeobox 1 220879400-220885059 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA005968 Uncertain Approved Nucleoplasm
Cytosol Renal cancer:7.28e-6 (unfavourable) Expressed in all Tissue enhanced bone marrow: 60.5 lung: 27.2 HMBOX1 FLJ21616, HNF1LA, HOT1, PBHNF ENSG00000147421 Homeobox containing 1 8 28890394-29064764 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA055855, HPA058586, CAB070418 Approved Validated Nucleoplasm
Nuclear bodies
Cytosol Expressed in all Mixed testis: 14.0 HMG20A FLJ10739, HMGX1, HMGXB1 ENSG00000140382 High mobility group 20A 15 77420412-77485607 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA008126 Supported Approved Nucleus Expressed in all Expressed in all spleen: 49.8 HMG20B BRAF25, BRAF35, HMGX2, HMGXB2, SMARCE1r, SOXL ENSG00000064961 High mobility group 20B 19 3572777-3579088 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA050220, HPA053157, HPA069832 Approved Validated Nucleoplasm Endometrial cancer:1.72e-7 (favourable), Urothelial cancer:2.89e-5 (favourable) Expressed in all Expressed in all prostate: 64.9 HMGA1 HMGIY ENSG00000137309 High mobility group AT-hook 1 6 34236873-34246231 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB032200 Uncertain Approved Nucleus
Nucleoli Liver cancer:1.29e-6 (unfavourable), Lung cancer:3.36e-4 (unfavourable), Endometrial cancer:7.13e-4 (unfavourable), Pancreatic cancer:8.71e-4 (unfavourable) Expressed in all Expressed in all lymph node: 165.8 HMGA2 BABL, HMGIC, LIPO ENSG00000149948 High mobility group AT-hook 2 12 65824131-65966295 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB017809, HPA039076 Approved Supported Nucleus
Nucleoli Urothelial cancer:2.86e-4 (unfavourable), Head and neck cancer:4.79e-4 (unfavourable) Mixed Mixed testis: 3.7 HMGXB3 HMGX3, KIAA0194, SMF ENSG00000113716 HMG box domain containing 3 5 150000046-150053142 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA005967 Approved Nucleoli Liver cancer:3.37e-5 (unfavourable) Expressed in all Tissue enriched 11 parathyroid gland: 278.2 prostate: 26.2 HMGXB4 HMG2L1, THC211630 ENSG00000100281 HMG box domain containing 4 22 35257452-35295807 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA000725 Approved Colorectal cancer:3.24e-5 (favourable), Pancreatic cancer:1.16e-4 (unfavourable), Liver cancer:4.79e-4 (unfavourable) Expressed in all Expressed in all endometrium: 18.7 HMX1 H6, NKX5-3 ENSG00000215612 H6 family homeobox 1 4 8846076-8871817 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at transcript level Tissue enhanced Tissue enhanced cerebral cortex: 1.1 testis: 0.9 HMX2 NKX5-2 ENSG00000188816 H6 family homeobox 2 10 123148122-123150672 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA043379 Uncertain Tissue enhanced Tissue enriched 6 kidney: 1.2 duodenum: 0.2 HMX3 NKX5-1 ENSG00000188620 H6 family homeobox 3 10 123135962-123137741 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA069659 Approved Nucleus
Microtubule organizing center Mixed Not detected adipose tissue,small intestine: 0.3 HNF1B HNF1beta, LFB3, MODY5, TCF2, VHNF1 ENSG00000275410 HNF1 homeobox B 17 37686432-37745247 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA002083, CAB068192 Supported Supported Nucleoplasm Urothelial cancer:2.51e-6 (favourable), Renal cancer:6.00e-4 (favourable) Tissue enhanced Tissue enhanced gallbladder: 21.6;kidney: 25.2 lung: 9.6 HNF4A HNF4, MODY, MODY1, NR2A1, TCF14 ENSG00000101076 Hepatocyte nuclear factor 4, alpha 20 44355700-44434596 Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA004712, CAB019417 Supported Supported Nucleoplasm Tissue enhanced Group enriched 7 colon: 58.9;duodenum: 105.9;kidney: 44.3;liver: 50.9;rectum: 48.5;small intestine: 92.8;stomach: 22.1 gallbladder: 9.2 HNF4G NR2A2 ENSG00000164749 Hepatocyte nuclear factor 4, gamma 8 75407914-75566843 Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA005438, HPA010610 Supported Approved Nucleoplasm
Cytosol Mixed Group enriched 5 duodenum: 103.0;small intestine: 128.1 rectum: 21.4 HOMEZ KIAA1443 ENSG00000215271 Homeobox and leucine zipper encoding 14 23272422-23299447 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA036316, HPA036317 Approved Supported Nucleus
Nucleoli Renal cancer:1.17e-11 (favourable), Ovarian cancer:2.41e-5 (favourable), Thyroid cancer:1.75e-4 (favourable) Expressed in all Expressed in all testis: 41.5 HOPX HOP, LAGY, NECC1, OB1, SMAP31 ENSG00000171476 HOP homeobox 4 56647988-56681899 Predicted intracellular proteins, Transcription factors Evidence at protein level CAB018632, HPA030180 Supported Mixed Tissue enhanced epididymis: 647.0;skin: 840.3 esophagus: 527.6 HOXA1 HOX1, HOX1F ENSG00000105991 Homeobox A1 7 27092993-27095996 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Head and neck cancer:6.73e-5 (unfavourable) Mixed Tissue enhanced urinary bladder: 8.7 parathyroid gland,skin: 2.7 HOXA10 HOX1, HOX1H ENSG00000253293 Homeobox A10 7 27170591-27180261 Predicted intracellular proteins, Transcription factors Evidence at protein level CAB019384 Approved Supported Nucleoplasm
Nuclear bodies Mixed Tissue enhanced endometrium: 116.3;smooth muscle: 67.0 prostate: 42.4 HOXA11 HOX1, HOX1I ENSG00000005073 Homeobox A11 7 27181510-27185223 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA006770, HPA035623 Supported Supported Nucleoplasm Renal cancer:2.57e-5 (unfavourable) Mixed Tissue enhanced endometrium: 96.0;smooth muscle: 67.7 cervix, uterine: 18.3 HOXA13 HOX1, HOX1J ENSG00000106031 Homeobox A13 7 27193503-27200106 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA046098 Approved Nucleoplasm
Intermediate filaments Tissue enhanced Tissue enhanced cervix, uterine: 33.9;placenta: 24.3;prostate: 36.5;seminal vesicle: 32.2 rectum: 13.3 HOXA2 HOX1K ENSG00000105996 Homeobox A2 7 27100354-27102811 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA078220 Approved Nucleus
Vesicles Mixed Tissue enhanced parathyroid gland: 8.1 epididymis: 6.1 HOXA3 HOX1, HOX1E ENSG00000105997 Homeobox A3 7 27106184-27152581 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA029157 Uncertain Supported Nucleoplasm Renal cancer:2.52e-6 (unfavourable) Mixed Tissue enhanced fallopian tube: 25.4 parathyroid gland: 11.3 HOXA4 HOX1, HOX1D ENSG00000197576 Homeobox A4 7 27128507-27130799 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA060088 Approved Validated Nuclear bodies Endometrial cancer:6.37e-4 (unfavourable) Mixed Tissue enhanced fallopian tube: 36.8;parathyroid gland: 34.7 esophagus: 16.4 HOXA5 HOX1, HOX1C ENSG00000106004 Homeobox A5 7 27141052-27143668 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA029319 Uncertain Endometrial cancer:2.28e-4 (unfavourable) Mixed Tissue enhanced adrenal gland: 110.5;epididymis: 59.1 fallopian tube: 43.5 HOXA6 HOX1, HOX1B ENSG00000106006 Homeobox A6 7 27145396-27150603 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA004203 Approved Endometrial cancer:1.40e-4 (unfavourable), Renal cancer:2.03e-4 (favourable) Mixed Tissue enhanced fallopian tube: 10.1 endometrium: 9.0 HOXA7 HOX1, HOX1A ENSG00000122592 Homeobox A7 7 27153716-27157936 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA074048 Approved Nucleoplasm
Nuclear membrane Renal cancer:1.15e-5 (favourable), Endometrial cancer:7.87e-5 (unfavourable) Mixed Mixed epididymis: 22.3 HOXA9 HOX1, HOX1G ENSG00000078399 Homeobox A9 7 27162435-27175180 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA061982 Uncertain Supported Nucleus Mixed Mixed kidney: 12.5 HOXB1 HOX2, HOX2I ENSG00000120094 Homeobox B1 17 48528526-48530997 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA044576 Uncertain Tissue enriched Not detected testis: 0.3 HOXB13 ENSG00000159184 Homeobox B13 17 48724763-48729178 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB004438, HPA062852, HPA065019 Supported Validated Nucleoplasm Tissue enriched Tissue enhanced prostate: 112.2;rectum: 39.9 colon: 21.9 HOXB2 HOX2, HOX2H ENSG00000173917 Homeobox B2 17 48540894-48544989 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA047857 Supported Nucleus Glioma:3.01e-4 (unfavourable) Expressed in all Tissue enhanced epididymis: 56.0 cervix, uterine: 24.6 HOXB3 HOX2, HOX2G ENSG00000120093 Homeobox B3 17 48548870-48604912 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB009860, HPA064990 Approved Supported Nucleus Urothelial cancer:8.45e-6 (favourable) Mixed Tissue enhanced epididymis: 85.0 fallopian tube: 39.8 HOXB4 HOX2, HOX2F ENSG00000182742 Homeobox B4 17 48575513-48580111 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA057432 Uncertain Approved Nucleus
Centrosome Ovarian cancer:2.23e-4 (unfavourable) Mixed Tissue enhanced epididymis: 15.9 fallopian tube: 12.4 HOXB5 HOX2, HOX2A ENSG00000120075 Homeobox B5 17 48591257-48593961 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA074454 Supported Nucleus Urothelial cancer:8.59e-5 (favourable), Lung cancer:4.61e-4 (unfavourable), Endometrial cancer:6.28e-4 (favourable) Tissue enhanced Tissue enhanced epididymis: 20.8 fallopian tube: 11.0 HOXB6 HOX2, HOX2B ENSG00000108511 Homeobox B6 17 48595751-48604992 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA042063 Approved Nucleus
Golgi apparatus Endometrial cancer:2.46e-4 (favourable) Tissue enhanced Tissue enhanced epididymis: 48.4;seminal vesicle: 29.8 cervix, uterine: 26.3 HOXB7 HOX2, HOX2C ENSG00000260027 Homeobox B7 17 48607227-48633572 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA049940 Uncertain Supported Nucleoplasm
Nuclear bodies
Cytosol Urothelial cancer:2.39e-4 (favourable) Mixed Tissue enhanced epididymis: 161.9 cervix, uterine: 32.9 HOXB8 HOX2, HOX2D ENSG00000120068 Homeobox B8 17 48611377-48614939 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA075905 Supported Nucleoplasm Renal cancer:1.30e-7 (favourable) Tissue enhanced Tissue enhanced epididymis: 67.4;seminal vesicle: 32.6 cervix, uterine: 16.9 HOXB9 HOX2, HOX2E ENSG00000170689 Homeobox B9 17 48621159-48626356 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA031463 Approved Nucleoplasm
Mitochondria Head and neck cancer:6.64e-5 (unfavourable), Endometrial cancer:4.47e-4 (unfavourable) Tissue enhanced Tissue enhanced epididymis: 105.5 colon: 26.5 HOXC10 HOX3I ENSG00000180818 Homeobox C10 12 53985065-53990279 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA053919 Uncertain Supported Nuclear bodies Mixed Group enriched 8 kidney: 18.8;skeletal muscle: 40.3;skin: 8.4 breast: 2.6 HOXC11 HOX3H ENSG00000123388 Homeobox C11 12 53973126-53977643 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors Evidence at protein level HPA038291 Uncertain Supported Nucleoplasm
Cytosol Mixed Tissue enhanced skin: 2.3 testis: 1.2 HOXC12 HOC3F, HOX3, HOX3F ENSG00000123407 Homeobox C12 12 53954834-53958956 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA055632 Uncertain Mixed Not detected skin: 0.7 HOXC13 HOX3, HOX3G ENSG00000123364 Homeobox C13 12 53938765-53946544 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA051634 Supported Mixed Tissue enriched 7 skin: 4.6 breast: 0.6 HOXC4 HOX3, HOX3E ENSG00000198353 Homeobox C4 12 54016931-54056030 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA053910 Supported Nucleus Mixed Tissue enhanced fallopian tube: 33.6 kidney: 9.4 HOXC5 HOX3, HOX3D ENSG00000172789 Homeobox C5 12 54032853-54035358 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA026794 Uncertain Supported Nucleoplasm Tissue enhanced Tissue enhanced fallopian tube: 6.0 ovary: 3.1 HOXC6 HOX3, HOX3C ENSG00000197757 Homeobox C6 12 53990624-54030823 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA054981 Supported Nucleoplasm
Cytosol Renal cancer:3.55e-6 (unfavourable) Mixed Mixed epididymis: 22.0 HOXC8 HOX3, HOX3A ENSG00000037965 Homeobox C8 12 54009106-54012362 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA028911, CAB037020 Uncertain Approved Nucleoplasm
Microtubules Renal cancer:1.47e-5 (unfavourable) Mixed Tissue enhanced epididymis: 20.9;smooth muscle: 12.7 adrenal gland: 7.7 HOXC9 HOX3, HOX3B ENSG00000180806 Homeobox C9 12 53994895-54003337 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA063965, HPA072160 Validated Nucleoplasm Mixed Tissue enhanced skeletal muscle: 6.2 adipose tissue: 3.3 HOXD1 HOX4, HOX4G ENSG00000128645 Homeobox D1 2 176188579-176190907 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA040062, HPA056900 Supported Nucleoplasm Tissue enhanced Tissue enhanced epididymis: 8.6;fallopian tube: 7.4 lung: 4.6 HOXD10 HOX4, HOX4D ENSG00000128710 Homeobox D10 2 176108790-176119942 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA065871 Approved Nucleoplasm
Cytosol
Cytoplasmic bodies Renal cancer:1.92e-6 (unfavourable) Mixed Tissue enhanced endometrium: 48.0;smooth muscle: 24.9 kidney: 12.6 HOXD11 HOX4, HOX4F ENSG00000128713 Homeobox D11 2 176104216-176109754 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA055155 Approved Nucleoplasm Mixed Tissue enhanced endometrium: 5.9 colon,smooth muscle: 1.6 HOXD12 HOX4H ENSG00000170178 Homeobox D12 2 176099730-176101193 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA059444 Uncertain Not detected Tissue enhanced colon: 1.0;rectum: 1.1;seminal vesicle: 1.8 prostate: 0.8 HOXD13 HOX4I, SPD ENSG00000128714 Homeobox D13 2 176092891-176095938 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA064064 Supported Nucleus Colorectal cancer:6.95e-5 (unfavourable) Mixed Group enriched 8 cervix, uterine: 7.9;colon: 5.1;prostate: 18.4;rectum: 9.6;seminal vesicle: 24.4 urinary bladder: 1.6 HOXD3 HOX1D, HOX4, HOX4A ENSG00000128652 Homeobox D3 2 176136612-176173102 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA051831, HPA063671 Validated Nucleoplasm
Nuclear bodies Tissue enhanced Tissue enriched 6 epididymis: 45.8 fallopian tube: 8.1 HOXD4 HOX4, HOX4B ENSG00000170166 Homeobox D4 2 176151222-176153226 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA054383, HPA070349 Approved Validated Nucleus
Cell Junctions Tissue enhanced Tissue enhanced endometrium: 23.5;epididymis: 22.6 fallopian tube: 15.4 HOXD8 HOX4, HOX4E ENSG00000175879 Homeobox D8 2 176129694-176132695 Predicted intracellular proteins, Transcription factors Evidence at transcript level Lung cancer:3.78e-4 (unfavourable) Mixed Tissue enhanced epididymis: 121.2;kidney: 83.6 ovary: 43.6 HOXD9 HOX4, HOX4C ENSG00000128709 Homeobox D9 2 176122720-176124937 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA068683 Supported Nucleus
Nucleoli Liver cancer:1.08e-5 (unfavourable), Colorectal cancer:8.25e-4 (unfavourable), Head and neck cancer:9.58e-4 (favourable) Expressed in all Tissue enhanced endometrium: 45.3 smooth muscle: 23.6 HSF1 HSTF1 ENSG00000185122 Heat shock transcription factor 1 8 144291591-144314722 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB004239, HPA008888 Supported Supported Nucleoplasm
Cytosol Liver cancer:4.95e-4 (unfavourable), Endometrial cancer:8.93e-4 (unfavourable) Expressed in all Expressed in all testis: 127.1 HSF2 ENSG00000025156 Heat shock transcription factor 2 6 122399546-122433119 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB016067, HPA031455 Approved Supported Nucleoplasm Liver cancer:1.51e-6 (unfavourable), Renal cancer:7.65e-4 (unfavourable) Expressed in all Expressed in all testis: 71.1 HSF4 CTM ENSG00000102878 Heat shock transcription factor 4 16 67164681-67169945 Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA048584 Supported Nuclear speckles Renal cancer:2.19e-6 (unfavourable), Colorectal cancer:8.24e-5 (unfavourable) Expressed in all Mixed adrenal gland: 14.9 HSF5 FLJ40311 ENSG00000176160 Heat shock transcription factor family member 5 17 58420167-58488384 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA063613 Supported Not detected Tissue enriched 64 testis: 94.4 lymph node: 1.4 HSFX1 LW-1 ENSG00000171116 Heat shock transcription factor family, X-linked 1 X 149774068-149776867 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA051700 Uncertain Not detected Mixed ovary: 4.6 HSFX2 ENSG00000268738 Heat shock transcription factor family, X-linked 2 X 149592515-149594716 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA051700 Uncertain Not detected Tissue enriched 9 testis: 9.3 seminal vesicle: 1.0 HSFY1 HSF2L, HSFY ENSG00000172468 Heat shock transcription factor, Y-linked 1 Y 18546671-18588963 Predicted intracellular proteins, Transcription factors Evidence at protein level Not detected Tissue enriched 106 testis: 24.7 epididymis,kidney: 0.2 HSFY2 FLJ25453 ENSG00000169953 Heat shock transcription factor, Y-linked 2 Y 18731440-18828662 Predicted intracellular proteins, Transcription factors Evidence at protein level Not detected Tissue enriched 175 testis: 24.5 kidney: 0.1 ID1 bHLHb24, dJ857M17.1.2 ENSG00000125968 Inhibitor of DNA binding 1, dominant negative helix-loop-helix protein 20 31605283-31606515 Cancer-related genes, Plasma proteins, Predicted secreted proteins, Transcription factors Evidence at protein level CAB025915, HPA051456, HPA058518 Approved Validated Nucleoplasm
Golgi apparatus Lung cancer:4.85e-4 (unfavourable) Expressed in all Expressed in all seminal vesicle: 211.5 ID2 bHLHb26, GIG8 ENSG00000115738 Inhibitor of DNA binding 2, dominant negative helix-loop-helix protein 2 8678845-8684453 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA027612 Approved Nucleoplasm
Nuclear bodies
Centrosome Head and neck cancer:9.95e-4 (favourable) Expressed in all Tissue enriched 5 parathyroid gland: 1947.2 thyroid gland: 357.9 ID3 bHLHb25, HEIR-1 ENSG00000117318 Inhibitor of DNA binding 3, dominant negative helix-loop-helix protein 1 23557918-23559794 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB021353, HPA024677 Approved Supported Nucleoplasm Endometrial cancer:1.27e-5 (favourable) Expressed in all Mixed seminal vesicle: 90.6 ID4 bHLHb27 ENSG00000172201 Inhibitor of DNA binding 4, dominant negative helix-loop-helix protein 6 19837386-19840684 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA060800 Supported Nucleus Pancreatic cancer:2.49e-4 (favourable) Expressed in all Tissue enhanced thyroid gland: 623.1 fallopian tube: 127.6 IKZF1 hIk-1, Hs.54452, IKAROS, LyF-1, PPP1R92, ZNFN1A1 ENSG00000185811 IKAROS family zinc finger 1 (Ikaros) 7 50304124-50405101 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors Evidence at protein level CAB009247, HPA035221, HPA035222 Supported Approved Nucleoplasm
Nucleoli
Vesicles Cervical cancer:2.02e-4 (favourable), Breast cancer:4.28e-4 (favourable), Head and neck cancer:8.63e-4 (favourable) Expressed in all Tissue enhanced lymph node: 84.0;tonsil: 58.0 appendix: 55.9 IKZF2 Helios, ZNFN1A2 ENSG00000030419 IKAROS family zinc finger 2 (Helios) 2 212999691-213152427 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA059142 Approved Approved Nucleoplasm
Nuclear bodies
Cytosol Mixed Mixed esophagus: 21.4 IKZF3 Aiolos, ZNFN1A3 ENSG00000161405 IKAROS family zinc finger 3 (Aiolos) 17 39757715-39864188 Predicted intracellular proteins, Transcription factors Evidence at protein level CAB017105, HPA024377 Supported Uncertain Plasma membrane
Cytosol Cervical cancer:6.85e-6 (favourable), Head and neck cancer:4.16e-4 (favourable), Melanoma:5.42e-4 (favourable), Renal cancer:7.38e-4 (unfavourable) Mixed Tissue enhanced lymph node: 45.2;spleen: 32.2;tonsil: 40.9 appendix: 26.4 IKZF4 Eos, ZNFN1A4 ENSG00000123411 IKAROS family zinc finger 4 (Eos) 12 56007659-56038435 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA046270, HPA049016 Approved Supported Nucleoplasm
Nuclear bodies Lung cancer:3.46e-4 (favourable), Pancreatic cancer:4.37e-4 (favourable) Mixed Mixed parathyroid gland: 16.1 IKZF5 FLJ22973, Pegasus, ZNFN1A5 ENSG00000095574 IKAROS family zinc finger 5 (Pegasus) 10 122990806-123008817 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA015297, HPA051574 Supported Nucleoplasm
Plasma membrane
Cytosol Expressed in all Expressed in all bone marrow: 21.4 INSM1 IA-1, IA1 ENSG00000173404 Insulinoma-associated 1 20 20368121-20370949 Predicted intracellular proteins, Transcription factors Evidence at protein level Mixed Tissue enhanced adrenal gland: 9.4;stomach: 5.7 duodenum: 3.1 INSM2 IA-6 ENSG00000168348 Insulinoma-associated 2 14 35534042-35537054 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA044885, HPA051925 Uncertain Approved Nucleoplasm Not detected Tissue enhanced cerebral cortex: 1.3 testis: 0.7 IRF1 MAR ENSG00000125347 Interferon regulatory factor 1 5 132481609-132490798 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB011662, HPA063131 Supported Supported Nucleoplasm
Cytosol Renal cancer:1.09e-7 (unfavourable) Expressed in all Expressed in all spleen: 137.5 IRF2 ENSG00000168310 Interferon regulatory factor 2 4 184387713-184474580 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA030813, CAB032306, HPA057327 Supported Validated Nucleoplasm
Cytosol Breast cancer:6.95e-5 (favourable), Thyroid cancer:8.34e-5 (favourable) Expressed in all Expressed in all spleen: 75.4 IRF3 ENSG00000126456 Interferon regulatory factor 3 19 49659569-49665875 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA004895, CAB013018 Approved Supported Cytosol Renal cancer:1.56e-7 (unfavourable), Urothelial cancer:3.61e-4 (favourable) Expressed in all Expressed in all lymph node: 47.9 IRF4 LSIRF, MUM1 ENSG00000137265 Interferon regulatory factor 4 6 391739-411447 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA002038, HPA002698, CAB013508 Supported Supported Nucleoplasm Head and neck cancer:1.64e-6 (favourable), Breast cancer:6.44e-4 (favourable) Tissue enriched Tissue enhanced lymph node: 27.4 tonsil: 25.0 IRF5 ENSG00000128604 Interferon regulatory factor 5 7 128937612-128950035 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA046700 Approved Expressed in all Mixed spleen: 25.3 IRF6 LPS, OFC6, VWS, VWS1 ENSG00000117595 Interferon regulatory factor 6 1 209785623-209806175 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA063121, HPA076162 Approved Validated Nucleus
Cytosol Renal cancer:0.00e+0 (favourable) Mixed Mixed skin: 84.2 IRF7 ENSG00000185507 Interferon regulatory factor 7 11 612553-615999 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB017694, HPA052757 Approved Uncertain Nucleoplasm
Cytosol Renal cancer:1.71e-10 (unfavourable) Expressed in all Mixed bone marrow: 1.8 IRF8 ICSBP, ICSBP1, IRF-8 ENSG00000140968 Interferon regulatory factor 8 16 85898803-85922609 Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA002267, HPA002531, CAB013480 Supported Validated Nucleoplasm Expressed in all Tissue enhanced lymph node: 302.0;spleen: 209.3;tonsil: 242.0 appendix: 122.6 IRF9 ISGF3G ENSG00000213928 Interferon regulatory factor 9 14 24161053-24166565 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001862 Approved Supported Cytosol Renal cancer:7.58e-8 (unfavourable), Urothelial cancer:9.92e-4 (favourable) Expressed in all Expressed in all spleen: 96.0 IRX1 IRX-5 ENSG00000170549 Iroquois homeobox 1 5 3596054-3601403 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA043160 Uncertain Supported Nucleoplasm
Golgi apparatus Group enriched Tissue enhanced breast: 7.7;kidney: 5.3;salivary gland: 5.7 lung: 3.6 IRX2 ENSG00000170561 Iroquois homeobox 2 5 2745845-2751662 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA050895, HPA054669 Approved Approved Nucleus
Nucleoli Pancreatic cancer:8.84e-4 (favourable) Mixed Tissue enhanced breast: 29.4;lung: 28.1 skin: 19.6 IRX3 IRX-1 ENSG00000177508 Iroquois homeobox 3 16 54283304-54286763 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA062522 Approved Vesicles Expressed in all Tissue enhanced breast: 95.2 skin: 70.3 IRX4 ENSG00000113430 Iroquois homeobox 4 5 1877413-1887236 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA064094 Uncertain Nucleus
Vesicles Mixed Tissue enhanced prostate: 5.0;skin: 6.9 esophagus: 1.4 IRX5 IRX-2a ENSG00000176842 Iroquois homeobox 5 16 54930862-54934485 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA047130 Approved Nuclear speckles
Microtubules
Cytosol Lung cancer:4.59e-4 (favourable) Tissue enhanced Tissue enhanced breast: 18.6;lung: 10.8;skin: 11.1 salivary gland: 5.5 IRX6 IRX-3, IRX7 ENSG00000159387 Iroquois homeobox 6 16 55323760-55330760 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA018332 Uncertain Approved Nucleus
Mitochondria Lung cancer:3.34e-4 (favourable) Tissue enhanced Tissue enhanced adipose tissue: 8.6 heart muscle: 4.0 ISL1 Isl-1, ISLET1 ENSG00000016082 ISL LIM homeobox 1 5 51383391-51394738 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA057416 Uncertain Validated Nucleoplasm Tissue enhanced Group enriched 5 placenta: 10.6;prostate: 15.3;seminal vesicle: 25.6;stomach: 9.8 testis: 2.9 ISL2 FLJ10160 ENSG00000159556 ISL LIM homeobox 2 15 76336724-76342476 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA075192 Approved Rods & Rings Mixed Not detected salivary gland: 0.8 ISX RAXLX ENSG00000175329 Intestine-specific homeobox 22 35066136-35087387 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA060328 Approved Supported Nucleoplasm
Nuclear bodies Tissue enhanced Group enriched 37 colon: 27.9;duodenum: 38.5;rectum: 28.6;small intestine: 30.3 smooth muscle: 0.8 JARID2 JMJ ENSG00000008083 Jumonji, AT rich interactive domain 2 6 15246296-15522040 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA063889, CAB069890 Uncertain Supported Nucleus
Mitochondria Expressed in all Mixed bone marrow: 36.6 JDP2 JUNDM2 ENSG00000140044 Jun dimerization protein 2 14 75427716-75474111 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA059511 Supported Approved Nucleoplasm
Nuclear speckles Colorectal cancer:8.58e-5 (unfavourable) Expressed in all Expressed in all spleen: 87.3 JUN AP-1, c-Jun ENSG00000177606 Jun proto-oncogene 1 58780788-58784327 Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB003801, CAB007780, HPA059474 Supported Validated Nucleoplasm Expressed in all Expressed in all thyroid gland: 312.9 JUNB ENSG00000171223 Jun B proto-oncogene 19 12791496-12793315 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB004464, HPA019149 Approved Validated Nucleoplasm Renal cancer:1.05e-4 (unfavourable), Ovarian cancer:3.65e-4 (unfavourable) Expressed in all Expressed in all adrenal gland: 322.6 JUND AP-1 ENSG00000130522 Jun D proto-oncogene 19 18279760-18281622 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB005268, HPA063029 Supported Supported Nucleus Breast cancer:6.15e-5 (favourable) Expressed in all Expressed in all bone marrow: 278.3 KAT5 cPLA2, ESA1, HTATIP, HTATIP1, PLIP, TIP60, ZC2HC5 ENSG00000172977 K(lysine) acetyltransferase 5 11 65711996-65719604 Enzymes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA016953 Approved Supported Nucleoplasm Renal cancer:1.10e-13 (favourable) Expressed in all Expressed in all parathyroid gland: 81.9 KAT6A MOZ, MYST3, RUNXBP2, ZC2HC6A, ZNF220 ENSG00000083168 K(lysine) acetyltransferase 6A 8 41929479-42051990 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB017023, HPA063266, HPA065052 Supported Approved Nucleoli
Nuclear speckles
Cytosol Expressed in all Expressed in all parathyroid gland: 33.9 KAT6B Morf, MOZ2, MYST4, qkf, querkopf, ZC2HC6B ENSG00000156650 K(lysine) acetyltransferase 6B 10 74825582-75032622 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA006104 Supported Approved Nucleus
Nuclear bodies Renal cancer:4.82e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 17.0 KAT7 HBO1, HBOA, MYST2, ZC2HC7 ENSG00000136504 K(lysine) acetyltransferase 7 17 49788555-49835030 Enzymes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA044470 Approved Supported Nucleoplasm Expressed in all Expressed in all testis: 106.4 KAT8 FLJ14040, hMOF, MOF, MYST1, ZC2HC8 ENSG00000103510 K(lysine) acetyltransferase 8 16 31115754-31131393 Enzymes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA066324 Supported Nucleoplasm Lung cancer:6.34e-4 (favourable) Expressed in all Expressed in all ovary: 61.5 KDM2A CXXC8, DKFZP434M1735, FBL11, FBL7, FBXL11, FLJ00115, JHDM1A, KIAA1004, LILINA ENSG00000173120 Lysine (K)-specific demethylase 2A 11 67119269-67258087 Enzymes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB012272, HPA044251 Supported Approved Nucleus Expressed in all Expressed in all testis: 59.8 KDM5A JARID1A, RBBP2 ENSG00000073614 Lysine (K)-specific demethylase 5A 12 280129-389454 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA006201 Approved Nuclear bodies
Cytosol Expressed in all Expressed in all testis: 42.5 KDM5B CT31, JARID1B, PLU-1, PPP1R98, RBBP2H1A ENSG00000117139 Lysine (K)-specific demethylase 5B 1 202724491-202809470 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA027179, HPA053723, CAB068193 Supported Supported Nucleus Expressed in all Tissue enriched 7 testis: 227.1 skin: 30.7 KDM5C DXS1272E, JARID1C, MRX13, SMCX, XE169 ENSG00000126012 Lysine (K)-specific demethylase 5C X 53191321-53225422 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA038244, HPA046147 Validated Nucleoplasm
Cytosol Liver cancer:2.11e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 65.5 KDM5D HY, HYA, JARID1D, KIAA0234, SMCY ENSG00000012817 Lysine (K)-specific demethylase 5D Y 19703865-19744939 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA049086, HPA060807 Uncertain Approved Nucleoli fibrillar center Head and neck cancer:3.58e-5 (favourable) Mixed Mixed small intestine: 37.3 KLF1 EKLF ENSG00000105610 Kruppel-like factor 1 (erythroid) 19 12884423-12887181 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA051850 Supported Not detected Tissue enriched 24 bone marrow: 25.8 placenta: 1.0 KLF10 EGRA, TIEG, TIEG1 ENSG00000155090 Kruppel-like factor 10 8 102648779-102655902 Predicted intracellular proteins, Transcription factors Evidence at protein level Lung cancer:2.61e-5 (unfavourable) Expressed in all Expressed in all lung: 100.0 KLF11 MODY7, TIEG2, Tieg3 ENSG00000172059 Kruppel-like factor 11 2 10042849-10054836 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA058276 Approved Nucleoplasm
Focal adhesion sites
Cytosol Expressed in all Expressed in all testis: 57.1 KLF12 AP-2rep, AP2REP, HSPC122 ENSG00000118922 Kruppel-like factor 12 13 73686089-74133905 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA064146 Approved Nucleoplasm
Cytosol Endometrial cancer:5.03e-6 (unfavourable) Expressed in all Mixed lymph node: 17.8 KLF13 BTEB3, FKLF-2, NSLP1, RFLAT-1 ENSG00000169926 Kruppel-like factor 13 15 31326855-31435665 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Renal cancer:2.37e-9 (favourable) Expressed in all Expressed in all bone marrow: 37.8 KLF15 KKLF ENSG00000163884 Kruppel-like factor 15 3 126342635-126357442 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA028866 Uncertain Renal cancer:3.27e-7 (favourable) Tissue enhanced Tissue enhanced ovary: 42.7 adipose tissue: 37.0 KLF16 BTEB4, DRRF, NSLP2 ENSG00000129911 Kruppel-like factor 16 19 1852399-1863568 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA052481 Approved Supported Nucleus Renal cancer:2.93e-5 (unfavourable) Expressed in all Mixed cerebral cortex: 17.6 KLF17 FLJ40160, Zfp393, ZNF393 ENSG00000171872 Kruppel-like factor 17 1 44118850-44135140 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA024629 Approved Tissue enriched Tissue enhanced testis: 8.1 smooth muscle: 1.7 KLF2 LKLF ENSG00000127528 Kruppel-like factor 2 19 16324817-16327874 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA055964 Approved Approved Nucleoplasm Liver cancer:8.55e-4 (favourable) Expressed in all Expressed in all adipose tissue: 115.7 KLF3 BKLF ENSG00000109787 Kruppel-like factor 3 (basic) 4 38664196-38701042 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA049512, HPA065054 Supported Supported Nucleoplasm Renal cancer:4.36e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 62.2 KLF4 EZF, GKLF ENSG00000136826 Kruppel-like factor 4 (gut) 9 107484852-107490482 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA002926 Supported Supported Nucleoplasm Renal cancer:3.93e-5 (favourable) Expressed in all Expressed in all esophagus: 129.0 KLF5 BTEB2, CKLF, IKLF ENSG00000102554 Kruppel-like factor 5 (intestinal) 13 73054976-73077542 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA040398 Approved Supported Nucleoplasm
Golgi apparatus
Vesicles Pancreatic cancer:2.55e-4 (unfavourable) Expressed in all Tissue enhanced skin: 280.2 esophagus: 217.1 KLF6 BCD1, COPEB, CPBP, GBF, PAC1, ST12, Zf9 ENSG00000067082 Kruppel-like factor 6 10 3775996-3785281 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB013529, HPA069585 Supported Approved Nucleus
Nucleoli fibrillar center
Vesicles
Cytosol Renal cancer:2.28e-4 (favourable) Expressed in all Expressed in all thyroid gland: 321.3 KLF7 UKLF ENSG00000118263 Kruppel-like factor 7 (ubiquitous) 2 207074137-207167267 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA030490 Approved Approved Golgi apparatus Renal cancer:4.26e-4 (favourable) Expressed in all Expressed in all smooth muscle: 30.6 KLF8 BKLF3, DXS741, ZNF741 ENSG00000102349 Kruppel-like factor 8 X 56232421-56287889 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA071740 Supported Nucleoplasm Head and neck cancer:3.32e-4 (favourable) Mixed Tissue enhanced skin: 33.9 esophagus: 17.0 KLF9 BTEB1 ENSG00000119138 Kruppel-like factor 9 9 70384597-70414624 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA029308 Approved Nucleoplasm
Plasma membrane
Cytosol Renal cancer:6.59e-6 (favourable) Expressed in all Expressed in all smooth muscle: 88.0 KMT2A ALL-1, CXXC7, HRX, HTRX1, MLL, MLL1A, TRX1 ENSG00000118058 Lysine (K)-specific methyltransferase 2A 11 118436490-118526832 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB017794, CAB024270, HPA044910 Supported Supported Nucleoplasm
Cytosol Expressed in all Expressed in all parathyroid gland: 31.1 KMT2B CXXC10, HRX2, KIAA0304, MLL1B, MLL2, MLL4, TRX2, WBP7 ENSG00000272333 Lysine (K)-specific methyltransferase 2B 19 35718019-35738878 Cancer-related genes, Enzymes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA006487 Approved Nucleoplasm
Cytosol Expressed in all Expressed in all testis: 28.8 L3MBTL1 dJ138B7.3, DKFZp586P1522, KIAA0681, L3MBTL, ZC2HC3 ENSG00000185513 L(3)mbt-like 1 (Drosophila) 20 43507680-43550950 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA056389 Supported Nucleus
Plasma membrane Mixed Mixed testis: 10.1 LBX1 HPX6, LBX1H ENSG00000138136 Ladybird homeobox 1 10 101226195-101229794 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA002016, HPA002086 Uncertain Approved Nucleoplasm
Nuclear bodies Not detected Tissue enriched 65 skeletal muscle: 9.1 lung: 0.1 LBX2 ENSG00000179528 Ladybird homeobox 2 2 74497517-74503316 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA044257 Uncertain Approved Nucleus
Midbody Mixed Tissue enhanced duodenum: 5.5;small intestine: 5.4 liver: 3.5 LEF1 TCF10, TCF1ALPHA, TCF7L3 ENSG00000138795 Lymphoid enhancer-binding factor 1 4 108047545-108168956 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA002087, CAB019405 Approved Approved Nucleoplasm
Nuclear bodies
Cytosol Renal cancer:2.47e-6 (unfavourable), Endometrial cancer:1.37e-5 (favourable) Expressed in all Tissue enhanced lymph node: 42.2 tonsil: 29.3 LEUTX ENSG00000213921 Leucine twenty homeobox 19 39776595-39786135 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA041498 Uncertain Approved Nucleus
Nucleoli Not detected Not detected all non-specific tissues: 0.0 LHX1 LIM-1, LIM1 ENSG00000273706 LIM homeobox 1 17 36936785-36944612 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at transcript level CAB002770 Uncertain Endometrial cancer:3.63e-5 (unfavourable) Tissue enhanced Tissue enriched 6 kidney: 1.3 fallopian tube: 0.2 LHX2 hLhx2, LH-2 ENSG00000106689 LIM homeobox 2 9 124001670-124033301 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA000838 Supported Approved Nucleoplasm Cervical cancer:9.52e-4 (favourable) Group enriched Tissue enriched 11 cerebral cortex: 56.4 placenta: 5.1 LHX3 ENSG00000107187 LIM homeobox 3 9 136196250-136205109 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Not detected Not detected cerebral cortex: 0.4 LHX4 Gsh4 ENSG00000121454 LIM homeobox 4 1 180230286-180278982 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA055705 Approved Nuclear speckles Not detected Mixed testis: 2.5 LHX5 ENSG00000089116 LIM homeobox 5 12 113462034-113472280 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA053908 Uncertain Mixed Tissue enhanced cerebral cortex: 1.4 stomach: 0.3 LHX6 LHX6.1 ENSG00000106852 LIM homeobox 6 9 122202577-122229626 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA047854, HPA058319 Approved Uncertain Nucleoli fibrillar center
Plasma membrane Mixed Mixed cerebral cortex: 8.1 LHX8 Lhx7 ENSG00000162624 LIM homeobox 8 1 75128434-75161533 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA071806 Approved Nucleus
Nucleoli
Cytosol Not detected Tissue enhanced placenta: 1.8;testis: 1.4;tonsil: 1.6 gallbladder,urinary bladder: 1.0 LHX9 ENSG00000143355 LIM homeobox 9 1 197911902-197935478 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA009695 Uncertain Approved Nucleus Mixed Tissue enhanced ovary: 11.4;testis: 4.5 lung: 2.2 LMX1A LMX1, LMX1.1 ENSG00000162761 LIM homeobox transcription factor 1, alpha 1 165201867-165356715 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA028051, HPA030088 Uncertain Approved Nucleoplasm
Golgi apparatus
Vesicles Not detected Tissue enhanced duodenum: 1.1;testis: 2.4 adipose tissue,rectum,small intestine: 0.6 LMX1B NPS1 ENSG00000136944 LIM homeobox transcription factor 1, beta 9 126614443-126701032 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA073716 Approved Nucleus Tissue enriched Tissue enhanced breast: 5.8;salivary gland: 11.2 testis: 2.2 LRRFIP1 FLAP-1, FLIIAP1, GCF-2, HUFI-1, TRIP ENSG00000124831 Leucine rich repeat (in FLII) interacting protein 1 2 237627576-237813682 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA006979 Approved Supported Cytosol Expressed in all Expressed in all parathyroid gland: 123.5 LRRFIP2 HUFI-2 ENSG00000093167 Leucine rich repeat (in FLII) interacting protein 2 3 37052656-37183689 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA035956, HPA042023 Uncertain Approved Plasma membrane
Actin filaments Cervical cancer:6.31e-4 (favourable) Expressed in all Expressed in all testis: 130.5 LYAR ZC2HC2, ZLYAR ENSG00000145220 Ly1 antibody reactive 4 4267701-4290169 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA035881 Supported Supported Nucleus
Nucleoli Renal cancer:4.36e-10 (unfavourable), Liver cancer:3.20e-5 (unfavourable), Ovarian cancer:8.82e-4 (favourable) Expressed in all Tissue enriched 7 testis: 185.2 lymph node: 27.9 LYL1 bHLHa18 ENSG00000104903 Lymphoblastic leukemia associated hematopoiesis regulator 1 19 13099033-13103161 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA075004 Approved Golgi apparatus Renal cancer:3.89e-4 (unfavourable) Expressed in all Tissue enhanced bone marrow: 22.9;spleen: 21.2 appendix: 14.8 MAF c-MAF ENSG00000178573 V-maf avian musculoaponeurotic fibrosarcoma oncogene homolog 16 79585843-79600714 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB010296, HPA028289 Approved Renal cancer:3.74e-4 (unfavourable) Expressed in all Tissue enhanced parathyroid gland: 147.2 small intestine: 93.1 MAFA hMafA, RIPE3b1 ENSG00000182759 V-maf avian musculoaponeurotic fibrosarcoma oncogene homolog A 8 143419182-143430406 Predicted intracellular proteins, Transcription factors Evidence at protein level Mixed Group enriched 11 skeletal muscle: 8.6;testis: 2.5 placenta: 0.5 MAFB KRML ENSG00000204103 V-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B 20 40685848-40689240 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA005653 Approved Approved Nucleus
Nucleoli Endometrial cancer:5.64e-4 (unfavourable) Expressed in all Tissue enriched 7 parathyroid gland: 677.4 spleen: 103.7 MAFF hMafF ENSG00000185022 V-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F 22 38200767-38216511 Predicted intracellular proteins, Transcription factors Evidence at protein level CAB025341, HPA055371 Approved Approved Nucleus
Mitochondria Breast cancer:4.32e-4 (favourable) Expressed in all Mixed gallbladder: 66.4 MAFG MGC13090, MGC20149 ENSG00000197063 V-maf avian musculoaponeurotic fibrosarcoma oncogene homolog G 17 81918270-81927714 Predicted intracellular proteins, Transcription factors Evidence at protein level CAB025573 Approved Liver cancer:1.90e-6 (unfavourable), Endometrial cancer:5.82e-4 (unfavourable) Expressed in all Expressed in all cerebral cortex: 28.3 MAFK NFE2U, P18 ENSG00000198517 V-maf avian musculoaponeurotic fibrosarcoma oncogene homolog K 7 1530714-1543043 Predicted intracellular proteins, Transcription factors Evidence at protein level CAB026820, HPA060841 Approved Validated Nucleoplasm Expressed in all Expressed in all placenta: 36.6 MAX bHLHd4, bHLHd5, bHLHd6, bHLHd7, bHLHd8 ENSG00000125952 MYC associated factor X 14 65006174-65102695 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB000328, HPA003474 Supported Supported Nucleoplasm
Golgi apparatus
Vesicles Thyroid cancer:2.12e-4 (favourable), Renal cancer:5.57e-4 (unfavourable) Expressed in all Expressed in all spleen: 80.2 MAZ Pur-1, ZF87, Zif87, ZNF801 ENSG00000103495 MYC-associated zinc finger protein (purine-binding transcription factor) 16 29806106-29811164 Predicted intracellular proteins, Predicted secreted proteins, Transcription factors Evidence at protein level HPA048315, HPA059495, HPA065930 Approved Supported Nucleus Thyroid cancer:2.22e-4 (unfavourable), Renal cancer:5.15e-4 (unfavourable) Expressed in all Expressed in all prostate: 195.5 MBD1 CXXC3, PCM1 ENSG00000141644 Methyl-CpG binding domain protein 1 18 50266882-50281774 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB009017, CAB036003 Approved Supported Nucleus Prostate cancer:1.70e-6 (unfavourable), Liver cancer:5.08e-6 (unfavourable) Expressed in all Expressed in all testis: 109.0 MECOM EVI1, MDS1, MDS1-EVI1, PRDM3 ENSG00000085276 MDS1 and EVI1 complex locus 3 169083499-169663618 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA046537 Supported Supported Nuclear speckles Pancreatic cancer:2.59e-4 (unfavourable) Mixed Mixed stomach: 66.8 MEF2A RSRFC4, RSRFC9 ENSG00000068305 Myocyte enhancer factor 2A 15 99565417-99716466 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB004499, HPA046597 Approved Supported Nucleoplasm Renal cancer:6.93e-4 (favourable), Stomach cancer:7.96e-4 (unfavourable) Expressed in all Expressed in all cerebral cortex: 68.4 MEF2B RSRFR2 ENSG00000213999 Myocyte enhancer factor 2B 19 19145568-19170289 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA004734 Supported Not detected Group enriched 9 appendix: 18.2;lymph node: 46.3;tonsil: 28.2 spleen: 3.3 MEF2C ENSG00000081189 Myocyte enhancer factor 2C 5 88717117-88904257 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA005533, CAB068196, CAB068197 Supported Supported Nucleoplasm
Vesicles Renal cancer:1.01e-4 (unfavourable) Expressed in all Expressed in all cerebral cortex: 221.1 MEF2D ENSG00000116604 Myocyte enhancer factor 2D 1 156463727-156500828 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA004807, HPA007114 Supported Validated Nucleoplasm Renal cancer:7.53e-4 (unfavourable) Expressed in all Expressed in all skeletal muscle: 55.5 MEIS1 ENSG00000143995 Meis homeobox 1 2 66433452-66573869 Disease related genes, Predicted intracellular proteins, Predicted secreted proteins, Transcription factors Evidence at protein level CAB011521, HPA056000, HPA058641 Approved Supported Nucleoplasm Head and neck cancer:2.70e-5 (favourable), Renal cancer:1.69e-4 (unfavourable) Tissue enhanced Expressed in all endometrium: 91.8 MEIS2 HsT18361, MRG1 ENSG00000134138 Meis homeobox 2 15 36889204-37101299 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003256, CAB004999 Supported Approved Nucleoplasm
Cytosol Renal cancer:2.64e-7 (unfavourable) Mixed Mixed endometrium: 63.8 MEIS3 DKFZp547H236, MRG2 ENSG00000105419 Meis homeobox 3 19 47403124-47419523 Predicted intracellular proteins, Predicted secreted proteins, Transcription factors Evidence at protein level HPA046699 Uncertain Approved Nucleoplasm Renal cancer:1.78e-6 (unfavourable) Mixed Tissue enhanced endometrium: 82.2 cerebral cortex: 65.0 MEOX1 MOX1 ENSG00000005102 Mesenchyme homeobox 1 17 43640388-43661954 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA045214 Uncertain Uncertain Nucleoli
Mitochondria Mixed Tissue enhanced adipose tissue: 25.3 spleen: 16.8 MEOX2 GAX, MOX2 ENSG00000106511 Mesenchyme homeobox 2 7 15611212-15686812 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA053793 Supported Tissue enriched Tissue enhanced adipose tissue: 28.5;placenta: 57.2 lung: 10.9 MESP1 bHLHc5, MGC10676 ENSG00000166823 Mesoderm posterior bHLH transcription factor 1 15 89748661-89751310 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA069981 Supported Nucleus
Nucleoli Group enriched Tissue enhanced adipose tissue: 4.8;prostate: 4.0 cerebral cortex: 1.4 MESP2 bHLHc6, SCDO2 ENSG00000188095 Mesoderm posterior bHLH transcription factor 2 15 89760591-89778754 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Mixed Mixed cervix, uterine,testis: 1.1 MGA FLJ12634, KIAA0518, MAD5, MXD5 ENSG00000174197 MGA, MAX dimerization protein 15 41621224-41773081 Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins, Transcription factors Evidence at protein level HPA042278, HPA058183 Approved Supported Nucleoplasm
Cytosol Expressed in all Expressed in all testis: 16.0 MIER1 hMI-ER1, KIAA1610, MI-ER1 ENSG00000198160 Mesoderm induction early response 1, transcriptional regulator 1 66924895-66988619 Predicted intracellular proteins, Predicted secreted proteins, Transcription factors Evidence at protein level HPA019589, HPA050306 Supported Validated Nucleoplasm Glioma:6.18e-8 (favourable), Colorectal cancer:4.96e-4 (favourable) Expressed in all Expressed in all bone marrow: 63.2 MIER2 KIAA1193 ENSG00000105556 Mesoderm induction early response 1, family member 2 19 301444-344807 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA041439 Uncertain Approved Nucleoplasm
Cytosol Renal cancer:7.22e-6 (unfavourable), Endometrial cancer:1.72e-5 (favourable), Colorectal cancer:2.89e-4 (unfavourable) Expressed in all Mixed testis: 12.8 MIER3 DKFZp686L09111, DKFZp781I1119, FLJ35954 ENSG00000155545 Mesoderm induction early response 1, family member 3 5 56919602-56971675 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA058349, HPA065946 Uncertain Validated Nucleoplasm Expressed in all Expressed in all colon: 30.7 MITF bHLHe32, MI, WS2, WS2A ENSG00000187098 Microphthalmia-associated transcription factor 3 69739435-69968337 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB002578, HPA003259 Supported Renal cancer:8.35e-10 (favourable) Group enriched Tissue enhanced cervix, uterine: 80.4;endometrium: 78.8 smooth muscle: 68.6 MIXL1 MILD1, MIXL ENSG00000185155 Mix paired-like homeobox 1 226223618-226227054 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA005662 Approved Nucleus Tissue enriched Tissue enhanced tonsil: 3.2 lymph node: 2.8 MKX C10orf48, IRXL1, MGC39616 ENSG00000150051 Mohawk homeobox 10 27672875-27746060 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA006927 Uncertain Approved Nucleoplasm
Nuclear speckles Mixed Tissue enhanced ovary: 13.6;prostate: 26.1 fallopian tube: 8.1 MLX bHLHd13, MAD7, MXD7, TCFL4 ENSG00000108788 MLX, MAX dimerization protein 17 42567068-42573239 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB025329, HPA052766, HPA064438 Approved Approved Nucleoplasm
Nuclear membrane
Cytosol Expressed in all Expressed in all duodenum: 47.6 MLXIP bHLHe36, KIAA0867, MIR, MONDOA ENSG00000175727 MLX interacting protein 12 122078722-122147347 Predicted intracellular proteins, Predicted secreted proteins, Transcription factors Evidence at protein level HPA023084 Approved Liver cancer:2.28e-4 (unfavourable), Renal cancer:2.92e-4 (unfavourable) Expressed in all Expressed in all rectum: 24.8 MLXIPL bHLHd14, CHREBP, MIO, MONDOB, WBSCR14, WS-bHLH ENSG00000009950 MLX interacting protein-like 7 73593194-73624543 Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transcription factors Evidence at protein level HPA064640 Supported Nucleus Tissue enriched Tissue enhanced adipose tissue: 60.8;duodenum: 60.3 liver: 47.2 MNT bHLHd3, MAD6, MXD6, ROX ENSG00000070444 MAX network transcriptional repressor 17 2384060-2401118 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA059532, HPA067578 Validated Nucleoplasm Expressed in all Expressed in all cerebral cortex: 15.3 MNX1 HB9, HLXB9, HOXHB9, SCRA1 ENSG00000130675 Motor neuron and pancreas homeobox 1 7 156994051-157010651 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA071717 Approved Nucleus
Nucleoli
Cytosol Mixed Tissue enhanced duodenum: 7.5;small intestine: 6.8 colon: 3.8 MSC ABF-1, bHLHa22 ENSG00000178860 Musculin 8 71841549-71844468 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA062878 Supported Nucleoplasm Renal cancer:1.07e-13 (unfavourable), Liver cancer:4.83e-5 (unfavourable), Glioma:7.15e-4 (unfavourable) Expressed in all Mixed placenta: 22.6 MSGN1 pMesogenin1 ENSG00000151379 Mesogenin 1 2 17816496-17817101 Predicted intracellular proteins, Transcription factors No evidence Not detected Not detected esophagus: 0.4 MSX1 HOX7, HYD1, OFC5 ENSG00000163132 Msh homeobox 1 4 4859666-4863936 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB026198, HPA063895, HPA073604 Supported Supported Nucleoplasm Endometrial cancer:1.64e-7 (favourable), Renal cancer:1.18e-5 (unfavourable) Tissue enriched Group enriched 6 cervix, uterine: 60.9;endometrium: 23.8 adipose tissue: 6.7 MSX2 CRS2, FPP, HOX8, MSH, PFM, PFM1 ENSG00000120149 Msh homeobox 2 5 174724533-174730893 Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA005652 Uncertain Supported Nuclear speckles Endometrial cancer:8.43e-5 (favourable), Lung cancer:6.93e-4 (unfavourable) Mixed Tissue enhanced placenta: 47.5 parathyroid gland: 16.4 MTA1 ENSG00000182979 Metastasis associated 1 14 105419820-105470729 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB004508, HPA005544 Supported Validated Nucleoplasm
Cytosol Pancreatic cancer:9.48e-5 (favourable), Liver cancer:4.62e-4 (unfavourable) Expressed in all Expressed in all testis: 35.8 MTA2 MTA1-L1, MTA1L1 ENSG00000149480 Metastasis associated 1 family, member 2 11 62593214-62601840 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB005315, HPA006214, CAB017522 Supported Validated Nucleoplasm Liver cancer:4.82e-5 (unfavourable) Expressed in all Expressed in all skin: 88.6 MTA3 KIAA1266 ENSG00000057935 Metastasis associated 1 family, member 3 2 42494569-42756947 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA039433 Approved Supported Nucleus
Vesicles Endometrial cancer:2.30e-4 (unfavourable), Liver cancer:4.69e-4 (unfavourable) Expressed in all Expressed in all testis: 52.2 MTF1 ENSG00000188786 Metal-regulatory transcription factor 1 1 37809567-37859620 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA028604, HPA028689 Uncertain Validated Nucleoplasm Expressed in all Mixed bone marrow: 13.2 MXD1 bHLHc58, MAD, MAD1 ENSG00000059728 MAX dimerization protein 1 2 69897688-69942945 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001599 Supported Uncertain Nucleoplasm
Mitochondria
Cytosol Endometrial cancer:8.14e-6 (unfavourable), Pancreatic cancer:8.50e-4 (unfavourable) Expressed in all Tissue enhanced bone marrow: 114.0;esophagus: 102.3 appendix: 57.5 MXD3 bHLHc13, MAD3 ENSG00000213347 MAX dimerization protein 3 5 177301461-177312757 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA070111 Approved Nucleus
Nucleoli Liver cancer:3.60e-4 (unfavourable) Expressed in all Tissue enhanced bone marrow: 24.3 skin: 12.6 MXD4 bHLHc12, MAD4, MST149, MSTP149 ENSG00000123933 MAX dimerization protein 4 4 2247432-2262294 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA053363 Supported Cytosol Pancreatic cancer:1.39e-5 (favourable), Head and neck cancer:2.21e-5 (favourable) Expressed in all Expressed in all spleen: 42.0 MXI1 bHLHc11, MAD2, MXD2, MXI ENSG00000119950 MAX interactor 1, dimerization protein 10 110207605-110287365 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA035319, HPA056762 Approved Supported Nucleus
Nucleoli Renal cancer:1.02e-5 (unfavourable), Prostate cancer:9.17e-4 (unfavourable) Expressed in all Expressed in all cerebral cortex: 88.4 MYB c-myb ENSG00000118513 V-myb avian myeloblastosis viral oncogene homolog 6 135181315-135219173 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB017704 Approved Approved Nucleus
Plasma membrane Prostate cancer:9.65e-4 (favourable), Stomach cancer:9.87e-4 (favourable) Tissue enhanced Tissue enhanced breast: 25.9;rectum: 29.6 colon: 25.7 MYBL1 A-myb, AMYB ENSG00000185697 V-myb avian myeloblastosis viral oncogene homolog-like 1 8 66562175-66614247 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA008791, CAB017780 Uncertain Approved Nucleus
Nucleoli
Cytosol Renal cancer:2.03e-8 (unfavourable) Mixed Tissue enhanced lymph node: 24.5;testis: 21.3 tonsil: 15.4 MYBL2 B-MYB, BMYB ENSG00000101057 V-myb avian myeloblastosis viral oncogene homolog-like 2 20 43667019-43716496 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB017114, HPA030530, HPA055416 Uncertain Validated Nucleoplasm
Cytosol Renal cancer:0.00e+0 (unfavourable), Liver cancer:2.11e-7 (unfavourable), Endometrial cancer:9.73e-4 (unfavourable) Tissue enriched Tissue enhanced bone marrow: 57.1;lymph node: 68.1;tonsil: 51.7 appendix: 33.8 MYC bHLHe39, c-Myc, MYCC ENSG00000136997 V-myc avian myelocytomatosis viral oncogene homolog 8 127735434-127741434 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB000084, CAB010307, HPA055893, HPA066556 Supported Validated Nucleoplasm Renal cancer:5.49e-8 (unfavourable), Urothelial cancer:4.96e-5 (unfavourable), Ovarian cancer:7.52e-4 (unfavourable) Expressed in all Expressed in all adipose tissue: 144.4 MYCL bHLHe38, LMYC, MYCL1 ENSG00000116990 V-myc avian myelocytomatosis viral oncogene lung carcinoma derived homolog 1 39895426-39902256 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA063132 Supported Nucleus Lung cancer:4.49e-4 (favourable) Expressed in all Tissue enhanced skin: 41.7 urinary bladder: 24.6 MYCN bHLHe37, MYCNOT, N-myc, NMYC ENSG00000134323 V-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog 2 15940564-15947007 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA057420 Approved Nucleus
Nucleoli Tissue enhanced Tissue enhanced placenta: 9.6 cerebral cortex: 5.3 MYF5 bHLHc2 ENSG00000111049 Myogenic factor 5 12 80716912-80719673 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA041691 Supported Nucleoplasm Not detected Tissue enhanced skeletal muscle: 1.9 esophagus,prostate: 0.3 MYF6 bHLHc4, MRF4 ENSG00000111046 Myogenic factor 6 (herculin) 12 80707498-80709474 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Head and neck cancer:2.05e-4 (unfavourable) Group enriched Tissue enriched 18 skeletal muscle: 99.2 esophagus: 5.3 MYNN SBBIZ1, ZBTB31, ZNF902 ENSG00000085274 Myoneurin 3 169772831-169789716 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA045149 Approved Supported Nucleus Expressed in all Expressed in all testis: 18.2 MYOD1 bHLHc1, MYF3, MYOD, PUM ENSG00000129152 Myogenic differentiation 1 11 17719568-17722131 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA051362 Supported Nucleoplasm
Nuclear bodies
Cytosol Tissue enhanced Tissue enriched 12 skeletal muscle: 9.0 prostate: 0.7 MYOG bHLHc3, MYF4 ENSG00000122180 Myogenin (myogenic factor 4) 1 203083132-203086036 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA028336, HPA038093 Approved Supported Nucleoplasm Group enriched Tissue enriched 12 skeletal muscle: 31.7 prostate: 2.7 MYRF C11orf9, MRF, Ndt80, pqn-47 ENSG00000124920 Myelin regulatory factor 11 61752642-61788518 Enzymes, Plasma proteins, Predicted membrane proteins, Transcription factors Evidence at protein level HPA018310 Approved Nucleoplasm
Cytosol Renal cancer:2.01e-4 (unfavourable) Mixed Tissue enhanced cerebral cortex: 67.6;stomach: 62.4 gallbladder: 38.4 MYT1 MTF1, MYTI, NZF2, PLPB1, ZC2HC4A ENSG00000196132 Myelin transcription factor 1 20 64151791-64242253 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA006303 Uncertain Supported Nucleoplasm
Cytosol Tissue enhanced Group enriched 7 adrenal gland: 2.5;cerebral cortex: 5.7 testis: 0.6 MYT1L KIAA1106, NZF1, ZC2HC4B ENSG00000186487 Myelin transcription factor 1-like 2 1789113-2331260 Predicted intracellular proteins, Transcription factors Evidence at protein level Not detected Tissue enriched 11 cerebral cortex: 60.2 testis: 5.3 MZF1 MZF-1, MZF1B, Zfp98, ZNF42, ZSCAN6 ENSG00000099326 Myeloid zinc finger 1 19 58561931-58573575 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001757 Approved Supported Nucleus Renal cancer:2.83e-8 (unfavourable), Urothelial cancer:4.09e-5 (favourable), Pancreatic cancer:7.97e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 14.7 NANOG FLJ12581, FLJ40451 ENSG00000111704 Nanog homeobox 12 7787794-7799141 Predicted intracellular proteins, Transcription factors Evidence at protein level CAB019380 Supported Tissue enriched Tissue enhanced testis: 2.0 lung,skin: 0.7 NANOGNB ENSG00000205857 NANOG neighbor homeobox 12 7765216-7774121 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA060371 Uncertain Tissue enriched Not detected testis: 0.5 NCOA1 bHLHe74, F-SRC-1, KAT13A, NCoA-1, RIP160, SRC1 ENSG00000084676 Nuclear receptor coactivator 1 2 24491914-24770702 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB019402, HPA070213, HPA070520 Supported Validated Nucleoplasm
Plasma membrane
Cytosol Expressed in all Expressed in all parathyroid gland: 58.0 NCOA2 bHLHe75, GRIP1, KAT13C, NCoA-2, TIF2 ENSG00000140396 Nuclear receptor coactivator 2 8 70109762-70403805 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA060243 Supported Nucleoplasm
Nuclear bodies Renal cancer:5.08e-4 (favourable) Expressed in all Expressed in all epididymis: 35.4 NCOA3 ACTR, AIB1, bHLHe42, CAGH16, KAT13B, p/CIP, RAC3, SRC-3, SRC3, TNRC16, TRAM-1 ENSG00000124151 Nuclear receptor coactivator 3 20 47501902-47656877 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB009800, HPA024210 Supported Supported Nucleoplasm
Cytosol Liver cancer:8.09e-4 (unfavourable) Expressed in all Expressed in all lymph node: 45.3 NCOR1 hCIT529I10, hN-CoR, KIAA1047, MGC104216, N-CoR, PPP1R109, TRAC1 ENSG00000141027 Nuclear receptor corepressor 1 17 16029157-16218185 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA043246, HPA050288, HPA051168, CAB072830 Supported Validated Nucleoplasm
Cytosol Renal cancer:7.92e-5 (favourable) Expressed in all Expressed in all parathyroid gland: 84.0 NCOR2 CTG26, SMRT, SMRTE, TNRC14, TRAC-1 ENSG00000196498 Nuclear receptor corepressor 2 12 124324415-124567589 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001928 Approved Supported Nucleoplasm Expressed in all Expressed in all cerebral cortex: 81.4 NEUROD1 BETA2, BHF-1, bHLHa3, MODY6, NEUROD ENSG00000162992 Neuronal differentiation 1 2 181673088-181680876 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003278, CAB022450 Approved Glioma:6.83e-5 (favourable) Tissue enhanced Tissue enhanced cerebral cortex: 6.0;duodenum: 6.2;small intestine: 4.5;stomach: 4.9 pancreas: 1.8 NEUROD2 bHLHa1, NDRF ENSG00000171532 Neuronal differentiation 2 17 39603536-39609777 Predicted intracellular proteins, Transcription factors Evidence at protein level Tissue enhanced Tissue enriched 146 cerebral cortex: 14.9 stomach: 0.1 NEUROD4 ATH-3, Atoh3, bHLHa4, MATH-3 ENSG00000123307 Neuronal differentiation 4 12 55019945-55030014 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA015545 Supported Not detected Tissue enhanced adrenal gland: 2.3;testis: 1.0 cerebral cortex: 0.4 NEUROD6 Atoh2, bHLHa2, Math-2, Nex1, NEX1M ENSG00000164600 Neuronal differentiation 6 7 31337461-31340894 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA027046 Approved Not detected Tissue enriched 225 cerebral cortex: 22.4 all non-specific tissues: 0.0 NEUROG1 AKA, bHLHa6, Math4C, NEUROD3, ngn1 ENSG00000181965 Neurogenin 1 5 135534282-135535949 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Tissue enriched Not detected all non-specific tissues: 0.0 NEUROG2 Atoh4, bHLHa8, Math4A, ngn-2, NGN2 ENSG00000178403 Neurogenin 2 4 112513516-112516172 Predicted intracellular proteins, Transcription factors Evidence at transcript level CAB012342 Uncertain Tissue enhanced Tissue enhanced testis: 1.5 cerebral cortex: 0.4 NEUROG3 Atoh5, bHLHa7, Math4B, ngn3 ENSG00000122859 Neurogenin 3 10 69571698-69573238 Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA039785 Uncertain Tissue enhanced Tissue enhanced duodenum: 2.9;small intestine: 1.3 colon,rectum: 0.4 NFAT5 KIAA0827, NF-AT5, NFATL1, NFATZ, OREBP, TONEBP ENSG00000102908 Nuclear factor of activated T-cells 5, tonicity-responsive 16 69565094-69704666 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA057304, HPA069711 Approved Supported Nucleus
Cytosol Renal cancer:1.08e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 37.6 NFATC1 NF-ATC, NFAT2, NFATc ENSG00000131196 Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 18 79395856-79529325 Predicted intracellular proteins, Transcription factors Evidence at protein level CAB004513, HPA071732 Supported Supported Nucleoplasm
Nuclear bodies Expressed in all Mixed lymph node: 25.0 NFATC2 NF-ATP, NFAT1, NFATp ENSG00000101096 Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 20 51386957-51562831 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA008789, CAB018567, HPA024369 Supported Supported Nucleoplasm
Cytosol Renal cancer:1.57e-4 (unfavourable) Expressed in all Expressed in all gallbladder: 26.8 NFATC3 NFAT4, NFATX ENSG00000072736 Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 16 68084751-68229259 Predicted intracellular proteins, Transcription factors Evidence at protein level CAB004514, HPA023844, HPA050665 Approved Supported Nucleoplasm
Cytosol Expressed in all Expressed in all testis: 49.9 NFATC4 NFAT3 ENSG00000100968 Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 14 24365673-24379604 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA031641, CAB032859, HPA076526 Uncertain Supported Nuclear speckles
Cytosol Renal cancer:1.81e-6 (unfavourable), Colorectal cancer:5.84e-4 (unfavourable) Expressed in all Mixed endometrium: 75.4 NFE2 NF-E2 ENSG00000123405 Nuclear factor, erythroid 2 12 54292111-54301121 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001914 Approved Mixed Tissue enriched 6 bone marrow: 68.7 spleen: 12.1 NFE2L1 FLJ00380, LCR-F1, NRF1, TCF11 ENSG00000082641 Nuclear factor, erythroid 2-like 1 17 48048329-48061487 Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transcription factors Evidence at protein level HPA063384, HPA065424 Approved Approved Nucleus
Cytosol Renal cancer:5.79e-6 (favourable), Endometrial cancer:8.20e-5 (favourable), Head and neck cancer:2.73e-4 (unfavourable) Expressed in all Expressed in all skeletal muscle: 468.1 NFE2L2 NRF2 ENSG00000116044 Nuclear factor, erythroid 2-like 2 2 177227595-177392697 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA002990, CAB020317, HPA043438 Supported Approved Nucleus
Plasma membrane
Cytosol Renal cancer:2.26e-4 (favourable) Expressed in all Expressed in all esophagus: 267.9 NFE2L3 Nrf3 ENSG00000050344 Nuclear factor, erythroid 2-like 3 7 26152240-26187125 Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transcription factors Evidence at protein level HPA055889 Supported Approved Nucleoplasm
Vesicles Renal cancer:7.58e-12 (unfavourable), Pancreatic cancer:6.62e-5 (unfavourable), Stomach cancer:2.14e-4 (favourable) Expressed in all Tissue enhanced placenta: 51.1 appendix: 14.8 NFIA KIAA1439, NFI-L ENSG00000162599 Nuclear factor I/A 1 60865259-61462793 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA006111, HPA008884 Supported Validated Nucleoplasm Urothelial cancer:2.03e-4 (unfavourable), Renal cancer:7.01e-4 (favourable), Head and neck cancer:7.30e-4 (favourable) Expressed in all Expressed in all thyroid gland: 53.5 NFIB NFI-RED, NFIB2, NFIB3 ENSG00000147862 Nuclear factor I/B 9 14081843-14398983 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003956 Supported Supported Nucleus
Nucleoli fibrillar center Renal cancer:3.53e-4 (favourable) Expressed in all Mixed breast: 44.4 NFIC CTF, CTF5, NF-I, NFI ENSG00000141905 Nuclear factor I/C (CCAAT-binding transcription factor) 19 3359563-3469217 Predicted intracellular proteins, Transcription factors Evidence at protein level CAB004300, CAB004674, HPA052625 Supported Validated Nucleus
Nucleoli fibrillar center Endometrial cancer:1.52e-6 (favourable) Expressed in all Expressed in all skeletal muscle: 68.9 NFIL3 E4BP4, IL3BP1, NF-IL3A, NFIL3A ENSG00000165030 Nuclear factor, interleukin 3 regulated 9 91409045-91423862 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003261 Approved Approved Nuclear bodies Renal cancer:3.23e-6 (unfavourable) Expressed in all Expressed in all bone marrow: 137.4 NFIX NF1A ENSG00000008441 Nuclear factor I/X (CCAAT-binding transcription factor) 19 12995608-13098796 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA007533 Supported Supported Nucleoplasm Lung cancer:2.35e-4 (favourable), Liver cancer:4.66e-4 (favourable) Expressed in all Expressed in all cerebral cortex: 192.0 NFKB1 KBF1, NF-kappaB, NF-kB1, NFkappaB, NFKB-p50, p105, p50 ENSG00000109320 Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 4 102501329-102617302 Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors Evidence at protein level CAB004031, HPA027305 Supported Supported Nucleoplasm
Cytosol Renal cancer:1.76e-4 (favourable) Expressed in all Expressed in all bone marrow: 57.0 NFKB2 LYT-10, NF-kB2, p105, p52 ENSG00000077150 Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) 10 102394110-102402529 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA008422, CAB022098, HPA023900 Supported Approved Nucleoplasm
Cytosol Renal cancer:6.69e-12 (unfavourable), Melanoma:8.45e-5 (favourable), Colorectal cancer:3.86e-4 (unfavourable) Expressed in all Expressed in all appendix: 72.8 NFKBIA IkappaBalpha, IKBA, MAD-3, NFKBI ENSG00000100906 Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha 14 35401511-35404749 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB003815, HPA029207 Approved Validated Cytosol Breast cancer:1.33e-5 (favourable) Expressed in all Expressed in all bone marrow: 713.0 NFKBIB IKBB, TRIP9 ENSG00000104825 Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta 19 38899700-38908893 Predicted intracellular proteins, Transcription factors Evidence at protein level CAB010447, HPA063734 Approved Approved Nucleoplasm
Centrosome
Cytosol Expressed in all Tissue enhanced testis: 16.6 appendix: 7.3 NFKBID IkappaBNS, TA-NFKBH ENSG00000167604 Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, delta 19 35887653-35902303 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA043573 Approved Mitochondria Urothelial cancer:8.34e-6 (favourable), Head and neck cancer:5.43e-4 (favourable), Breast cancer:6.01e-4 (favourable) Expressed in all Tissue enhanced bone marrow: 9.8 appendix: 6.1 NFKBIE IKBE ENSG00000146232 Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon 6 44258166-44265788 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA002692, HPA005941, CAB010272 Supported Supported Nucleus
Nucleoli fibrillar center
Cytosol Renal cancer:1.37e-6 (unfavourable), Breast cancer:1.72e-5 (favourable), Liver cancer:3.50e-4 (unfavourable), Urothelial cancer:8.07e-4 (favourable) Expressed in all Mixed appendix: 26.8 NFKBIL1 IKBL, NFKBIL ENSG00000204498 Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1 6 31546870-31558829 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Endometrial cancer:3.38e-4 (unfavourable) Expressed in all Mixed fallopian tube: 4.1 NFKBIZ FLJ34463, INAP, MAIL ENSG00000144802 Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta 3 101827991-101861022 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA010547, HPA075363 Supported Supported Nuclear speckles
Cytoplasmic bodies Renal cancer:4.30e-8 (unfavourable) Expressed in all Expressed in all bone marrow: 269.0 NFX1 MGC20369, NFX2, TEG-42, Tex42 ENSG00000086102 Nuclear transcription factor, X-box binding 1 9 33290511-33371157 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA056310, HPA061382, HPA073519 Approved Validated Nucleus
Cytosol Ovarian cancer:3.75e-4 (favourable) Expressed in all Expressed in all thyroid gland: 41.6 NFXL1 HOZFP ENSG00000170448 Nuclear transcription factor, X-box binding-like 1 4 47847233-47914667 Predicted membrane proteins, Transcription factors Evidence at protein level HPA059132 Approved Approved Nucleoplasm Liver cancer:9.28e-4 (unfavourable) Expressed in all Mixed testis: 24.8 NFYA CBF-B, HAP2, NF-YA ENSG00000001167 Nuclear transcription factor Y, alpha 6 41072945-41099976 Predicted intracellular proteins, Transcription factors Evidence at protein level CAB009250, HPA050779 Supported Supported Nucleoplasm Liver cancer:8.74e-4 (unfavourable) Expressed in all Expressed in all testis: 71.0 NFYB CBF-A, HAP3, NF-YB ENSG00000120837 Nuclear transcription factor Y, beta 12 104117077-104138289 Predicted intracellular proteins, Transcription factors Evidence at protein level CAB004211 Supported Supported Nucleoplasm Renal cancer:9.28e-5 (unfavourable) Expressed in all Expressed in all seminal vesicle: 122.9 NFYC CBF-C, NF-YC ENSG00000066136 Nuclear transcription factor Y, gamma 1 40691570-40771603 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA055011 Supported Nucleoplasm Renal cancer:1.24e-4 (favourable), Liver cancer:7.24e-4 (unfavourable) Expressed in all Expressed in all thyroid gland: 60.0 NHLH1 bHLHa35, HEN1, NSCL, NSCL1 ENSG00000171786 Nescient helix loop helix 1 1 160367067-160372848 Predicted intracellular proteins, Transcription factors Evidence at transcript level CAB033854 Uncertain Group enriched Not detected skin: 0.8 NHLH2 bHLHa34, HEN2, NSCL2 ENSG00000177551 Nescient helix loop helix 2 1 115836377-115843917 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA055238 Uncertain Approved Nucleoplasm
Nuclear bodies Not detected Tissue enhanced skin: 3.9 cerebral cortex,testis: 0.8 NKX1-1 HSPX153, SAX2 ENSG00000235608 NK1 homeobox 1 4 1402932-1406331 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA029367 Uncertain Not detected Not detected testis: 0.1 NKX1-2 bB238F13.2, C10orf121 ENSG00000229544 NK1 homeobox 2 10 124445239-124450184 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA029367 Uncertain Tissue enhanced Not detected cerebral cortex: 0.7 NKX2-1 BCH, NKX2A, TITF1, TTF-1, TTF1 ENSG00000136352 NK2 homeobox 1 14 36516392-36521149 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB000078, CAB053633, HPA074316 Supported Uncertain Golgi apparatus
Vesicles Group enriched Group enriched 174 lung: 102.0;thyroid gland: 103.6 stomach: 0.5 NKX2-2 NKX2.2, NKX2B ENSG00000125820 NK2 homeobox 2 20 21511010-21514026 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003468 Approved Group enriched Tissue enhanced cerebral cortex: 10.0;stomach: 2.6 duodenum: 2.4 NKX2-3 CSX3, NKX2.3, NKX2C, NKX4-3 ENSG00000119919 NK2 homeobox 3 10 99532933-99536524 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA047561 Uncertain Uncertain Nucleoli
Cytosol Tissue enhanced Tissue enhanced small intestine: 12.9;spleen: 30.1 duodenum: 11.8 NKX2-4 NKX2.4, NKX2D ENSG00000125816 NK2 homeobox 4 20 21395367-21398028 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA074996 Approved Nuclear bodies Not detected Tissue enriched 10 testis: 2.2 epididymis: 0.2 NKX2-5 CSX, CSX1, NKX2.5, NKX2E, NKX4-1 ENSG00000183072 NK2 homeobox 5 5 173232109-173235357 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA065034 Approved Nucleoplasm
Cytosol Mixed Group enriched 130 heart muscle: 33.8;spleen: 14.8 breast,placenta,urinary bladder: 0.1 NKX2-6 CSX2, NKX4-2 ENSG00000180053 NK2 homeobox 6 8 23702451-23706598 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Not detected Not detected all non-specific tissues: 0.0 NKX2-8 Nkx2-9, NKX2.8, NKX2H ENSG00000136327 NK2 homeobox 8 14 36580579-36582607 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA062879 Uncertain Approved Nucleoplasm
Plasma membrane Mixed Tissue enhanced testis: 3.1 lung: 0.6 NKX3-1 BAPX2, NKX3.1, NKX3A ENSG00000167034 NK3 homeobox 1 8 23678693-23682927 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Tissue enriched Tissue enriched 12 prostate: 517.0 testis: 44.8 NKX3-2 BAPX1, NKX3.2, NKX3B ENSG00000109705 NK3 homeobox 2 4 13540830-13545050 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA027564 Approved Approved Nucleoplasm Mixed Tissue enhanced spleen: 2.8 smooth muscle: 1.6 NKX6-1 Nkx6.1, NKX6A ENSG00000163623 NK6 homeobox 1 4 84491987-84498450 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA036774, CAB070169 Supported Supported Nucleoplasm Mixed Tissue enhanced esophagus: 6.9;thyroid gland: 2.9 testis: 1.4 NKX6-2 GTX, NKX6.1, NKX6B ENSG00000148826 NK6 homeobox 2 10 132783179-132786052 Predicted intracellular proteins, Transcription factors Evidence at transcript level Tissue enriched Group enriched 26 cerebral cortex: 15.8;stomach: 17.1 testis: 0.6 NKX6-3 FLJ25169 ENSG00000165066 NK6 homeobox 3 8 41645178-41650669 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA042790 Uncertain Group enriched Tissue enhanced duodenum: 17.7;stomach: 51.1 parathyroid gland: 7.8 NOBOX OG2, Og2x ENSG00000106410 NOBOX oogenesis homeobox 7 144397240-144410227 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Tissue enhanced Not detected testis: 0.7 NONO NMT55, NRB54, P54, P54NRB, PPP1R114 ENSG00000147140 Non-POU domain containing, octamer-binding X 71283192-71301168 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB022069, HPA054094, HPA054559 Supported Validated Nucleoplasm Endometrial cancer:9.29e-4 (unfavourable) Expressed in all Expressed in all ovary: 245.1 NOTO ENSG00000214513 Notochord homeobox 2 73202258-73212513 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA034660 Uncertain Not detected Not detected skin: 0.4 NPAS1 bHLHe11, MOP5, PASD5 ENSG00000130751 Neuronal PAS domain protein 1 19 47019820-47045775 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA043364, HPA072259 Approved Approved Nucleoplasm Tissue enhanced Group enriched 5 cerebral cortex: 3.9;skin: 4.4;spleen: 1.9;stomach: 2.7 lymph node: 0.6 NPAS2 bHLHe9, MOP4, PASD4 ENSG00000170485 Neuronal PAS domain protein 2 2 100820152-100996829 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA019674 Uncertain Supported Approved Nucleoplasm Renal cancer:3.55e-7 (unfavourable), Liver cancer:2.07e-4 (unfavourable) Expressed in all Mixed esophagus: 27.5 NPAS3 bHLHe12, MOP6, PASD6 ENSG00000151322 Neuronal PAS domain protein 3 14 32934933-33804176 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA002892 Approved Approved Nucleoplasm Tissue enhanced Tissue enhanced cerebral cortex: 25.0 cervix, uterine: 10.0 NPAS4 bHLHe79, Le-PAS, NXF, PASD10 ENSG00000174576 Neuronal PAS domain protein 4 11 66421004-66426707 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA039255 Uncertain Not detected Tissue enhanced cerebral cortex: 4.1;endometrium: 1.9 smooth muscle: 1.5 NR0B1 AHC, AHCH, DAX1, DSS, NR0B1 ENSG00000169297 Nuclear receptor subfamily 0, group B, member 1 X 30304206-30309598 Cancer-related genes, Disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA070839 Supported Nucleoplasm Tissue enhanced Group enriched 7 adrenal gland: 27.9;testis: 34.9 ovary: 4.2 NR0B2 SHP ENSG00000131910 Nuclear receptor subfamily 0, group B, member 2 1 26911489-26913966 Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level Group enriched Tissue enhanced duodenum: 80.8;liver: 48.6 small intestine: 29.6 NR1D1 ear-1, hRev, Rev-ErbAalpha, THRA1, THRAL ENSG00000126368 Nuclear receptor subfamily 1, group D, member 1 17 40092787-40100725 Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA007935 Uncertain Supported Nuclear bodies Melanoma:1.36e-4 (favourable), Colorectal cancer:1.94e-4 (unfavourable) Expressed in all Mixed cerebral cortex: 37.5 NR1D2 BD73, EAR-1r, Hs.37288, HZF2, RVR ENSG00000174738 Nuclear receptor subfamily 1, group D, member 2 3 23945260-23980618 Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA053868, HPA054798 Approved Approved Nucleoplasm Renal cancer:4.47e-7 (favourable) Expressed in all Expressed in all thyroid gland: 89.9 NR1H2 LXR-b, NER, NER-I, RIP15, UNR ENSG00000131408 Nuclear receptor subfamily 1, group H, member 2 19 50329653-50382982 Cancer-related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA056838, HPA070212 Uncertain Approved Nucleoplasm Colorectal cancer:9.86e-4 (unfavourable) Expressed in all Expressed in all bone marrow: 87.8 NR1H3 LXR-a, RLD-1 ENSG00000025434 Nuclear receptor subfamily 1, group H, member 3 11 47248300-47269032 Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA036443, CAB037109 Approved Renal cancer:1.40e-5 (unfavourable), Urothelial cancer:3.40e-4 (favourable), Endometrial cancer:5.05e-4 (favourable), Liver cancer:5.60e-4 (unfavourable) Expressed in all Expressed in all adipose tissue: 55.1 NR1H4 FXR, HRR-1, HRR1, RIP14 ENSG00000012504 Nuclear receptor subfamily 1, group H, member 4 12 100473708-100564413 Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA047699 Approved Nucleoplasm Group enriched Tissue enhanced liver: 66.4;small intestine: 45.2 duodenum: 30.7 NR1I2 BXR, ONR1, PAR2, PXR, SXR ENSG00000144852 Nuclear receptor subfamily 1, group I, member 2 3 119780484-119818485 FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA029309, HPA055121, HPA073926 Validated Nucleoplasm Group enriched Group enriched 12 colon: 9.3;duodenum: 23.2;gallbladder: 6.0;liver: 19.7;rectum: 9.4;small intestine: 26.3 stomach: 1.3 NR1I3 CAR, CAR1, MB67 ENSG00000143257 Nuclear receptor subfamily 1, group I, member 3 1 161229666-161238302 Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA051365 Approved Nucleoplasm Tissue enriched Tissue enriched 9 liver: 82.0 kidney: 9.6 NR2C1 TR2, TR2-11 ENSG00000120798 Nuclear receptor subfamily 2, group C, member 1 12 95020229-95073703 Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA035040, HPA035041, HPA067767 Supported Supported Nucleus
Cell Junctions
Cytosol Renal cancer:1.03e-6 (unfavourable), Liver cancer:5.18e-5 (unfavourable), Urothelial cancer:5.62e-5 (favourable) Expressed in all Mixed testis: 21.8 NR2C2 hTAK1, TAK1, TR2R1, TR4 ENSG00000177463 Nuclear receptor subfamily 2, group C, member 2 3 14947584-15053600 Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA006313 Approved Validated Nucleoplasm Head and neck cancer:1.51e-5 (favourable) Expressed in all Expressed in all testis: 38.8 NR2E1 TLL, TLX, XTLL ENSG00000112333 Nuclear receptor subfamily 2, group E, member 1 6 108166058-108188809 Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA036954, HPA055642 Approved Approved Nuclear bodies Tissue enriched Tissue enriched 46 cerebral cortex: 11.5 adrenal gland,parathyroid gland: 0.2 NR2E3 PNR, rd7, RP37 ENSG00000278570 Nuclear receptor subfamily 2, group E, member 3 15 71792638-71818259 Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level Mixed Not detected cervix, uterine,testis: 0.7 NR2F1 COUP-TFI, EAR-3, ERBAL3, SVP44, TCFCOUP1, TFCOUP1 ENSG00000175745 Nuclear receptor subfamily 2, group F, member 1 5 93583337-93594615 Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB019281 Approved Nucleoplasm
Cytosol Urothelial cancer:1.47e-4 (unfavourable), Renal cancer:3.47e-4 (unfavourable) Expressed in all Mixed placenta: 75.3 NR2F2 ARP1, COUP-TFII, COUPTFB, NF-E3, SVP40, TFCOUP2 ENSG00000185551 Nuclear receptor subfamily 2, group F, member 2 15 96325938-96340263 Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level Expressed in all Tissue enhanced ovary: 360.9 endometrium: 186.6 NR2F6 EAR-2, ERBAL2 ENSG00000160113 Nuclear receptor subfamily 2, group F, member 6 19 17231883-17245940 Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level Endometrial cancer:4.36e-4 (unfavourable) Expressed in all Mixed duodenum: 31.8 NR3C1 GR, GRL ENSG00000113580 Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) 5 143277931-143435512 Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA004248, CAB010435 Supported Validated Nucleoplasm
Mitochondria
Cytosol Renal cancer:1.72e-6 (unfavourable), Endometrial cancer:3.64e-5 (unfavourable) Expressed in all Expressed in all placenta: 66.4 NR3C2 MLR, MR ENSG00000151623 Nuclear receptor subfamily 3, group C, member 2 4 148078762-148444698 Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB009155, HPA074979 Supported Approved Nucleoplasm Renal cancer:3.10e-11 (favourable) Mixed Mixed thyroid gland: 32.1 NR4A1 GFRP1, HMR, N10, NAK-1, NGFIB, NUR77, TR3 ENSG00000123358 Nuclear receptor subfamily 4, group A, member 1 12 52022832-52059507 Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA059742 Supported Nucleus
Cytosol Renal cancer:6.99e-4 (favourable) Expressed in all Expressed in all adrenal gland: 753.5 NR4A2 HZF-3, NOT, NURR1, RNR1, TINUR ENSG00000153234 Nuclear receptor subfamily 4, group A, member 2 2 156324432-156342348 Cancer-related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA000543, CAB010481 Uncertain Supported Nuclear speckles Expressed in all Tissue enhanced adrenal gland: 175.5 ovary: 95.2 NR4A3 CHN, CSMF, MINOR, NOR1 ENSG00000119508 Nuclear receptor subfamily 4, group A, member 3 9 99821855-99866891 Cancer-related genes, Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA043360 Uncertain Breast cancer:5.97e-4 (favourable) Mixed Tissue enhanced adrenal gland: 89.5 urinary bladder: 43.5 NR5A1 AD4BP, ELP, FTZ1, FTZF1, SF-1 ENSG00000136931 Nuclear receptor subfamily 5, group A, member 1 9 124481236-124507430 Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level Group enriched Group enriched 6 adrenal gland: 138.2;ovary: 36.3;spleen: 154.3 testis: 19.6 NR5A2 B1F2, FTF, FTZ-F1, FTZ-F1beta, hB1F, hB1F-2, LRH-1 ENSG00000116833 Nuclear receptor subfamily 5, group A, member 2 1 200027602-200177424 Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA005455, HPA017067 Supported Uncertain Nuclear speckles Tissue enhanced Mixed small intestine: 19.8 NR6A1 CT150, GCNF, GCNF1, RTR ENSG00000148200 Nuclear receptor subfamily 6, group A, member 1 9 124517275-124771310 Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA031461, HPA045145 Supported Nucleus Tissue enriched Tissue enriched 8 testis: 42.5 thyroid gland: 5.1 NRF1 ALPHA-PAL, EWG ENSG00000106459 Nuclear respiratory factor 1 7 129611714-129757082 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA029329 Approved Supported Nucleoplasm
Cytosol Liver cancer:6.02e-4 (unfavourable) Expressed in all Expressed in all fallopian tube: 20.7 NRL D14S46E, NRL-MAF, RP27 ENSG00000129535 Neural retina leucine zipper 14 24080107-24115014 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB026066, HPA064599 Supported Supported Nucleoplasm
Cytosol Mixed Mixed parathyroid gland: 4.1 OLIG1 BHLHB6, bHLHe21 ENSG00000184221 Oligodendrocyte transcription factor 1 21 33070144-33072420 Predicted intracellular proteins, Transcription factors Evidence at protein level Tissue enriched Tissue enriched 103 cerebral cortex: 143.0 kidney: 1.3 OLIG2 BHLHB1, bHLHe19, OLIGO2, PRKCBP2, RACK17 ENSG00000205927 Oligodendrocyte lineage transcription factor 2 21 33025845-33029196 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003254, CAB019381 Supported Uncertain Nucleoplasm
Plasma membrane Tissue enriched Tissue enriched 239 cerebral cortex: 91.2 duodenum: 0.3 OLIG3 Bhlhb7, bHLHe20 ENSG00000177468 Oligodendrocyte transcription factor 3 6 137492202-137494250 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA018303, CAB024865 Uncertain Not detected Not detected esophagus: 0.1 ONECUT1 HNF-6, HNF6, HNF6A ENSG00000169856 One cut homeobox 1 15 52756989-52791078 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003457 Approved Group enriched Group enriched 6 gallbladder: 8.5;liver: 5.9;pancreas: 2.3;testis: 1.8 bone marrow: 0.7 ONECUT2 OC-2 ENSG00000119547 One cut homeobox 2 18 57435685-57491297 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA057058 Approved Supported Nucleoplasm
Actin filaments Group enriched Tissue enhanced duodenum: 10.6;gallbladder: 16.4 liver: 4.5 ONECUT3 ENSG00000205922 One cut homeobox 3 19 1752373-1780988 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA059936 Supported Nucleoplasm Group enriched Tissue enhanced stomach: 4.1 gallbladder: 1.0 OSR1 ODD ENSG00000143867 Odd-skipped related transciption factor 1 2 19351485-19358653 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA015525 Uncertain Mixed Mixed adipose tissue: 21.9 OSR2 FLJ90037 ENSG00000164920 Odd-skipped related transciption factor 2 8 98944403-98952104 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA052425, HPA063486 Uncertain Approved Nucleus
Plasma membrane Head and neck cancer:2.44e-5 (favourable) Mixed Tissue enhanced endometrium: 204.6;fallopian tube: 143.0 ovary: 102.5 OTP ENSG00000171540 Orthopedia homeobox 5 77628712-77639688 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA039365 Uncertain Tissue enriched Not detected lung,testis: 0.1 OTX1 ENSG00000115507 Orthodenticle homeobox 1 2 63050057-63057836 Predicted intracellular proteins, Transcription factors Evidence at protein level CAB012341, HPA052122 Approved Uncertain Nuclear speckles
Cytosol Mixed Tissue enhanced cerebral cortex: 1.7;skin: 6.1 prostate: 0.9 OTX2 ENSG00000165588 Orthodenticle homeobox 2 14 56799905-56810479 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA000633 Approved Tissue enriched Not detected testis: 0.5 OVOL1 HOVO1 ENSG00000172818 Ovo-like zinc finger 1 11 65787022-65797219 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003984 Uncertain Approved Nucleus Renal cancer:1.00e-13 (favourable), Endometrial cancer:1.87e-4 (unfavourable) Mixed Tissue enhanced esophagus: 37.4;skin: 33.5;testis: 35.3 urinary bladder: 16.0 OVOL2 bA504H3.3, HOVO2, ZNF339 ENSG00000125850 Ovo-like zinc finger 2 20 17956979-18059188 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA038531 Uncertain Approved Nucleoplasm
Cytosol Mixed Tissue enhanced stomach: 8.2 colon: 3.6 OVOL3 HOVO3 ENSG00000105261 Ovo-like zinc finger 3 19 36111151-36113711 Predicted intracellular proteins, Transcription factors Evidence at transcript level Not detected Tissue enhanced skin: 1.0;testis: 2.9 appendix: 0.4 PATZ1 dJ400N23, MAZR, PATZ, RIAZ, ZBTB19, ZNF278, ZSG ENSG00000100105 POZ (BTB) and AT hook containing zinc finger 1 22 31325804-31346232 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA047893, HPA048315 Approved Supported Nucleoplasm Renal cancer:8.54e-8 (favourable), Urothelial cancer:7.79e-6 (favourable), Glioma:6.53e-5 (favourable), Lung cancer:8.71e-5 (favourable) Expressed in all Expressed in all parathyroid gland: 39.8 PAX1 ENSG00000125813 Paired box 1 20 21705659-21718486 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Tissue enriched Tissue enriched 10 parathyroid gland: 182.0 tonsil: 18.2 PAX2 ENSG00000075891 Paired box 2 10 100735603-100829941 Disease related genes, Predicted intracellular proteins, Predicted secreted proteins, Transcription factors Evidence at protein level CAB013024, HPA047704, HPA070751 Supported Supported Nucleoli
Golgi apparatus Endometrial cancer:4.56e-4 (unfavourable) Group enriched Group enriched 5 epididymis: 36.6;fallopian tube: 18.8;kidney: 25.2;seminal vesicle: 19.8 cervix, uterine: 4.9 PAX3 HUP2, WS1 ENSG00000135903 Paired box 3 2 222199888-222298996 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA063659, HPA069000 Uncertain Supported Nucleoplasm Tissue enriched Group enriched 9 breast: 1.2;skeletal muscle: 1.1;skin: 3.2;testis: 2.4 prostate: 0.2 PAX4 MODY9 ENSG00000106331 Paired box 4 7 127610292-127615928 Disease related genes, Predicted intracellular proteins, Predicted secreted proteins, Transcription factors Evidence at protein level Not detected Tissue enhanced duodenum: 1.2;rectum: 1.3 small intestine,testis: 0.6 PAX5 BSAP ENSG00000196092 Paired box 5 9 36833275-37034185 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB026269, CAB026869, HPA056394, HPA068498 Supported Approved Nucleoplasm
Vesicles
Cytosol Mixed Tissue enhanced lymph node: 49.1;spleen: 26.7;tonsil: 35.2 appendix: 20.2 PAX6 AN, AN2, D11S812E, WAGR ENSG00000007372 Paired box 6 11 31784792-31817961 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA030775, CAB034143 Supported Validated Nucleoplasm Tissue enhanced Group enriched 6 cerebral cortex: 24.4;stomach: 12.1 testis: 2.9 PAX7 Hup1 ENSG00000009709 Paired box 7 1 18631006-18748866 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Group enriched Group enriched 7 cerebral cortex: 1.4;skeletal muscle: 2.2 esophagus,testis: 0.2 PAX8 ENSG00000125618 Paired box 8 2 113215997-113278950 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA030062, HPA064554 Validated Nucleoplasm Endometrial cancer:1.75e-5 (unfavourable) Group enriched Tissue enriched 10 thyroid gland: 642.7 kidney: 65.0 PAX9 ENSG00000198807 Paired box 9 14 36657568-36679715 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA038462 Uncertain Approved Nucleoplasm
Mitochondria Cervical cancer:5.38e-4 (favourable) Mixed Group enriched 8 esophagus: 56.3;parathyroid gland: 101.3;salivary gland: 21.8 tonsil: 7.8 PBRM1 BAF180, PB1 ENSG00000163939 Polybromo 1 3 52545352-52685917 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA015629, HPA059373 Uncertain Supported Nucleoplasm Expressed in all Expressed in all thyroid gland: 44.5 PBX1 ENSG00000185630 Pre-B-cell leukemia homeobox 1 1 164555584-164899296 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003505, HPA003881, CAB018768 Supported Validated Nucleoplasm Mixed Expressed in all endometrium: 246.5 PBX2 G17, HOX12, PBX2MHC ENSG00000204304 Pre-B-cell leukemia homeobox 2 6 32184741-32190186 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA061478 Supported Approved Nucleoplasm Endometrial cancer:8.90e-5 (unfavourable), Ovarian cancer:6.84e-4 (favourable) Expressed in all Expressed in all epididymis: 35.5 PBX3 ENSG00000167081 Pre-B-cell leukemia homeobox 3 9 125747345-125967377 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003881 Supported Approved Nucleoplasm Expressed in all Expressed in all parathyroid gland: 334.1 PBX4 ENSG00000105717 Pre-B-cell leukemia homeobox 4 19 19561707-19618916 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA049859, HPA056469 Approved Uncertain Vesicles Urothelial cancer:5.94e-7 (favourable), Cervical cancer:8.69e-6 (favourable) Mixed Tissue enhanced testis: 2.6;thyroid gland: 2.2 lymph node: 0.8 PDX1 IDX-1, IPF1, MODY4, PDX-1, STF-1 ENSG00000139515 Pancreatic and duodenal homeobox 1 13 27920020-27926231 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB025873, HPA059146 Supported Supported Nucleoplasm Group enriched Tissue enriched 7 duodenum: 44.8 stomach: 6.3 PEG3 KIAA0287, ZKSCAN22, ZNF904, ZSCAN24 ENSG00000198300 Paternally expressed 3 19 56810083-56840728 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA026070 Approved Supported Nucleoplasm Thyroid cancer:1.56e-4 (unfavourable) Tissue enhanced Tissue enhanced ovary: 339.5;placenta: 196.4 adrenal gland: 102.6 PGR NR3C3, PR ENSG00000082175 Progesterone receptor 11 101029624-101130524 Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB000068, HPA004751, HPA008428, HPA017176, CAB055100 Supported Endometrial cancer:5.76e-8 (favourable) Group enriched Group enriched 6 cervix, uterine: 95.8;endometrium: 171.3;fallopian tube: 52.8;smooth muscle: 113.5 ovary: 19.4 PHF5A bK223H9.2, INI, MGC1346, Rds3, SAP14b, SF3b14b, SF3B7 ENSG00000100410 PHD finger protein 5A 22 41459717-41468725 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA028885 Supported Validated Nucleoplasm Liver cancer:3.02e-8 (unfavourable) Expressed in all Expressed in all lymph node: 40.3 PHOX2A ARIX, CFEOM2, FEOM2, PMX2A ENSG00000165462 Paired-like homeobox 2a 11 72239077-72245664 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA065621 Approved Nucleus
Nuclear membrane
Vesicles Tissue enriched Tissue enriched 14 adrenal gland: 26.5 appendix: 1.8 PHOX2B NBPhox, Phox2b, PMX2B ENSG00000109132 Paired-like homeobox 2b 4 41744082-41748970 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA074325 Supported Nucleoplasm Not detected Tissue enriched 8 adrenal gland: 10.4 small intestine: 1.2 PHTF1 PHTF ENSG00000116793 Putative homeodomain transcription factor 1 1 113696831-113759489 Plasma proteins, Predicted membrane proteins, Transcription factors Evidence at protein level HPA059486 Approved Nucleoli
Nuclear bodies Renal cancer:1.21e-6 (unfavourable) Expressed in all Tissue enhanced testis: 54.1 parathyroid gland: 18.8 PHTF2 DKFZp434D166 ENSG00000006576 Putative homeodomain transcription factor 2 7 77798792-77957503 Predicted membrane proteins, Transcription factors Evidence at protein level HPA012312 Uncertain Approved Nucleoplasm
Cytosol Renal cancer:3.09e-7 (unfavourable), Thyroid cancer:2.78e-4 (unfavourable) Expressed in all Mixed parathyroid gland: 60.8 PITX1 BFT, POTX, PTX1 ENSG00000069011 Paired-like homeodomain 1 5 135027735-135034813 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA008743 Approved Supported Nucleoli Tissue enhanced Tissue enriched 5 esophagus: 212.7 salivary gland: 38.8 PITX2 ARP1, Brx1, IGDS, IHG2, IRID2, Otlx2, RGS, RIEG, RIEG1, RS ENSG00000164093 Paired-like homeodomain 2 4 110617423-110642123 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA050074, HPA062728 Validated Nucleus Mixed Tissue enhanced placenta: 71.9 skeletal muscle: 18.3 PITX3 ASMD ENSG00000107859 Paired-like homeodomain 3 10 102230186-102241474 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Not detected Group enriched 10 adipose tissue: 1.2;skeletal muscle: 5.6 testis: 0.3 PKNOX1 PREP1 ENSG00000160199 PBX/knotted 1 homeobox 1 21 42974510-43033931 Predicted intracellular proteins, Transcription factors Evidence at protein level CAB004285, HPA057215, HPA065017 Approved Validated Nucleoplasm Liver cancer:4.54e-8 (unfavourable), Pancreatic cancer:6.71e-4 (favourable) Expressed in all Mixed thyroid gland: 16.8 PKNOX2 ENSG00000165495 PBX/knotted 1 homeobox 2 11 125164687-125433389 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA028867, CAB034342, HPA055368, HPA066962 Supported Validated Nucleoplasm Tissue enhanced Mixed thyroid gland: 20.1 PLAG1 ZNF912 ENSG00000181690 Pleiomorphic adenoma gene 1 8 56160904-56211324 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA072290 Approved Nuclear speckles Mixed Mixed ovary: 5.9 PLAGL1 LOT1, ZAC ENSG00000118495 Pleiomorphic adenoma gene-like 1 6 143940300-144064599 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA055706 Supported Nuclear bodies
Golgi apparatus
Vesicles Renal cancer:4.94e-6 (unfavourable), Stomach cancer:6.61e-4 (unfavourable) Mixed Expressed in all placenta: 362.2 PLAGL2 ZNF900 ENSG00000126003 Pleiomorphic adenoma gene-like 2 20 32192503-32207791 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA005900 Uncertain Approved Nucleoplasm
Cytosol Expressed in all Expressed in all testis: 25.7 POGZ KIAA0461, ZNF280E, ZNF635m ENSG00000143442 Pogo transposable element with ZNF domain 1 151402724-151459465 Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA006800, HPA008781 Approved Validated Nucleoplasm Renal cancer:3.92e-5 (unfavourable), Urothelial cancer:4.40e-4 (favourable), Endometrial cancer:8.67e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 74.9 POU1F1 GHF-1, PIT1, POU1F1a ENSG00000064835 POU class 1 homeobox 1 3 87259404-87276587 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA041646, HPA050624 Supported Not detected Not detected adipose tissue,adrenal gland,cerebral cortex,endometrium,epididymis,gallbladder,kidney,lung,parathyroid gland,prostate,skeletal muscle,spleen,thyroid gland,tonsil: 0.1 POU2F1 OCT1, OTF1 ENSG00000143190 POU class 2 homeobox 1 1 167220829-167427345 Predicted intracellular proteins, Transcription factors Evidence at protein level CAB002608, HPA058559, HPA064323 Supported Supported Nucleoplasm
Endoplasmic reticulum
Vesicles Renal cancer:2.98e-5 (unfavourable) Expressed in all Mixed parathyroid gland: 7.9 POU2F2 OCT2, OTF2 ENSG00000028277 POU class 2 homeobox 2 19 42086110-42196585 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB002513, HPA040368, HPA062096, HPA064404 Supported Supported Nucleoplasm Renal cancer:7.57e-11 (unfavourable) Mixed Group enriched 6 appendix: 37.8;lymph node: 62.5;spleen: 37.2;tonsil: 45.5 urinary bladder: 8.1 POU2F3 Epoc-1, OCT11, PLA-1, Skn-1a ENSG00000137709 POU class 2 homeobox 3 11 120236640-120319944 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA019652 Supported Thyroid cancer:8.14e-4 (favourable) Mixed Group enriched 12 parathyroid gland: 15.3;skin: 72.5 seminal vesicle: 3.8 POU3F1 OCT6, OTF6, SCIP ENSG00000185668 POU class 3 homeobox 1 1 38043827-38046794 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA055980, HPA073824 Validated Nucleoplasm Mixed Tissue enriched 18 skin: 38.6 cerebral cortex: 2.1 POU3F2 BRN2, OCT7, OTF7, POUF3 ENSG00000184486 POU class 3 homeobox 2 6 98834592-98839490 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA047081, HPA056261 Approved Supported Nucleus Tissue enriched Tissue enriched 67 cerebral cortex: 20.4 testis: 0.3 POU3F3 BRN1, OTF8 ENSG00000198914 POU class 3 homeobox 3 2 104855511-104860471 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA052792, HPA056039, HPA067151 Supported Supported Nucleus Endometrial cancer:4.26e-5 (unfavourable) Group enriched Group enriched 51 cerebral cortex: 36.6;epididymis: 34.9;kidney: 28.3;seminal vesicle: 17.2 skin: 0.5 POU3F4 BRN4, DFN3, DFNX2, OTF9 ENSG00000196767 POU class 3 homeobox 4 X 83508250-83512127 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA031984 Uncertain Tissue enriched Tissue enriched 11 cerebral cortex: 8.0 kidney: 0.7 POU4F1 BRN3A, RDC-1 ENSG00000152192 POU class 4 homeobox 1 13 78598362-78603560 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA068024 Supported Mixed Tissue enhanced testis: 2.4 tonsil: 0.7 POU4F2 Brn-3b, BRN3B ENSG00000151615 POU class 4 homeobox 2 4 146638893-146642474 Predicted intracellular proteins, Transcription factors Evidence at protein level Not detected Tissue enriched 18 testis: 1.8 all non-specific tissues: 0.0 POU4F3 BRN3C, DFNA15 ENSG00000091010 POU class 4 homeobox 3 5 146339024-146340520 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA038215 Uncertain Supported Nucleoplasm Tissue enhanced Not detected all non-specific tissues: 0.0 POU5F1 MGC22487, OCT3, Oct4, OTF3 ENSG00000204531 POU class 5 homeobox 1 6 31164337-31180731 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB025600, CAB026380, HPA058267 Approved Supported Nucleoplasm
Cytosol Urothelial cancer:2.04e-5 (favourable) Tissue enriched Mixed small intestine: 5.8 POU5F1B OTF3C, OTF3P1, POU5F1P1 ENSG00000212993 POU class 5 homeobox 1B 8 127414290-127420069 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA058267 Supported Nucleoplasm Tissue enhanced Not detected parathyroid gland: 0.7 POU5F2 FLJ25680, SPRM-1 ENSG00000248483 POU domain class 5, transcription factor 2 5 93734806-93741637 Predicted intracellular proteins, Transcription factors Evidence at transcript level Not detected Tissue enriched 158 testis: 15.7 all non-specific tissues: 0.0 POU6F1 BRN5, MPOU, TCFB1 ENSG00000184271 POU class 6 homeobox 1 12 51186936-51217693 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA047021, HPA050411 Supported Supported Nuclear bodies
Actin filaments Pancreatic cancer:6.61e-4 (favourable) Expressed in all Mixed cerebral cortex: 25.2 POU6F2 RPF-1 ENSG00000106536 POU class 6 homeobox 2 7 38977998-39493095 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA008699 Uncertain Mixed Tissue enhanced cerebral cortex: 3.1;placenta: 1.8 gallbladder,testis: 1.2 PPARA hPPAR, NR1C1, PPAR ENSG00000186951 Peroxisome proliferator-activated receptor alpha 22 46150521-46243756 FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA058901, HPA067049 Supported Nucleus Renal cancer:4.39e-9 (favourable) Expressed in all Expressed in all kidney: 24.0 PPARD FAAR, NR1C2, NUC1, NUCII ENSG00000112033 Peroxisome proliferator-activated receptor delta 6 35342558-35428191 FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB017635 Approved Liver cancer:4.57e-4 (unfavourable) Expressed in all Expressed in all placenta: 40.1 PPARG NR1C3, PPARG1, PPARG2, PPARgamma ENSG00000132170 Peroxisome proliferator-activated receptor gamma 3 12287368-12434356 Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB004282, HPA051239, HPA063663 Approved Validated Nucleus
Vesicles Renal cancer:1.59e-8 (favourable), Liver cancer:3.41e-5 (unfavourable), Urothelial cancer:5.52e-5 (favourable) Expressed in all Tissue enhanced adipose tissue: 172.8 placenta: 58.6 PPP1R13L IASPP, RAI ENSG00000104881 Protein phosphatase 1, regulatory subunit 13 like 19 45379634-45406349 Predicted intracellular proteins, Transcription factors Evidence at protein level CAB005016, HPA041231, HPA059883 Approved Validated Cytosol Lung cancer:3.39e-5 (unfavourable), Ovarian cancer:5.40e-4 (unfavourable) Expressed in all Tissue enhanced skin: 191.2 esophagus: 54.1 PRDM1 BLIMP1, PRDI-BF1 ENSG00000057657 PR domain containing 1, with ZNF domain 6 106086320-106109939 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA030033 Approved Approved Nucleus
Nucleoli Renal cancer:9.81e-5 (unfavourable) Expressed in all Tissue enhanced esophagus: 61.3 endometrium: 30.1 PRDM10 KIAA1231, MGC131802, PFM7 ENSG00000170325 PR domain containing 10 11 129899706-130002835 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA026997 Approved Approved Nucleoplasm
Nucleoli fibrillar center
Vesicles Expressed in all Mixed parathyroid gland,skin: 7.4 PRDM13 ENSG00000112238 PR domain containing 13 6 99606730-99615578 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA070592 Uncertain Not detected Not detected all non-specific tissues: 0.0 PRDM14 ENSG00000147596 PR domain containing 14 8 70051651-70071693 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA019094, HPA057070 Uncertain Uncertain Nucleoplasm Tissue enriched Tissue enhanced testis: 1.8 epididymis,skin: 0.5 PRDM15 C21orf83, ZNF298 ENSG00000141956 PR domain containing 15 21 41798225-41879482 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA024268, HPA029255, HPA029256 Uncertain Supported Nucleoplasm
Nuclear bodies Expressed in all Mixed lymph node: 8.9 PRDM16 KIAA1675, MEL1, MGC166915, PFM13 ENSG00000142611 PR domain containing 16 1 3069168-3438621 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA050343, HPA060467 Validated Nucleoplasm Thyroid cancer:4.70e-5 (unfavourable) Mixed Mixed duodenum: 7.8 PRDM2 HUMHOXY1, KMT8, MTB-ZF, RIZ, RIZ1, RIZ2 ENSG00000116731 PR domain containing 2, with ZNF domain 1 13700198-13825079 Enzymes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA005809 Approved Approved Nucleus
Golgi apparatus Expressed in all Expressed in all bone marrow: 51.3 PRDM4 PFM1 ENSG00000110851 PR domain containing 4 12 107732866-107761272 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA024322, HPA067437 Approved Supported Nucleoplasm Renal cancer:3.15e-7 (favourable), Liver cancer:1.86e-4 (unfavourable), Melanoma:7.66e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 88.4 PRDM5 PFM2 ENSG00000138738 PR domain containing 5 4 120684919-120922870 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA051406 Supported Supported Nucleus
Nucleoli
Nuclear bodies Mixed Mixed parathyroid gland: 20.6 PRDM6 ENSG00000061455 PR domain containing 6 5 123089121-123194266 Enzymes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA030322, HPA030324 Uncertain Uncertain Nucleoplasm Mixed Tissue enhanced gallbladder: 5.2;placenta: 5.9 lung: 4.0 PRDM8 ENSG00000152784 PR domain containing 8 4 80183879-80204329 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA057253 Approved Nuclear bodies Tissue enhanced Tissue enhanced prostate: 41.3;seminal vesicle: 37.8 cerebral cortex: 23.3 PRDM9 MSBP3, PFM6, ZNF899 ENSG00000164256 PR domain containing 9 5 23443586-23528597 Enzymes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA059555 Uncertain Not detected Group enriched 10 epididymis: 4.3;testis: 7.7 bone marrow: 0.6 PRKRIR DAP4, P52rIPK, THAP12 ENSG00000137492 Protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 11 76349956-76380971 Plasma proteins, Predicted membrane proteins, Transcription factors Evidence at protein level HPA008758 Approved Approved Nucleoplasm Expressed in all Expressed in all endometrium: 42.6 PROP1 ENSG00000175325 PROP paired-like homeobox 1 5 177992235-177996242 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Not detected Not detected all non-specific tissues: 0.0 PROX1 ENSG00000117707 Prospero homeobox 1 1 213983181-214041502 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA000842, HPA001030 Supported Nucleoplasm Tissue enhanced Tissue enhanced liver: 45.5 adrenal gland: 13.4 PROX2 FLJ36749 ENSG00000119608 Prospero homeobox 2 14 74852871-74871940 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA045057 Uncertain Not detected Mixed skin: 2.5 PRRX1 PHOX1, PMX1 ENSG00000116132 Paired related homeobox 1 1 170662728-170739419 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA051084 Uncertain Supported Nucleus
Nucleoli Renal cancer:6.60e-10 (unfavourable) Mixed Mixed cervix, uterine: 135.2 PRRX2 PMX2, PRX2 ENSG00000167157 Paired related homeobox 2 9 129665641-129722674 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA006607, HPA026808 Approved Approved Nucleoplasm
Nuclear bodies Mixed Tissue enhanced cervix, uterine: 9.8;skin: 10.7 testis: 6.3 PSPC1 FLJ10955, PSP1 ENSG00000121390 Paraspeckle component 1 13 19674752-19783019 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA038904 Supported Approved Nucleoplasm
Nucleoli fibrillar center Thyroid cancer:1.46e-4 (favourable), Liver cancer:2.21e-4 (unfavourable) Expressed in all Expressed in all testis: 45.2 PTF1A bHLHa29, PTF1-p48 ENSG00000168267 Pancreas specific transcription factor, 1a 10 23192327-23194252 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB022612 Approved Nucleoplasm Tissue enhanced Tissue enriched 6 pancreas: 7.7 testis: 1.2 PURA PUR-ALPHA, PUR1, PURALPHA ENSG00000185129 Purine-rich element binding protein A 5 140107777-140125619 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Renal cancer:4.77e-5 (favourable) Expressed in all Mixed parathyroid gland: 26.4 PURB PURBETA ENSG00000146676 Purine-rich element binding protein B 7 44876293-44885361 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA048766 Supported Nucleus Expressed in all Expressed in all cerebral cortex: 24.6 PURG PURG-A, PURG-B ENSG00000172733 Purine-rich element binding protein G 8 30995802-31033715 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA047746 Uncertain Approved Nucleus
Nucleoli
Plasma membrane Tissue enhanced Tissue enhanced cerebral cortex: 6.6;testis: 4.8 endometrium: 2.6 RARA NR1B1, RAR ENSG00000131759 Retinoic acid receptor, alpha 17 40309192-40357643 Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA058282 Supported Nucleus
Cytosol Endometrial cancer:2.60e-4 (favourable) Expressed in all Expressed in all gallbladder: 68.9 RARB HAP, NR1B2, RRB2 ENSG00000077092 Retinoic acid receptor, beta 3 25174332-25597932 Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB002617, HPA004174 Supported Validated Nucleoplasm Renal cancer:3.43e-5 (favourable) Expressed in all Mixed placenta: 20.5 RARG NR1B3, RARC ENSG00000172819 Retinoic acid receptor, gamma 12 53210567-53232980 Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA053883 Supported Supported Nucleoplasm Renal cancer:3.08e-6 (unfavourable), Endometrial cancer:3.68e-6 (unfavourable) Expressed in all Tissue enhanced skin: 143.7 esophagus: 77.6 RAX RX ENSG00000134438 Retina and anterior neural fold homeobox 18 59267035-59274086 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Not detected Not detected prostate: 0.1 RAX2 ARMD6, CORD11, MGC15631, RAXL1 ENSG00000173976 Retina and anterior neural fold homeobox 2 19 3769089-3772221 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA052533 Uncertain Not detected Tissue enhanced parathyroid gland: 1.1 fallopian tube: 0.7 RBAK ZNF769 ENSG00000146587 RB-associated KRAB zinc finger 7 5045821-5069488 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA071231 Supported Nucleoplasm Expressed in all Expressed in all parathyroid gland: 14.6 RBPJ CBF1, IGKJRB, IGKJRB1, KBF2, RBP-J, RBPJK, RBPSUH, SUH ENSG00000168214 Recombination signal binding protein for immunoglobulin kappa J region 4 26163455-26435131 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA060647 Supported Nucleoplasm Endometrial cancer:2.98e-4 (favourable) Expressed in all Expressed in all placenta: 76.7 RBPJL RBP-L, RBPSUHL, SUH, SUHL ENSG00000124232 Recombination signal binding protein for immunoglobulin kappa J region-like 20 45306851-45317824 Predicted intracellular proteins, Transcription factors Evidence at protein level CAB006846 Supported Group enriched Tissue enriched 151 pancreas: 205.7 stomach: 1.3 RC3H2 FLJ20301, FLJ20713, MNAB, RNF164 ENSG00000056586 Ring finger and CCCH-type domains 2 9 122844556-122905341 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA042863 Approved Supported Cytosol Renal cancer:5.50e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 25.0 RCOR2 ENSG00000167771 REST corepressor 2 11 63911221-63916844 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA021638 Uncertain Approved Nucleus
Vesicles
Midbody Mixed Tissue enhanced cerebral cortex: 13.2 testis: 3.7 RCOR3 FLJ10876 ENSG00000117625 REST corepressor 3 1 211258377-211316385 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA007413 Supported Approved Nucleus
Nucleoli Glioma:1.92e-5 (favourable), Lung cancer:5.75e-5 (favourable) Expressed in all Expressed in all testis: 67.1 REL c-Rel, I-Rel ENSG00000162924 V-rel avian reticuloendotheliosis viral oncogene homolog 2 60881521-60931610 Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors Evidence at protein level CAB004404 Uncertain Mixed Mixed bone marrow: 29.9 RELA NFKB3, p65 ENSG00000173039 V-rel avian reticuloendotheliosis viral oncogene homolog A 11 65653596-65663094 Cancer-related genes, Disease related genes, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors Evidence at protein level CAB004264, CAB005030, HPA063461 Supported Validated Cytosol Renal cancer:5.66e-4 (unfavourable), Liver cancer:9.18e-4 (unfavourable) Expressed in all Expressed in all endometrium: 62.1 RELB REL-B ENSG00000104856 V-rel avian reticuloendotheliosis viral oncogene homolog B 19 45001430-45038198 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB007753, HPA040506 Approved Supported Nucleoplasm
Cytosol Renal cancer:2.99e-6 (unfavourable), Breast cancer:1.55e-4 (favourable) Expressed in all Expressed in all appendix: 25.8 RERE ARG, ARP, ATN1L, DNB1, KIAA0458 ENSG00000142599 Arginine-glutamic acid dipeptide (RE) repeats 1 8352397-8817643 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA024093 Uncertain Expressed in all Expressed in all endometrium: 93.0 REST NRSF, XBR ENSG00000084093 RE1-silencing transcription factor 4 56907876-56935844 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA006079, CAB068222 Supported Approved Nucleoplasm
Cytosol Renal cancer:9.50e-5 (favourable) Expressed in all Expressed in all parathyroid gland: 31.6 RFX1 EF-C ENSG00000132005 Regulatory factor X, 1 (influences HLA class II expression) 19 13961538-14007039 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA048722 Approved Supported Nucleoplasm Head and neck cancer:2.42e-4 (favourable), Pancreatic cancer:4.92e-4 (favourable) Expressed in all Expressed in all testis: 16.8 RFX2 FLJ14226 ENSG00000087903 Regulatory factor X, 2 (influences HLA class II expression) 19 5993164-6199572 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA048969 Supported Approved Nucleoplasm
Golgi apparatus
Cytosol Endometrial cancer:2.67e-4 (favourable), Cervical cancer:2.80e-4 (favourable), Pancreatic cancer:7.36e-4 (favourable) Mixed Tissue enhanced testis: 93.2 fallopian tube: 32.5 RFX3 ENSG00000080298 Regulatory factor X, 3 (influences HLA class II expression) 9 3218297-3526004 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA035689 Approved Approved Nucleoplasm
Vesicles Breast cancer:1.47e-4 (favourable) Mixed Tissue enhanced testis: 38.4 fallopian tube: 18.1 RFX4 ENSG00000111783 Regulatory factor X, 4 (influences HLA class II expression) 12 106582907-106762803 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA050527 Supported Approved Nucleus Tissue enriched Group enriched 184 cerebral cortex: 30.9;testis: 135.3 prostate: 0.4 RFX5 ENSG00000143390 Regulatory factor X, 5 (influences HLA class II expression) 1 151340640-151347357 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA018519 Supported Expressed in all Expressed in all lymph node: 86.8 RFX6 dJ955L16.1, MGC33442, RFXDC1 ENSG00000185002 Regulatory factor X, 6 6 116877212-116932163 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA037696, HPA037697 Approved Supported Nucleus
Nucleoli Pancreatic cancer:3.59e-4 (favourable) Tissue enhanced Tissue enhanced adrenal gland: 6.0;stomach: 7.3 duodenum: 2.3 RFX7 FLJ12994, RFXDC2 ENSG00000181827 Regulatory factor X, 7 15 56087280-56243266 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA035462 Supported Approved Nucleus
Nuclear membrane Renal cancer:1.12e-5 (unfavourable) Expressed in all Mixed testis: 8.3 RFX8 FLJ42986 ENSG00000196460 RFX family member 8, lacking RFX DNA binding domain 2 101397361-101474703 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA059745 Approved Nucleoplasm
Nuclear bodies Mixed Tissue enhanced bone marrow: 2.6 testis: 1.3 RFXANK ANKRA1, BLS, F14150_1, MGC138628, RFX-B ENSG00000064490 Regulatory factor X-associated ankyrin-containing protein 19 19192229-19201869 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA049157, HPA053330 Approved Validated Nucleoplasm Expressed in all Expressed in all fallopian tube: 49.7 RFXAP ENSG00000133111 Regulatory factor X-associated protein 13 36819224-36829104 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA032035 Approved Nuclear speckles Lung cancer:2.26e-5 (favourable), Pancreatic cancer:4.18e-4 (favourable), Stomach cancer:4.91e-4 (favourable) Expressed in all Mixed testis: 12.1 RHOXF1 OTEX, PEPP1 ENSG00000101883 Rhox homeobox family, member 1 X 120109053-120115937 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA056506 Approved Mixed Tissue enriched 9 testis: 15.5 adipose tissue: 1.6 RHOXF2 CT107, PEPP-2, PEPP2, THG1 ENSG00000131721 Rhox homeobox family, member 2 X 120158561-120165630 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003314, CAB020794 Supported Tissue enhanced Tissue enriched 155 testis: 20.7 epididymis,skin: 0.1 RHOXF2B ENSG00000203989 Rhox homeobox family, member 2B X 120070672-120077705 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003314 Supported Not detected Tissue enriched 17 testis: 2.7 fallopian tube,ovary,skin,spleen: 0.1 RLF Zn-15L, ZNF292L ENSG00000117000 Rearranged L-myc fusion 1 40161373-40240921 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA054653, HPA057300 Uncertain Approved Nucleus Renal cancer:7.68e-6 (unfavourable), Liver cancer:1.75e-4 (unfavourable) Expressed in all Expressed in all bone marrow: 20.8 RORA NR1F1, ROR1, ROR2, ROR3, RZRA ENSG00000069667 RAR-related orphan receptor A 15 60488284-61229319 Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB009861 Approved Renal cancer:5.42e-6 (favourable) Mixed Expressed in all skin: 76.4 RORB NR1F2, ROR-BETA, RZRB ENSG00000198963 RAR-related orphan receptor B 9 74497365-74693177 Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA008393 Uncertain Approved Nucleus Group enriched Tissue enhanced cerebral cortex: 12.6;cervix, uterine: 14.0 prostate: 7.6 RORC NR1F3, RORG, RZRG, TOR ENSG00000143365 RAR-related orphan receptor C 1 151806071-151831872 Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA065620 Supported Nuclear bodies Renal cancer:2.94e-5 (favourable), Colorectal cancer:1.83e-4 (favourable) Mixed Mixed thyroid gland: 51.8 RREB1 HNT ENSG00000124782 Ras responsive element binding protein 1 6 7107597-7251980 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001756, HPA034843 Approved Supported Nucleoli fibrillar center
Nuclear speckles Renal cancer:1.41e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 22.9 RUNX1 AML1, AMLCR1, CBFA2, PEBP2A2 ENSG00000159216 Runt-related transcription factor 1 21 34787801-36004667 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA004176, HPA037912 Supported Validated Nucleoplasm
Vesicles Renal cancer:3.44e-15 (unfavourable) Expressed in all Mixed breast: 33.8 RUNX2 AML3, CBFA1, CCD, CCD1, PEBP2A1, PEBP2aA1 ENSG00000124813 Runt-related transcription factor 2 6 45328157-45664349 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB008374, HPA022040, CAB062561, CAB068226 Supported Validated Nucleoplasm Renal cancer:3.97e-9 (unfavourable), Urothelial cancer:6.66e-5 (unfavourable), Stomach cancer:2.24e-4 (unfavourable) Mixed Mixed cervix, uterine: 10.5 RUNX3 AML2, CBFA3, PEBP2A3 ENSG00000020633 Runt-related transcription factor 3 1 24899511-24965121 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA004195, CAB025416, HPA059006 Supported Supported Nucleus
Cytosol Renal cancer:5.59e-5 (unfavourable), Colorectal cancer:8.71e-4 (unfavourable) Expressed in all Tissue enhanced spleen: 51.3 bone marrow: 45.3 RXRA NR2B1 ENSG00000186350 Retinoid X receptor, alpha 9 134317098-134440585 Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB004565, CAB005352 Supported Supported Nucleus
Golgi apparatus Renal cancer:5.58e-4 (unfavourable), Pancreatic cancer:7.02e-4 (favourable) Expressed in all Mixed esophagus: 25.9 RXRB H-2RIIBP, NR2B2, RCoR-1 ENSG00000204231 Retinoid X receptor, beta 6 33193588-33200688 Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB002003, HPA063653 Approved Supported Nucleus Expressed in all Mixed epididymis: 15.5 RXRG NR2B3 ENSG00000143171 Retinoid X receptor, gamma 1 165400917-165445355 Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB002615 Uncertain Thyroid cancer:9.40e-5 (favourable) Group enriched Tissue enhanced skeletal muscle: 16.7 cervix, uterine: 4.6 SALL1 Hsal1, TBS, ZNF794 ENSG00000103449 Spalt-like transcription factor 1 16 51135975-51151367 Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA049829 Uncertain Approved Nucleus
Cytosol Renal cancer:1.91e-7 (favourable), Endometrial cancer:1.28e-4 (favourable) Group enriched Tissue enhanced thyroid gland: 40.0 cerebral cortex: 30.4 SALL2 Hsal2, KIAA0360, ZNF795 ENSG00000165821 Spalt-like transcription factor 2 14 21521081-21537216 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA004162 Approved Approved Nucleus
Vesicles Pancreatic cancer:1.23e-4 (favourable), Endometrial cancer:3.97e-4 (unfavourable) Mixed Tissue enhanced parathyroid gland: 66.6 cerebral cortex: 42.5 SALL3 ZNF796 ENSG00000256463 Spalt-like transcription factor 3 18 78980275-79002677 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA016656 Uncertain Tissue enriched Tissue enhanced cerebral cortex: 4.1;prostate: 2.5 kidney: 0.9 SALL4 dJ1112F19.1, ZNF797 ENSG00000101115 Spalt-like transcription factor 4 20 51782331-51802520 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA015291, HPA015791 Supported Validated Nucleoplasm Tissue enriched Group enriched 6 parathyroid gland: 6.6;prostate: 1.4;testis: 5.8;thyroid gland: 3.5 epididymis,urinary bladder: 0.6 SATB1 ENSG00000182568 SATB homeobox 1 3 18345387-18445588 Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transcription factors Evidence at protein level HPA051769, CAB056144 Supported Supported Nucleoplasm
Nuclear bodies Renal cancer:1.96e-7 (favourable), Pancreatic cancer:8.97e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 75.1 SATB2 FLJ21474, KIAA1034 ENSG00000119042 SATB homeobox 2 2 199269500-199471266 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001042, CAB023669, HPA029543, CAB062562, CAB067751, CAB068229, CAB068230, CAB068231 Supported Supported Nucleoplasm Renal cancer:5.37e-8 (favourable) Tissue enhanced Group enriched 6 cerebral cortex: 22.8;colon: 37.7;rectum: 48.3 small intestine: 6.5 SCRT1 DKFZp547F072, ZNF898 ENSG00000261678 Scratch family zinc finger 1 8 144330565-144336281 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA045265 Uncertain Approved Nuclear bodies Tissue enhanced Tissue enriched 7 cerebral cortex: 10.9 adrenal gland: 1.5 SCRT2 ZNF898B ENSG00000215397 Scratch family zinc finger 2 20 661596-676179 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA067697 Approved Nucleoplasm Tissue enriched Not detected cerebral cortex: 0.7 SCX bHLHa41, bHLHa48, SCXA, SCXB ENSG00000260428 Scleraxis bHLH transcription factor 8 144266560-144268481 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA043183 Uncertain Glioma:2.46e-4 (unfavourable) Group enriched Tissue enhanced skeletal muscle: 5.3 parathyroid gland: 3.3 SEBOX OG9, OG9X ENSG00000274529 SEBOX homeobox 17 28364268-28365244 Predicted intracellular proteins, Transcription factors No evidence HPA045689 Uncertain Not detected Not detected testis: 0.6 SFPQ PPP1R140, PSF ENSG00000116560 Splicing factor proline/glutamine-rich 1 35176378-35193148 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB009886, HPA047513, HPA054689 Supported Validated Nucleoplasm Liver cancer:7.91e-13 (unfavourable), Breast cancer:9.56e-5 (favourable) Expressed in all Expressed in all bone marrow: 135.7 SHOX GCFX, PHOG, SHOXY, SS ENSG00000185960 Short stature homeobox X 624344-659411 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA035141, HPA060931 Validated Nucleoplasm
Vesicles Not detected Mixed spleen: 1.1 SHOX2 OG12, OG12X, SHOT ENSG00000168779 Short stature homeobox 2 3 158095954-158106503 Predicted intracellular proteins, Transcription factors Evidence at transcript level Mixed Tissue enhanced adipose tissue: 4.1;testis: 3.3 cervix, uterine: 2.8 SIM1 bHLHe14 ENSG00000112246 Single-minded family bHLH transcription factor 1 6 100385015-100464929 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA024385 Approved Nuclear speckles Renal cancer:5.32e-7 (favourable) Tissue enhanced Tissue enhanced epididymis: 3.4;kidney: 11.1;seminal vesicle: 3.1 skeletal muscle: 1.2 SIM2 bHLHe15, MGC119447, SIM ENSG00000159263 Single-minded family bHLH transcription factor 2 21 36699133-36749917 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA029295 Approved Supported Nucleoplasm
Nuclear bodies Endometrial cancer:2.10e-4 (unfavourable), Urothelial cancer:2.88e-4 (favourable) Tissue enhanced Tissue enhanced esophagus: 22.9;kidney: 13.0 prostate: 9.1 SIX1 DFNA23 ENSG00000126778 SIX homeobox 1 14 60643415-60658259 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001893, CAB058690 Supported Supported Nucleus
Nucleoli Endometrial cancer:8.92e-6 (unfavourable), Lung cancer:3.94e-4 (favourable) Mixed Group enriched 6 cervix, uterine: 23.0;parathyroid gland: 57.4;prostate: 21.5;salivary gland: 21.7;skeletal muscle: 41.5 adipose tissue: 5.7 SIX2 ENSG00000170577 SIX homeobox 2 2 45005161-45009430 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA052782, HPA056958 Uncertain Supported Nucleoplasm
Nuclear membrane Mixed Group enriched 5 cervix, uterine: 18.6;parathyroid gland: 8.5;prostate: 6.1;salivary gland: 9.5;skeletal muscle: 6.7 adipose tissue: 1.9 SIX3 HPE2 ENSG00000138083 SIX homeobox 3 2 44941898-44946077 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA067988 Approved Nucleoplasm Mixed Tissue enriched 30 parathyroid gland: 38.9 cervix, uterine: 1.2 SIX4 AREC3 ENSG00000100625 SIX homeobox 4 14 60709528-60724348 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA031794 Uncertain Approved Nucleoplasm Mixed Tissue enhanced parathyroid gland: 23.5 skeletal muscle: 4.7 SIX5 DMAHP ENSG00000177045 SIX homeobox 5 19 45764785-45769226 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA042068 Approved Expressed in all Mixed ovary: 33.6 SIX6 OPTX2, Six9 ENSG00000184302 SIX homeobox 6 14 60508951-60512850 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001403 Supported Approved Nucleoplasm Tissue enriched Not detected testis: 0.1 SMAD1 JV4-1, MADH1, MADR1 ENSG00000170365 SMAD family member 1 4 145481194-145558079 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB005389 Approved Supported Nucleus
Plasma membrane
Cytosol Expressed in all Expressed in all parathyroid gland: 69.4 SMAD2 JV18-1, MADH2, MADR2 ENSG00000175387 SMAD family member 2 18 47808957-47931146 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors Evidence at protein level CAB025507, HPA067203, CAB073546 Approved Supported Nucleus
Nucleoli
Cytosol Liver cancer:9.44e-5 (unfavourable) Expressed in all Expressed in all thyroid gland: 126.1 SMAD3 HsT17436, JV15-2, MADH3 ENSG00000166949 SMAD family member 3 15 67063763-67195195 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB008094, HPA046386, HPA067203, CAB069409 Approved Validated Nucleoplasm
Cytosol Pancreatic cancer:2.48e-4 (unfavourable) Expressed in all Expressed in all esophagus: 54.4 SMAD4 DPC4, MADH4 ENSG00000141646 SMAD family member 4 18 51028394-51085045 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA019154 Approved Supported Nucleoplasm
Centrosome
Cytosol Renal cancer:1.92e-5 (favourable) Expressed in all Expressed in all parathyroid gland: 38.7 SMAD5 Dwfc, JV5-1, MADH5 ENSG00000113658 SMAD family member 5 5 136132845-136188747 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA058931 Approved Supported Nucleoplasm
Cytosol Expressed in all Expressed in all endometrium: 42.9 SMAD6 HsT17432, MADH6, MADH7 ENSG00000137834 SMAD family member 6 15 66702228-66782848 Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA061917 Supported Nucleus
Nuclear bodies
Golgi apparatus Urothelial cancer:5.45e-5 (favourable) Expressed in all Tissue enhanced lung: 16.9 placenta: 10.6 SMAD7 MADH7, MADH8 ENSG00000101665 SMAD family member 7 18 48919853-48950711 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB026212, HPA028897 Approved Supported Nucleoplasm
Cytosol Endometrial cancer:5.61e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 41.1 SMAD9 MADH6, MADH9 ENSG00000120693 SMAD family member 9 13 36844831-36920765 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB009119, HPA031162 Approved Supported Nucleoplasm
Cytosol Glioma:4.39e-4 (favourable), Thyroid cancer:4.92e-4 (unfavourable) Mixed Tissue enhanced thyroid gland: 62.6 prostate: 22.6 SMARCA1 hSNF2L, ISWI, NURF140, SNF2L, SNF2L1, SNF2LB, SWI ENSG00000102038 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 X 129446501-129523500 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003335, HPA064712 Uncertain Supported Nucleoplasm
Vesicles Pancreatic cancer:3.03e-4 (favourable), Renal cancer:5.09e-4 (favourable) Expressed in all Mixed testis: 112.7 SMARCA5 hISWI, hSNF2H, ISWI ENSG00000153147 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5 4 143513463-143557486 Predicted intracellular proteins, Transcription factors Evidence at protein level CAB005227, HPA008751 Supported Supported Nucleus
Nucleoli fibrillar center Liver cancer:1.61e-4 (unfavourable) Expressed in all Expressed in all testis: 59.0 SMARCC1 BAF155, CRACC1, Rsc8, SRG3 ENSG00000173473 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 3 47585272-47782106 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB011576, CAB016336, HPA024352, HPA026853 Supported Validated Nucleoplasm Colorectal cancer:3.34e-4 (favourable), Liver cancer:3.37e-4 (unfavourable) Expressed in all Expressed in all prostate: 35.6 SMARCC2 BAF170, CRACC2, Rsc8 ENSG00000139613 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2 12 56162983-56189567 Predicted intracellular proteins, Transcription factors Evidence at protein level CAB004321, HPA021213, HPA061788 Supported Validated Nucleoplasm Expressed in all Expressed in all cerebral cortex: 77.0 SMARCE1 BAF57 ENSG00000073584 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1 17 40624962-40648508 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003916, CAB037318 Supported Supported Nucleoplasm Expressed in all Expressed in all endometrium: 72.9 SNAI1 SLUGH2, SNA, SNAH, SNAIL, SNAIL1 ENSG00000124216 Snail family zinc finger 1 20 49982999-49988886 Predicted intracellular proteins, Transcription factors Evidence at protein level CAB005883 Supported Supported Nucleus
Cytosol Renal cancer:2.63e-7 (unfavourable), Thyroid cancer:8.82e-7 (unfavourable), Lung cancer:1.61e-5 (unfavourable), Colorectal cancer:4.76e-4 (unfavourable) Expressed in all Tissue enhanced gallbladder: 26.3 thyroid gland: 13.3 SNAI2 SLUG, SLUGH1, SNAIL2 ENSG00000019549 Snail family zinc finger 2 8 48917690-48921740 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB011671 Supported Approved Nucleus Renal cancer:4.69e-8 (unfavourable), Urothelial cancer:7.16e-4 (unfavourable), Pancreatic cancer:7.83e-4 (unfavourable) Expressed in all Mixed cervix, uterine: 67.1 SNAI3 SMUC, Zfp293, ZNF293 ENSG00000185669 Snail family zinc finger 3 16 88677682-88686493 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA016757, HPA071127 Uncertain Approved Nucleoplasm Cervical cancer:1.39e-4 (favourable), Pancreatic cancer:3.58e-4 (favourable) Mixed Tissue enhanced skeletal muscle: 10.9 lymph node: 4.4 SNAPC4 FLJ13451, PTFalpha, SNAP190 ENSG00000165684 Small nuclear RNA activating complex, polypeptide 4, 190kDa 9 136375577-136398797 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA046627, HPA073243 Uncertain Approved Nucleoplasm
Nuclear membrane Pancreatic cancer:4.52e-5 (favourable) Expressed in all Expressed in all testis: 14.1 SOHLH1 bA100C15.3, bHLHe80, C9orf157, NOHLH, SPATA27, TEB2 ENSG00000165643 Spermatogenesis and oogenesis specific basic helix-loop-helix 1 9 135693407-135699528 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA059439 Approved Nuclear speckles Mixed Group enriched 27 cerebral cortex: 6.4;testis: 13.4 skin: 0.3 SOHLH2 bHLHe81, FLJ20449, SPATA28, TEB1 ENSG00000120669 Spermatogenesis and oogenesis specific basic helix-loop-helix 2 13 36168208-36214615 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA029182, HPA029183 Uncertain Vesicles Mixed Tissue enriched 13 testis: 46.0 prostate: 3.5 SOX1 ENSG00000182968 SRY (sex determining region Y)-box 1 13 112067647-112070488 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Group enriched Group enriched 8 cerebral cortex: 3.6;testis: 1.5 skin: 0.3 SOX10 DOM, WS2E, WS4 ENSG00000100146 SRY (sex determining region Y)-box 10 22 37970686-37987422 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB003171, HPA068898 Supported Supported Nucleoplasm Not detected Tissue enhanced cerebral cortex: 56.8;salivary gland: 50.8 breast: 24.0 SOX11 ENSG00000176887 SRY (sex determining region Y)-box 11 2 5692667-5701385 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA000536, CAB056152, CAB056153 Approved Group enriched Tissue enriched 14 cerebral cortex: 5.4 smooth muscle: 0.3 SOX12 SOX22 ENSG00000177732 SRY (sex determining region Y)-box 12 20 325401-330224 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA055052, HPA061627 Supported Nucleoplasm Liver cancer:6.64e-5 (unfavourable) Expressed in all Mixed cerebral cortex: 10.3 SOX13 ICA12, MGC117216, Sox-13 ENSG00000143842 SRY (sex determining region Y)-box 13 1 204073115-204127743 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA051790, HPA054843 Validated Nucleoplasm Colorectal cancer:6.49e-4 (unfavourable) Expressed in all Mixed parathyroid gland: 52.4 SOX14 SOX28 ENSG00000168875 SRY (sex determining region Y)-box 14 3 137764284-137766338 Predicted intracellular proteins, Transcription factors Evidence at protein level Tissue enhanced Group enriched 18 placenta: 2.4;prostate: 1.1 testis: 0.1 SOX15 SOX20, SOX26, SOX27 ENSG00000129194 SRY (sex determining region Y)-box 15 17 7588178-7590170 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA067196, HPA074049 Supported Supported Nucleus
Nucleoli
Golgi apparatus
Vesicles Tissue enhanced Tissue enhanced skin: 40.6 esophagus: 17.5 SOX17 ENSG00000164736 SRY (sex determining region Y)-box 17 8 54457935-54460888 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB025594, HPA068399 Supported Approved Nucleoplasm Endometrial cancer:2.76e-4 (favourable) Group enriched Tissue enhanced cervix, uterine: 30.1;endometrium: 32.1;fallopian tube: 30.1 adipose tissue: 14.7 SOX18 ENSG00000203883 SRY (sex determining region Y)-box 18 20 64047582-64049641 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA073703 Approved Nucleus Expressed in all Tissue enhanced adipose tissue: 32.9 lung: 12.0 SOX2 ENSG00000181449 SRY (sex determining region Y)-box 2 3 181711924-181714436 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB010648, HPA045725 Approved Supported Nucleoplasm Tissue enhanced Tissue enriched 8 cerebral cortex: 118.3 esophagus: 14.9 SOX21 SOX25 ENSG00000125285 SRY (sex determining region Y)-box 21 13 94709622-94712399 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA064084 Approved Nucleus Glioma:1.34e-4 (favourable), Cervical cancer:7.60e-4 (favourable) Tissue enhanced Group enriched 6 cerebral cortex: 18.0;esophagus: 6.9;skin: 19.4;stomach: 33.9 tonsil: 3.2 SOX3 PHP ENSG00000134595 SRY (sex determining region Y)-box 3 X 140502987-140505503 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA054720, HPA075003 Validated Nucleoplasm Tissue enhanced Tissue enriched 7 fallopian tube: 11.7 testis: 1.7 SOX30 ENSG00000039600 SRY (sex determining region Y)-box 30 5 157625679-157671480 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA006159, CAB009382 Supported Mixed Tissue enriched 90 testis: 144.0 fallopian tube: 1.6 SOX4 ENSG00000124766 SRY (sex determining region Y)-box 4 6 21592769-21598619 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA029901 Approved Supported Nucleoplasm
Mitochondria Liver cancer:2.57e-5 (unfavourable) Expressed in all Expressed in all endometrium: 80.4 SOX5 L-SOX5, MGC35153 ENSG00000134532 SRY (sex determining region Y)-box 5 12 23529500-23951032 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA060499 Supported Nucleoplasm Mixed Tissue enhanced testis: 58.3 cerebral cortex: 11.7 SOX6 ENSG00000110693 SRY (sex determining region Y)-box 6 11 15966449-16739591 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001923, HPA003908 Approved Approved Nucleoplasm Renal cancer:6.47e-12 (favourable) Mixed Tissue enhanced testis: 25.8 bone marrow: 16.6 SOX7 ENSG00000171056 SRY (sex determining region Y)-box 7 8 10723768-10730512 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA009065 Approved Approved Nuclear speckles
Golgi apparatus Expressed in all Tissue enhanced placenta: 49.2 lung: 18.7 SOX8 ENSG00000005513 SRY (sex determining region Y)-box 8 16 981808-986979 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA041640, HPA058665 Approved Supported Nucleus Tissue enriched Tissue enriched 29 cerebral cortex: 110.2 salivary gland: 3.8 SOX9 CMD1, CMPD1, SRA1 ENSG00000125398 SRY (sex determining region Y)-box 9 17 72121020-72126420 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001758, CAB022456, CAB068240 Supported Validated Nucleoplasm Lung cancer:2.07e-4 (unfavourable) Expressed in all Mixed cerebral cortex: 61.5 SP1 ENSG00000185591 Sp1 transcription factor 12 53380176-53416446 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB000330, HPA001853, HPA012292 Supported Validated Nucleoplasm Pancreatic cancer:1.43e-4 (unfavourable) Expressed in all Expressed in all endometrium: 53.9 SP100 ENSG00000067066 SP100 nuclear antigen 2 230415942-230544090 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA016707, HPA017384 Supported Supported Nucleus
Nuclear bodies Renal cancer:1.61e-4 (unfavourable) Expressed in all Expressed in all bone marrow: 139.9 SP110 IFI41, IFI75 ENSG00000135899 SP110 nuclear body protein 2 230167293-230225729 Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA047036, HPA058554 Approved Supported Nucleus Renal cancer:1.17e-5 (unfavourable) Expressed in all Expressed in all spleen: 64.1 SP140 LYSP100-A, LYSP100-B ENSG00000079263 SP140 nuclear body protein 2 230203110-230313215 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA006162, HPA067493 Supported Approved Nucleoli fibrillar center
Mitochondria Mixed Group enriched 6 appendix: 34.0;lymph node: 65.2;spleen: 38.9;tonsil: 52.9 urinary bladder: 7.9 SP140L ENSG00000185404 SP140 nuclear body protein-like 2 230327184-230403732 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA055864 Uncertain Approved Nucleoplasm Renal cancer:5.09e-10 (unfavourable) Expressed in all Mixed spleen: 29.2 SP2 KIAA0048 ENSG00000167182 Sp2 transcription factor 17 47896150-47928957 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003357, CAB010245 Supported Validated Nucleoplasm
Vesicles Renal cancer:1.82e-5 (favourable) Expressed in all Expressed in all parathyroid gland: 31.3 SP3 SPR-2 ENSG00000172845 Sp3 transcription factor 2 173906459-173965702 Predicted intracellular proteins, Transcription factors Evidence at protein level CAB004580, HPA032145 Approved Supported Renal cancer:2.46e-5 (unfavourable) Expressed in all Expressed in all thyroid gland: 79.3 SP4 HF1B, MGC130008, MGC130009, SPR-1 ENSG00000105866 Sp4 transcription factor 7 21428034-21514822 Predicted intracellular proteins, Transcription factors Evidence at protein level CAB010246, HPA040395 Uncertain Validated Nucleoplasm
Cytosol Expressed in all Mixed parathyroid gland: 14.8 SP5 ENSG00000204335 Sp5 transcription factor 2 170715351-170718078 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA074123 Approved Nucleus
Nucleoli Mixed Tissue enhanced endometrium: 3.9 stomach: 2.4 SP6 Epfn, KLF14 ENSG00000189120 Sp6 transcription factor 17 47844908-47855874 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA024516, HPA044469 Supported Nucleoplasm
Mitotic spindle
Centrosome Lung cancer:2.11e-6 (unfavourable), Urothelial cancer:5.72e-4 (favourable), Stomach cancer:6.39e-4 (favourable) Mixed Tissue enhanced placenta: 32.3;seminal vesicle: 14.6 skin: 7.2 SP7 osterix, OSX ENSG00000170374 Sp7 transcription factor 12 53326575-53345315 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA029964, HPA063202 Approved Approved Not detected Tissue enhanced testis: 1.3 parathyroid gland,thyroid gland: 0.4 SP8 ENSG00000164651 Sp8 transcription factor 7 20782283-20786886 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA054006 Uncertain Approved Nucleus Tissue enhanced Tissue enriched 12 prostate: 9.8 skin: 0.8 SP9 ZNF990 ENSG00000217236 Sp9 transcription factor 2 174334946-174338492 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA062616 Uncertain Approved Mitochondria Mixed Tissue enhanced fallopian tube: 1.4 skin: 0.9 SPDEF bA375E1.3, PDEF ENSG00000124664 SAM pointed domain containing ETS transcription factor 6 34537802-34556333 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA055707 Supported Nucleus
Nucleoli Endometrial cancer:9.26e-9 (favourable) Group enriched Tissue enhanced prostate: 154.8 breast,cervix, uterine: 42.1 SPI1 OF, PU.1, SFPI1, SPI-1, SPI-A ENSG00000066336 Spi-1 proto-oncogene 11 47354860-47378576 Predicted intracellular proteins, Predicted membrane proteins, Transcription factors Evidence at protein level CAB004079, HPA044653 Supported Supported Nucleoplasm Renal cancer:2.07e-5 (unfavourable) Expressed in all Expressed in all bone marrow: 212.9 SPIB SPI-B ENSG00000269404 Spi-B transcription factor (Spi-1/PU.1 related) 19 50418938-50431313 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA018523 Uncertain Head and neck cancer:2.14e-5 (favourable), Breast cancer:4.76e-5 (favourable) Mixed Tissue enhanced appendix: 56.0;lymph node: 104.6;tonsil: 95.1 spleen: 40.0 SPIC MGC40611, SPI-C ENSG00000166211 Spi-C transcription factor (Spi-1/PU.1 related) 12 101475421-101486997 Predicted intracellular proteins, Transcription factors Evidence at transcript level Tissue enhanced Tissue enriched 12 spleen: 47.3 lymph node: 4.0 SREBF1 bHLHd1, SREBP-1c, SREBP1 ENSG00000072310 Sterol regulatory element binding transcription factor 1 17 17810399-17837002 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors Evidence at protein level CAB005406, HPA043343, HPA043878 Uncertain Supported Golgi apparatus
Cytosol Endometrial cancer:2.66e-4 (favourable), Pancreatic cancer:9.05e-4 (favourable) Expressed in all Expressed in all adrenal gland: 92.9 SREBF2 bHLHd2, SREBP2 ENSG00000198911 Sterol regulatory element binding transcription factor 2 22 41833079-41907308 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors Evidence at protein level HPA031962, HPA031963 Approved Supported Nucleoplasm
Vesicles
Mitochondria Renal cancer:1.37e-4 (favourable) Expressed in all Expressed in all cerebral cortex: 118.8 SRF MCM1 ENSG00000112658 Serum response factor 6 43171299-43181507 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001819, CAB005416 Supported Supported Nucleus Renal cancer:2.01e-5 (unfavourable) Expressed in all Expressed in all smooth muscle: 69.3 SRY TDF ENSG00000184895 Sex determining region Y Y 2786855-2787699 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Tissue enhanced Tissue enhanced skin: 1.0;testis: 2.8 esophagus: 0.7 SSRP1 FACT80 ENSG00000149136 Structure specific recognition protein 1 11 57325985-57335877 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA002697 Approved Approved Nucleus
Cytosol Liver cancer:4.03e-7 (unfavourable), Pancreatic cancer:1.40e-4 (unfavourable), Renal cancer:5.63e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 122.9 ST18 KIAA0535, NZF3, ZC2HC10, ZNF387 ENSG00000147488 Suppression of tumorigenicity 18, zinc finger 8 52110839-52460959 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA044919 Uncertain Tissue enhanced Tissue enriched 7 cerebral cortex: 11.6 stomach: 1.5 STAT1 ISGF-3, STAT91 ENSG00000115415 Signal transducer and activator of transcription 1, 91kDa 2 190964358-191020960 Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA000931, HPA000982, CAB004049 Approved Validated Nucleoplasm
Cytosol Renal cancer:1.22e-5 (unfavourable), Ovarian cancer:1.75e-4 (favourable), Pancreatic cancer:4.23e-4 (unfavourable) Expressed in all Expressed in all lymph node: 196.3 STAT2 STAT113 ENSG00000170581 Signal transducer and activator of transcription 2, 113kDa 12 56341597-56360155 Predicted intracellular proteins, Transcription factors Evidence at protein level CAB003858, HPA018888 Approved Supported Plasma membrane
Cytosol Renal cancer:4.78e-13 (unfavourable), Endometrial cancer:4.75e-4 (unfavourable) Expressed in all Expressed in all spleen: 48.7 STAT3 APRF ENSG00000168610 Signal transducer and activator of transcription 3 (acute-phase response factor) 17 42313324-42388568 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001671, CAB003859, HPA058603, CAB068241, CAB068242 Supported Supported Nucleoplasm
Cytosol Expressed in all Expressed in all gallbladder: 127.9 STAT4 ENSG00000138378 Signal transducer and activator of transcription 4 2 191029576-191151596 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001860, CAB013108 Approved Renal cancer:1.07e-8 (unfavourable), Pancreatic cancer:5.88e-4 (favourable) Mixed Tissue enhanced testis: 50.3 spleen: 18.8 STAT5A MGF, STAT5 ENSG00000126561 Signal transducer and activator of transcription 5A 17 42287547-42311943 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB003860, HPA027873, HPA042128, HPA049883, HPA051156 Approved Validated Nucleoplasm
Cytosol Breast cancer:5.87e-4 (favourable) Expressed in all Expressed in all adipose tissue: 90.2 STAT5B ENSG00000173757 Signal transducer and activator of transcription 5B 17 42199168-42276707 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB004298, HPA042128, HPA049883, HPA051156 Approved Renal cancer:2.39e-5 (favourable), Pancreatic cancer:1.63e-4 (favourable), Endometrial cancer:9.37e-4 (favourable) Expressed in all Expressed in all endometrium: 70.8 STAT6 D12S1644, IL-4-STAT ENSG00000166888 Signal transducer and activator of transcription 6, interleukin-4 induced 12 57095408-57132139 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001861 Approved Validated Nucleoplasm
Cytosol Urothelial cancer:1.14e-4 (favourable), Endometrial cancer:1.69e-4 (favourable), Thyroid cancer:7.76e-4 (favourable) Expressed in all Expressed in all skin: 164.0 T ENSG00000164458 T brachyury transcription factor 6 166157656-166168700 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003322 Uncertain Supported Nucleus Tissue enriched Tissue enriched 23 parathyroid gland: 9.8 testis: 0.4 TADA2B MGC21874 ENSG00000173011 Transcriptional adaptor 2B 4 7041899-7057952 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA035770 Approved Approved Nuclear speckles Renal cancer:7.17e-11 (favourable), Urothelial cancer:1.59e-4 (favourable) Expressed in all Expressed in all thyroid gland: 27.4 TAF1 BA2R, CCG1, CCGS, DYT3, DYT3/TAF1, KAT4, NSCL2, TAF2A, TAFII250 ENSG00000147133 TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa X 71366239-71532374 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001075, CAB016283 Supported Validated Nucleoplasm Renal cancer:6.03e-4 (unfavourable), Lung cancer:6.54e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 25.7 TAL1 bHLHa17, SCL, TCL5 ENSG00000162367 T-cell acute lymphocytic leukemia 1 1 47216290-47232220 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB017805, HPA047866 Approved Approved Nucleus Mixed Tissue enhanced bone marrow: 17.7 placenta: 10.0 TAL2 bHLHa19 ENSG00000186051 T-cell acute lymphocytic leukemia 2 9 105662457-105663112 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA030886 Uncertain Approved Cytosol Renal cancer:2.69e-4 (favourable) Tissue enhanced Group enriched 5 kidney: 3.4;skeletal muscle: 4.8 epididymis: 0.8 TBP GTF2D1, SCA17, TFIID ENSG00000112592 TATA box binding protein 6 170554302-170572870 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB009442, HPA049805 Approved Supported Nucleoplasm Liver cancer:1.51e-7 (unfavourable) Expressed in all Expressed in all testis: 65.3 TBPL1 STUD, TLF, TLP, TRF2 ENSG00000028839 TBP-like 1 6 133952170-133990432 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA071810, HPA071813 Approved Validated Nucleoplasm
Nucleoli Liver cancer:7.91e-5 (unfavourable), Renal cancer:4.14e-4 (unfavourable), Glioma:4.67e-4 (favourable), Pancreatic cancer:7.23e-4 (favourable) Expressed in all Tissue enriched 8 testis: 226.1 thyroid gland: 28.1 TBPL2 TBP2, TRF3 ENSG00000182521 TATA box binding protein like 2 14 55413541-55456726 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA056241 Uncertain Tissue enriched Mixed testis: 2.1 TBR1 ENSG00000136535 T-box, brain, 1 2 161416094-161425870 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA051256 Approved Not detected Tissue enriched 29 cerebral cortex: 30.7 testis: 1.0 TBX1 CATCH22, VCF ENSG00000184058 T-box 1 22 19756703-19783593 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA029330 Approved Nuclear bodies
Cytoplasmic bodies Urothelial cancer:8.90e-4 (favourable) Mixed Tissue enhanced skeletal muscle: 23.0 testis: 10.5 TBX10 TBX13, TBX7 ENSG00000167800 T-box 10 11 67631303-67639560 Predicted secreted proteins, Transcription factors Evidence at protein level HPA047881 Uncertain Group enriched Group enriched 27 colon: 9.0;duodenum: 6.0;rectum: 8.8;small intestine: 10.8 appendix,testis: 0.3 TBX15 TBX14 ENSG00000092607 T-box 15 1 118883046-118989556 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA052245, HPA053713 Uncertain Approved Nucleoplasm
Centrosome Renal cancer:5.57e-8 (unfavourable) Mixed Group enriched 7 adipose tissue: 17.0;breast: 8.8;liver: 24.1;skeletal muscle: 42.2 lymph node: 3.2 TBX18 ENSG00000112837 T-box 18 6 84687351-84764519 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Mixed Mixed adipose tissue: 6.1 TBX19 dj747L4.1, TPIT ENSG00000143178 T-box 19 1 168281040-168314426 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA005800 Supported Approved Nuclear speckles Renal cancer:4.55e-9 (unfavourable) Expressed in all Mixed endometrium: 5.3 TBX2 ENSG00000121068 T-box 2 17 61399896-61409466 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA008586, CAB013636 Approved Approved Nucleoplasm
Cytosol Expressed in all Tissue enhanced lung: 50.2 seminal vesicle: 39.7 TBX20 ENSG00000164532 T-box 20 7 35202430-35254147 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Not detected Tissue enhanced heart muscle: 26.9 adrenal gland: 5.7 TBX21 T-bet, TBLYM ENSG00000073861 T-box 21 17 47733244-47746119 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB009524, CAB030043 Supported Mixed Tissue enhanced lymph node: 8.6;spleen: 11.2 bone marrow: 6.4 TBX22 CLPA, CPX ENSG00000122145 T-box 22 X 80014756-80031769 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Not detected Group enriched 18 testis: 10.4;thyroid gland: 3.4 seminal vesicle: 0.3 TBX3 TBX3-ISO, UMS, XHL ENSG00000135111 T-box 3 12 114670254-114684164 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA005799 Approved Nucleoplasm
Cytosol Urothelial cancer:3.28e-4 (favourable) Expressed in all Tissue enhanced adrenal gland: 201.8 prostate: 114.3 TBX4 ENSG00000121075 T-box 4 17 61452404-61485110 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB032413, HPA044457, HPA050669 Uncertain Supported Vesicles Mixed Group enriched 6 lung: 43.9;placenta: 29.7;prostate: 13.1 urinary bladder: 4.9 TBX5 HOS ENSG00000089225 T-box 5 12 114353931-114408442 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA008786, HPA064683 Uncertain Approved Nucleoplasm Mixed Group enriched 7 heart muscle: 47.1;lung: 18.0;placenta: 46.6 prostate: 5.2 TBX6 ENSG00000149922 T-box 6 16 30085793-30091887 Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Mixed Mixed stomach: 4.5 TCF12 bHLHb20, HEB, HsT17266, HTF4 ENSG00000140262 Transcription factor 12 15 56918623-57299281 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins, Transcription factors Evidence at protein level CAB004432, HPA065827 Approved Supported Nucleoplasm
Nuclear speckles Renal cancer:5.24e-5 (unfavourable), Melanoma:8.89e-4 (unfavourable) Expressed in all Expressed in all cervix, uterine: 115.4 TCF15 bHLHa40, EC2, PARAXIS ENSG00000125878 Transcription factor 15 (basic helix-loop-helix) 20 603797-610398 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA050998, HPA060221 Uncertain Supported Nuclear speckles Ovarian cancer:3.25e-4 (unfavourable) Mixed Group enriched 5 adipose tissue: 9.0;heart muscle: 5.5;placenta: 8.0;skeletal muscle: 7.2;testis: 2.2 lung: 1.2 TCF21 bHLHa23, POD1 ENSG00000118526 Transcription factor 21 6 133889138-133895553 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA013189 Uncertain Mixed Tissue enhanced placenta: 62.1;spleen: 47.8 ovary: 32.1 TCF23 bHLHa24, OUT ENSG00000163792 Transcription factor 23 2 27149004-27156974 Predicted intracellular proteins, Transcription factors Evidence at transcript level Mixed Tissue enhanced endometrium: 33.7;ovary: 22.6;smooth muscle: 30.5 fallopian tube: 13.9 TCF25 KIAA1049, Nulp1 ENSG00000141002 Transcription factor 25 (basic helix-loop-helix) 16 89873586-89911384 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA041699, HPA041786 Uncertain Endometrial cancer:6.95e-4 (favourable) Expressed in all Expressed in all cerebral cortex: 124.9 TCF3 bHLHb21, E2A, E47, ITF1, MGC129647, MGC129648, VDIR ENSG00000071564 Transcription factor 3 19 1609290-1652605 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB018351, HPA049808, HPA062476 Approved Validated Nucleoplasm Renal cancer:1.53e-4 (unfavourable), Liver cancer:2.46e-4 (unfavourable) Expressed in all Expressed in all lymph node: 104.6 TCF4 bHLHb19, E2-2, ITF2, SEF2-1B ENSG00000196628 Transcription factor 4 18 55222331-55664787 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB020722, HPA025958 Approved Approved Nucleoplasm
Cytosol Renal cancer:7.24e-5 (unfavourable), Urothelial cancer:9.95e-4 (unfavourable) Expressed in all Expressed in all cerebral cortex: 90.8 TCF7 TCF-1 ENSG00000081059 Transcription factor 7 (T-cell specific, HMG-box) 5 134114711-134151865 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB019403, HPA058863, HPA070505 Supported Validated Nucleoplasm Expressed in all Tissue enhanced lymph node: 111.6 appendix: 74.8 TCF7L1 TCF3 ENSG00000152284 Transcription factor 7-like 1 (T-cell specific, HMG-box) 2 85133410-85310388 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA071298 Supported Nucleoplasm
Cytosol Liver cancer:6.16e-5 (unfavourable), Endometrial cancer:1.70e-4 (unfavourable), Renal cancer:2.06e-4 (unfavourable), Stomach cancer:2.72e-4 (unfavourable), Urothelial cancer:5.38e-4 (unfavourable) Expressed in all Mixed adipose tissue,endometrium: 22.8 TCF7L2 TCF-4, TCF4 ENSG00000148737 Transcription factor 7-like 2 (T-cell specific, HMG-box) 10 112950250-113167678 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB013535, HPA038800 Supported Supported Nucleoplasm
Nuclear bodies Expressed in all Expressed in all endometrium: 33.6 TCFL5 bHLHe82, CHA, E2BP-1, Figlb ENSG00000101190 Transcription factor-like 5 (basic helix-loop-helix) 20 62841115-62861763 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA055223 Approved Supported Nucleoplasm Endometrial cancer:3.24e-4 (unfavourable) Expressed in all Expressed in all testis: 143.8 TEAD1 AA, TCF13, TEF-1 ENSG00000187079 TEA domain family member 1 (SV40 transcriptional enhancer factor) 11 12674591-12944483 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA057339, HPA062471 Validated Nucleus
Cytosol Expressed in all Mixed parathyroid gland: 84.8 TEAD2 ETF, TEF-4, TEF4 ENSG00000074219 TEA domain family member 2 19 49340595-49362457 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA066292, HPA069963 Supported Nucleoplasm Liver cancer:8.66e-4 (unfavourable) Expressed in all Mixed endometrium: 58.7 TEAD3 ETFR-1, TEAD5, TEF-5 ENSG00000007866 TEA domain family member 3 6 35473597-35497076 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA028906 Uncertain Renal cancer:1.01e-7 (unfavourable), Endometrial cancer:5.09e-4 (unfavourable) Expressed in all Mixed smooth muscle: 75.1 TEAD4 EFTR-2, RTEF-1, TCF13L1, TEF-3, TEFR-1 ENSG00000197905 TEA domain family member 4 12 2959330-3040673 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA056896 Uncertain Supported Nucleoplasm Renal cancer:9.78e-9 (unfavourable) Tissue enriched Tissue enhanced skeletal muscle: 38.8 thyroid gland: 18.0 TEF KIAA1655 ENSG00000167074 Thyrotrophic embryonic factor 22 41367333-41399326 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Renal cancer:3.47e-11 (favourable) Expressed in all Mixed cerebral cortex: 57.7 TET1 bA119F7.1, CXXC6, KIAA1676, LCX ENSG00000138336 Tet methylcytosine dioxygenase 1 10 68560656-68694482 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB014886, HPA019032, HPA057273 Approved Supported Nucleus
Nuclear membrane Tissue enriched Mixed parathyroid gland: 2.4 TFAM TCF6, TCF6L2 ENSG00000108064 Transcription factor A, mitochondrial 10 58385022-58399221 Predicted intracellular proteins, Predicted secreted proteins, Transcription factors Evidence at protein level HPA040648, HPA063684 Supported Validated Mitochondria Renal cancer:2.22e-5 (favourable), Ovarian cancer:2.74e-4 (favourable), Endometrial cancer:8.73e-4 (unfavourable) Expressed in all Expressed in all testis: 62.0 TFAP2A AP-2, AP2TF, TFAP2 ENSG00000137203 Transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) 6 10393186-10419659 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB000326, HPA028850, HPA056871 Supported Validated Nucleoplasm Lung cancer:1.09e-4 (unfavourable) Tissue enhanced Tissue enhanced breast: 39.8;placenta: 42.1;skin: 76.2 epididymis: 25.2 TFAP2B AP2-B ENSG00000008196 Transcription factor AP-2 beta (activating enhancer binding protein 2 beta) 6 50818723-50847613 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA034683, HPA062942 Approved Approved Nucleoplasm Tissue enriched Tissue enhanced epididymis: 38.7 breast: 9.5 TFAP2C AP2-GAMMA, ERF1, hAP-2g, TFAP2G ENSG00000087510 Transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma) 20 56629302-56639283 Predicted intracellular proteins, Transcription factors Evidence at protein level CAB016061, CAB016079, HPA055179, HPA057076 Supported Supported Nucleoplasm Cervical cancer:6.90e-4 (favourable) Tissue enhanced Tissue enhanced skin: 63.1 breast: 31.6 TFAP2D TFAP2BL1 ENSG00000008197 Transcription factor AP-2 delta (activating enhancer binding protein 2 delta) 6 50713828-50772988 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA048962 Uncertain Tissue enriched Not detected cerebral cortex,testis: 0.1 TFAP2E AP2E ENSG00000116819 Transcription factor AP-2 epsilon (activating enhancer binding protein 2 epsilon) 1 35573370-35595328 Predicted intracellular proteins, Transcription factors Evidence at transcript level Mixed Tissue enhanced skin: 7.2 lymph node: 2.1 TFAP4 AP-4, bHLHc41 ENSG00000090447 Transcription factor AP-4 (activating enhancer binding protein 4) 16 4257186-4273075 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001912 Supported Supported Nucleoplasm
Mitochondria Renal cancer:4.31e-6 (unfavourable), Liver cancer:3.32e-4 (unfavourable) Expressed in all Mixed ovary: 12.0 TFCP2 CP2, LBP-1C, LSF, TFCP2C ENSG00000135457 Transcription factor CP2 12 51093663-51173134 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA070247 Supported Nucleoplasm
Cytosol Melanoma:1.18e-4 (unfavourable), Liver cancer:1.83e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 43.6 TFCP2L1 CRTR1, LBP-9 ENSG00000115112 Transcription factor CP2-like 1 2 121216587-121285207 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA029708 Uncertain Supported Nucleoli fibrillar center Renal cancer:7.72e-6 (favourable) Mixed Tissue enhanced kidney: 48.7 thyroid gland: 45.6 TFDP1 Dp-1, DP1, DRTF1 ENSG00000198176 Transcription factor Dp-1 13 113584721-113641470 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB033605, HPA044754, HPA068909 Supported Validated Nucleoplasm Liver cancer:1.03e-4 (unfavourable), Stomach cancer:6.17e-4 (favourable), Renal cancer:7.57e-4 (favourable) Expressed in all Expressed in all bone marrow: 100.1 TFDP2 Dp-2 ENSG00000114126 Transcription factor Dp-2 (E2F dimerization partner 2) 3 141944428-142149544 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB018396 Supported Supported Nucleus
Vesicles Cervical cancer:6.32e-4 (favourable), Renal cancer:9.84e-4 (favourable) Expressed in all Expressed in all testis: 127.0 TFE3 bHLHe33, TFEA ENSG00000068323 Transcription factor binding to IGHM enhancer 3 X 49028726-49043486 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA023881 Approved Supported Nucleoplasm
Cytosol Renal cancer:2.19e-8 (unfavourable), Liver cancer:6.03e-5 (unfavourable) Expressed in all Expressed in all seminal vesicle: 24.2 TFEB bHLHe35, TCFEB ENSG00000112561 Transcription factor EB 6 41683978-41736259 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA049532 Supported Nucleoplasm Renal cancer:1.06e-5 (favourable), Pancreatic cancer:4.77e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 53.4 TFEC bHLHe34, TCFEC, TFECL ENSG00000105967 Transcription factor EC 7 115935148-116159896 Predicted intracellular proteins, Transcription factors Evidence at protein level CAB032260, HPA063577 Approved Supported Nucleoplasm Tissue enhanced Mixed appendix: 27.1 TGIF1 HPE4, TGIF ENSG00000177426 TGFB-induced factor homeobox 1 18 3411608-3459978 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA062160 Supported Nucleoplasm Pancreatic cancer:6.47e-4 (unfavourable) Expressed in all Expressed in all epididymis: 159.9 TGIF2 ENSG00000118707 TGFB-induced factor homeobox 2 20 36573488-36593950 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA053786 Supported Nucleoplasm Expressed in all Mixed fallopian tube: 37.9 TGIF2LX ENSG00000153779 TGFB-induced factor homeobox 2-like, X-linked X 89921882-89922883 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA034543 Supported Approved Nucleoplasm Tissue enhanced Tissue enriched 134 testis: 13.3 all non-specific tissues: 0.0 TGIF2LY ENSG00000176679 TGFB-induced factor homeobox 2-like, Y-linked Y 3579041-3580041 Predicted intracellular proteins, Transcription factors Evidence at protein level Not detected Tissue enriched 74 testis: 7.3 all non-specific tissues: 0.0 THAP1 4833431A01Rik, DYT6, FLJ10477 ENSG00000131931 THAP domain containing, apoptosis associated protein 1 8 42836674-42843325 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA071310 Supported Nucleus Expressed in all Mixed testis: 17.6 THAP10 ENSG00000129028 THAP domain containing 10 15 70881342-70892785 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA041416 Uncertain Approved Nucleoplasm
Cytosol Renal cancer:3.05e-5 (favourable) Expressed in all Mixed cerebral cortex: 10.0 THAP11 CTG-B43a, CTG-B45d, HRIHFB2206 ENSG00000168286 THAP domain containing 11 16 67842082-67844195 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA041434, HPA042189 Supported Validated Nucleoplasm
Cytokinetic bridge Expressed in all Expressed in all fallopian tube: 25.1 THAP2 DKFZP564I0422 ENSG00000173451 THAP domain containing, apoptosis associated protein 2 12 71663009-71680639 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA039790 Approved Approved Nucleoplasm
Golgi apparatus Expressed in all Mixed adrenal gland: 35.3 THAP3 ENSG00000041988 THAP domain containing, apoptosis associated protein 3 1 6624866-6635586 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA067114 Approved Approved Nucleus Colorectal cancer:1.33e-4 (unfavourable) Expressed in all Expressed in all ovary: 17.8 THAP4 CGI-36 ENSG00000176946 THAP domain containing 4 2 241584405-241637449 Predicted intracellular proteins, Predicted membrane proteins, Transcription factors Evidence at protein level HPA044982, HPA053448 Uncertain Approved Nucleoplasm
Nuclear speckles Renal cancer:1.46e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 81.6 THAP5 DKFZp313O1132 ENSG00000177683 THAP domain containing 5 7 108554543-108569750 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA043170, HPA051488 Approved Validated Nucleus Renal cancer:8.99e-4 (favourable) Expressed in all Expressed in all testis: 46.5 THAP6 MGC30052 ENSG00000174796 THAP domain containing 6 4 75513946-75550473 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA035767 Uncertain Approved Nucleus
Centrosome Expressed in all Expressed in all testis: 44.1 THAP7 MGC10963 ENSG00000184436 THAP domain containing 7 22 20999104-21002196 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003083 Approved Approved Nucleus
Vesicles Expressed in all Expressed in all testis: 20.4 THAP8 FLJ32891 ENSG00000161277 THAP domain containing 8 19 36034985-36054762 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA064056, HPA070139 Approved Nucleoplasm Liver cancer:1.32e-4 (unfavourable), Pancreatic cancer:3.19e-4 (favourable) Expressed in all Mixed testis: 9.0 THAP9 FLJ34093 ENSG00000168152 THAP domain containing 9 4 82900684-82919969 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA037420, HPA037421 Uncertain Approved Mitochondria Renal cancer:3.50e-5 (favourable) Expressed in all Mixed testis: 11.4 THRA AR7, EAR-7.1/EAR-7.2, ERBA, ERBA1, NR1A1, THRA1, THRA2, THRA3 ENSG00000126351 Thyroid hormone receptor, alpha 17 40058290-40093867 Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA009654, CAB023349 Uncertain Supported Cytosol Renal cancer:6.05e-8 (favourable), Lung cancer:1.84e-4 (favourable) Expressed in all Expressed in all cerebral cortex: 239.6 THRB ERBA-BETA, ERBA2, GRTH, NR1A2, PRTH, THR1, THRB1, THRB2 ENSG00000151090 Thyroid hormone receptor, beta 3 24117160-24495282 Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB002008, CAB002009, HPA061035 Approved Supported Nuclear bodies Renal cancer:9.46e-8 (favourable) Mixed Mixed cerebral cortex: 36.4 TLX1 HOX11, TCL3 ENSG00000107807 T-cell leukemia homeobox 1 10 101130505-101137789 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Colorectal cancer:7.32e-4 (unfavourable) Mixed Tissue enriched 5 spleen: 32.5 salivary gland: 6.1 TLX2 Enx, HOX11L1, NCX, Tlx2 ENSG00000115297 T-cell leukemia homeobox 2 2 74513463-74517147 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA040969, HPA062254 Uncertain Approved Nucleoplasm Mixed Tissue enhanced adrenal gland: 2.7 testis: 0.8 TLX3 HOX11L2, RNX ENSG00000164438 T-cell leukemia homeobox 3 5 171309284-171312134 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA074512 Approved Nucleoplasm
Centrosome Tissue enhanced Not detected all non-specific tissues: 0.0 TONSL IKBR, NFKBIL2 ENSG00000160949 Tonsoku-like, DNA repair protein 8 144428775-144444444 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA024679, HPA046494 Uncertain Validated Nucleoplasm
Nuclear bodies Renal cancer:2.62e-7 (unfavourable), Liver cancer:2.84e-4 (unfavourable) Expressed in all Mixed bone marrow: 5.4 TOX KIAA0808, TOX1 ENSG00000198846 Thymocyte selection-associated high mobility group box 8 58805418-59119208 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA018322, HPA073241 Supported Approved Nucleus
Nucleoli fibrillar center Renal cancer:1.90e-7 (unfavourable), Lung cancer:5.20e-4 (favourable) Expressed in all Mixed lymph node: 21.3 TOX2 C20orf100, dJ1108D11.2, GCX-1 ENSG00000124191 TOX high mobility group box family member 2 20 43914864-44069616 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA049900, HPA058396 Approved Supported Nucleoplasm Renal cancer:7.45e-8 (unfavourable), Endometrial cancer:2.60e-4 (unfavourable) Expressed in all Mixed parathyroid gland: 19.5 TOX3 CAGF9, TNRC9 ENSG00000103460 TOX high mobility group box family member 3 16 52438005-52547802 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA040376 Approved Approved Nucleoplasm Renal cancer:3.08e-12 (favourable), Urothelial cancer:3.95e-4 (favourable) Mixed Mixed stomach: 18.0 TOX4 C14orf92, KIAA0737, LCP1 ENSG00000092203 TOX high mobility group box family member 4 14 21476597-21499175 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA017880, HPA027551 Approved Approved Nucleus
Nucleoli
Vesicles Renal cancer:8.38e-5 (favourable), Liver cancer:3.46e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 34.8 TP53 LFS1, p53 ENSG00000141510 Tumor protein p53 17 7661779-7687550 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters Evidence at protein level CAB002973, CAB039238, CAB039239, HPA051244, CAB072876 Supported Validated Nucleoplasm Endometrial cancer:1.35e-4 (favourable), Prostate cancer:5.01e-4 (unfavourable) Expressed in all Expressed in all fallopian tube: 50.3 TP63 EEC3, KET, NBP, OFC8, p51, p53CP, p63, p73H, p73L, SHFM4, TP53CP, TP53L, TP73L ENSG00000073282 Tumor protein p63 3 189631416-189897279 Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB000083, HPA006288, HPA007010 Supported Validated Nucleoplasm
Golgi apparatus
Cytosol Breast cancer:1.07e-4 (favourable) Group enriched Tissue enhanced esophagus: 61.1;skin: 164.8 urinary bladder: 29.9 TP73 P73 ENSG00000078900 Tumor protein p73 1 3652520-3736201 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB002514, CAB003022, HPA027314, HPA044516 Supported Supported Nucleoplasm
Golgi apparatus Endometrial cancer:1.82e-4 (favourable), Cervical cancer:2.98e-4 (favourable), Head and neck cancer:9.50e-4 (favourable) Mixed Group enriched 5 fallopian tube: 11.0;skin: 8.1 prostate: 1.8 TPRX1 FLJ40321 ENSG00000178928 Tetra-peptide repeat homeobox 1 19 47801243-47819051 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA044922 Uncertain Not detected Tissue enriched 13 testis: 1.3 all non-specific tissues: 0.0 TRERF1 BCAR2, dJ139D8.5, HSA277276, RAPA, TReP-132 ENSG00000124496 Transcriptional regulating factor 1 6 42224931-42452051 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA027771, HPA051273, HPA059943 Supported Validated Nucleoplasm
Cytosol Renal cancer:3.67e-5 (unfavourable) Mixed Mixed testis: 11.0 TRPS1 GC79, LGCR ENSG00000104447 Trichorhinophalangeal syndrome I 8 115408496-115809673 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA060380 Supported Nucleoplasm Pancreatic cancer:3.16e-4 (unfavourable), Head and neck cancer:9.42e-4 (favourable) Tissue enriched Tissue enhanced breast: 73.5 testis: 22.4 TSC22D1 MGC17597, TGFB1I4, TSC22 ENSG00000102804 TSC22 domain family, member 1 13 44432143-44577147 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA077414 Approved Nucleoplasm
Nuclear bodies Renal cancer:4.54e-4 (favourable), Ovarian cancer:7.97e-4 (unfavourable) Expressed in all Expressed in all prostate: 263.0 TSC22D2 KIAA0669, TILZ4a, TILZ4b, TILZ4c ENSG00000196428 TSC22 domain family, member 2 3 150408335-150466431 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA004926 Approved Approved Cytosol Endometrial cancer:2.74e-4 (unfavourable), Renal cancer:5.80e-4 (unfavourable) Expressed in all Expressed in all endometrium: 37.8 TSC22D3 DIP, DSIPI, GILZ, hDIP, TSC-22R ENSG00000157514 TSC22 domain family, member 3 X 107713221-107777342 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001916 Approved Nuclear speckles
Golgi apparatus
Cytosol Endometrial cancer:2.43e-4 (unfavourable) Expressed in all Expressed in all appendix: 554.1 TSC22D4 THG-1, TILZ2 ENSG00000166925 TSC22 domain family, member 4 7 100463359-100479279 Predicted intracellular proteins, Predicted secreted proteins, Transcription factors Evidence at protein level HPA006757 Uncertain Approved Cytosol Colorectal cancer:2.66e-4 (unfavourable), Liver cancer:9.45e-4 (unfavourable) Expressed in all Expressed in all cerebral cortex: 278.9 TSHZ1 NY-CO-33, SDCCAG33, TSH1 ENSG00000179981 Teashirt zinc finger homeobox 1 18 75210755-75289950 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA006982 Approved Approved Nucleoplasm Thyroid cancer:1.71e-5 (unfavourable) Expressed in all Expressed in all ovary: 46.3 TSHZ2 C20orf17, OVC10-2, TSH2, ZABC2, ZNF218 ENSG00000182463 Teashirt zinc finger homeobox 2 20 52972407-53495330 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA038123 Uncertain Approved Nucleoplasm
Golgi apparatus Mixed Mixed ovary: 21.7 TSHZ3 KIAA1474, TSH3, ZNF537 ENSG00000121297 Teashirt zinc finger homeobox 3 19 31274945-31349547 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA008834 Approved Supported Nucleoplasm Renal cancer:2.92e-4 (unfavourable) Mixed Mixed ovary: 37.4 TWIST1 ACS3, bHLHa38, BPES2, BPES3, CRS, CRS1, H-twist, SCS, TWIST ENSG00000122691 Twist family bHLH transcription factor 1 7 19020991-19117672 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Mixed Tissue enhanced adipose tissue: 22.7;endometrium: 30.7 placenta: 17.2 TWIST2 bHLHa39, Dermo-1, DERMO1 ENSG00000233608 Twist family bHLH transcription factor 2 2 238848032-238910543 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA062870 Supported Nucleus
Nucleoli Mixed Tissue enhanced cervix, uterine: 40.2 adipose tissue: 27.3 UBP1 LBP-1a ENSG00000153560 Upstream binding protein 1 (LBP-1a) 3 33388336-33441371 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003967 Supported Nucleoplasm Colorectal cancer:1.81e-4 (favourable), Liver cancer:9.45e-4 (unfavourable) Expressed in all Expressed in all seminal vesicle: 53.9 UBTF NOR-90, UBF, UBF1, UBF2 ENSG00000108312 Upstream binding transcription factor, RNA polymerase I 17 44205033-44221626 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB004611, HPA006385 Supported Supported Validated Nucleoli fibrillar center Expressed in all Expressed in all lymph node: 82.3 UBTFL1 C11orf27 ENSG00000255009 Upstream binding transcription factor, RNA polymerase I-like 1 11 90085950-90087131 Predicted intracellular proteins, Transcription factors No evidence Not detected Not detected all non-specific tissues: 0.0 UNCX Uncx4.1 ENSG00000164853 UNC homeobox 7 1232907-1237318 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA063294 Approved Nucleoplasm Not detected Not detected kidney: 0.4 USF1 bHLHb11, MLTFI, UEF ENSG00000158773 Upstream transcription factor 1 1 161039251-161045977 Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB001480, HPA036233, HPA036535 Supported Validated Nucleoplasm Renal cancer:6.01e-12 (unfavourable), Urothelial cancer:1.95e-5 (favourable), Head and neck cancer:8.70e-4 (favourable) Expressed in all Expressed in all spleen: 35.5 USF2 bHLHb12, FIP ENSG00000105698 Upstream transcription factor 2, c-fos interacting 19 35268978-35279821 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA029764, HPA046567 Supported Nucleoplasm
Vesicles Pancreatic cancer:5.12e-5 (favourable), Urothelial cancer:3.28e-4 (favourable) Expressed in all Expressed in all cerebral cortex: 216.0 UTF1 ENSG00000171794 Undifferentiated embryonic cell transcription factor 1 10 133230274-133231558 Predicted intracellular proteins, Transcription factors Evidence at protein level Tissue enriched Tissue enriched 11 testis: 1.4 spleen: 0.1 VAX1 ENSG00000148704 Ventral anterior homeobox 1 10 117128521-117138301 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA028946 Uncertain Approved Nucleus
Nucleoli Not detected Tissue enhanced cerebral cortex: 1.4 testis: 0.5 VAX2 DRES93 ENSG00000116035 Ventral anterior homeobox 2 2 70900590-70933446 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA009708 Approved Nuclear speckles Mixed Tissue enhanced cerebral cortex: 3.3 adipose tissue,adrenal gland,breast,endometrium: 0.7 VDR NR1I1, PPP1R163 ENSG00000111424 Vitamin D (1,25- dihydroxyvitamin D3) receptor 12 47841537-47943048 Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB004617, HPA047740 Validated Nucleoplasm Renal cancer:4.89e-6 (favourable) Expressed in all Tissue enhanced parathyroid gland: 172.8 small intestine: 59.2 VENTX HPX42B, VENTX2 ENSG00000151650 VENT homeobox 10 133237404-133241929 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA050955 Uncertain Uncertain Nucleoli fibrillar center
Cytosol Tissue enriched Mixed appendix: 4.9 VEZF1 DB1, ZNF161 ENSG00000136451 Vascular endothelial zinc finger 1 17 57971547-57988259 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA027520, HPA048315 Uncertain Validated Nucleoplasm Colorectal cancer:6.14e-5 (favourable), Liver cancer:6.46e-4 (unfavourable) Expressed in all Expressed in all thyroid gland: 81.7 VSX1 PPCD, PPCD1, PPD ENSG00000100987 Visual system homeobox 1 20 25070885-25082365 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Not detected Mixed ovary: 1.7 VSX2 CHX10, HOX10, RET1 ENSG00000119614 Visual system homeobox 2 14 74239472-74262738 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003436 Uncertain Tissue enriched Not detected testis: 0.2 WHSC1 MMSET, NSD2 ENSG00000109685 Wolf-Hirschhorn syndrome candidate 1 4 1871424-1982207 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA015801, CAB068246, CAB068247 Supported Supported Nucleus Liver cancer:2.61e-4 (unfavourable), Renal cancer:7.19e-4 (unfavourable) Expressed in all Expressed in all testis: 66.9 WIZ ZNF803 ENSG00000011451 Widely interspaced zinc finger motifs 19 15419980-15449951 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA022923, HPA023774 Supported Validated Nucleoplasm
Midbody Endometrial cancer:5.12e-5 (unfavourable) Expressed in all Expressed in all testis: 31.0 WT1 AWT1, GUD, WAGR, WIT-2 ENSG00000184937 Wilms tumor 1 11 32387775-32435630 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB000327, HPA035717, HPA053848 Supported Supported Nucleoplasm Tissue enriched Tissue enhanced endometrium: 112.0;fallopian tube: 123.1;smooth muscle: 78.9 testis: 53.8 XBP1 XBP2 ENSG00000100219 X-box binding protein 1 22 28794555-28800597 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors Evidence at protein level Not detected Expressed in all breast: 907.4 YBX1 BP-8, CSDA2, CSDB, DBPB, MDR-NF1, NSEP-1, NSEP1, YB-1, YB1 ENSG00000065978 Y box binding protein 1 1 42682427-42702349 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB005875, HPA040304, HPA057159 Supported Validated Vesicles
Cytosol Liver cancer:9.87e-10 (unfavourable), Renal cancer:3.59e-7 (unfavourable) Expressed in all Expressed in all testis: 1538.1 YBX2 Contrin, CSDA3, MSY2 ENSG00000006047 Y box binding protein 2 17 7288252-7294615 Predicted intracellular proteins, Transcription factors Evidence at protein level CAB012332, HPA053904, HPA056744 Supported Supported Nucleoli fibrillar center Endometrial cancer:6.50e-5 (unfavourable) Mixed Tissue enriched 64 testis: 384.9 adipose tissue: 6.0 YBX3 CSDA, CSDA1, dbpA, ZONAB ENSG00000060138 Y box binding protein 3 12 10699089-10723312 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA034838 Approved Supported Cytosol Renal cancer:6.17e-13 (unfavourable) Expressed in all Expressed in all skeletal muscle: 1301.2 YY1 DELTA, INO80S, NF-E1, UCRBP, YIN-YANG-1 ENSG00000100811 YY1 transcription factor 14 100238298-100282792 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001119, CAB009392 Supported Supported Nucleoplasm
Nucleoli fibrillar center
Vesicles Liver cancer:3.44e-4 (unfavourable), Endometrial cancer:6.13e-4 (unfavourable) Expressed in all Expressed in all thyroid gland: 65.8 YY2 ZNF631 ENSG00000230797 YY2 transcription factor X 21855987-21858727 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001119, HPA030335 Approved Approved Nuclear bodies Mixed Tissue enhanced testis: 10.9 endometrium: 2.8 ZBED1 ALTE, DREF, hDREF, KIAA0785, TRAMP ENSG00000214717 Zinc finger, BED-type containing 1 X 2486414-2500967 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA077591 Approved Nucleoplasm
Nuclear membrane
Centrosome Renal cancer:3.13e-4 (unfavourable) Expressed in all Expressed in all cervix, uterine: 24.5 ZBED2 MGC10796 ENSG00000177494 Zinc finger, BED-type containing 2 3 111592900-111595443 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA029786 Uncertain Approved Nuclear bodies
Mitochondria
Cytosol Pancreatic cancer:8.83e-4 (unfavourable) Tissue enriched Tissue enhanced fallopian tube: 30.1;thyroid gland: 112.7 lung: 15.0 ZBED3 MGC15435 ENSG00000132846 Zinc finger, BED-type containing 3 5 77072072-77087323 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA055995 Approved Approved Nucleoplasm
Plasma membrane Renal cancer:1.68e-4 (favourable) Expressed in all Mixed thyroid gland: 18.7 ZBED4 KIAA0637 ENSG00000100426 Zinc finger, BED-type containing 4 22 49853842-49890078 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA045341 Approved Supported Nucleoplasm Expressed in all Expressed in all lymph node: 7.8 ZBED5 Buster1 ENSG00000236287 Zinc finger, BED-type containing 5 11 10812074-10858796 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA048472, HPA050994 Uncertain Approved Nucleus
Nucleoli fibrillar center
Golgi apparatus Liver cancer:2.19e-5 (unfavourable), Urothelial cancer:3.87e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 94.8 ZBED6 ENSG00000257315 Zinc finger, BED-type containing 6 1 203796309-203800558 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA068807 Approved Nucleoplasm
Microtubule organizing center Expressed in all Mixed parathyroid gland: 17.6 ZBTB1 KIAA0997, ZNF909 ENSG00000126804 Zinc finger and BTB domain containing 1 14 64503712-64533690 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA050516 Approved Supported Nucleoplasm
Nuclear membrane Head and neck cancer:4.92e-4 (favourable) Expressed in all Expressed in all bone marrow: 53.6 ZBTB11 ZNF-U69274, ZNF913 ENSG00000066422 Zinc finger and BTB domain containing 11 3 101648889-101677495 Predicted intracellular proteins, Predicted membrane proteins, Transcription factors Evidence at protein level HPA015328, HPA024138 Approved Validated Nucleoplasm Endometrial cancer:7.49e-4 (unfavourable) Expressed in all Expressed in all bone marrow: 23.5 ZBTB12 C6orf46, D6S59E, G10, NG35 ENSG00000204366 Zinc finger and BTB domain containing 12 6 31899607-31901992 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA047161 Approved Renal cancer:1.52e-4 (unfavourable) Expressed in all Mixed endometrium: 1.8 ZBTB14 ZFP161, ZNF478 ENSG00000198081 Zinc finger and BTB domain containing 14 18 5289019-5297053 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA050758, HPA070819 Uncertain Validated Nucleus
Nucleoli
Cytosol Expressed in all Expressed in all lymph node: 29.3 ZBTB16 PLZF, ZNF145 ENSG00000109906 Zinc finger and BTB domain containing 16 11 114059593-114250676 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001499, CAB004540 Uncertain Renal cancer:2.21e-4 (favourable) Tissue enhanced Mixed ovary: 59.6 ZBTB17 MIZ1, pHZ-67, ZNF151, ZNF60 ENSG00000116809 Zinc finger and BTB domain containing 17 1 15941869-15976132 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA005789 Approved Liver cancer:2.38e-6 (unfavourable), Renal cancer:3.27e-5 (unfavourable), Urothelial cancer:2.04e-4 (favourable) Expressed in all Expressed in all testis: 21.9 ZBTB18 C2H2-171, RP58, TAZ-1, ZNF238 ENSG00000179456 Zinc finger and BTB domain containing 18 1 244048939-244057476 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA044652 Supported Nucleoplasm
Microtubules
Cytokinetic bridge Urothelial cancer:6.78e-6 (favourable), Endometrial cancer:1.34e-4 (favourable) Expressed in all Expressed in all cerebral cortex: 76.5 ZBTB2 bA351K16.2, KIAA1483, ZNF437 ENSG00000181472 Zinc finger and BTB domain containing 2 6 151364117-151391548 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA023136, HPA023137, HPA023458, HPA023487 Approved Supported Nucleoplasm
Cytosol Renal cancer:9.36e-6 (unfavourable), Liver cancer:1.21e-5 (unfavourable) Expressed in all Expressed in all thyroid gland: 49.8 ZBTB20 DKFZp566F123, DPZF, ODA-8S, ZNF288 ENSG00000181722 Zinc finger and BTB domain containing 20 3 114338094-115147271 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA015551, HPA016815 Approved Supported Nucleoplasm
Nuclear bodies Tissue enhanced Tissue enriched 5 testis: 20.9 ovary: 3.8 ZBTB21 KIAA1227, ZNF295 ENSG00000173276 Zinc finger and BTB domain containing 21 21 41986831-42010387 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA024655, HPA031757, HPA031758 Approved Validated Nucleus Expressed in all Mixed adrenal gland: 47.9 ZBTB22 BING1, fru, fruitless, ZBTB22A, ZNF297, ZNF297A ENSG00000236104 Zinc finger and BTB domain containing 22 6 33314406-33317942 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA043848 Approved Nucleoplasm Expressed in all Tissue enhanced parathyroid gland: 28.5 epididymis,thyroid gland: 11.7 ZBTB24 BIF1, KIAA0441, PATZ2, ZNF450 ENSG00000112365 Zinc finger and BTB domain containing 24 6 109462594-109483237 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA017872, HPA049003 Uncertain Approved Nucleus
Cytokinetic bridge
Centrosome Liver cancer:3.15e-4 (unfavourable) Expressed in all Mixed parathyroid gland: 13.7 ZBTB25 C14orf51, KUP, ZNF46 ENSG00000089775 Zinc finger and BTB domain containing 25 14 64449106-64505213 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA054699 Uncertain Validated Nucleoplasm Renal cancer:3.56e-6 (unfavourable) Expressed in all Mixed thyroid gland: 14.7 ZBTB26 ZNF481 ENSG00000171448 Zinc finger and BTB domain containing 26 9 122915566-122931500 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA021444 Uncertain Expressed in all Mixed testis: 18.1 ZBTB32 FAXF, FAZF, Rog, TZFP, ZNF538 ENSG00000011590 Zinc finger and BTB domain containing 32 19 35704527-35717038 Predicted intracellular proteins, Transcription factors Evidence at protein level Mixed Tissue enriched 11 testis: 43.4 lymph node: 3.9 ZBTB33 kaiso, WUGSC:H_DJ525N14.1, ZNF-kaiso, ZNF348 ENSG00000177485 Zinc finger and BTB domain containing 33 X 120250752-120258398 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA000755, CAB001980, HPA005732 Approved Validated Nucleus
Plasma membrane
Cytosol Expressed in all Expressed in all parathyroid gland: 23.0 ZBTB34 KIAA1993, MGC24652, ZNF918 ENSG00000177125 Zinc finger and BTB domain containing 34 9 126860665-126885878 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA023893 Approved Supported Nucleoplasm Expressed in all Mixed placenta: 9.5 ZBTB37 MGC2629, ZNF908 ENSG00000185278 Zinc finger and BTB domain containing 37 1 173868082-173903549 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA023438 Approved Approved Nucleus
Nucleoli fibrillar center
Cytosol Mixed Tissue enhanced testis: 17.3 spleen: 5.5 ZBTB38 CIBZ, FLJ35036, PPP1R171, ZNF921 ENSG00000177311 Zinc finger and BTB domain containing 38 3 141324213-141449792 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA014865, HPA059378 Validated Nucleoplasm Expressed in all Expressed in all parathyroid gland: 129.7 ZBTB39 KIAA0352, ZNF922 ENSG00000166860 Zinc finger and BTB domain containing 39 12 56998834-57006446 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA016866, HPA020306 Uncertain Approved Vesicles Expressed in all Mixed testis: 13.4 ZBTB4 KAISO-L1, KIAA1538, ZNF903 ENSG00000174282 Zinc finger and BTB domain containing 4 17 7459366-7484263 Predicted intracellular proteins, Transcription factors Evidence at protein level CAB008980, HPA064763 Supported Supported Nucleoplasm
Nuclear bodies
Cytosol Renal cancer:1.65e-9 (favourable), Pancreatic cancer:2.53e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 166.8 ZBTB40 KIAA0478, ZNF923 ENSG00000184677 Zinc finger and BTB domain containing 40 1 22451851-22531157 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA042386 Approved Nucleus Liver cancer:7.78e-8 (unfavourable), Pancreatic cancer:4.12e-5 (favourable), Head and neck cancer:2.01e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 20.5 ZBTB41 DKFZp686C06120, FLJ36199, FRBZ1, ZNF924 ENSG00000177888 Zinc finger and BTB domain containing 41 1 197153680-197200542 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA034841, HPA034842 Uncertain Approved Nucleus
Nuclear membrane
Cytosol Liver cancer:5.86e-4 (unfavourable) Expressed in all Mixed thyroid gland: 12.7 ZBTB42 ZNF925 ENSG00000179627 Zinc finger and BTB domain containing 42 14 104800596-104804712 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA000703, HPA066961 Uncertain Supported Nucleus Renal cancer:2.30e-9 (favourable) Expressed in all Mixed prostate: 8.0 ZBTB43 FLJ22470, KIAA0414, ZBTB22B, ZNF-X, ZNF297B ENSG00000169155 Zinc finger and BTB domain containing 43 9 126805006-126838210 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA016825 Approved Approved Nucleus
Nucleoli Renal cancer:8.73e-4 (favourable) Expressed in all Expressed in all bone marrow: 38.8 ZBTB44 BTBD15, HSPC063, ZNF851 ENSG00000196323 Zinc finger and BTB domain containing 44 11 130226677-130314686 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA052589 Approved Approved Nucleoplasm Expressed in all Expressed in all testis: 75.4 ZBTB45 FLJ14486, ZNF499 ENSG00000119574 Zinc finger and BTB domain containing 45 19 58513530-58538911 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA035754 Uncertain Approved Cytosol Renal cancer:5.38e-4 (favourable) Expressed in all Expressed in all cerebral cortex,thyroid gland: 10.6 ZBTB46 BTBD4, BZEL, FLJ13502, RINZF, ZNF340 ENSG00000130584 Zinc finger and BTB domain containing 46 20 63743666-63831244 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA013997 Uncertain Approved Nucleus Pancreatic cancer:2.17e-4 (favourable) Expressed in all Mixed spleen: 13.8 ZBTB47 DKFZp434N0615, KIAA1190, ZNF651 ENSG00000114853 Zinc finger and BTB domain containing 47 3 42653684-42665854 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA074057 Approved Nucleoplasm Renal cancer:7.96e-5 (favourable) Expressed in all Expressed in all cerebral cortex: 48.0 ZBTB48 HKR3, ZNF855 ENSG00000204859 Zinc finger and BTB domain containing 48 1 6580001-6589280 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA030417 Uncertain Approved Nucleoplasm
Cytosol Pancreatic cancer:5.19e-6 (favourable), Cervical cancer:1.04e-4 (favourable) Expressed in all Expressed in all testis: 32.9 ZBTB49 FLJ38559, ZNF509 ENSG00000168826 Zinc finger and BTB domain containing 49 4 4290251-4321786 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA024450 Approved Approved Nucleoplasm
Microtubules
Cytosol Urothelial cancer:2.88e-5 (favourable), Pancreatic cancer:1.76e-4 (favourable), Head and neck cancer:5.24e-4 (favourable) Expressed in all Mixed testis: 7.3 ZBTB5 KIAA0354 ENSG00000168795 Zinc finger and BTB domain containing 5 9 37438114-37465399 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA021521 Approved Approved Nucleoplasm
Nuclear bodies
Golgi apparatus Expressed in all Expressed in all thyroid gland: 17.6 ZBTB6 ZID, ZNF482 ENSG00000186130 Zinc finger and BTB domain containing 6 9 122908056-122913330 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA054111, HPA076894 Approved Approved Nucleoplasm
Mitochondria Glioma:9.75e-6 (favourable), Renal cancer:5.08e-4 (favourable) Expressed in all Mixed thyroid gland: 12.5 ZBTB7A DKFZp547O146, FBI-1, LRF, pokemon, ZBTB7, ZNF857A ENSG00000178951 Zinc finger and BTB domain containing 7A 19 4044364-4066945 Predicted intracellular proteins, Transcription factors Evidence at protein level CAB037214, CAB037285, HPA046387 Supported Approved Nucleoplasm Renal cancer:1.34e-6 (favourable), Endometrial cancer:6.50e-6 (favourable), Stomach cancer:1.79e-4 (favourable), Pancreatic cancer:2.99e-4 (unfavourable) Expressed in all Expressed in all cerebral cortex: 23.9 ZBTB7B c-Krox, hcKrox, ZBTB15, ZFP67, ZNF857B ENSG00000160685 Zinc finger and BTB domain containing 7B 1 155002630-155018522 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA006811, HPA025820 Approved Validated Nucleoplasm Expressed in all Expressed in all skin: 89.6 ZBTB7C ZBTB36, ZNF857C ENSG00000184828 Zinc finger and BTB domain containing 7C 18 48026673-48410752 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA014433 Uncertain Colorectal cancer:1.59e-4 (favourable) Mixed Mixed esophagus: 31.9 ZBTB8B DKFZp547H154, RP1-27O5.1, ZNF916B ENSG00000273274 Zinc finger and BTB domain containing 8B 1 32465069-32496686 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA027818, HPA028690, HPA055553 Approved Tissue enhanced Not detected cerebral cortex: 0.6 ZC3H4 C19orf7, KIAA1064 ENSG00000130749 Zinc finger CCCH-type containing 4 19 47064187-47113752 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA040934, HPA041068 Supported Validated Nucleoplasm
Cytosol Urothelial cancer:2.23e-4 (favourable) Expressed in all Expressed in all spleen: 13.8 ZC3H6 FLJ41410, FLJ45877, KIAA2035, ZC3HDC6 ENSG00000188177 Zinc finger CCCH-type containing 6 2 112275594-112340063 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA036019, HPA036020 Uncertain Expressed in all Mixed ovary: 7.6 ZC3H8 Fliz1, ZC3HDC8 ENSG00000144161 Zinc finger CCCH-type containing 8 2 112211525-112255136 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA034803, HPA034804 Approved Supported Nucleoplasm
Nuclear bodies Endometrial cancer:1.12e-6 (unfavourable), Renal cancer:1.89e-4 (unfavourable) Expressed in all Expressed in all testis: 16.2 ZEB1 AREB6, BZP, FECD6, NIL-2-A, PPCD3, TCF8, ZEB, Zfhep, Zfhx1a ENSG00000148516 Zinc finger E-box binding homeobox 1 10 31318495-31529814 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA027524, CAB058686 Supported Supported Nucleoplasm Renal cancer:7.34e-6 (unfavourable) Expressed in all Mixed endometrium: 78.7 ZEB2 KIAA0569, SIP-1, SIP1, ZFHX1B ENSG00000169554 Zinc finger E-box binding homeobox 2 2 144384081-144524583 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003456 Approved Approved Nucleus
Nucleoli
Cytosol Renal cancer:6.04e-5 (unfavourable) Expressed in all Expressed in all cerebral cortex: 95.9 ZFAT KIAA1485, ZFAT1, ZNF406 ENSG00000066827 Zinc finger and AT hook domain containing 8 134477788-134713049 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA020989, HPA063592 Supported Approved Nucleoplasm
Nuclear bodies Expressed in all Group enriched 6 kidney: 10.4;placenta: 44.0 testis: 4.4 ZFHX2 KIAA1056, KIAA1762, ZFH-5, ZNF409 ENSG00000136367 Zinc finger homeobox 2 14 23520855-23556192 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA000720, HPA005146 Uncertain Approved Nucleus
Nucleoli fibrillar center Mixed Tissue enhanced testis: 13.1 parathyroid gland: 4.0 ZFHX3 ATBF1, ZNF927 ENSG00000140836 Zinc finger homeobox 3 16 72782885-73059698 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA059353 Uncertain Supported Nucleoplasm Renal cancer:1.37e-5 (favourable), Breast cancer:1.55e-4 (unfavourable) Expressed in all Tissue enhanced parathyroid gland: 28.7 thyroid gland: 12.5 ZFHX4 FLJ20980, ZFH4 ENSG00000091656 Zinc finger homeobox 4 8 76681219-76867285 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA023837 Uncertain Approved Nucleoplasm
Nucleoli fibrillar center Mixed Tissue enhanced testis: 12.2 seminal vesicle: 7.9 ZFP1 FLJ34243, ZNF475 ENSG00000184517 ZFP1 zinc finger protein 16 75148492-75172236 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA044916, HPA062910 Uncertain Approved Nucleus Glioma:5.81e-5 (favourable), Stomach cancer:9.80e-4 (unfavourable) Expressed in all Mixed cerebral cortex: 25.1 ZFP14 KIAA1559, ZNF531 ENSG00000142065 ZFP14 zinc finger protein 19 36334453-36379199 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA030637 Uncertain Approved Nuclear speckles Urothelial cancer:2.75e-5 (favourable) Expressed in all Mixed parathyroid gland: 8.6 ZFP2 FLJ21628, ZNF751 ENSG00000198939 ZFP2 zinc finger protein 5 178895894-178933212 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA023364 Uncertain Mixed Mixed testis: 7.8 ZFP28 KIAA1431, mkr5 ENSG00000196867 ZFP28 zinc finger protein 19 56538948-56556810 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA028879 Uncertain Approved Nucleoplasm
Cytosol Mixed Mixed ovary: 13.0 ZFP3 FLJ30726, ZNF752 ENSG00000180787 ZFP3 zinc finger protein 17 5078248-5096374 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA053085, HPA057290 Approved Approved Nucleoplasm
Cytosol Renal cancer:7.69e-7 (favourable), Pancreatic cancer:1.07e-4 (favourable), Lung cancer:1.38e-4 (favourable), Cervical cancer:5.68e-4 (favourable) Mixed Mixed parathyroid gland: 12.8 ZFP30 KIAA0961, ZNF745 ENSG00000120784 ZFP30 zinc finger protein 19 37613749-37692337 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA030606 Uncertain Approved Cytosol Renal cancer:3.86e-4 (favourable) Expressed in all Mixed testis: 14.2 ZFP37 ZNF906 ENSG00000136866 ZFP37 zinc finger protein 9 113038380-113056759 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA049112 Uncertain Approved Nucleus
Vesicles Glioma:9.22e-5 (favourable) Mixed Mixed ovary: 8.8 ZFP42 REX1, ZNF754 ENSG00000179059 ZFP42 zinc finger protein 4 187995771-188005050 Predicted intracellular proteins, Transcription factors Evidence at protein level CAB025557 Uncertain Tissue enriched Tissue enhanced testis: 3.5 skin: 1.2 ZFP57 bA145L22, bA145L22.2, C6orf40, ZNF698 ENSG00000204644 ZFP57 zinc finger protein 6 29672392-29681110 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA047172 Uncertain Pancreatic cancer:1.95e-4 (favourable) Tissue enriched Not detected cerebral cortex,heart muscle: 0.4 ZFP62 FLJ34231, ZET, ZNF755 ENSG00000196670 ZFP62 zinc finger protein 5 180847611-180861285 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA048629 Approved Approved Nucleoplasm
Actin filaments Expressed in all Expressed in all thyroid gland: 39.5 ZFP64 dJ548G19.1, dJ831D17.1, FLJ10734, FLJ12628, ZNF338 ENSG00000020256 ZFP64 zinc finger protein 20 52051663-52204308 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA035112, HPA058387 Uncertain Approved Nucleus Liver cancer:9.86e-7 (unfavourable) Expressed in all Expressed in all skin: 13.9 ZFP69 FLJ16030, ZFP69A, ZKSCAN23A, ZNF642, ZSCAN54A ENSG00000187815 ZFP69 zinc finger protein 1 40477215-40496343 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA027808, HPA054942 Uncertain Approved Nucleus Renal cancer:5.00e-6 (unfavourable), Head and neck cancer:9.31e-4 (favourable) Expressed in all Mixed testis: 6.8 ZFP69B FLJ34293, ZKSCAN23B, ZNF643, ZSCAN54B ENSG00000187801 ZFP69 zinc finger protein B 1 40450102-40463718 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA044289 Uncertain Approved Nucleus
Cytosol Mixed Mixed cerebral cortex: 3.7 ZFP82 KIAA1948, MGC45380, ZNF545 ENSG00000181007 ZFP82 zinc finger protein 19 36383120-36418656 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA060470 Uncertain Mixed Mixed thyroid gland: 8.8 ZFP90 KIAA1954, NK10, ZNF756 ENSG00000184939 ZFP90 zinc finger protein 16 68530090-68576072 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA029017 Uncertain Supported Vesicles
Plasma membrane
Centrosome Renal cancer:1.78e-4 (favourable) Expressed in all Mixed parathyroid gland: 31.1 ZFP91 PZF, ZNF757 ENSG00000186660 ZFP91 zinc finger protein 11 58579111-58621042 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA024037, CAB025417, HPA065325 Approved Supported Nucleus
Nucleoli Pancreatic cancer:3.74e-6 (unfavourable) Expressed in all Expressed in all testis: 175.0 ZFP92 ZNF897 ENSG00000189420 ZFP92 zinc finger protein X 153418322-153426481 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA003030 Uncertain Tissue enhanced Mixed fallopian tube: 5.2 ZFPM1 FOG, FOG1, ZC2HC11A, ZNF89A ENSG00000179588 Zinc finger protein, FOG family member 1 16 88453317-88537016 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA046603 Supported Approved Nucleoplasm
Cytosol Urothelial cancer:4.24e-4 (favourable) Expressed in all Mixed stomach: 13.9 ZFPM2 FOG2, hFOG-2, ZC2HC11B, ZNF89B ENSG00000169946 Zinc finger protein, FOG family member 2 8 104590733-105804532 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA004094 Approved Supported Nucleoplasm Mixed Tissue enhanced ovary: 40.6 smooth muscle: 25.8 ZFX ZNF926 ENSG00000005889 Zinc finger protein, X-linked X 24149173-24216255 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001748, HPA003877, HPA071863 Supported Approved Nucleoplasm
Nucleoli Expressed in all Expressed in all parathyroid gland: 32.5 ZFY ZNF911 ENSG00000067646 Zinc finger protein, Y-linked Y 2935281-2982506 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001748, HPA071863 Uncertain Approved Nucleoplasm
Nucleoli Head and neck cancer:3.58e-5 (favourable) Mixed Mixed testis: 12.8 ZGLP1 GATAD3, GLP-1, GLP1 ENSG00000220201 Zinc finger, GATA-like protein 1 19 10304803-10309880 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA049855 Uncertain Approved Nucleus
Vesicles Mixed Mixed testis: 3.1 ZGPAT dJ583P15.3, FLJ14972, GPATC6, GPATCH6, KIAA1847, MGC44880, ZC3H9, ZC3HDC9, ZIP ENSG00000197114 Zinc finger, CCCH-type with G patch domain 20 63707465-63736142 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA056705 Supported Nucleus
Plasma membrane Head and neck cancer:6.17e-5 (favourable) Expressed in all Expressed in all liver: 26.9 ZHX1 ENSG00000165156 Zinc fingers and homeoboxes 1 8 123248451-123275541 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA055357, HPA060251 Validated Nucleoplasm Endometrial cancer:6.09e-4 (unfavourable) Expressed in all Expressed in all thyroid gland: 62.7 ZHX2 KIAA0854 ENSG00000178764 Zinc fingers and homeoboxes 2 8 122781394-122974512 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA006769, HPA006996 Supported Expressed in all Expressed in all ovary: 32.7 ZHX3 KIAA0395, TIX1 ENSG00000174306 Zinc fingers and homeoboxes 3 20 41178448-41317672 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA046498 Supported Nucleoplasm Urothelial cancer:1.84e-5 (unfavourable), Renal cancer:2.53e-5 (favourable), Endometrial cancer:1.62e-4 (unfavourable), Thyroid cancer:7.52e-4 (unfavourable) Expressed in all Expressed in all testis: 43.3 ZIC1 ZIC, ZNF201 ENSG00000152977 Zic family member 1 3 147393422-147510293 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA004098 Supported Supported Nucleoplasm Tissue enhanced Tissue enriched 9 cerebral cortex: 23.8 skin: 2.5 ZIC2 HPE5 ENSG00000043355 Zic family member 2 13 99981772-99986773 Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA055031 Approved Nuclear bodies Cervical cancer:2.64e-4 (favourable), Liver cancer:2.91e-4 (unfavourable) Mixed Tissue enriched 6 cerebral cortex: 7.4 testis: 1.2 ZIC3 HTX, HTX1, ZNF203 ENSG00000156925 Zic family member 3 X 137566142-137577691 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA047934, HPA052936 Approved Supported Nucleoplasm Tissue enriched Tissue enhanced cerebral cortex: 1.6;testis: 1.3 epididymis: 0.3 ZIC4 ENSG00000174963 Zic family member 4 3 147386046-147406860 Predicted intracellular proteins, Predicted secreted proteins, Transcription factors Evidence at transcript level HPA030194 Uncertain Approved Nucleus
Cytosol Mixed Tissue enhanced cerebral cortex: 4.3;skin: 1.4 testis: 0.7 ZIC5 ENSG00000139800 Zic family member 5 13 99962964-99971909 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA074045 Uncertain Nucleoplasm
Vesicles Mixed Group enriched 45 cerebral cortex: 2.3;testis: 6.6 all non-specific tissues: 0.0 ZIK1 ZNF762 ENSG00000171649 Zinc finger protein interacting with K protein 1 19 57578456-57593777 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA059975 Uncertain Approved Intermediate filaments Mixed Mixed parathyroid gland: 12.0 ZIM2 ZNF656 ENSG00000269699 Zinc finger, imprinted 2 19 56774552-56840729 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA071856 Approved Nuclear speckles
Cytosol Not detected Group enriched 6 adrenal gland: 5.8;cerebral cortex: 5.1;ovary: 10.0;placenta: 6.8;testis: 7.8 endometrium: 1.1 ZIM3 ZNF657 ENSG00000141946 Zinc finger, imprinted 3 19 57134096-57145202 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA034575 Uncertain Not detected Not detected testis: 0.8 ZKSCAN1 KOX18, PHZ-37, ZNF139, ZNF36, ZSCAN33 ENSG00000106261 Zinc finger with KRAB and SCAN domains 1 7 100015572-100041689 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA006672 Uncertain Approved Nucleus
Nuclear bodies
Mitochondria Expressed in all Expressed in all skin: 39.1 ZKSCAN2 FLJ23199, ZNF694, ZSCAN34 ENSG00000155592 Zinc finger with KRAB and SCAN domains 2 16 25236001-25257931 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA049141 Uncertain Approved Nucleoplasm
Nucleoli fibrillar center
Golgi apparatus Renal cancer:1.70e-6 (favourable) Expressed in all Mixed testis: 7.6 ZKSCAN3 ZF47, Zfp47, ZNF306, ZNF309, ZSCAN35 ENSG00000189298 Zinc finger with KRAB and SCAN domains 3 6 28349914-28369177 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA009637 Approved Supported Nucleoplasm Glioma:6.55e-4 (favourable) Expressed in all Mixed parathyroid gland: 9.9 ZKSCAN4 FLJ32136, P1P373C6, p373c6.1, ZNF307, ZNF427, ZSCAN36 ENSG00000187626 Zinc finger with KRAB and SCAN domains 4 6 28244623-28252224 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA009637 Approved Supported Nucleoplasm Liver cancer:1.90e-6 (unfavourable), Lung cancer:5.04e-4 (favourable) Expressed in all Mixed testis: 18.2 ZKSCAN5 ZFP95, ZNF914, ZSCAN37 ENSG00000196652 Zinc finger with KRAB and SCAN domains 5 7 99504651-99534700 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003201 Uncertain Approved Intermediate filaments Liver cancer:7.59e-6 (unfavourable), Thyroid cancer:1.13e-4 (unfavourable) Expressed in all Mixed testis: 14.9 ZKSCAN7 FLJ12738, ZNF167, ZNF448, ZNF64, ZSCAN39 ENSG00000196345 Zinc finger with KRAB and SCAN domains 7 3 44555193-44594173 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA048312, HPA049906, HPA071850 Uncertain Validated Cytosol Mixed Mixed ovary: 4.1 ZKSCAN8 LD5-1, ZNF192, ZSCAN40 ENSG00000198315 Zinc finger with KRAB and SCAN domains 8 6 28141910-28159472 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003483 Approved Approved Nucleus
Cytosol Endometrial cancer:1.33e-4 (unfavourable) Expressed in all Expressed in all endometrium: 24.8 ZNF10 KOX1 ENSG00000256223 Zinc finger protein 10 12 133130575-133159465 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003204 Uncertain Approved Nucleus
Vesicles
Plasma membrane Expressed in all Expressed in all parathyroid gland: 40.2 ZNF100 ENSG00000197020 Zinc finger protein 100 19 21722766-21767628 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA059135 Uncertain Urothelial cancer:5.47e-4 (favourable) Mixed Mixed testis: 11.9 ZNF101 DKFZp570I0164, HZF12 ENSG00000181896 Zinc finger protein 101 19 19668796-19683509 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA023449, HPA055486 Uncertain Cervical cancer:5.76e-5 (favourable), Stomach cancer:1.11e-4 (favourable), Head and neck cancer:2.15e-4 (favourable), Ovarian cancer:2.26e-4 (favourable), Urothelial cancer:4.37e-4 (favourable), Lung cancer:6.65e-4 (favourable) Expressed in all Tissue enhanced lymph node: 31.9 tonsil: 23.3 ZNF107 smap-7, ZFD25, ZNF588 ENSG00000196247 Zinc finger protein 107 7 64666083-64711582 Predicted intracellular proteins, Transcription factors Evidence at transcript level Renal cancer:2.62e-4 (unfavourable) Expressed in all Mixed lymph node: 19.7 ZNF112 ZFP112, ZNF228 ENSG00000062370 Zinc finger protein 112 19 44326555-44367217 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA023856 Approved Approved Centrosome Renal cancer:1.54e-5 (favourable) Mixed Mixed testis: 13.7 ZNF114 MGC17986 ENSG00000178150 Zinc finger protein 114 19 48172318-48287608 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA025019, HPA029553 Uncertain Approved Nucleus
Cytosol Head and neck cancer:3.29e-4 (unfavourable) Mixed Tissue enhanced thyroid gland: 10.3 parathyroid gland: 3.9 ZNF117 H-plk, HPF9 ENSG00000152926 Zinc finger protein 117 7 64971776-65006684 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA031148 Approved Nucleoli fibrillar center
Cytosol Renal cancer:2.17e-11 (unfavourable) Expressed in all Mixed adrenal gland: 25.2 ZNF121 D19S204, ZHC32, ZNF20 ENSG00000197961 Zinc finger protein 121 19 9560353-9584533 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA054961 Uncertain Uncertain Nucleoplasm
Nucleoli
Centrosome Urothelial cancer:5.75e-5 (favourable), Ovarian cancer:6.59e-5 (favourable), Renal cancer:1.01e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 23.1 ZNF124 HZF-16, HZF16 ENSG00000196418 Zinc finger protein 124 1 247121975-247172016 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA031127 Uncertain Approved Nucleus
Nuclear membrane Urothelial cancer:1.03e-4 (favourable) Expressed in all Mixed salivary gland: 16.8 ZNF131 pHZ-10, ZBTB35 ENSG00000172262 Zinc finger protein 131 5 43065176-43192021 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA007023, HPA027748, HPA074630 Approved Validated Nucleoplasm
Intermediate filaments Liver cancer:1.56e-4 (unfavourable) Expressed in all Expressed in all testis: 59.1 ZNF132 pHZ-12 ENSG00000131849 Zinc finger protein 132 19 58432814-58440222 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA008726 Uncertain Approved Vesicles
Intermediate filaments Renal cancer:7.26e-13 (favourable), Pancreatic cancer:1.92e-4 (favourable) Mixed Mixed parathyroid gland: 10.6 ZNF133 pHZ-13, pHZ-66, ZNF150 ENSG00000125846 Zinc finger protein 133 20 18288283-18316996 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001493 Supported Approved Nucleus
Vesicles Liver cancer:4.46e-6 (unfavourable), Renal cancer:2.20e-5 (unfavourable) Expressed in all Expressed in all epididymis: 19.7 ZNF134 pHZ-15 ENSG00000213762 Zinc finger protein 134 19 57614233-57624723 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA009064 Supported Approved Nucleoplasm Cervical cancer:1.03e-4 (unfavourable), Renal cancer:2.61e-4 (favourable), Head and neck cancer:5.21e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 25.2 ZNF135 pHZ-17, ZNF61, ZNF78L1 ENSG00000176293 Zinc finger protein 135 19 58059239-58086310 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA006961 Approved Approved Cytosol Renal cancer:3.93e-5 (favourable) Mixed Mixed parathyroid gland: 24.5 ZNF136 pHZ-20 ENSG00000196646 Zinc finger protein 136 19 12163064-12189881 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA054120 Approved Nucleoli Renal cancer:4.75e-5 (favourable) Expressed in all Mixed thyroid gland: 14.5 ZNF138 pHZ-32 ENSG00000197008 Zinc finger protein 138 7 64794388-64833681 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA077435 Uncertain Cytosol Expressed in all Mixed cerebral cortex: 9.2 ZNF14 GIOT-4, KOX6 ENSG00000105708 Zinc finger protein 14 19 19710471-19733097 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA049863 Uncertain Approved Nucleus
Cytosol Renal cancer:8.09e-6 (favourable), Lung cancer:7.96e-4 (favourable) Expressed in all Mixed thyroid gland: 13.3 ZNF140 pHZ-39 ENSG00000196387 Zinc finger protein 140 12 133079838-133107544 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA048332 Uncertain Expressed in all Expressed in all endometrium: 14.5 ZNF141 D4S90, pHZ-44 ENSG00000131127 Zinc finger protein 141 4 337814-384864 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Urothelial cancer:4.76e-4 (favourable) Expressed in all Mixed adrenal gland: 15.0 ZNF142 KIAA0236, pHZ-49 ENSG00000115568 Zinc finger protein 142 2 218637916-218659655 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA049594 Uncertain Approved Nucleus
Nucleoli fibrillar center Liver cancer:1.35e-5 (unfavourable) Expressed in all Expressed in all parathyroid gland: 15.0 ZNF143 pHZ-1, SBF, STAF ENSG00000166478 Zinc finger protein 143 11 9460319-9528524 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003263, HPA074818 Supported Approved Nucleoplasm
Nuclear bodies
Vesicles Liver cancer:1.76e-5 (unfavourable), Renal cancer:6.78e-4 (unfavourable) Expressed in all Expressed in all testis: 31.5 ZNF146 OZF ENSG00000167635 Zinc finger protein 146 19 36214602-36238774 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003358 Supported Supported Nucleoli Expressed in all Expressed in all parathyroid gland: 62.1 ZNF148 BERF-1, BFCOL1, HT-BETA, pHZ-52, ZBP-89, ZFP148 ENSG00000163848 Zinc finger protein 148 3 125225561-125375354 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001656, CAB017486 Supported Supported Nucleus
Golgi apparatus Pancreatic cancer:2.88e-4 (unfavourable) Expressed in all Expressed in all thyroid gland: 50.2 ZNF154 pHZ-92 ENSG00000179909 Zinc finger protein 154 19 57697367-57709194 Predicted intracellular proteins, Transcription factors Evidence at transcript level Mixed Mixed parathyroid gland: 9.6 ZNF155 pHZ-96 ENSG00000204920 Zinc finger protein 155 19 43967862-43998325 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003220 Uncertain Approved Nucleoplasm
Cytosol Mixed Mixed parathyroid gland: 14.6 ZNF157 HZF22 ENSG00000147117 Zinc finger protein 157 X 47370583-47414305 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA003319 Uncertain Tissue enhanced Mixed fallopian tube: 2.1 ZNF16 KOX9 ENSG00000170631 Zinc finger protein 16 8 144930358-144950888 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA035782, HPA061835 Uncertain Supported Nucleus
Nucleoli Head and neck cancer:2.39e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 16.0 ZNF160 F11, FLJ00032, HKr18, HZF5, KIAA1611, KR18 ENSG00000170949 Zinc finger protein 160 19 53066606-53103436 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA023599 Uncertain Approved Nuclear speckles
Cytosol Urothelial cancer:2.67e-5 (favourable) Expressed in all Expressed in all spleen: 38.0 ZNF165 CT53, ZSCAN7 ENSG00000197279 Zinc finger protein 165 6 28080975-28089563 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA007247 Approved Nuclear speckles
Microtubules Renal cancer:1.19e-5 (favourable), Urothelial cancer:9.82e-5 (favourable), Ovarian cancer:2.10e-4 (favourable) Mixed Tissue enhanced testis: 35.8 epididymis: 7.5 ZNF169 MGC51961 ENSG00000175787 Zinc finger protein 169 9 94259311-94301454 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA041769 Uncertain Approved Nuclear speckles
Cytosol Mixed Mixed spleen: 7.9 ZNF17 FLJ40864, FLJ46058, FLJ46615, HPF3, KIAA1947, KOX10 ENSG00000186272 Zinc finger protein 17 19 57411163-57421939 Predicted intracellular proteins, Transcription factors Evidence at transcript level Pancreatic cancer:6.03e-4 (favourable) Expressed in all Mixed parathyroid gland: 9.0 ZNF174 ZSCAN8 ENSG00000103343 Zinc finger protein 174 16 3401235-3409370 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA009656 Approved Supported Nucleoplasm
Actin filaments
Cytosol Expressed in all Expressed in all parathyroid gland: 27.7 ZNF175 OTK18 ENSG00000105497 Zinc finger protein 175 19 51571298-51592508 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA002717 Uncertain Supported Nucleoplasm
Intermediate filaments
Cytosol Thyroid cancer:6.64e-4 (unfavourable) Mixed Mixed parathyroid gland: 21.2 ZNF177 ENSG00000188629 Zinc finger protein 177 19 9363020-9382617 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003141 Uncertain Not detected Mixed testis: 13.4 ZNF18 HDSG1, KOX11, Zfp535, ZKSCAN6, ZNF535, ZSCAN38 ENSG00000154957 Zinc finger protein 18 17 11977439-11997510 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA006144 Uncertain Approved Nucleoplasm
Golgi apparatus
Plasma membrane
Cytosol Renal cancer:3.06e-6 (unfavourable), Pancreatic cancer:5.12e-6 (favourable), Cervical cancer:6.32e-4 (favourable) Expressed in all Expressed in all testis: 22.2 ZNF180 HHZ168 ENSG00000167384 Zinc finger protein 180 19 44474428-44500524 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA028979, HPA028980 Uncertain Approved Nucleoplasm Expressed in all Mixed parathyroid gland: 11.9 ZNF181 HHZ181, MGC44316 ENSG00000197841 Zinc finger protein 181 19 34734155-34745378 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA043701, HPA062305 Uncertain Approved Nucleus Pancreatic cancer:1.05e-4 (favourable), Melanoma:2.60e-4 (unfavourable), Urothelial cancer:5.45e-4 (favourable) Expressed in all Expressed in all ovary: 21.6 ZNF182 HHZ150, KOX14, Zfp182, ZNF21 ENSG00000147118 Zinc finger protein 182 X 47974851-48003978 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA059574 Uncertain Approved Nucleus Urothelial cancer:1.55e-7 (favourable), Renal cancer:2.42e-5 (unfavourable), Liver cancer:3.73e-4 (unfavourable) Expressed in all Mixed thyroid gland: 9.5 ZNF184 ENSG00000096654 Zinc finger protein 184 6 27450743-27473118 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003226 Uncertain Approved Nucleus
Cytosol Ovarian cancer:4.41e-5 (favourable) Expressed in all Mixed testis: 15.2 ZNF189 ENSG00000136870 Zinc finger protein 189 9 101398873-101410660 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA034814 Uncertain Approved Intermediate filaments Renal cancer:5.32e-4 (favourable) Expressed in all Expressed in all epididymis: 102.8 ZNF19 KOX12, MGC51021 ENSG00000157429 Zinc finger protein 19 16 71464555-71565089 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA053189, HPA063685 Uncertain Approved Mitochondria Mixed Expressed in all testis: 32.3 ZNF195 ENSG00000005801 Zinc finger protein 195 11 3339261-3379222 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA030605 Uncertain Approved Nucleus
Cytosol Urothelial cancer:4.79e-7 (favourable), Liver cancer:3.53e-5 (unfavourable), Renal cancer:7.89e-5 (unfavourable), Prostate cancer:4.24e-4 (unfavourable) Expressed in all Expressed in all epididymis: 21.2 ZNF197 D3S1363E, P18, ZKSCAN9, ZNF166, ZSCAN41 ENSG00000186448 Zinc finger protein 197 3 44584888-44648471 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA054567 Uncertain Approved Nucleoplasm Prostate cancer:6.78e-4 (unfavourable) Expressed in all Mixed parathyroid gland: 9.2 ZNF2 A1-5, Zfp661, ZNF661 ENSG00000275111 Zinc finger protein 2 2 95165432-95184317 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA041358 Uncertain Approved Nucleoplasm
Plasma membrane
Cytosol Lung cancer:4.69e-5 (favourable) Expressed in all Mixed parathyroid gland: 6.3 ZNF20 KOX13 ENSG00000132010 Zinc finger protein 20 19 12092843-12140407 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA020887 Uncertain Approved Nucleoplasm
Plasma membrane Not detected Mixed testis: 9.3 ZNF200 ENSG00000010539 Zinc finger protein 200 16 3222325-3236221 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA018981, HPA059310 Uncertain Approved Mitochondria Expressed in all Tissue enhanced testis: 31.5 placenta: 8.7 ZNF202 ZKSCAN10, ZSCAN42 ENSG00000166261 Zinc finger protein 202 11 123724177-123741675 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA061946 Supported Nucleoplasm
Mitochondria Renal cancer:9.93e-7 (unfavourable), Liver cancer:2.52e-6 (unfavourable) Expressed in all Expressed in all testis: 16.7 ZNF205 Zfp13, ZNF210 ENSG00000122386 Zinc finger protein 205 16 3112560-3120517 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001791 Uncertain Approved Nucleoplasm Expressed in all Expressed in all parathyroid gland: 17.1 ZNF208 PMIDP, ZNF95 ENSG00000160321 Zinc finger protein 208 19 21932958-22010949 Predicted intracellular proteins, Transcription factors Evidence at transcript level Tissue enhanced Mixed testis: 16.8 ZNF211 CH2H2-25, ZNF-25 ENSG00000121417 Zinc finger protein 211 19 57630395-57642779 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA011340, HPA049967 Approved Approved Mitochondria
Rods & Rings Expressed in all Expressed in all parathyroid gland: 32.1 ZNF212 C2H2-150 ENSG00000170260 Zinc finger protein 212 7 149239651-149255609 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA049807, HPA054178 Uncertain Supported Nucleus Expressed in all Expressed in all testis: 15.4 ZNF213 CR53, ZKSCAN21, ZSCAN53 ENSG00000085644 Zinc finger protein 213 16 3129777-3142805 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA035000, HPA056750 Uncertain Approved Nucleus
Nuclear membrane
Vesicles
Cytosol Liver cancer:6.74e-4 (unfavourable) Expressed in all Mixed testis: 16.9 ZNF214 ENSG00000149050 Zinc finger protein 214 11 6999318-7020368 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA055391 Uncertain Mixed Mixed fallopian tube: 6.8 ZNF215 ZKSCAN11, ZSCAN43 ENSG00000149054 Zinc finger protein 215 11 6926404-6984632 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA047243, HPA051010 Approved Approved Nucleoplasm
Vesicles Mixed Mixed lymph node: 4.8 ZNF217 ZABC1 ENSG00000171940 Zinc finger protein 217 20 53567065-53609907 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA051857 Approved Validated Nuclear speckles Expressed in all Mixed testis: 43.7 ZNF219 ENSG00000165804 Zinc finger protein 219 14 21090046-21104722 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA030761, HPA056168 Approved Supported Nucleus Expressed in all Expressed in all skin: 44.0 ZNF22 HKR-T1, KOX15, Zfp422, ZNF422 ENSG00000165512 Zinc finger protein 22 10 45000475-45005326 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA016736, HPA054893 Approved Validated Nucleus Renal cancer:1.11e-5 (unfavourable), Stomach cancer:8.06e-4 (unfavourable) Expressed in all Expressed in all placenta: 46.6 ZNF222 ENSG00000159885 Zinc finger protein 222 19 44025342-44033112 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA004086 Approved Approved Nucleoplasm
Nuclear bodies Pancreatic cancer:5.56e-7 (favourable) Expressed in all Mixed testis: 16.8 ZNF223 ENSG00000178386 Zinc finger protein 223 19 44051367-44067991 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA067823 Approved Nucleus
Mitochondria Mixed Mixed thyroid gland: 10.6 ZNF224 BMZF-2, KOX22, ZNF255, ZNF27 ENSG00000267680 Zinc finger protein 224 19 44094339-44109886 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA054045 Approved Supported Nucleus
Nuclear membrane Urothelial cancer:1.53e-7 (favourable), Renal cancer:5.32e-4 (unfavourable) Expressed in all Expressed in all spleen: 36.1 ZNF225 ENSG00000256294 Zinc finger protein 225 19 44112181-44134816 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA073778 Approved Nucleoplasm Mixed Tissue enhanced testis: 22.7 breast: 10.5 ZNF226 ENSG00000167380 Zinc finger protein 226 19 44165073-44178381 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA006145, CAB034353 Uncertain Approved Nuclear bodies Urothelial cancer:2.37e-5 (favourable), Pancreatic cancer:8.34e-4 (favourable) Expressed in all Expressed in all thyroid gland: 39.7 ZNF227 ENSG00000131115 Zinc finger protein 227 19 44207547-44237268 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA030573 Uncertain Approved Plasma membrane Urothelial cancer:2.64e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 18.4 ZNF229 ENSG00000278318 Zinc finger protein 229 19 44417519-44448578 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA001494 Uncertain Approved Vesicles
Plasma membrane Renal cancer:8.43e-5 (favourable) Mixed Tissue enhanced parathyroid gland: 6.5 fallopian tube,thyroid gland: 3.1 ZNF23 KOX16, Zfp612, ZNF359, ZNF612 ENSG00000167377 Zinc finger protein 23 16 71447597-71463095 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA023534 Uncertain Approved Cytosol Not detected Mixed cerebral cortex: 12.2 ZNF230 FDZF2 ENSG00000159882 Zinc finger protein 230 19 44002948-44013926 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA006172 Approved Mitochondria Mixed Mixed ovary,spleen: 5.1 ZNF232 ZSCAN11 ENSG00000167840 Zinc finger protein 232 17 5105541-5123116 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA027309, HPA028611 Uncertain Supported Nucleus
Vesicles
Cytosol Liver cancer:4.66e-4 (unfavourable), Pancreatic cancer:6.55e-4 (favourable) Expressed in all Mixed epididymis,ovary: 4.3 ZNF233 FLJ38032 ENSG00000159915 Zinc finger protein 233 19 44259880-44275317 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA020975 Uncertain Approved Nucleoplasm Mixed Tissue enhanced testis: 26.5 cerebral cortex: 5.9 ZNF234 HZF4, ZNF269 ENSG00000263002 Zinc finger protein 234 19 44141557-44160309 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001664 Approved Approved Nuclear bodies Urothelial cancer:4.34e-5 (favourable) Expressed in all Mixed parathyroid gland: 9.1 ZNF235 ANF270, HZF6, ZFP93, ZNF270 ENSG00000159917 Zinc finger protein 235 19 44228729-44305046 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA045582 Uncertain Supported Nucleoplasm Mixed Mixed parathyroid gland: 6.2 ZNF236 ENSG00000130856 Zinc finger protein 236 18 76822607-76970727 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA008600 Uncertain Approved Nucleoplasm
Cell Junctions
Cytosol Expressed in all Mixed testis: 13.2 ZNF239 HOK-2, MOK2 ENSG00000196793 Zinc finger protein 239 10 43556344-43574618 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA030843, HPA046679 Uncertain Approved Nucleus
Nuclear bodies Renal cancer:4.70e-7 (unfavourable) Expressed in all Mixed testis: 14.6 ZNF24 KOX17, Zfp191, ZNF191, ZSCAN3 ENSG00000172466 Zinc finger protein 24 18 35332212-35345482 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA024062, CAB025642 Supported Supported Nucleus Renal cancer:1.44e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 56.2 ZNF248 bA162G10.3 ENSG00000198105 Zinc finger protein 248 10 37776526-37858106 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA018237, HPA018287, HPA018455 Uncertain Approved Nucleoplasm Lung cancer:1.04e-4 (favourable), Pancreatic cancer:1.22e-4 (favourable), Renal cancer:2.25e-4 (unfavourable), Prostate cancer:6.71e-4 (unfavourable) Expressed in all Mixed parathyroid gland: 25.3 ZNF25 FLJ31890, KOX19, Zfp9 ENSG00000175395 Zinc finger protein 25 10 37949572-37976633 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA030190 Uncertain Approved Nucleoplasm
Golgi apparatus Expressed in all Mixed cerebral cortex: 27.0 ZNF250 MGC9718, ZFP647, ZNF647 ENSG00000196150 Zinc finger protein 250 8 144876497-144902168 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA020853 Uncertain Supported Nuclear speckles Renal cancer:2.43e-7 (favourable), Urothelial cancer:8.26e-4 (favourable) Expressed in all Expressed in all thyroid gland: 20.1 ZNF251 ENSG00000198169 Zinc finger protein 251 8 144720907-144756417 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA018290 Approved Approved Nucleoplasm Renal cancer:1.42e-9 (unfavourable) Expressed in all Mixed thyroid gland: 13.7 ZNF253 BMZF-1, FLJ90391, ZNF411 ENSG00000256771 Zinc finger protein 253 19 19865886-19894674 Predicted intracellular proteins, Transcription factors Evidence at transcript level Renal cancer:9.69e-5 (favourable), Glioma:1.11e-4 (favourable), Ovarian cancer:2.19e-4 (favourable) Expressed in all Mixed thyroid gland: 25.8 ZNF254 BMZF-5, HD-ZNF1, ZNF539, ZNF91L ENSG00000213096 Zinc finger protein 254 19 24033405-24129961 Predicted intracellular proteins, Transcription factors Evidence at transcript level Lung cancer:8.60e-4 (favourable), Urothelial cancer:9.96e-4 (favourable) Expressed in all Mixed thyroid gland: 29.2 ZNF256 BMZF-3 ENSG00000152454 Zinc finger protein 256 19 57940833-57947675 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA055390 Uncertain Supported Nucleus Expressed in all Mixed testis: 7.9 ZNF257 BMZF-4 ENSG00000197134 Zinc finger protein 257 19 22052452-22091480 Predicted intracellular proteins, Transcription factors Evidence at transcript level Ovarian cancer:2.05e-4 (favourable) Tissue enhanced Mixed testis: 4.3 ZNF26 FLJ20755, KOX20 ENSG00000198393 Zinc finger protein 26 12 132986365-133032952 Predicted intracellular proteins, Predicted secreted proteins, Transcription factors Evidence at protein level HPA018329, HPA042406 Uncertain Approved Nuclear bodies
Mitochondria Mixed Mixed epididymis: 7.1 ZNF260 ozrf1, Zfp260 ENSG00000254004 Zinc finger protein 260 19 36510695-36528660 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA028806 Approved Supported Nucleoplasm
Cytosol Renal cancer:1.44e-4 (favourable) Expressed in all Mixed parathyroid gland: 20.3 ZNF263 FPM315, ZKSCAN12, ZSCAN44 ENSG00000006194 Zinc finger protein 263 16 3263800-3301401 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA035085, HPA035086 Uncertain Supported Nucleoplasm
Mitotic spindle
Cytosol Expressed in all Expressed in all parathyroid gland: 60.7 ZNF264 KIAA0412 ENSG00000083844 Zinc finger protein 264 19 57191500-57222846 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA057665 Uncertain Expressed in all Expressed in all testis: 18.3 ZNF266 HZF1 ENSG00000174652 Zinc finger protein 266 19 9412598-9435578 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA026836, HPA054110 Uncertain Validated Nucleus
Vesicles
Rods & Rings Head and neck cancer:3.94e-6 (favourable), Pancreatic cancer:3.03e-5 (favourable), Urothelial cancer:9.15e-5 (favourable), Cervical cancer:1.41e-4 (favourable), Renal cancer:1.82e-4 (unfavourable), Lung cancer:4.47e-4 (favourable) Expressed in all Expressed in all epididymis: 115.7 ZNF267 HZF2 ENSG00000185947 Zinc finger protein 267 16 31873758-31917357 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003866 Approved Approved Nucleoplasm Renal cancer:1.58e-6 (unfavourable) Expressed in all Mixed appendix: 25.6 ZNF268 HZF3 ENSG00000090612 Zinc finger protein 268 12 133181409-133214831 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001794 Approved Approved Actin filaments
Cytosol Expressed in all Mixed parathyroid gland: 23.0 ZNF273 HZF9 ENSG00000198039 Zinc finger protein 273 7 64870172-64930966 Predicted intracellular proteins, Transcription factors Evidence at protein level Mixed Mixed testis: 2.8 ZNF274 ZKSCAN19, ZSCAN51 ENSG00000171606 Zinc finger protein 274 19 58183029-58213562 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA028880 Uncertain Supported Nucleus
Centrosome Prostate cancer:1.75e-4 (unfavourable), Glioma:4.26e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 39.6 ZNF275 ENSG00000063587 Zinc finger protein 275 X 153334155-153360110 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA000566 Approved Approved Nucleoli Expressed in all Expressed in all adrenal gland: 79.7 ZNF276 CENP-Z, CENPZ, MGC45417, ZADT, ZFP276, ZNF477 ENSG00000158805 Zinc finger protein 276 16 89720400-89740903 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA021309, HPA022255 Uncertain Approved Nucleus
Nucleoli
Plasma membrane
Cytosol Renal cancer:3.37e-4 (unfavourable) Expressed in all Expressed in all spleen: 23.2 ZNF277 NRIF4, ZNF277P ENSG00000198839 Zinc finger protein 277 7 112206588-112343096 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA027307 Uncertain Approved Nucleoplasm
Plasma membrane Renal cancer:9.47e-4 (favourable) Expressed in all Expressed in all thyroid gland: 33.4 ZNF28 DKFZp781D0275, KOX24 ENSG00000198538 Zinc finger protein 28 19 52797409-52857600 Predicted intracellular proteins, Transcription factors Evidence at transcript level Breast cancer:9.29e-4 (unfavourable) Expressed in all Mixed thyroid gland: 17.9 ZNF280A 3'OY11.1, SUHW1, ZNF280, ZNF636 ENSG00000169548 Zinc finger protein 280A 22 22513736-22520270 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA044475 Uncertain Uncertain Nucleoplasm Tissue enhanced Not detected adrenal gland: 0.3 ZNF280B 5'OY11.1, SUHW2, ZNF279, ZNF632 ENSG00000275004 Zinc finger protein 280B 22 22484421-22509154 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA059519 Uncertain Approved Nucleoplasm Mixed Tissue enriched 7 testis: 12.6 cerebral cortex: 1.8 ZNF280C FLJ20095, SUHW3, ZNF633 ENSG00000056277 Zinc finger protein 280C X 130202711-130268899 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA051494, HPA055788 Uncertain Approved Nucleus
Nucleoli fibrillar center Expressed in all Tissue enhanced testis: 17.4 epididymis: 6.2 ZNF280D FLJ20086, SUHW4, ZNF634 ENSG00000137871 Zinc finger protein 280D 15 56630181-56918571 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA030233 Approved Approved Nucleoplasm
Golgi apparatus
Centrosome
Cytosol Expressed in all Expressed in all endometrium: 31.6 ZNF281 ZBP-99 ENSG00000162702 Zinc finger protein 281 1 200404940-200410056 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA051228 Uncertain Validated Nucleoplasm Renal cancer:2.60e-5 (unfavourable), Cervical cancer:1.16e-4 (unfavourable) Expressed in all Expressed in all bone marrow: 21.5 ZNF282 HUB1 ENSG00000170265 Zinc finger protein 282 7 149195485-149226248 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA024374 Supported Approved Nucleoplasm
Cytosol Liver cancer:3.03e-5 (unfavourable) Expressed in all Expressed in all cervix, uterine: 14.8 ZNF283 ENSG00000167637 Zinc finger protein 283 19 43827292-43852017 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA072977 Approved Nucleoplasm Mixed Mixed parathyroid gland: 10.0 ZNF284 DKFZp781F1775 ENSG00000186026 Zinc finger protein 284 19 44072144-44089613 Predicted intracellular proteins, Transcription factors Evidence at transcript level Mixed Mixed skin: 3.6 ZNF285 ZNF285A ENSG00000267508 Zinc finger protein 285 19 44382298-44401608 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA046100, HPA049212 Uncertain Mixed Mixed ovary: 7.8 ZNF286A KIAA1874, ZNF286 ENSG00000187607 Zinc finger protein 286A 17 15699577-15720787 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA021594 Approved Nucleoli Mixed Mixed ovary: 21.8 ZNF286B ZNF286C, ZNF286L, ZNF590 ENSG00000249459 Zinc finger protein 286B 17 18658429-18682262 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA068125 Uncertain Approved Nuclear speckles
Cytosol Mixed Mixed ovary: 2.7 ZNF287 ZKSCAN13, ZSCAN45 ENSG00000141040 Zinc finger protein 287 17 16551387-16569206 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA029290 Uncertain Approved Golgi apparatus Renal cancer:5.28e-5 (favourable) Mixed Mixed parathyroid gland: 12.8 ZNF292 bA393I2.3, KIAA0530, ZFP292, Zn-15, Zn-16 ENSG00000188994 Zinc finger protein 292 6 87152833-87264196 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA032154, HPA050618 Uncertain Approved Nucleus
Nuclear membrane Expressed in all Expressed in all endometrium,ovary: 17.0 ZNF296 ZNF342 ENSG00000170684 Zinc finger protein 296 19 45071500-45076588 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA046940, HPA049576 Uncertain Approved Nucleoplasm
Centrosome Head and neck cancer:5.24e-4 (favourable) Expressed in all Mixed spleen: 3.9 ZNF3 A8-51, FLJ20216, HF.12, KOX25, PP838, Zfp113 ENSG00000166526 Zinc finger protein 3 7 100064033-100082548 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003719 Supported Approved Approved Nucleoplasm Melanoma:1.59e-4 (unfavourable), Urothelial cancer:2.20e-4 (favourable), Lung cancer:5.73e-4 (favourable) Expressed in all Expressed in all fallopian tube: 55.2 ZNF30 DKFZp686N19164, FLJ20562, KOX28 ENSG00000168661 Zinc finger protein 30 19 34926903-34945170 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA030400 Uncertain Approved Nucleoplasm
Cytosol Pancreatic cancer:1.16e-4 (favourable) Expressed in all Mixed fallopian tube: 5.0 ZNF300 ENSG00000145908 Zinc finger protein 300 5 150894392-150904983 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA028975, HPA051777 Uncertain Supported Nucleoplasm
Nucleoli Renal cancer:3.21e-6 (unfavourable) Expressed in all Mixed ovary: 12.4 ZNF302 ZNF135L, ZNF140L, ZNF327 ENSG00000089335 Zinc finger protein 302 19 34677639-34686397 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA059503 Approved Vesicles
Cytokinetic bridge Endometrial cancer:2.03e-5 (unfavourable), Urothelial cancer:9.85e-5 (favourable), Renal cancer:5.41e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 41.4 ZNF304 ENSG00000131845 Zinc finger protein 304 19 57351307-57359898 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA050531 Approved Approved Nuclear speckles Renal cancer:1.52e-7 (favourable), Melanoma:4.95e-4 (unfavourable) Expressed in all Mixed parathyroid gland: 15.6 ZNF311 ENSG00000197935 Zinc finger protein 311 6 28994785-29005316 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA050541 Uncertain Mixed Not detected fallopian tube: 0.4 ZNF316 ENST00000305834, MZF-3 ENSG00000205903 Zinc finger protein 316 7 6637322-6656432 Predicted intracellular proteins, Transcription factors Evidence at protein level Pancreatic cancer:6.03e-5 (favourable) Expressed in all Expressed in all parathyroid gland: 50.0 ZNF317 ENSG00000130803 Zinc finger protein 317 19 9140380-9163424 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA042075, HPA048625 Approved Validated Nucleoplasm Expressed in all Expressed in all parathyroid gland: 20.4 ZNF319 KIAA1388, Zfp319 ENSG00000166188 Zinc finger protein 319 16 57994668-58000453 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA052584 Uncertain Approved Nucleus Pancreatic cancer:5.87e-5 (favourable), Liver cancer:1.90e-4 (unfavourable) Expressed in all Mixed parathyroid gland: 13.7 ZNF32 KOX30 ENSG00000169740 Zinc finger protein 32 10 43643859-43648856 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA039148, HPA059640 Supported Nucleoplasm
Nuclear bodies Pancreatic cancer:3.02e-4 (favourable), Liver cancer:7.08e-4 (unfavourable) Expressed in all Expressed in all epididymis: 70.7 ZNF320 DKFZp686G16228, ZFPL ENSG00000182986 Zinc finger protein 320 19 52863790-52897693 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA043696 Uncertain Approved Nucleoli
Cytosol Expressed in all Mixed parathyroid gland: 25.1 ZNF322 bA457M11.2, bA457M11.3, HCG12, ZNF322A, ZNF388, ZNF489 ENSG00000181315 Zinc finger protein 322 6 26634383-26659752 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA043161, HPA046692 Approved Supported Nucleus
Centrosome
Cytosol Glioma:1.75e-4 (favourable), Lung cancer:8.57e-4 (favourable) Expressed in all Mixed parathyroid gland: 28.7 ZNF324 ZF5128, ZNF324A ENSG00000083812 Zinc finger protein 324 19 58467045-58475436 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA039774 Uncertain Approved Nucleus
Nuclear membrane
Cytosol Renal cancer:1.34e-7 (favourable), Pancreatic cancer:4.74e-5 (favourable), Thyroid cancer:6.99e-4 (unfavourable) Expressed in all Mixed cerebral cortex: 8.6 ZNF324B FLJ45850 ENSG00000249471 Zinc finger protein 324B 19 58451604-58457833 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA023400 Uncertain Approved Nucleoli
Cytosol Pancreatic cancer:2.83e-4 (favourable) Expressed in all Mixed spleen: 4.8 ZNF329 FLJ12586 ENSG00000181894 Zinc finger protein 329 19 58126252-58155110 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA044373 Uncertain Approved Nucleoplasm
Nuclear membrane Renal cancer:8.58e-9 (favourable) Expressed in all Mixed parathyroid gland: 16.3 ZNF331 RITA, ZNF361, ZNF463 ENSG00000130844 Zinc finger protein 331 19 53520981-53580269 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA063157 Approved Nucleoplasm Stomach cancer:4.79e-4 (unfavourable), Thyroid cancer:7.43e-4 (unfavourable) Expressed in all Expressed in all adrenal gland: 210.3 ZNF333 KIAA1806 ENSG00000160961 Zinc finger protein 333 19 14689801-14733746 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors Evidence at protein level HPA043973, HPA054680 Uncertain Approved Nucleoplasm Mixed Mixed endometrium: 11.2 ZNF334 bA179N14.1 ENSG00000198185 Zinc finger protein 334 20 46499630-46513559 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA050022 Uncertain Approved Nucleus
Cytosol Mixed Mixed ovary: 19.3 ZNF335 bA465L10.2, NIF-1 ENSG00000198026 Zinc finger protein 335 20 45948653-45972172 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA063999, HPA071230 Validated Nucleoplasm Renal cancer:2.77e-5 (unfavourable), Liver cancer:1.59e-4 (unfavourable), Head and neck cancer:4.48e-4 (favourable), Prostate cancer:7.04e-4 (unfavourable) Expressed in all Expressed in all skin: 24.7 ZNF337 dJ694B14.1 ENSG00000130684 Zinc finger protein 337 20 25674215-25696841 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA044303, HPA064219 Uncertain Approved Nuclear speckles
Plasma membrane Renal cancer:2.87e-6 (unfavourable) Mixed Expressed in all parathyroid gland: 28.7 ZNF33A FLJ23404, KIAA0065, KOX31, KOX5, ZNF11A, ZNF33, ZZAPK ENSG00000189180 Zinc finger protein 33A 10 38010650-38065088 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA005538, HPA056638 Approved Uncertain Nucleoli
Endoplasmic reticulum Expressed in all Expressed in all parathyroid gland: 34.5 ZNF33B KOX2, KOX31, ZNF11B ENSG00000196693 Zinc finger protein 33B 10 42574185-42638568 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA005538, HPA056638 Approved Uncertain Nucleoli
Endoplasmic reticulum Expressed in all Expressed in all fallopian tube: 31.9 ZNF34 KOX32 ENSG00000196378 Zinc finger protein 34 8 144773114-144787345 Predicted intracellular proteins, Predicted secreted proteins, Transcription factors Evidence at protein level HPA053925, HPA060755, HPA066805 Uncertain Validated Nucleoplasm
Cytosol Expressed in all Expressed in all ovary: 12.8 ZNF341 dJ553F4.3 ENSG00000131061 Zinc finger protein 341 20 33731657-33792269 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA023240, HPA024607, HPA067108 Uncertain Approved Nucleoplasm
Vesicles Liver cancer:1.87e-4 (unfavourable), Head and neck cancer:3.93e-4 (favourable) Expressed in all Mixed testis: 2.3 ZNF343 MGC10715 ENSG00000088876 Zinc finger protein 343 20 2481817-2524702 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA030587, HPA052438 Approved Approved Nucleoplasm Liver cancer:1.38e-6 (unfavourable), Renal cancer:4.53e-5 (unfavourable) Expressed in all Mixed parathyroid gland: 15.7 ZNF345 HZF10 ENSG00000251247 Zinc finger protein 345 19 36850361-36913029 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA025816 Uncertain Mixed Mixed testis: 18.4 ZNF347 ZNF1111 ENSG00000197937 Zinc finger protein 347 19 53124072-53159075 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA023448 Uncertain Approved Microtubules Mixed Expressed in all spleen: 14.4 ZNF35 HF.10, HF10, Zfp105 ENSG00000169981 Zinc finger protein 35 3 44648727-44660791 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA051859, HPA054738 Uncertain Approved Nucleoplasm Expressed in all Mixed testis: 9.2 ZNF350 ZBRK1, ZFQR ENSG00000256683 Zinc finger protein 350 19 51964343-51986856 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001521 Uncertain Supported Nucleoplasm
Nuclear bodies Urothelial cancer:2.54e-4 (favourable) Expressed in all Mixed prostate: 47.4 ZNF354A EZNF, HKL1, KID-1, KID1, TCF17 ENSG00000169131 Zinc finger protein 354A 5 178711592-178730702 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA052043 Approved Supported Nucleus
Nucleoli
Cytosol Renal cancer:3.45e-6 (unfavourable), Ovarian cancer:8.28e-4 (favourable) Expressed in all Expressed in all testis: 16.7 ZNF354B FLJ25008, KID2 ENSG00000178338 Zinc finger protein 354B 5 178859953-178888122 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA029056 Approved Approved Nucleoplasm Renal cancer:1.30e-5 (unfavourable), Head and neck cancer:9.52e-4 (favourable) Expressed in all Expressed in all placenta: 19.7 ZNF354C KID3 ENSG00000177932 Zinc finger protein 354C 5 179060415-179083537 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA030904 Uncertain Supported Nuclear membrane
Cytosol Mixed Mixed ovary: 9.2 ZNF358 FLJ10390, ZFEND ENSG00000198816 Zinc finger protein 358 19 7515292-7521026 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA030887, HPA063624 Approved Approved Nucleus Pancreatic cancer:2.50e-4 (favourable) Expressed in all Expressed in all ovary: 85.4 ZNF362 FLJ25476, lin-29, RN ENSG00000160094 Zinc finger protein 362 1 33256545-33300719 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA059239 Uncertain Approved Nucleus
Nucleoli Expressed in all Expressed in all spleen: 22.6 ZNF366 FLJ39796 ENSG00000178175 Zinc finger protein 366 5 72442652-72507727 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA023128, HPA023526 Uncertain Mixed Mixed placenta: 10.2 ZNF37A KOX21, ZNF37 ENSG00000075407 Zinc finger protein 37A 10 38094336-38125544 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003172 Approved Approved Vesicles Renal cancer:2.31e-4 (unfavourable), Liver cancer:2.83e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 18.1 ZNF382 FLJ14686, KS1 ENSG00000161298 Zinc finger protein 382 19 36604817-36634113 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA049259 Approved Approved Nuclear speckles Mixed Mixed cerebral cortex: 10.9 ZNF383 FLJ35863 ENSG00000188283 Zinc finger protein 383 19 37217926-37248738 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA063945 Approved Supported Nucleus
Nuclear membrane Urothelial cancer:3.71e-4 (favourable), Pancreatic cancer:9.97e-4 (favourable) Expressed in all Mixed thyroid gland: 9.3 ZNF384 CAGH1A, CIZ, NMP4, NP, TNRC1 ENSG00000126746 Zinc finger protein 384 12 6666477-6689572 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA004051 Supported Supported Nucleoplasm Expressed in all Expressed in all endometrium: 65.7 ZNF391 dJ153G14.3 ENSG00000124613 Zinc finger protein 391 6 27374615-27403904 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA050886 Uncertain Ovarian cancer:1.89e-4 (favourable) Mixed Mixed testis: 8.9 ZNF394 FLJ12298, ZKSCAN14, ZSCAN46 ENSG00000160908 Zinc finger protein 394 7 99486519-99500324 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA051421, HPA054639 Uncertain Approved Nucleoplasm
Cytosol Urothelial cancer:1.09e-4 (favourable), Lung cancer:2.11e-4 (favourable), Breast cancer:3.56e-4 (favourable) Expressed in all Expressed in all bone marrow: 62.2 ZNF396 FLJ31213, ZSCAN14 ENSG00000186496 Zinc finger protein 396 18 35366697-35377337 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA006686 Uncertain Mixed Mixed thyroid gland: 14.4 ZNF397 MGC13250, ZNF47, ZSCAN15 ENSG00000186812 Zinc finger protein 397 18 35241030-35267133 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA026087 Uncertain Approved Nucleoli
Plasma membrane
Microtubules
Cytosol Pancreatic cancer:9.44e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 32.8 ZNF398 KIAA1339, P51, P71, ZER6 ENSG00000197024 Zinc finger protein 398 7 149126416-149182802 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA071533 Approved Nucleoplasm
Mitochondria Expressed in all Expressed in all testis: 16.0 ZNF404 ENSG00000176222 Zinc finger protein 404 19 43872363-43901385 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA032014 Uncertain Approved Nucleus
Nucleoli Mixed Mixed epididymis: 12.9 ZNF407 FLJ13839, FLJ20307, KIAA1703 ENSG00000215421 Zinc finger protein 407 18 74597870-75065671 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA028255, HPA041673 Uncertain Approved Nucleoplasm
Plasma membrane Renal cancer:9.79e-5 (favourable) Expressed in all Mixed parathyroid gland: 8.8 ZNF408 FLJ12827 ENSG00000175213 Zinc finger protein 408 11 46700818-46705912 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA017892 Uncertain Approved Microtubule organizing center
Cytosol Liver cancer:6.59e-5 (unfavourable) Expressed in all Expressed in all bone marrow: 8.3 ZNF41 MGC8941, MRX89 ENSG00000147124 Zinc finger protein 41 X 47445879-47482946 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA069102 Supported Approved Nucleoplasm Renal cancer:6.95e-4 (favourable), Head and neck cancer:8.32e-4 (favourable) Expressed in all Mixed parathyroid gland: 19.1 ZNF410 APA-1, APA1 ENSG00000119725 Zinc finger protein 410 14 73886617-73932511 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA002871 Approved Nuclear bodies Mixed Expressed in all testis: 80.7 ZNF414 MGC15716, Zfp414 ENSG00000133250 Zinc finger protein 414 19 8509678-8514164 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA053769 Approved Approved Nucleus
Cytosol Head and neck cancer:1.67e-6 (favourable), Endometrial cancer:4.17e-4 (favourable), Pancreatic cancer:4.59e-4 (favourable), Urothelial cancer:8.71e-4 (favourable) Expressed in all Expressed in all spleen: 12.6 ZNF415 ENSG00000170954 Zinc finger protein 415 19 53107879-53133077 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA005553 Approved Approved Nucleoli fibrillar center
Microtubules Mixed Mixed testis: 39.6 ZNF416 FLJ20557 ENSG00000083817 Zinc finger protein 416 19 57571566-57578927 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA063318 Approved Nuclear bodies
Cytosol Renal cancer:1.20e-5 (favourable) Expressed in all Mixed testis: 7.8 ZNF417 MGC34079 ENSG00000173480 Zinc finger protein 417 19 57900296-57916610 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA042125, HPA043288, HPA056213 Uncertain Uncertain Nucleoplasm Urothelial cancer:3.48e-4 (favourable) Expressed in all Expressed in all epididymis: 59.5 ZNF418 FLJ31551, KIAA1956 ENSG00000196724 Zinc finger protein 418 19 57921884-57935393 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA043800, HPA053762, HPA072145 Approved Uncertain Nucleus Prostate cancer:1.72e-4 (unfavourable) Mixed Mixed parathyroid gland: 14.5 ZNF419 ZAPHIR, ZNF419A ENSG00000105136 Zinc finger protein 419 19 57487711-57496097 Predicted intracellular proteins, Predicted secreted proteins, Transcription factors Evidence at protein level HPA003152, HPA003274 Uncertain Supported Nucleus
Nucleoli fibrillar center Urothelial cancer:2.53e-5 (favourable), Prostate cancer:6.47e-4 (unfavourable) Expressed in all Mixed parathyroid gland: 15.7 ZNF420 FLJ32191 ENSG00000197050 Zinc finger protein 420 19 37007857-37130314 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA053022, HPA059675 Approved Approved Nucleoplasm Glioma:4.88e-5 (favourable), Renal cancer:1.83e-4 (favourable) Expressed in all Mixed testis: 18.4 ZNF423 Ebfaz, JBTS19, KIAA0760, NPHP14, OAZ, Roaz, Zfp104 ENSG00000102935 Zinc finger protein 423 16 49487524-49857919 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA015258, HPA065820 Uncertain Validated Nucleus Mixed Mixed fallopian tube: 15.2 ZNF425 ENSG00000204947 Zinc finger protein 425 7 149102784-149126346 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA020087 Uncertain Supported Nucleus Mixed Mixed parathyroid gland: 5.5 ZNF426 MGC2663 ENSG00000130818 Zinc finger protein 426 19 9523224-9538627 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA029342 Approved Approved Nucleoplasm Renal cancer:2.57e-6 (favourable), Urothelial cancer:1.81e-4 (favourable), Head and neck cancer:3.74e-4 (favourable) Expressed in all Mixed esophagus: 23.2 ZNF429 ENSG00000197013 Zinc finger protein 429 19 21496682-21556270 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA004139 Approved Nucleus Ovarian cancer:1.96e-8 (favourable), Pancreatic cancer:7.30e-4 (favourable) Mixed Mixed thyroid gland: 17.1 ZNF43 HTF6, KOX27, ZNF39L1 ENSG00000198521 Zinc finger protein 43 19 21804949-21852125 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA050271 Uncertain Ovarian cancer:3.16e-5 (favourable) Mixed Mixed testis: 17.0 ZNF430 FLJ13659 ENSG00000118620 Zinc finger protein 430 19 21020620-21060050 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA059135 Uncertain Mixed Mixed ovary: 15.8 ZNF431 KIAA1969 ENSG00000196705 Zinc finger protein 431 19 21142024-21196053 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA059135 Uncertain Mixed Mixed ovary: 26.7 ZNF432 KIAA0798 ENSG00000256087 Zinc finger protein 432 19 52031379-52095738 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA052082, HPA060274, HPA065606 Uncertain Supported Nucleoplasm Urothelial cancer:4.11e-5 (favourable), Renal cancer:6.47e-4 (unfavourable) Expressed in all Expressed in all prostate: 20.7 ZNF433 FLJ40981 ENSG00000197647 Zinc finger protein 433 19 12014732-12035741 Predicted intracellular proteins, Predicted secreted proteins, Transcription factors Evidence at protein level HPA073724 Uncertain Approved Nuclear bodies Renal cancer:8.33e-15 (favourable) Expressed in all Expressed in all testis: 52.3 ZNF436 KIAA1710, Zfp46 ENSG00000125945 Zinc finger protein 436 1 23359448-23369442 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA043817 Approved Supported Nucleoplasm
Cytosol Expressed in all Mixed ovary: 12.4 ZNF438 bA330O11.1 ENSG00000183621 Zinc finger protein 438 10 30820207-31031937 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA039843 Uncertain Supported Nucleoplasm
Cytosol Expressed in all Mixed thyroid gland: 16.2 ZNF439 DKFZp571K0837 ENSG00000171291 Zinc finger protein 439 19 11848726-11883750 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA047845 Uncertain Uncertain Nucleus Mixed Mixed parathyroid gland: 25.1 ZNF44 KOX7, ZNF504, ZNF55, ZNF58 ENSG00000197857 Zinc finger protein 44 19 12224686-12294887 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003146 Supported Approved Nucleoplasm
Microtubules
Cytosol Urothelial cancer:9.21e-6 (favourable), Lung cancer:7.54e-4 (favourable), Head and neck cancer:8.74e-4 (favourable) Expressed in all Mixed skin: 8.6 ZNF440 FLJ37933 ENSG00000171295 Zinc finger protein 440 19 11814284-11835201 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA047845 Uncertain Uncertain Nucleus Renal cancer:1.18e-4 (favourable), Prostate cancer:3.57e-4 (unfavourable), Urothelial cancer:9.88e-4 (favourable) Expressed in all Mixed fallopian tube: 23.2 ZNF441 FLJ38637 ENSG00000197044 Zinc finger protein 441 19 11767000-11784078 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA063338 Approved Nuclear speckles Expressed in all Mixed thyroid gland: 12.1 ZNF442 FLJ14356 ENSG00000198342 Zinc finger protein 442 19 12345949-12365905 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA045738, HPA053407 Uncertain Approved Nuclear membrane
Vesicles Mixed Mixed ovary: 6.0 ZNF443 ZK1 ENSG00000180855 Zinc finger protein 443 19 12429707-12441112 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003150, HPA018683 Supported Uncertain Nucleoplasm
Microtubule organizing center Renal cancer:2.74e-7 (favourable), Urothelial cancer:3.91e-4 (favourable) Expressed in all Mixed parathyroid gland: 6.9 ZNF444 EZF2, FLJ11137, ZSCAN17 ENSG00000167685 Zinc finger protein 444 19 56132599-56160893 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA056895, HPA065203 Approved Supported Nucleus
Nucleoli Urothelial cancer:1.87e-4 (favourable), Renal cancer:2.61e-4 (unfavourable) Expressed in all Expressed in all seminal vesicle: 29.1 ZNF445 ZKSCAN15, ZNF168, ZSCAN47 ENSG00000185219 Zinc finger protein 445 3 44431720-44477670 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA006678 Uncertain Approved Nucleus
Mitochondria
Cytosol Expressed in all Mixed parathyroid gland: 7.1 ZNF446 FLJ20626, ZKSCAN20, ZSCAN52 ENSG00000083838 Zinc finger protein 446 19 58474017-58481230 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA052786 Approved Nuclear speckles Pancreatic cancer:1.32e-4 (favourable) Expressed in all Mixed fallopian tube: 12.1 ZNF449 FLJ23614, ZSCAN19 ENSG00000173275 Zinc finger protein 449 X 135344796-135363152 Predicted intracellular proteins, Predicted secreted proteins, Transcription factors Evidence at protein level HPA018079 Uncertain Approved Nucleoplasm
Cytosol Expressed in all Expressed in all parathyroid gland: 12.0 ZNF45 ZNF13 ENSG00000124459 Zinc finger protein 45 19 43912629-43935278 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA038611, HPA075124 Uncertain Supported Nucleoplasm Expressed in all Mixed parathyroid gland: 18.1 ZNF451 COASTER, dJ417I1.1, KIAA0576, KIAA1702 ENSG00000112200 Zinc finger protein 451 6 57086844-57170307 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA028838 Approved Nucleus Expressed in all Expressed in all testis: 50.1 ZNF454 FLJ37444 ENSG00000178187 Zinc finger protein 454 5 178941191-178966433 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA024556 Uncertain Mixed Mixed testis: 4.0 ZNF460 HZF8, ZNF272 ENSG00000197714 Zinc finger protein 460 19 57280051-57293569 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA053004, HPA066506 Uncertain Approved Nucleoplasm Mixed Mixed adrenal gland: 6.4 ZNF461 GIOT-1, MGC33911 ENSG00000197808 Zinc finger protein 461 19 36637192-36666853 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA021139 Uncertain Approved Nucleus
Nucleoli
Golgi apparatus Endometrial cancer:3.64e-4 (unfavourable) Expressed in all Mixed thyroid gland: 6.1 ZNF462 DKFZP762N2316, KIAA1803, Zfp462 ENSG00000148143 Zinc finger protein 462 9 106863097-107013634 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA022283 Uncertain Approved Nucleoplasm Renal cancer:6.19e-4 (favourable) Mixed Mixed parathyroid gland: 15.5 ZNF467 EZI, Zfp467 ENSG00000181444 Zinc finger protein 467 7 149764182-149773479 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA042907 Uncertain Approved Mitochondria Pancreatic cancer:4.56e-4 (favourable) Expressed in all Mixed spleen: 14.4 ZNF468 ENSG00000204604 Zinc finger protein 468 19 52838008-52857649 Predicted intracellular proteins, Transcription factors Evidence at transcript level Renal cancer:3.94e-7 (favourable), Breast cancer:6.87e-4 (unfavourable) Expressed in all Expressed in all thyroid gland: 20.3 ZNF469 KIAA1858 ENSG00000225614 Zinc finger protein 469 16 88427471-88440757 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA069784 Approved Vesicles Mixed Mixed cervix, uterine: 2.3 ZNF470 CZF-1, FLJ26175 ENSG00000197016 Zinc finger protein 470 19 56567511-56588911 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA029000 Uncertain Supported Nucleoplasm
Nuclear bodies Mixed Mixed cerebral cortex: 5.8 ZNF471 KIAA1396, Z1971 ENSG00000196263 Zinc finger protein 471 19 56507843-56530221 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA066695 Uncertain Supported Nucleus Renal cancer:2.37e-4 (favourable) Mixed Mixed ovary: 28.0 ZNF479 KR19 ENSG00000185177 Zinc finger protein 479 7 57119614-57139864 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at transcript level Not detected Tissue enriched 42 testis: 4.2 all non-specific tissues: 0.0 ZNF48 DKFZp762K013, FLJ31751, MGC43952, ZNF553 ENSG00000180035 Zinc finger protein 48 16 30378106-30400108 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA023806 Uncertain Supported Mitochondria Pancreatic cancer:1.20e-6 (favourable), Renal cancer:7.50e-5 (favourable) Expressed in all Mixed parathyroid gland: 11.6 ZNF480 MGC32104 ENSG00000198464 Zinc finger protein 480 19 52297177-52325922 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA042218 Uncertain Supported Nucleoplasm Melanoma:1.65e-4 (unfavourable), Renal cancer:2.03e-4 (favourable) Expressed in all Mixed lymph node: 15.4 ZNF483 KIAA1962, ZKSCAN16, ZSCAN48 ENSG00000173258 Zinc finger protein 483 9 111525159-111577844 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA055041 Uncertain Approved Nucleoli Tissue enhanced Mixed cerebral cortex: 13.0 ZNF484 BA526D8.4, FLJ33884 ENSG00000127081 Zinc finger protein 484 9 92845031-92878038 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA028973 Uncertain Approved Nucleoplasm
Nuclear membrane
Cytosol Mixed Mixed parathyroid gland: 6.8 ZNF485 ENSG00000198298 Zinc finger protein 485 10 43606407-43617903 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA059356 Uncertain Breast cancer:5.24e-4 (unfavourable) Expressed in all Mixed testis: 7.1 ZNF487 KRBO1, ZNF487P ENSG00000243660 Zinc finger protein 487 10 43436841-43483179 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA037820 Uncertain Approved Nucleoplasm
Nuclear membrane
Cytosol Mixed Tissue enriched 5 testis: 51.1 fallopian tube: 9.8 ZNF490 KIAA1198 ENSG00000188033 Zinc finger protein 490 19 12577961-12640098 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA005576 Uncertain Mixed Mixed thyroid gland: 2.8 ZNF491 FLJ34791 ENSG00000177599 Zinc finger protein 491 19 11797667-11809622 Predicted intracellular proteins, Transcription factors Evidence at protein level Mixed Mixed parathyroid gland: 3.5 ZNF492 KIAA1473, ZNF115 ENSG00000229676 Zinc finger protein 492 19 22634324-22667670 Predicted intracellular proteins, Transcription factors Evidence at transcript level Group enriched Tissue enhanced testis: 3.6 bone marrow: 1.6 ZNF493 FLJ36504 ENSG00000196268 Zinc finger protein 493 19 21397119-21427573 Predicted intracellular proteins, Transcription factors Evidence at protein level Mixed Expressed in all thyroid gland: 34.6 ZNF496 MGC15548, ZKSCAN17, ZSCAN49 ENSG00000162714 Zinc finger protein 496 1 247297412-247331846 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA055834 Uncertain Golgi apparatus Expressed in all Expressed in all fallopian tube: 23.9 ZNF497 FLJ44773 ENSG00000174586 Zinc finger protein 497 19 58354357-58362848 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA047872 Uncertain Approved Nucleus
Cell Junctions Mixed Mixed fallopian tube: 10.7 ZNF500 KIAA0557, ZKSCAN18, ZSCAN50 ENSG00000103199 Zinc finger protein 500 16 4748239-4767624 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA035498, HPA057963 Supported Validated Nucleoplasm
Cytosol Stomach cancer:3.41e-4 (favourable) Expressed in all Mixed testis: 8.2 ZNF501 MGC21738, ZNF52 ENSG00000186446 Zinc finger protein 501 3 44729596-44737083 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA044161 Uncertain Approved Endoplasmic reticulum Mixed Mixed testis: 2.7 ZNF502 FLJ12515, FLJ14855 ENSG00000196653 Zinc finger protein 502 3 44712643-44723831 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA024761, HPA029557 Uncertain Renal cancer:4.51e-5 (favourable), Urothelial cancer:2.06e-4 (favourable) Expressed in all Mixed testis: 5.0 ZNF506 DKFZp761G1812 ENSG00000081665 Zinc finger protein 506 19 19785839-19821751 Predicted intracellular proteins, Transcription factors Evidence at transcript level Expressed in all Expressed in all thyroid gland: 16.2 ZNF507 KIAA1084 ENSG00000168813 Zinc finger protein 507 19 32345594-32387667 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA030964, HPA049728 Uncertain Supported Nucleoli
Cytosol Expressed in all Expressed in all testis: 34.8 ZNF510 KIAA0972 ENSG00000081386 Zinc finger protein 510 9 96755865-96778129 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA049139 Uncertain Approved Nucleoplasm
Plasma membrane Renal cancer:5.94e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 12.2 ZNF511 MGC30006 ENSG00000198546 Zinc finger protein 511 10 133308475-133313162 Predicted membrane proteins, Predicted secreted proteins, Transcription factors Evidence at protein level HPA035360 Uncertain Renal cancer:1.13e-4 (unfavourable) Expressed in all Expressed in all ovary: 11.4 ZNF512 KIAA1805 ENSG00000243943 Zinc finger protein 512 2 27582969-27623215 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA031430 Approved Validated Nucleus Lung cancer:5.08e-9 (favourable), Endometrial cancer:5.10e-4 (unfavourable), Pancreatic cancer:5.19e-4 (favourable), Breast cancer:9.79e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 44.9 ZNF512B GM632, MGC149845, MGC149846 ENSG00000196700 Zinc finger protein 512B 20 63956702-64048758 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA006688 Approved Approved Nucleoplasm Expressed in all Expressed in all parathyroid gland: 17.7 ZNF513 FLJ32203, RP58 ENSG00000163795 Zinc finger protein 513 2 27377231-27380790 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA051493 Uncertain Liver cancer:6.21e-5 (unfavourable) Expressed in all Expressed in all testis: 25.9 ZNF514 FLJ14457 ENSG00000144026 Zinc finger protein 514 2 95147330-95165413 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA028974 Approved Approved Nucleoplasm
Nuclear bodies Expressed in all Expressed in all epididymis: 32.4 ZNF516 HsT287, KIAA0222 ENSG00000101493 Zinc finger protein 516 18 76358190-76495190 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA015792 Uncertain Approved Nucleoplasm
Cytosol Renal cancer:1.21e-4 (favourable), Liver cancer:2.79e-4 (unfavourable), Breast cancer:7.09e-4 (favourable), Pancreatic cancer:7.96e-4 (favourable) Expressed in all Expressed in all endometrium: 54.1 ZNF517 ENSG00000197363 Zinc finger protein 517 8 144798876-144811169 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA055337 Approved Nucleoplasm Pancreatic cancer:1.66e-4 (favourable) Expressed in all Mixed skin: 7.5 ZNF518A KIAA0335, ZNF518 ENSG00000177853 Zinc finger protein 518A 10 96129715-96205288 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA029049 Approved Nucleus Expressed in all Mixed testis: 30.6 ZNF518B KIAA1729 ENSG00000178163 Zinc finger protein 518B 4 10439874-10457410 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA031215, HPA031216 Approved Approved Nucleus Mixed Mixed testis: 16.9 ZNF519 FLJ36809, HsT2362 ENSG00000175322 Zinc finger protein 519 18 14057457-14132490 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA028982 Uncertain Approved Nucleoli Mixed Mixed endometrium: 4.0 ZNF521 EHZF, Evi3 ENSG00000198795 Zinc finger protein 521 18 25061926-25352190 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA023056, HPA023849 Approved Approved Nucleoplasm Mixed Mixed spleen: 29.4 ZNF524 MGC23143 ENSG00000171443 Zinc finger protein 524 19 55600022-55603138 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA050981 Uncertain Approved Nucleus Urothelial cancer:4.98e-8 (favourable) Expressed in all Expressed in all spleen: 16.0 ZNF526 KIAA1951, MGC4267 ENSG00000167625 Zinc finger protein 526 19 42220271-42228201 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA023070, HPA056609 Uncertain Approved Nucleus
Golgi apparatus
Vesicles Expressed in all Mixed skin: 6.2 ZNF527 KIAA1829 ENSG00000189164 Zinc finger protein 527 19 37371061-37393066 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA037740, HPA037741 Uncertain Approved Nuclear speckles
Golgi apparatus Mixed Mixed parathyroid gland: 4.5 ZNF528 KIAA1827 ENSG00000167555 Zinc finger protein 528 19 52397849-52418412 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA065435 Approved Nuclear speckles
Cytosol Expressed in all Expressed in all thyroid gland: 31.1 ZNF529 KIAA1615 ENSG00000186020 Zinc finger protein 529 19 36534774-36605276 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA031311 Uncertain Approved Nucleoplasm Urothelial cancer:1.39e-5 (favourable) Expressed in all Mixed testis: 18.2 ZNF530 KIAA1508 ENSG00000183647 Zinc finger protein 530 19 57599885-57612722 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA045868 Uncertain Approved Vesicles Mixed Mixed spleen: 3.2 ZNF532 FLJ10697 ENSG00000074657 Zinc finger protein 532 18 58862600-58986480 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA015322 Approved Approved Nucleoplasm
Golgi apparatus Endometrial cancer:6.46e-5 (unfavourable), Urothelial cancer:5.76e-4 (unfavourable) Expressed in all Mixed endometrium: 103.7 ZNF534 FLJ25344, KRBO3 ENSG00000198633 Zinc finger protein 534 19 52429187-52452315 Predicted intracellular proteins, Transcription factors Evidence at transcript level Tissue enriched Tissue enhanced testis: 2.4 cerebral cortex: 0.9 ZNF536 KIAA0390 ENSG00000198597 Zinc finger protein 536 19 30228290-30713538 Predicted intracellular proteins, Transcription factors Evidence at protein level Mixed Tissue enhanced cerebral cortex: 19.1 thyroid gland: 5.3 ZNF540 DKFZp547B0714 ENSG00000171817 Zinc finger protein 540 19 37551406-37614097 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003444 Supported Supported Nucleoplasm
Vesicles
Cytosol Mixed Mixed thyroid gland: 13.2 ZNF541 DKFZp434I1930 ENSG00000118156 Zinc finger protein 541 19 47520685-47555856 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA058541 Approved Nucleoplasm
Cytosol Cervical cancer:2.94e-4 (favourable) Tissue enhanced Tissue enriched 11 testis: 19.2 ovary: 1.7 ZNF543 DKFZp434H055 ENSG00000178229 Zinc finger protein 543 19 57320509-57330776 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA029736, HPA057665 Uncertain Approved Nuclear speckles
Cytosol Renal cancer:2.03e-5 (favourable) Expressed in all Mixed ovary: 6.0 ZNF544 AF020591 ENSG00000198131 Zinc finger protein 544 19 58228594-58277495 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA002732 Approved Approved Nucleoplasm Liver cancer:1.04e-5 (unfavourable), Melanoma:3.65e-5 (unfavourable) Expressed in all Expressed in all testis: 49.3 ZNF546 MGC43537, ZNF49 ENSG00000187187 Zinc finger protein 546 19 39984134-40021041 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA030838 Approved Nucleus
Cytosol Mixed Tissue enhanced testis: 14.4 parathyroid gland: 3.3 ZNF547 FLJ31100 ENSG00000152433 Zinc finger protein 547 19 57363477-57379565 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA056001 Uncertain Mixed Mixed thyroid gland: 5.2 ZNF548 FLJ32932 ENSG00000188785 Zinc finger protein 548 19 57389850-57402992 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA066042 Uncertain Approved Nucleus Breast cancer:7.85e-4 (favourable) Expressed in all Expressed in all lymph node: 33.1 ZNF549 FLJ34917 ENSG00000121406 Zinc finger protein 549 19 57527325-57557542 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA039511 Uncertain Approved Nucleoplasm
Cytosol Mixed Mixed parathyroid gland: 10.2 ZNF550 MGC41917 ENSG00000251369 Zinc finger protein 550 19 57535257-57559863 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003251 Uncertain Approved Vesicles
Microtubules Prostate cancer:2.21e-4 (unfavourable) Expressed in all Mixed parathyroid gland: 13.5 ZNF551 DKFZp686H1038 ENSG00000204519 Zinc finger protein 551 19 57681969-57717301 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA038187, HPA038188 Uncertain Approved Nucleoplasm
Nuclear speckles Melanoma:7.68e-5 (unfavourable), Renal cancer:1.32e-4 (favourable) Expressed in all Mixed testis: 8.1 ZNF552 FLJ21603 ENSG00000178935 Zinc finger protein 552 19 57803841-57814913 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA043800, HPA053762, HPA072145 Uncertain Uncertain Nucleus Colorectal cancer:2.66e-4 (favourable), Breast cancer:4.57e-4 (favourable), Head and neck cancer:9.96e-4 (favourable) Expressed in all Mixed breast: 34.7 ZNF554 FLJ34817 ENSG00000172006 Zinc finger protein 554 19 2819874-2835773 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA060247, HPA063358 Uncertain Supported Nucleoplasm
Nucleoli Renal cancer:1.99e-5 (favourable), Pancreatic cancer:4.69e-4 (favourable), Urothelial cancer:5.00e-4 (favourable), Lung cancer:9.31e-4 (favourable) Expressed in all Mixed cerebral cortex: 7.5 ZNF555 MGC26707 ENSG00000186300 Zinc finger protein 555 19 2841435-2860484 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA053956, HPA055430 Uncertain Mixed Mixed testis: 10.5 ZNF556 FLJ11637 ENSG00000172000 Zinc finger protein 556 19 2867335-2883445 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA060593 Approved Nucleus Mixed Tissue enhanced fallopian tube: 3.3;ovary: 6.5 testis: 1.3 ZNF557 MGC4054 ENSG00000130544 Zinc finger protein 557 19 7069444-7087968 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003151, HPA029291 Uncertain Approved Nucleus
Intermediate filaments
Cytosol Head and neck cancer:3.67e-6 (favourable), Pancreatic cancer:1.51e-4 (favourable), Lung cancer:2.62e-4 (favourable), Endometrial cancer:5.70e-4 (favourable) Expressed in all Mixed testis: 5.6 ZNF558 FLJ30932 ENSG00000167785 Zinc finger protein 558 19 8806170-8832328 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA003151 Uncertain Renal cancer:1.23e-6 (unfavourable), Urothelial cancer:9.30e-5 (favourable), Head and neck cancer:1.04e-4 (favourable) Expressed in all Mixed parathyroid gland: 18.7 ZNF559 MGC13105 ENSG00000188321 Zinc finger protein 559 19 9323772-9351162 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA059632, HPA065485 Approved Supported Nucleoplasm
Cytosol Ovarian cancer:6.99e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 39.9 ZNF560 FLJ31986 ENSG00000198028 Zinc finger protein 560 19 9466507-9498607 Predicted intracellular proteins, Transcription factors Evidence at transcript level Tissue enriched Tissue enriched 9 testis: 11.9 placenta: 1.2 ZNF561 MGC45408 ENSG00000171469 Zinc finger protein 561 19 9604680-9621399 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA055332, HPA062397 Uncertain Approved Nucleoplasm Renal cancer:1.16e-4 (favourable), Ovarian cancer:1.31e-4 (favourable) Expressed in all Expressed in all smooth muscle: 37.6 ZNF562 FLJ20079 ENSG00000171466 Zinc finger protein 562 19 9641808-9675086 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA055332, HPA062397 Uncertain Approved Nucleoplasm Head and neck cancer:4.17e-4 (favourable) Expressed in all Expressed in all esophagus: 19.1 ZNF563 FLJ34797 ENSG00000188868 Zinc finger protein 563 19 12317477-12333720 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA042136 Uncertain Expressed in all Tissue enhanced testis: 25.5 thyroid gland: 8.5 ZNF564 MGC26914 ENSG00000249709 Zinc finger protein 564 19 12525370-12551542 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA043998 Uncertain Approved Golgi apparatus Not detected Mixed thyroid gland: 10.5 ZNF565 FLJ36991 ENSG00000196357 Zinc finger protein 565 19 36182060-36246257 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA044123 Uncertain Approved Nucleoplasm
Nuclear bodies Expressed in all Mixed testis: 11.5 ZNF566 FLJ14779, MGC12515 ENSG00000186017 Zinc finger protein 566 19 36445119-36489902 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA023456 Uncertain Approved Nucleus Endometrial cancer:1.86e-4 (unfavourable) Expressed in all Mixed thyroid gland: 8.0 ZNF567 MGC45586 ENSG00000189042 Zinc finger protein 567 19 36687612-36727701 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA023937 Uncertain Approved Nucleoplasm
Cytosol Expressed in all Mixed testis: 16.1 ZNF568 DKFZp686B0797 ENSG00000198453 Zinc finger protein 568 19 36916329-36998700 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA052061 Uncertain Mixed Mixed parathyroid gland: 14.1 ZNF569 FLJ32053, ZAP1 ENSG00000196437 Zinc finger protein 569 19 37411155-37469275 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA052994 Uncertain Approved Nucleoplasm
Golgi apparatus
Vesicles Mixed Mixed testis: 20.7 ZNF57 ZNF424 ENSG00000171970 Zinc finger protein 57 19 2900898-2918476 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA061915 Approved Nucleoli Renal cancer:4.11e-9 (favourable), Lung cancer:6.26e-4 (favourable), Pancreatic cancer:7.72e-4 (favourable) Expressed in all Tissue enriched 5 testis: 58.4 skin: 11.6 ZNF570 FLJ30791 ENSG00000171827 Zinc finger protein 570 19 37467585-37488652 Predicted intracellular proteins, Predicted secreted proteins, Transcription factors Evidence at transcript level HPA028881 Uncertain Approved Nucleoplasm Renal cancer:4.06e-5 (favourable) Expressed in all Mixed testis: 10.7 ZNF571 HSPC059 ENSG00000180479 Zinc finger protein 571 19 37554782-37594790 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA054762 Approved Nucleus
Nucleoli
Plasma membrane Mixed Tissue enriched 5 thyroid gland: 130.2 testis: 25.9 ZNF572 FLJ38002 ENSG00000180938 Zinc finger protein 572 8 124973298-124979389 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA066838 Approved Approved Nuclear speckles Expressed in all Mixed testis: 6.7 ZNF573 FLJ30921 ENSG00000189144 Zinc finger protein 573 19 37735833-37817300 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA042776 Uncertain Approved Intermediate filaments
Cytosol Mixed Mixed testis: 4.5 ZNF574 FLJ22059 ENSG00000105732 Zinc finger protein 574 19 42068477-42081565 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA023196, HPA057274 Approved Supported Nucleoplasm Expressed in all Expressed in all testis: 40.2 ZNF575 FLJ32567 ENSG00000176472 Zinc finger protein 575 19 43525497-43536130 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA051865 Approved Approved Nucleus
Nucleoli fibrillar center
Cytosol Expressed in all Mixed colon: 4.5 ZNF576 MGC2508 ENSG00000124444 Zinc finger protein 576 19 43596392-43601157 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA050064 Uncertain Approved Nucleoplasm
Golgi apparatus Liver cancer:1.29e-4 (unfavourable) Expressed in all Expressed in all cerebral cortex,prostate: 14.7 ZNF577 MGC4400 ENSG00000161551 Zinc finger protein 577 19 51855802-51890950 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA041499, HPA046761 Uncertain Supported Nucleus
Nucleoli Urothelial cancer:2.03e-4 (favourable) Mixed Expressed in all testis: 42.1 ZNF578 FLJ31384 ENSG00000258405 Zinc finger protein 578 19 52453576-52512154 Predicted intracellular proteins, Transcription factors Evidence at protein level Tissue enriched Tissue enriched 5 testis: 14.0 thyroid gland: 2.7 ZNF579 FLJ35453 ENSG00000218891 Zinc finger protein 579 19 55576770-55580845 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA062812 Approved Approved Nucleus Renal cancer:1.00e-5 (unfavourable) Expressed in all Expressed in all gallbladder: 13.0 ZNF580 ENSG00000213015 Zinc finger protein 580 19 55635016-55643469 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA054058 Approved Approved Nucleus Renal cancer:5.79e-6 (unfavourable), Pancreatic cancer:2.36e-5 (favourable), Liver cancer:5.63e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 37.6 ZNF581 FLJ22550, HSPC189 ENSG00000171425 Zinc finger protein 581 19 55635459-55645622 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA059657 Uncertain Liver cancer:5.74e-5 (unfavourable) Expressed in all Expressed in all ovary: 21.6 ZNF582 FLJ30927 ENSG00000018869 Zinc finger protein 582 19 56375846-56393545 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA028858 Uncertain Approved Nucleoplasm
Cytosol Mixed Mixed thyroid gland: 13.4 ZNF583 FLJ31030 ENSG00000198440 Zinc finger protein 583 19 56397966-56436035 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA023805, HPA023957 Uncertain Approved Nucleoli
Cytosol Mixed Mixed testis: 13.7 ZNF584 FLJ39899 ENSG00000171574 Zinc finger protein 584 19 58401504-58418327 Predicted intracellular proteins, Predicted membrane proteins, Transcription factors Evidence at transcript level HPA043408, HPA048075 Uncertain Approved Nuclear speckles Expressed in all Mixed fallopian tube: 9.9 ZNF585A FLJ23765 ENSG00000196967 Zinc finger protein 585A 19 37106734-37172741 Predicted intracellular proteins, Transcription factors Evidence at transcript level Mixed Expressed in all thyroid gland: 17.7 ZNF585B FLJ14928, SZFP41 ENSG00000245680 Zinc finger protein 585B 19 37181579-37218153 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA075556 Approved Nucleoplasm
Cytoplasmic bodies Expressed in all Mixed parathyroid gland: 19.6 ZNF586 FLJ20070 ENSG00000083828 Zinc finger protein 586 19 57769655-57819939 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA030306, HPA060782 Approved Approved Nucleoli fibrillar center
Vesicles Breast cancer:9.83e-5 (favourable), Urothelial cancer:5.36e-4 (favourable) Expressed in all Expressed in all bone marrow: 16.3 ZNF587 FLJ14710, FLJ20813, UBF-fl, ZF6 ENSG00000198466 Zinc finger protein 587 19 57849857-57865112 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA042125, HPA043288, HPA056213 Uncertain Uncertain Nucleoplasm Renal cancer:7.98e-4 (unfavourable) Expressed in all Mixed rectum: 15.6 ZNF589 SZF1 ENSG00000164048 Zinc finger protein 589 3 48241100-48299253 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003145 Uncertain Approved Nucleoplasm Lung cancer:6.45e-5 (favourable), Pancreatic cancer:1.21e-4 (favourable), Head and neck cancer:1.71e-4 (favourable), Cervical cancer:2.50e-4 (favourable) Expressed in all Mixed prostate: 27.8 ZNF592 CAMOS, KIAA0211, SCAR5 ENSG00000166716 Zinc finger protein 592 15 84748635-84806432 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA020332, HPA021600 Approved Approved Nucleoplasm Expressed in all Expressed in all parathyroid gland: 16.5 ZNF594 KIAA1871 ENSG00000180626 Zinc finger protein 594 17 5179536-5191883 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA067178 Approved Nucleus Mixed Mixed ovary: 13.8 ZNF596 ENSG00000172748 Zinc finger protein 596 8 232137-247342 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA055463 Uncertain Approved Nucleoli
Mitochondria Mixed Tissue enhanced testis: 27.3 parathyroid gland: 12.9 ZNF597 FLJ33071, HIT-4 ENSG00000167981 Zinc finger protein 597 16 3432422-3443542 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA001556 Approved Approved Nucleus
Nucleoli
Cytosol Expressed in all Mixed testis: 7.3 ZNF599 FLJ30663 ENSG00000153896 Zinc finger protein 599 19 34758076-34773229 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA014701 Uncertain Approved Nucleoplasm
Plasma membrane
Cytosol Mixed Mixed epididymis: 14.4 ZNF600 DKFZp686F06123, KR-ZNF1 ENSG00000189190 Zinc finger protein 600 19 52764195-52818004 Predicted intracellular proteins, Transcription factors Evidence at protein level Renal cancer:4.98e-7 (unfavourable), Urothelial cancer:1.11e-5 (favourable) Expressed in all Mixed spleen: 8.1 ZNF605 ENSG00000196458 Zinc finger protein 605 12 132918308-132956306 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA061970, HPA062655 Uncertain Approved Nucleoplasm
Vesicles Expressed in all Mixed parathyroid gland,thyroid gland: 11.1 ZNF606 FLJ14260, KIAA1852, ZNF328 ENSG00000166704 Zinc finger protein 606 19 57977053-58003349 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA041712, HPA043584 Uncertain Supported Nucleoplasm Urothelial cancer:4.75e-6 (favourable) Expressed in all Expressed in all parathyroid gland: 18.9 ZNF607 FLJ14802, MGC13071 ENSG00000198182 Zinc finger protein 607 19 37696363-37719790 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA049465, HPA055018 Uncertain Approved Nucleoplasm Urothelial cancer:5.23e-5 (favourable) Expressed in all Mixed parathyroid gland: 9.4 ZNF610 FLJ36040 ENSG00000167554 Zinc finger protein 610 19 52336245-52367778 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA055771 Approved Renal cancer:1.05e-7 (favourable), Ovarian cancer:3.38e-4 (favourable) Mixed Tissue enhanced testis: 22.1 ovary: 10.4 ZNF611 MGC5384 ENSG00000213020 Zinc finger protein 611 19 52702813-52735073 Predicted intracellular proteins, Transcription factors Evidence at transcript level Renal cancer:3.33e-4 (favourable) Mixed Mixed fallopian tube: 10.5 ZNF613 FLJ13590 ENSG00000176024 Zinc finger protein 613 19 51879872-51948759 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA026833 Uncertain Approved Nucleoplasm
Vesicles Urothelial cancer:1.92e-6 (favourable) Expressed in all Tissue enhanced prostate: 25.7 parathyroid gland: 8.5 ZNF614 FLJ21941 ENSG00000142556 Zinc finger protein 614 19 52012765-52030240 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA021197 Uncertain Approved Nucleoplasm
Vesicles
Cytosol Expressed in all Mixed prostate: 15.5 ZNF615 FLJ33710 ENSG00000197619 Zinc finger protein 615 19 51991332-52008230 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA052422 Uncertain Approved Nucleoli
Mitochondria Urothelial cancer:2.98e-4 (favourable) Expressed in all Mixed prostate: 28.6 ZNF616 MGC45556 ENSG00000204611 Zinc finger protein 616 19 52113091-52139922 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA062639, HPA071539 Approved Approved Centrosome Expressed in all Expressed in all adrenal gland: 17.4 ZNF618 KIAA1952, NEDD10 ENSG00000157657 Zinc finger protein 618 9 113876282-114056591 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA023116, HPA061732 Uncertain Approved Nucleoplasm Renal cancer:5.22e-7 (favourable), Glioma:8.34e-4 (unfavourable) Expressed in all Mixed parathyroid gland: 16.2 ZNF619 FLJ90764 ENSG00000177873 Zinc finger protein 619 3 40477113-40490236 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA045094 Uncertain Approved Nucleoplasm
Intermediate filaments Expressed in all Mixed parathyroid gland: 7.7 ZNF620 MGC50836 ENSG00000177842 Zinc finger protein 620 3 40505992-40518736 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA031452 Uncertain Approved Plasma membrane Mixed Mixed thyroid gland: 6.0 ZNF621 FLJ45246 ENSG00000172888 Zinc finger protein 621 3 40524878-40574685 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA065518, HPA071440 Supported Nuclear speckles Expressed in all Expressed in all parathyroid gland: 22.9 ZNF623 KIAA0628 ENSG00000183309 Zinc finger protein 623 8 143636013-143656418 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA044372 Uncertain Approved Nucleus Endometrial cancer:2.94e-4 (unfavourable) Expressed in all Mixed endometrium: 6.1 ZNF624 KIAA1349 ENSG00000197566 Zinc finger protein 624 17 16620737-16653856 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA023157, HPA023244 Uncertain Approved Vesicles Mixed Mixed testis: 8.9 ZNF625 ENSG00000257591 Zinc finger protein 625 19 12142090-12156729 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA074014 Approved Nucleus
Mitochondria Mixed Mixed thyroid gland: 4.7 ZNF626 ENSG00000188171 Zinc finger protein 626 19 20620061-20661596 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA045631 Uncertain Approved Nucleoplasm
Nuclear membrane
Vesicles Mixed Expressed in all parathyroid gland: 52.0 ZNF627 FLJ90365 ENSG00000198551 Zinc finger protein 627 19 11559374-11619135 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA049770, HPA073463 Uncertain Approved Nucleus
Nucleoli Renal cancer:6.93e-7 (favourable), Head and neck cancer:8.12e-4 (favourable) Expressed in all Expressed in all thyroid gland: 20.6 ZNF628 ZEC, Zfp628 ENSG00000197483 Zinc finger protein 628 19 55476332-55484487 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA044451 Uncertain Approved Nucleoplasm Expressed in all Tissue enhanced testis: 7.3 spleen: 2.8 ZNF629 KIAA0326, ZNF65 ENSG00000102870 Zinc finger protein 629 16 30778449-30787202 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA019550, HPA056051 Uncertain Supported Nucleus
Golgi apparatus Renal cancer:4.57e-10 (favourable) Expressed in all Expressed in all parathyroid gland: 27.4 ZNF639 ANC-2H01, ZASC1 ENSG00000121864 Zinc finger protein 639 3 179322991-179338583 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA049023, HPA052163 Uncertain Supported Nucleoplasm Glioma:7.36e-5 (favourable), Liver cancer:2.13e-4 (unfavourable) Expressed in all Expressed in all thyroid gland: 68.7 ZNF641 FLJ31295 ENSG00000167528 Zinc finger protein 641 12 48337180-48351414 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA035189 Uncertain Supported Nucleoplasm Pancreatic cancer:8.30e-5 (favourable), Ovarian cancer:3.91e-4 (favourable) Expressed in all Expressed in all adrenal gland: 29.0 ZNF644 BM-005, KIAA1221, MGC60165, MGC70410 ENSG00000122482 Zinc finger protein 644 1 90915298-91022272 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA057795 Uncertain Uncertain Vesicles Colorectal cancer:4.27e-4 (favourable), Endometrial cancer:8.39e-4 (unfavourable) Expressed in all Expressed in all thyroid gland: 31.0 ZNF646 KIAA0296 ENSG00000167395 Zinc finger protein 646 16 31074422-31084196 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA042364 Uncertain Approved Nucleoplasm
Plasma membrane
Cytosol Liver cancer:1.28e-6 (unfavourable) Expressed in all Tissue enhanced testis: 34.4 spleen: 11.0 ZNF648 FLJ46813 ENSG00000179930 Zinc finger protein 648 1 182054570-182061712 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA053897 Uncertain Not detected Not detected ovary,testis: 0.6 ZNF649 FLJ12644 ENSG00000198093 Zinc finger protein 649 19 51889224-51905040 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA026541 Uncertain Renal cancer:4.60e-5 (favourable), Melanoma:7.44e-4 (unfavourable) Expressed in all Expressed in all prostate: 34.0 ZNF652 KIAA0924 ENSG00000198740 Zinc finger protein 652 17 49289206-49362473 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA044408 Uncertain Approved Nucleus Endometrial cancer:1.35e-4 (favourable) Expressed in all Mixed breast: 7.2 ZNF653 Zip67 ENSG00000161914 Zinc finger protein 653 19 11483427-11505923 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA023631, HPA023635 Uncertain Approved Nucleus
Cytosol Endometrial cancer:4.15e-4 (favourable), Colorectal cancer:8.37e-4 (unfavourable), Urothelial cancer:8.74e-4 (favourable) Expressed in all Mixed testis: 19.0 ZNF654 FLJ10997, FLJ21142 ENSG00000175105 Zinc finger protein 654 3 88139104-88144665 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA036172, HPA036173 Uncertain Approved Nucleus
Microtubules Prostate cancer:9.97e-6 (unfavourable) Expressed in all Mixed testis: 12.3 ZNF655 VIK, VIK-1 ENSG00000197343 Zinc finger protein 655 7 99558406-99576453 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA029534, HPA050750 Uncertain Supported Nucleoplasm
Plasma membrane Breast cancer:7.12e-4 (favourable), Melanoma:7.24e-4 (unfavourable) Expressed in all Expressed in all lymph node: 21.5 ZNF658 DKFZp572C163, FLJ32813, MGC35232 ENSG00000274349 Zinc finger protein 658 9 66856426-66932141 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA047730, HPA048668 Uncertain Approved Nucleoplasm Mixed Mixed skin: 9.7 ZNF66 FLJ16537, ZNF66P ENSG00000160229 Zinc finger protein 66 19 20776304-20807322 Predicted intracellular proteins, Predicted membrane proteins, Transcription factors Evidence at transcript level Mixed Tissue enhanced ovary: 9.8 thyroid gland: 3.9 ZNF660 FLJ36870 ENSG00000144792 Zinc finger protein 660 3 44578223-44599694 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA029705 Uncertain Uncertain Nucleoli fibrillar center
Cytosol Mixed Mixed ovary: 3.1 ZNF662 FLJ45880 ENSG00000182983 Zinc finger protein 662 3 42905731-42917641 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA039116, HPA040377 Uncertain Mixed Mixed skin: 13.3 ZNF664 DKFZp761B128, ZFOC1, ZNF176 ENSG00000179195 Zinc finger protein 664 12 123971845-124015439 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA047846 Approved Nucleoplasm Expressed in all Expressed in all parathyroid gland: 231.9 ZNF665 FLJ14345 ENSG00000197497 Zinc finger protein 665 19 53159213-53193386 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA023437 Uncertain Approved Nuclear membrane Mixed Mixed ovary: 3.8 ZNF667 FLJ14011 ENSG00000198046 Zinc finger protein 667 19 56439325-56478065 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA030731, HPA046673 Uncertain Approved Nucleus Mixed Mixed cerebral cortex: 18.3 ZNF668 FLJ13479 ENSG00000167394 Zinc finger protein 668 16 31060843-31074320 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA043048 Uncertain Approved Nucleus
Nucleoli Prostate cancer:6.24e-4 (unfavourable) Expressed in all Mixed testis: 8.0 ZNF669 FLJ12606 ENSG00000188295 Zinc finger protein 669 1 247099962-247104372 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA044043 Uncertain Approved Nucleoli Renal cancer:4.59e-7 (favourable) Expressed in all Mixed testis: 8.7 ZNF670 MGC12466 ENSG00000277462 Zinc finger protein 670 1 247036784-247078755 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003142 Uncertain Approved Nucleus
Cytosol Expressed in all Mixed testis: 6.1 ZNF671 FLJ23506 ENSG00000083814 Zinc finger protein 671 19 57719751-57727624 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA046099 Uncertain Approved Nucleoplasm Breast cancer:2.20e-4 (favourable), Pancreatic cancer:3.57e-4 (favourable) Mixed Mixed parathyroid gland: 16.4 ZNF672 FLJ22301 ENSG00000171161 Zinc finger protein 672 1 248838210-248849517 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA055779, HPA062506 Approved Validated Nucleoplasm Urothelial cancer:1.79e-5 (favourable), Pancreatic cancer:7.51e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 24.3 ZNF674 MRX92, ZNF673B ENSG00000251192 Zinc finger protein 674 X 46497727-46545457 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA031026, HPA065295 Uncertain Validated Nucleoplasm Mixed Mixed prostate: 3.2 ZNF675 TBZF, TIZ ENSG00000197372 Zinc finger protein 675 19 23525631-23687220 Predicted intracellular proteins, Transcription factors Evidence at protein level Mixed Expressed in all testis: 25.0 ZNF676 ENSG00000196109 Zinc finger protein 676 19 22179091-22196951 Predicted intracellular proteins, Transcription factors Evidence at transcript level Tissue enriched Tissue enhanced parathyroid gland: 4.3;testis: 4.0 thyroid gland: 3.0 ZNF677 MGC48625 ENSG00000197928 Zinc finger protein 677 19 53235381-53254898 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA023106, HPA024796 Approved Approved Nucleus
Centrosome Mixed Expressed in all testis: 71.0 ZNF678 MGC42493 ENSG00000181450 Zinc finger protein 678 1 227563543-227677443 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA028507 Uncertain Approved Nucleoli
Mitochondria
Cytosol Expressed in all Mixed thyroid gland: 9.0 ZNF679 MGC42415 ENSG00000197123 Zinc finger protein 679 7 64228474-64266931 Predicted intracellular proteins, Transcription factors Evidence at protein level Not detected Tissue enriched 18 testis: 1.8 all non-specific tissues: 0.0 ZNF680 FLJ90430 ENSG00000173041 Zinc finger protein 680 7 64519884-64563106 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA003173 Approved Nucleus Expressed in all Expressed in all thyroid gland: 42.3 ZNF681 FLJ31526 ENSG00000196172 Zinc finger protein 681 19 23739195-23758891 Predicted intracellular proteins, Transcription factors Evidence at transcript level Mixed Mixed testis: 4.7 ZNF682 BC39498_3 ENSG00000197124 Zinc finger protein 682 19 19997058-20039506 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA055998 Uncertain Uncertain Golgi apparatus Urothelial cancer:3.51e-4 (favourable) Tissue enhanced Mixed thyroid gland: 13.3 ZNF683 Hobit, MGC33414 ENSG00000176083 Zinc finger protein 683 1 26361634-26374522 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA023865 Uncertain Endometrial cancer:2.90e-5 (favourable), Urothelial cancer:3.45e-5 (favourable) Mixed Tissue enriched 11 testis: 78.7 lung: 7.1 ZNF684 MGC27466 ENSG00000117010 Zinc finger protein 684 1 40531561-40548169 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA059153 Uncertain Approved Nucleus
Cytosol Renal cancer:4.89e-10 (favourable) Expressed in all Mixed kidney: 6.8 ZNF687 KIAA1441 ENSG00000143373 Zinc finger protein 687 1 151281618-151292180 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA021193, HPA023948 Approved Validated Nucleoplasm Expressed in all Expressed in all parathyroid gland: 25.9 ZNF689 FLJ90415 ENSG00000156853 Zinc finger protein 689 16 30602558-30624012 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA054095, HPA055385 Approved Approved Nucleus
Nucleoli fibrillar center Pancreatic cancer:9.89e-4 (favourable) Expressed in all Expressed in all testis: 35.3 ZNF69 Cos5 ENSG00000198429 Zinc finger protein 69 19 11887784-11914329 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA047845 Uncertain Uncertain Nucleus Endometrial cancer:1.55e-4 (favourable) Mixed Tissue enhanced parathyroid gland: 25.3 kidney: 10.3 ZNF691 Zfp691 ENSG00000164011 Zinc finger protein 691 1 42846573-42852477 Predicted intracellular proteins, Predicted secreted proteins, Transcription factors Evidence at protein level HPA062527 Approved Approved Nucleus
Nucleoli
Vesicles Liver cancer:7.33e-6 (unfavourable), Pancreatic cancer:6.25e-5 (favourable) Expressed in all Expressed in all parathyroid gland: 21.4 ZNF692 AREBP, FLJ20531, Zfp692 ENSG00000171163 Zinc finger protein 692 1 248850006-248859144 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA059337, HPA062792 Uncertain Validated Nucleus
Nucleoli Renal cancer:7.72e-9 (unfavourable), Urothelial cancer:8.35e-5 (favourable), Pancreatic cancer:4.09e-4 (favourable) Expressed in all Expressed in all testis: 26.8 ZNF695 SBZF3 ENSG00000197472 Zinc finger protein 695 1 246945547-247008093 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA024743 Uncertain Approved Nuclear speckles Mixed Tissue enhanced testis: 1.2 placenta,small intestine: 0.6 ZNF696 FLJ14129 ENSG00000185730 Zinc finger protein 696 8 143289676-143298061 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA057855, HPA072473 Uncertain Approved Nucleus
Nucleoli Endometrial cancer:3.52e-5 (unfavourable), Cervical cancer:6.63e-5 (unfavourable), Pancreatic cancer:1.41e-4 (favourable) Expressed in all Mixed cerebral cortex: 9.8 ZNF697 MGC45731 ENSG00000143067 Zinc finger protein 697 1 119619422-119647773 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA049933 Uncertain Approved Nucleoplasm Renal cancer:6.20e-5 (favourable) Expressed in all Mixed placenta: 10.8 ZNF699 FLJ38144, hang ENSG00000196110 Zinc finger protein 699 19 9294275-9309838 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA058287 Uncertain Mixed Mixed parathyroid gland: 4.8 ZNF7 HF.16, KOX4 ENSG00000147789 Zinc finger protein 7 8 144827464-144847509 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA030296, HPA059090 Uncertain Approved Mitochondria Renal cancer:8.46e-8 (unfavourable) Expressed in all Expressed in all testis: 31.4 ZNF70 Cos17, MGC48959 ENSG00000187792 Zinc finger protein 70 22 23738678-23751092 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA018821 Uncertain Supported Cytosol Mixed Mixed ovary: 4.9 ZNF700 DKFZp434I1610 ENSG00000196757 Zinc finger protein 700 19 11925068-11950773 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA047845 Uncertain Uncertain Nucleus Renal cancer:2.01e-5 (unfavourable), Urothelial cancer:2.53e-5 (favourable), Head and neck cancer:1.27e-4 (favourable), Prostate cancer:1.75e-4 (unfavourable), Melanoma:2.58e-4 (unfavourable) Expressed in all Expressed in all skin: 19.1 ZNF701 FLJ10891 ENSG00000167562 Zinc finger protein 701 19 52555822-52587174 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA005532 Uncertain Approved Nucleoplasm
Microtubule organizing center Urothelial cancer:4.89e-5 (favourable) Mixed Mixed thyroid gland: 10.0 ZNF705A FLJ16353 ENSG00000196946 Zinc finger protein 705A 12 8138137-8188537 Predicted intracellular proteins, Transcription factors Evidence at transcript level Not detected Mixed cerebral cortex: 9.1 ZNF705D ENSG00000215343 Zinc finger protein 705D 8 12104389-12115516 Predicted intracellular proteins, Transcription factors Evidence at transcript level Not detected Tissue enriched 6 epididymis: 4.5 testis: 0.7 ZNF705G ENSG00000215372 Zinc finger protein 705G 8 7355517-7385558 Predicted intracellular proteins, Transcription factors Evidence at protein level Not detected Not detected testis: 0.9 ZNF707 ENSG00000181135 Zinc finger protein 707 8 143684452-143713898 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA044991 Approved Validated Nucleoplasm Endometrial cancer:6.79e-4 (unfavourable) Expressed in all Mixed skin: 4.9 ZNF708 KOX8, ZNF15, ZNF15L1 ENSG00000182141 Zinc finger protein 708 19 21221500-21329425 Predicted intracellular proteins, Transcription factors Evidence at protein level Ovarian cancer:3.53e-4 (favourable), Glioma:6.32e-4 (favourable) Expressed in all Mixed cerebral cortex: 17.8 ZNF709 FLJ38281 ENSG00000242852 Zinc finger protein 709 19 12461184-12513854 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA045573, HPA053153 Uncertain Approved Nucleoplasm Not detected Tissue enhanced testis: 13.9 thyroid gland: 4.8 ZNF71 Cos26, EZFIT ENSG00000197951 Zinc finger protein 71 19 56595264-56626481 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA018124 Uncertain Approved Nucleus
Nucleoli Expressed in all Mixed cerebral cortex: 5.4 ZNF710 DKFZp547K1113, FLJ00306, FLJ37393 ENSG00000140548 Zinc finger protein 710 15 90001392-90082206 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA030226, HPA030227, HPA030228 Supported Approved Nucleoplasm
Mitochondria Expressed in all Expressed in all appendix: 20.9 ZNF711 CMPX1, dJ75N13.1, MRX97, Zfp711, ZNF4, ZNF5, ZNF6 ENSG00000147180 Zinc finger protein 711 X 85244032-85273362 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA030654 Supported Approved Nucleoplasm Mixed Tissue enhanced testis: 69.6 cerebral cortex: 32.8 ZNF713 FLJ39963 ENSG00000178665 Zinc finger protein 713 7 55887475-55942225 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA059425, HPA062887 Uncertain Approved Nucleoli Mixed Mixed testis: 8.4 ZNF716 FLJ46189 ENSG00000182111 Zinc finger protein 716 7 57450177-57473546 Predicted intracellular proteins, Transcription factors Evidence at transcript level Tissue enriched Tissue enriched 6 testis: 1.1 bone marrow,cerebral cortex,duodenum,epididymis,gallbladder,lymph node,skin,thyroid gland: 0.1 ZNF721 KIAA1982 ENSG00000182903 Zinc finger protein 721 4 425815-499156 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA065313 Approved Microtubule organizing center
Cytosol Urothelial cancer:2.76e-4 (favourable) Expressed in all Expressed in all cerebral cortex: 30.9 ZNF724P ENSG00000196081 Zinc finger protein 724, pseudogene 19 23221599-23250390 Predicted intracellular proteins, Transcription factors Evidence at transcript level Mixed Mixed esophagus: 3.1 ZNF726 ENSG00000213967 Zinc finger protein 726 19 23914876-23945159 Predicted intracellular proteins, Transcription factors Evidence at transcript level Mixed Mixed breast: 7.3 ZNF727 ZNF727P ENSG00000214652 Zinc finger protein 727 7 64045443-64078549 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA051027, HPA061215 Uncertain Uncertain Nucleoplasm Tissue enhanced Mixed thyroid gland: 5.8 ZNF729 ENSG00000196350 Zinc finger protein 729 19 22286408-22317176 Predicted intracellular proteins, Transcription factors Evidence at protein level Tissue enriched Tissue enriched 22 testis: 3.8 breast,cerebral cortex,endometrium,parathyroid gland: 0.1 ZNF730 ENSG00000183850 Zinc finger protein 730 19 23075210-23147219 Predicted intracellular proteins, Transcription factors Evidence at transcript level Mixed Tissue enhanced testis: 9.5 ovary: 3.1 ZNF732 FLJ59067 ENSG00000186777 Zinc finger protein 732 4 270675-305321 Predicted intracellular proteins, Transcription factors Evidence at transcript level Tissue enhanced Tissue enhanced testis: 2.7 breast,skin: 0.8 ZNF735 ZNF735P ENSG00000223614 Zinc finger protein 735 7 64207090-64220508 Predicted intracellular proteins, Transcription factors Evidence at protein level Not detected Not detected testis: 0.2 ZNF736 ENSG00000234444 Zinc finger protein 736 7 64307459-64354860 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA051027, HPA061215 Uncertain Uncertain Nucleoplasm Endometrial cancer:3.03e-4 (unfavourable), Prostate cancer:5.01e-4 (unfavourable), Urothelial cancer:8.65e-4 (favourable) Mixed Mixed testis: 15.6 ZNF737 ZNF102 ENSG00000237440 Zinc finger protein 737 19 20535825-20565809 Predicted intracellular proteins, Transcription factors Evidence at transcript level Mixed Mixed thyroid gland: 66.8 ZNF74 Cos52, Zfp520, ZNF520 ENSG00000185252 Zinc finger protein 74 22 20394115-20408461 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003354 Approved Supported Nucleoplasm
Actin filaments Expressed in all Mixed ovary: 4.9 ZNF740 Zfp740 ENSG00000139651 Zinc finger protein 740 12 53180700-53195141 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA035691 Approved Approved Nucleus Melanoma:4.55e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 14.2 ZNF746 FLJ31413, PARIS ENSG00000181220 Zinc finger protein 746 7 149472794-149497817 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA020272 Approved Renal cancer:7.47e-6 (unfavourable), Liver cancer:2.32e-5 (unfavourable), Pancreatic cancer:4.22e-4 (favourable) Expressed in all Expressed in all testis: 23.2 ZNF749 FLJ16360 ENSG00000186230 Zinc finger protein 749 19 57435329-57445485 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA042082, HPA042091, HPA056001 Uncertain Approved Nucleoplasm
Nuclear membrane Expressed in all Mixed parathyroid gland: 4.2 ZNF75A FLJ31529 ENSG00000162086 Zinc finger protein 75a 16 3305406-3318852 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001665 Uncertain Approved Nucleoplasm
Nucleoli fibrillar center Expressed in all Expressed in all parathyroid gland: 45.5 ZNF75D D8C6, ZKSCAN24, ZNF75, ZNF82, ZSCAN28 ENSG00000186376 Zinc finger protein 75D X 135248920-135344087 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA004705 Supported Approved Nucleoplasm
Golgi apparatus Urothelial cancer:7.42e-5 (favourable), Renal cancer:1.31e-4 (favourable) Expressed in all Expressed in all prostate: 16.1 ZNF76 D6S229E, Zfp523, ZNF523 ENSG00000065029 Zinc finger protein 76 6 35258909-35295985 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA030090, HPA030091 Approved Approved Nucleoplasm
Cytosol Ovarian cancer:1.18e-4 (favourable), Pancreatic cancer:5.09e-4 (favourable) Expressed in all Expressed in all thyroid gland: 34.5 ZNF763 ZNF440L ENSG00000197054 Zinc finger protein 763 19 11965037-11980381 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA047845 Uncertain Uncertain Nucleus Mixed Mixed parathyroid gland: 11.4 ZNF764 MGC13138 ENSG00000169951 Zinc finger protein 764 16 30553764-30558498 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003203 Uncertain Approved Cytosol Endometrial cancer:6.84e-4 (favourable) Expressed in all Mixed testis: 6.0 ZNF765 ENSG00000196417 Zinc finger protein 765 19 53389793-53430413 Predicted intracellular proteins, Transcription factors Evidence at protein level Breast cancer:9.11e-4 (unfavourable) Mixed Mixed parathyroid gland: 12.9 ZNF766 ENSG00000196214 Zinc finger protein 766 19 52269571-52296046 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA044882, HPA063496 Uncertain Supported Centrosome Expressed in all Expressed in all testis: 43.5 ZNF768 FLJ23436 ENSG00000169957 Zinc finger protein 768 16 30524001-30526821 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA024630, HPA066512 Supported Approved Nucleus
Vesicles Renal cancer:9.30e-6 (favourable), Urothelial cancer:6.46e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 55.0 ZNF77 pT1 ENSG00000175691 Zinc finger protein 77 19 2933218-2944971 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA023397 Uncertain Approved Nucleus
Nucleoli Lung cancer:6.79e-6 (favourable), Endometrial cancer:6.65e-5 (favourable), Cervical cancer:8.49e-4 (favourable) Expressed in all Mixed breast: 5.7 ZNF770 FLJ20582, PRO1914 ENSG00000198146 Zinc finger protein 770 15 34978341-34988287 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA024518 Approved Expressed in all Expressed in all thyroid gland: 73.3 ZNF771 DSC43 ENSG00000179965 Zinc finger protein 771 16 30407297-30431108 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA030730, HPA046672, HPA059398 Uncertain Approved Nucleus
Nucleoli Expressed in all Mixed cerebral cortex: 7.1 ZNF772 DKFZp686I1569 ENSG00000197128 Zinc finger protein 772 19 57466663-57477570 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA031312 Uncertain Approved Cytosol Renal cancer:1.02e-6 (favourable) Mixed Mixed parathyroid gland: 19.7 ZNF773 MGC4728, ZNF419B ENSG00000152439 Zinc finger protein 773 19 57499915-57518404 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA003152 Uncertain Approved Nucleus
Nucleoli fibrillar center Mixed Mixed parathyroid gland: 13.2 ZNF774 MGC75360 ENSG00000196391 Zinc finger protein 774 15 90352245-90369146 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA030839, HPA030840 Uncertain Supported Intermediate filaments
Cytosol Mixed Mixed rectum: 8.2 ZNF775 MGC33584 ENSG00000196456 Zinc finger protein 775 7 150368790-150410597 Predicted intracellular proteins, Transcription factors Evidence at transcript level Pancreatic cancer:1.35e-5 (favourable), Renal cancer:2.84e-4 (favourable), Head and neck cancer:3.48e-4 (favourable) Expressed in all Mixed cerebral cortex: 7.7 ZNF776 FLJ38288 ENSG00000152443 Zinc finger protein 776 19 57746796-57758159 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA046653, HPA068553 Uncertain Approved Nucleus
Cytosol Cervical cancer:9.74e-4 (unfavourable) Expressed in all Mixed epididymis: 26.2 ZNF777 KIAA1285 ENSG00000196453 Zinc finger protein 777 7 149431363-149461123 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003252 Approved Approved Nucleus Expressed in all Expressed in all cerebral cortex: 10.4 ZNF778 FLJ31875 ENSG00000170100 Zinc finger protein 778 16 89217703-89237071 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA052057, HPA057151 Uncertain Supported Nucleus
Nuclear bodies Mixed Mixed parathyroid gland: 14.9 ZNF780A ZNF780 ENSG00000197782 Zinc finger protein 780A 19 40069152-40090938 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003311 Uncertain Approved Nucleus
Centrosome Urothelial cancer:9.30e-4 (favourable) Expressed in all Mixed parathyroid gland: 8.5 ZNF780B ZNF779 ENSG00000128000 Zinc finger protein 780B 19 40028260-40056209 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003311 Uncertain Approved Nucleus
Centrosome Expressed in all Mixed thyroid gland: 8.0 ZNF781 FLJ37549 ENSG00000196381 Zinc finger protein 781 19 37667751-37692322 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA062512 Uncertain Approved Nucleoplasm Mixed Mixed smooth muscle: 3.6 ZNF782 FLJ16636 ENSG00000196597 Zinc finger protein 782 9 96816472-96875623 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA011013 Approved Approved Nucleus
Mitochondria Expressed in all Mixed testis: 10.3 ZNF784 MGC75238 ENSG00000179922 Zinc finger protein 784 19 55620742-55624601 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA059676 Uncertain Approved Nucleus Urothelial cancer:1.02e-4 (favourable) Expressed in all Expressed in all skeletal muscle: 14.7 ZNF785 FLJ32130 ENSG00000197162 Zinc finger protein 785 16 30573740-30585771 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA030510 Approved Nucleoplasm
Plasma membrane Pancreatic cancer:2.03e-5 (favourable), Lung cancer:8.99e-4 (favourable) Expressed in all Expressed in all endometrium: 11.8 ZNF786 DKFZp762I137 ENSG00000197362 Zinc finger protein 786 7 149069643-149090782 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA021518, HPA053459 Uncertain Approved Nucleoplasm
Nuclear speckles Liver cancer:1.09e-4 (unfavourable), Pancreatic cancer:2.01e-4 (favourable) Expressed in all Mixed skin: 7.2 ZNF789 ENSG00000198556 Zinc finger protein 789 7 99472841-99503650 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA029500, HPA050793 Uncertain Validated Nucleoplasm Urothelial cancer:5.31e-6 (favourable), Renal cancer:3.56e-4 (unfavourable), Pancreatic cancer:7.14e-4 (favourable) Expressed in all Mixed prostate: 13.7 ZNF79 pT7 ENSG00000196152 Zinc finger protein 79 9 127424374-127445372 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA028977 Uncertain Approved Nucleoplasm
Plasma membrane
Cytosol Renal cancer:6.04e-7 (favourable), Pancreatic cancer:5.42e-5 (favourable), Endometrial cancer:6.83e-5 (favourable), Lung cancer:5.96e-4 (favourable) Expressed in all Mixed testis: 11.4 ZNF790 FLJ20350, MGC62100 ENSG00000197863 Zinc finger protein 790 19 36817428-36850787 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA056134, HPA060288 Uncertain Approved Nucleoli Endometrial cancer:7.66e-4 (unfavourable) Expressed in all Mixed testis: 21.0 ZNF791 FLJ90396 ENSG00000173875 Zinc finger protein 791 19 12610918-12633840 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA021537 Uncertain Approved Nucleus Urothelial cancer:1.39e-5 (favourable), Lung cancer:9.07e-4 (favourable) Expressed in all Expressed in all thyroid gland: 25.0 ZNF792 FLJ38451 ENSG00000180884 Zinc finger protein 792 19 34956354-34964049 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA035157, HPA035158 Supported Approved Nucleoplasm
Nuclear bodies Colorectal cancer:2.72e-4 (favourable) Expressed in all Mixed lung: 6.2 ZNF793 ENSG00000188227 Zinc finger protein 793 19 37506939-37548762 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA034781 Uncertain Approved Nucleus
Nucleoli
Cytosol Mixed Mixed testis: 16.8 ZNF799 HIT-40, MGC71805, ZNF842 ENSG00000196466 Zinc finger protein 799 19 12390016-12401271 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003150, HPA018683 Supported Uncertain Nucleoplasm
Microtubule organizing center Endometrial cancer:2.39e-4 (favourable) Mixed Mixed ovary: 7.6 ZNF8 HF.18, Zfp128 ENSG00000278129 Zinc finger protein 8 19 58278951-58302805 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA034797, HPA034798 Uncertain Approved Nucleoplasm
Nuclear bodies Mixed Mixed parathyroid gland: 4.7 ZNF80 pT17 ENSG00000174255 Zinc finger protein 80 3 114234631-114237578 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA065484 Uncertain Not detected Tissue enhanced breast: 6.4 lymph node: 2.7 ZNF800 ENSG00000048405 Zinc finger protein 800 7 127346790-127431924 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA023090, HPA052194 Approved Supported Nucleoli
Cytosol Expressed in all Expressed in all bone marrow: 48.0 ZNF805 ENSG00000204524 Zinc finger protein 805 19 57240685-57255135 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA057665, HPA058895 Uncertain Mixed Mixed parathyroid gland: 5.0 ZNF808 ENSG00000198482 Zinc finger protein 808 19 52527652-52564464 Predicted intracellular proteins, Transcription factors Evidence at protein level Urothelial cancer:3.88e-4 (favourable), Thyroid cancer:7.82e-4 (unfavourable) Expressed in all Mixed thyroid gland: 15.1 ZNF81 HFZ20, MRX45 ENSG00000197779 Zinc finger protein 81 X 47836902-48002561 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001689 Approved Mixed Mixed parathyroid gland: 9.9 ZNF812 ENSG00000224689 Zinc finger protein 812 19 9689924-9700817 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA055332 Uncertain Mixed Tissue enriched 8 esophagus: 24.0 urinary bladder: 3.1 ZNF813 FLJ16542 ENSG00000198346 Zinc finger protein 813 19 53467735-53496255 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA056406 Uncertain Approved Vesicles Expressed in all Mixed prostate: 8.8 ZNF814 ENSG00000204514 Zinc finger protein 814 19 57848731-57889074 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA043800, HPA053762, HPA072145 Approved Uncertain Nucleus Mixed Mixed thyroid gland: 18.5 ZNF816 ZNF816A ENSG00000180257 Zinc finger protein 816 19 52949379-52962911 Predicted intracellular proteins, Predicted membrane proteins, Transcription factors Evidence at protein level HPA042466 Uncertain Uncertain Nucleoli Expressed in all Mixed prostate: 20.4 ZNF823 HSZFP36 ENSG00000197933 Zinc finger protein 823 19 11721265-11739009 Predicted intracellular proteins, Transcription factors Evidence at transcript level Head and neck cancer:6.76e-5 (favourable), Renal cancer:4.49e-4 (favourable), Stomach cancer:5.05e-4 (favourable) Expressed in all Mixed parathyroid gland: 12.3 ZNF827 ENSG00000151612 Zinc finger protein 827 4 145757627-145938635 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA021166 Uncertain Approved Nucleoplasm Mixed Mixed prostate: 36.1 ZNF829 DKFZp779O175 ENSG00000185869 Zinc finger protein 829 19 36888124-36916291 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA073073 Approved Nucleus
Nuclear bodies Mixed Tissue enriched 5 testis: 18.3 ovary: 3.3 ZNF83 FLJ11015, HPF1, ZNF816B ENSG00000167766 Zinc finger protein 83 19 52594060-52690496 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA025970 Approved Approved Nucleoplasm Urothelial cancer:6.92e-6 (favourable), Renal cancer:3.13e-5 (unfavourable), Head and neck cancer:3.83e-4 (favourable), Ovarian cancer:9.06e-4 (favourable), Melanoma:9.20e-4 (unfavourable) Expressed in all Expressed in all epididymis: 110.8 ZNF835 BC37295_3 ENSG00000127903 Zinc finger protein 835 19 56661981-56671783 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA051136, HPA055356 Uncertain Approved Actin filaments Mixed Mixed ovary: 5.3 ZNF836 FLJ16287 ENSG00000196267 Zinc finger protein 836 19 52153864-52171643 Predicted intracellular proteins, Transcription factors Evidence at transcript level Renal cancer:3.77e-4 (favourable), Cervical cancer:5.11e-4 (favourable) Expressed in all Mixed adrenal gland: 34.9 ZNF837 ENSG00000152475 Zinc finger protein 837 19 58367618-58381060 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA042833 Uncertain Approved Nucleoli Renal cancer:1.76e-5 (favourable), Endometrial cancer:1.27e-4 (favourable) Expressed in all Mixed skin,spleen: 1.4 ZNF84 HPF2 ENSG00000198040 Zinc finger protein 84 12 133037292-133063304 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA028860 Approved Supported Nucleoplasm Liver cancer:1.59e-4 (unfavourable) Expressed in all Expressed in all thyroid gland: 32.9 ZNF841 LOC284371 ENSG00000197608 Zinc finger protein 841 19 52064466-52095765 Predicted intracellular proteins, Transcription factors Evidence at protein level Renal cancer:3.56e-6 (unfavourable), Urothelial cancer:8.92e-5 (favourable), Head and neck cancer:2.93e-4 (favourable) Expressed in all Mixed endometrium: 21.4 ZNF844 FLJ14959 ENSG00000223547 Zinc finger protein 844 19 12064699-12081565 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA046982 Uncertain Renal cancer:0.00e+0 (favourable) Expressed in all Mixed thyroid gland: 20.2 ZNF845 ENSG00000213799 Zinc finger protein 845 19 53333749-53354869 Predicted intracellular proteins, Transcription factors Evidence at protein level Renal cancer:3.98e-4 (favourable) Expressed in all Mixed thyroid gland: 8.2 ZNF846 ENSG00000196605 Zinc finger protein 846 19 9751993-9793180 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA034617, HPA034618 Approved Approved Actin filaments Head and neck cancer:5.25e-8 (favourable) Expressed in all Mixed seminal vesicle: 26.0 ZNF85 HPF4, HTF1 ENSG00000105750 Zinc finger protein 85 19 20923222-20950697 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA044760 Uncertain Supported Nucleus Ovarian cancer:6.45e-6 (favourable), Endometrial cancer:5.20e-5 (unfavourable) Mixed Tissue enhanced testis: 27.8 thyroid gland: 12.0 ZNF853 DKFZp434J1015 ENSG00000236609 Zinc finger protein 853 7 6615617-6624290 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA067690 Approved Approved Nucleoli Renal cancer:2.30e-6 (favourable) Mixed Mixed cerebral cortex: 17.4 ZNF860 ENSG00000197385 Zinc finger protein 860 3 31981771-31991628 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA063386 Uncertain Approved Nucleus
Nucleoli Mixed Mixed prostate: 4.5 ZNF878 ENSG00000257446 Zinc finger protein 878 19 12043805-12052939 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA052735 Uncertain Approved Nucleus
Nucleoli Tissue enriched Mixed testis: 1.4 ZNF879 DKFZp686E2433 ENSG00000234284 Zinc finger protein 879 5 179023752-179035064 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA068608 Uncertain Approved Nucleus Mixed Mixed testis: 11.2 ZNF880 ENSG00000221923 Zinc finger protein 880 19 52369917-52385795 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA077316 Approved Intermediate filaments Renal cancer:4.33e-8 (favourable) Expressed in all Expressed in all thyroid gland: 31.2 ZNF891 ENSG00000214029 Zinc finger protein 891 12 133106817-133130473 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA040301 Uncertain Mixed Mixed testis: 2.2 ZNF90 HTF9 ENSG00000213988 Zinc finger protein 90 19 20077994-20127076 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA003227 Uncertain Approved Nucleus
Golgi apparatus Tissue enhanced Tissue enhanced parathyroid gland: 8.5 thyroid gland: 3.6 ZNF91 HPF7, HTF10 ENSG00000167232 Zinc finger protein 91 19 23304991-23395560 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at transcript level Urothelial cancer:3.48e-4 (favourable), Renal cancer:7.58e-4 (favourable) Expressed in all Mixed thyroid gland: 17.5 ZNF92 HPF12, TF12 ENSG00000146757 Zinc finger protein 92 7 65373799-65401135 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA003173 Approved Nucleus Liver cancer:6.56e-4 (unfavourable) Expressed in all Mixed breast: 13.1 ZNF93 FLJ12488, HPF34, TF34, ZNF505 ENSG00000184635 Zinc finger protein 93 19 19900913-19935575 Predicted intracellular proteins, Transcription factors Evidence at protein level Ovarian cancer:9.31e-6 (favourable) Mixed Mixed thyroid gland: 14.2 ZNF98 F7175, ZNF739 ENSG00000197360 Zinc finger protein 98 19 22391019-22532485 Predicted intracellular proteins, Predicted secreted proteins, Transcription factors Evidence at transcript level Tissue enhanced Tissue enhanced ovary: 14.3;testis: 14.2 pancreas,thyroid gland: 7.8 ZNF99 C19orf9, MGC24986 ENSG00000213973 Zinc finger protein 99 19 22752183-22784107 Predicted intracellular proteins, Transcription factors Evidence at transcript level Tissue enriched Tissue enriched 7 testis: 3.0 cerebral cortex: 0.4 ZNFX1 FLJ11277, KIAA1404 ENSG00000124201 Zinc finger, NFX1-type containing 1 20 49237946-49278426 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA046629 Approved Approved Mitochondria Expressed in all Expressed in all lung: 27.1 ZSCAN1 FLJ33779, ZNF915 ENSG00000152467 Zinc finger and SCAN domain containing 1 19 58034032-58054631 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA007938 Uncertain Approved Nucleoli Ovarian cancer:7.36e-4 (favourable) Mixed Tissue enhanced epididymis: 7.6 cerebral cortex: 5.3 ZSCAN10 ZNF206 ENSG00000130182 Zinc finger and SCAN domain containing 10 16 3088890-3099317 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Tissue enriched Not detected skin: 0.6 ZSCAN12 dJ29K1.2, KIAA0426, ZFP96, ZNF29K1, ZNF305, ZNF96 ENSG00000158691 Zinc finger and SCAN domain containing 12 6 28378955-28399734 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA006637 Approved Approved Microtubules
Cytosol Expressed in all Mixed thyroid gland: 8.6 ZSCAN16 dJ265C24.3, FLJ22191, ZNF392, ZNF435 ENSG00000196812 Zinc finger and SCAN domain containing 16 6 28124560-28130082 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA007290 Supported Approved Nucleus Ovarian cancer:1.14e-5 (favourable), Urothelial cancer:3.41e-5 (favourable), Lung cancer:3.19e-4 (favourable), Cervical cancer:5.73e-4 (favourable) Expressed in all Mixed parathyroid gland: 12.7 ZSCAN2 FLJ20595, ZFP29, ZNF854 ENSG00000176371 Zinc finger and SCAN domain containing 2 15 84600986-84627796 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA007296, HPA024331 Supported Approved Nucleoplasm
Cytosol Urothelial cancer:4.16e-5 (favourable), Pancreatic cancer:3.52e-4 (favourable), Renal cancer:7.46e-4 (favourable) Expressed in all Expressed in all testis: 14.0 ZSCAN20 KOX29, ZNF31, ZNF360 ENSG00000121903 Zinc finger and SCAN domain containing 20 1 33472645-33496507 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA017933 Uncertain Approved Nucleoplasm Mixed Mixed parathyroid gland: 5.4 ZSCAN21 DKFZp434L134, NY-REN-21, Zipro1, ZNF38 ENSG00000166529 Zinc finger and SCAN domain containing 21 7 100049774-100065038 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA016948, HPA023591 Uncertain Approved Endoplasmic reticulum Thyroid cancer:4.71e-4 (unfavourable) Expressed in all Expressed in all testis: 20.5 ZSCAN22 HKR2, ZNF50 ENSG00000182318 Zinc finger and SCAN domain containing 22 19 58327019-58342332 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA006471 Uncertain Approved Plasma membrane
Actin filaments
Cytosol Expressed in all Mixed parathyroid gland: 3.6 ZSCAN23 dJ29K1.3.1, ZNF390, ZNF453 ENSG00000187987 Zinc finger and SCAN domain containing 23 6 28431930-28443502 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA035959, HPA035960 Uncertain Not detected Mixed parathyroid gland: 2.1 ZSCAN25 FLJ32468, ZNF498 ENSG00000197037 Zinc finger and SCAN domain containing 25 7 99616946-99632407 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA055127, HPA057173 Uncertain Approved Nucleus
Nucleoli fibrillar center Expressed in all Mixed parathyroid gland: 9.8 ZSCAN26 SRE-ZBP, ZNF187 ENSG00000197062 Zinc finger and SCAN domain containing 26 6 28267010-28278224 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA027521 Validated Nucleus
Nucleoli Renal cancer:6.79e-5 (unfavourable), Liver cancer:7.81e-5 (unfavourable), Urothelial cancer:1.68e-4 (favourable) Expressed in all Expressed in all ovary: 40.3 ZSCAN29 FLJ35867, Zfp690, ZNF690 ENSG00000140265 Zinc finger and SCAN domain containing 29 15 43358172-43371025 Predicted intracellular proteins, Predicted secreted proteins, Transcription factors Evidence at protein level HPA007241, HPA011109 Approved Approved Nucleoplasm
Plasma membrane
Actin filaments Expressed in all Expressed in all testis: 27.5 ZSCAN30 ZNF397OS, ZNF917 ENSG00000186814 Zinc finger and SCAN domain containing 30 18 35251058-35290245 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA007289 Approved Approved Nucleoplasm
Cytosol Expressed in all Expressed in all parathyroid gland: 27.1 ZSCAN31 ZNF310P, ZNF323 ENSG00000235109 Zinc finger and SCAN domain containing 31 6 28324693-28356271 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA007124 Approved Approved Nucleoplasm
Cytosol Renal cancer:2.19e-5 (favourable) Expressed in all Expressed in all testis: 40.7 ZSCAN32 FLJ20417, ZNF434 ENSG00000140987 Zinc finger and SCAN domain containing 32 16 3382081-3401065 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA005758 Uncertain Approved Nucleoplasm Mixed Expressed in all parathyroid gland: 14.4 ZSCAN4 FLJ35105, ZNF494 ENSG00000180532 Zinc finger and SCAN domain containing 4 19 57668935-57679152 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA006491 Uncertain Tissue enhanced Tissue enhanced stomach: 2.4 placenta: 1.2 ZSCAN5A MGC4161, ZNF495, ZSCAN5 ENSG00000131848 Zinc finger and SCAN domain containing 5A 19 56219670-56368383 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA041263, HPA043123, HPA046836, HPA060667 Uncertain Uncertain Nuclear speckles Mixed Tissue enhanced testis: 34.3 fallopian tube: 11.3 ZSCAN5B ZNF371, ZNF495B ENSG00000197213 Zinc finger and SCAN domain containing 5B 19 56189570-56197920 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA043123, HPA046836, HPA059494, HPA060667 Uncertain Uncertain Nuclear speckles Not detected Tissue enriched 22 testis: 2.7 fallopian tube: 0.1 ZSCAN5CP ZNF495C, ZSCAN5C ENSG00000204532 Zinc finger and SCAN domain containing 5C, pseudogene 19 56202301-56209452 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA041263, HPA043123, HPA046836, HPA060667 Uncertain Uncertain Nuclear speckles Not detected Not detected testis: 0.1 ZSCAN9 PRD51, ZNF193 ENSG00000137185 Zinc finger and SCAN domain containing 9 6 28224886-28233482 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA054512, HPA059951 Uncertain Approved Nucleoplasm Renal cancer:1.21e-6 (unfavourable), Urothelial cancer:1.16e-5 (favourable), Liver cancer:3.49e-4 (unfavourable) Expressed in all Expressed in all testis: 34.7 ZXDA ZNF896 ENSG00000198205 Zinc finger, X-linked, duplicated A X 57906708-57910820 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA043789 Approved Approved Nucleoplasm Renal cancer:8.55e-4 (favourable) Mixed Mixed ovary: 5.3 ZXDB ZNF905 ENSG00000198455 Zinc finger, X-linked, duplicated B X 57591652-57597545 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA043789 Approved Approved Nucleoplasm Expressed in all Expressed in all parathyroid gland: 9.9 ZXDC FLJ13861, MGC11349 ENSG00000070476 ZXD family zinc finger C 3 126437601-126475919 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA049593 Supported Nucleoli
Vesicles Liver cancer:2.27e-4 (unfavourable) Expressed in all Expressed in all bone marrow: 25.5